
<html lang="en"     class="pb-page"  data-request-id="bac7601b-103f-47d6-b075-efb74ce6594a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2021.64.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c02239"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Nimbolide, a Neem Limonoid, Is a Promising Candidate for the Anticancer Drug Arsenal" /></meta><meta name="dc.Creator" content="Siddavaram  Nagini" /></meta><meta name="dc.Creator" content="Ramesh  Nivetha" /></meta><meta name="dc.Creator" content="Manikandan  Palrasu" /></meta><meta name="dc.Creator" content="Rajakishore  Mishra" /></meta><meta name="dc.Description" content="Nimbolide, a major limonoid constituent of Azadirachta indica, commonly known as neem, has attracted increasing research attention owing to its wide spectrum of pharmacological properties, predomin..." /></meta><meta name="Description" content="Nimbolide, a major limonoid constituent of Azadirachta indica, commonly known as neem, has attracted increasing research attention owing to its wide spectrum of pharmacological properties, predomin..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 19, 2021" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c02239" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02239" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c02239" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02239" /></link>
        
    
    

<title>Nimbolide, a Neem Limonoid, Is a Promising Candidate for the Anticancer Drug Arsenal | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c02239" /></meta><meta property="og:title" content="Nimbolide, a Neem Limonoid, Is a Promising Candidate for the Anticancer Drug Arsenal" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/large/jm0c02239_0004.jpeg" /></meta><meta property="og:description" content="Nimbolide, a major limonoid constituent of Azadirachta indica, commonly known as neem, has attracted increasing research attention owing to its wide spectrum of pharmacological properties, predominantly anticancer activity. Nimbolide is reported to exert potent antiproliferative effects on a myriad cancer cell lines and chemotherapeutic efficacy in preclinical animal tumor models. The potentiality of nimbolide to circumvent multidrug resistance and aid in targeted protein degradation broaden its utility in enhancing therapeutic modalities and outcome. Accumulating evidence indicates that nimbolide prevents the acquisition of cancer hallmarks such as sustained proliferation, apoptosis evasion, invasion, angiogenesis, metastasis, and inflammation by modulating kinase-driven oncogenic signaling networks. Nimbolide has been demonstrated to abrogate aberrant activation of cellular signaling by influencing the subcellular localization of transcription factors and phosphorylation of kinases in addition to influencing the epigenome. Nimbolide, with its ever-expanding repertoire of molecular targets, is a valuable addition to the anticancer drug arsenal." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c02239"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02239">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c02239&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c02239&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c02239&amp;href=/doi/10.1021/acs.jmedchem.0c02239" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3560-3577</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01930" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.1c00125" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Nimbolide, a Neem Limonoid, Is a Promising Candidate for the Anticancer Drug Arsenal</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Siddavaram Nagini</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Siddavaram Nagini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry & Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamil Nadu 608002, India</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#0675686a6764677346616b676f6a2865696b"><span class="__cf_email__" data-cfemail="01726f6d6063607441666c60686d2f626e6c">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Siddavaram++Nagini">Siddavaram Nagini</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8889-6013" title="Orcid link">http://orcid.org/0000-0001-8889-6013</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Ramesh Nivetha</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ramesh Nivetha</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry & Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamil Nadu 608002, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ramesh++Nivetha">Ramesh Nivetha</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Manikandan Palrasu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manikandan Palrasu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Surgery, University of Miami Miller School of Medicine, Rosenstiel Medical Sciences Building, Suite 4116, 1600 NW 10th Avenue, Miami, Florida 33136, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manikandan++Palrasu">Manikandan Palrasu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Rajakishore Mishra</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rajakishore Mishra</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Life Sciences, School of Natural Sciences, Central University of Jharkhand, Ratu-Lohardaga Road, Brambe, Ranchi, Jharkhand 835205, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rajakishore++Mishra">Rajakishore Mishra</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02239&amp;href=/doi/10.1021%2Facs.jmedchem.0c02239" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3560â3577</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 19, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 December 2020</li><li><span class="item_label"><b>Published</b> online</span>19 March 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 April 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c02239" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02239</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3560%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSiddavaram%2BNagini%252C%2BRamesh%2BNivetha%252C%2BManikandan%2BPalrasu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D7%26contentID%3Dacs.jmedchem.0c02239%26title%3DNimbolide%252C%2Ba%2BNeem%2BLimonoid%252C%2BIs%2Ba%2BPromising%2BCandidate%2Bfor%2Bthe%2BAnticancer%2BDrug%2BArsenal%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3577%26publicationDate%3DApril%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c02239"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">951</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c02239" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Nimbolide, a Neem Limonoid, Is a Promising Candidate for the Anticancer Drug Arsenal&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Siddavaram&quot;,&quot;last_name&quot;:&quot;Nagini&quot;},{&quot;first_name&quot;:&quot;Ramesh&quot;,&quot;last_name&quot;:&quot;Nivetha&quot;},{&quot;first_name&quot;:&quot;Manikandan&quot;,&quot;last_name&quot;:&quot;Palrasu&quot;},{&quot;first_name&quot;:&quot;Rajakishore&quot;,&quot;last_name&quot;:&quot;Mishra&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;3560-3577&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c02239&quot;},&quot;abstract&quot;:&quot;Nimbolide, a major limonoid constituent of Azadirachta indica, commonly known as neem, has attracted increasing research attention owing to its wide spectrum of pharmacological properties, predominantly anticancer activity. Nimbolide is reported to exert potent antiproliferative effects on a myriad cancer cell lines and chemotherapeutic efficacy in preclinical animal tumor models. The potentiality of nimbolide to circumvent multidrug resistance and aid in targeted protein degradation broaden its utility in enhancing therapeutic modalities and outcome. Accumulating evidence indicates that nimbolide prevents the acquisition of cancer hallmarks such as sustained proliferation, apoptosis evasion, invasion, angiogenesis, metastasis, and inflammation by modulating kinase-driven oncogenic signaling networks. Nimbolide has been demonstrated to abrogate aberrant activation of cellular signaling by influencing the subcellular localization of transcription factors and phosphorylation of kinases in addition to influencin&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02239&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02239" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02239&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02239" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02239&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02239" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02239&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02239&amp;href=/doi/10.1021/acs.jmedchem.0c02239" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c02239" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c02239" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c02239%26sid%3Dliteratum%253Aachs%26pmid%3D33739088%26genre%3Darticle%26aulast%3DNagini%26date%3D2021%26atitle%3DNimbolide%252C%2Ba%2BNeem%2BLimonoid%252C%2BIs%2Ba%2BPromising%2BCandidate%2Bfor%2Bthe%2BAnticancer%2BDrug%2BArsenal%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D7%26spage%3D3560%26epage%3D3577%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291297" title="Cell signaling">Cell signaling</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/jmcmar.2021.64.issue-7/20210408/jmcmar.2021.64.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/medium/jm0c02239_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/large/jm0c02239_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02239&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Nimbolide, a major limonoid constituent of <i>Azadirachta indica</i>, commonly known as neem, has attracted increasing research attention owing to its wide spectrum of pharmacological properties, predominantly anticancer activity. Nimbolide is reported to exert potent antiproliferative effects on a myriad cancer cell lines and chemotherapeutic efficacy in preclinical animal tumor models. The potentiality of nimbolide to circumvent multidrug resistance and aid in targeted protein degradation broaden its utility in enhancing therapeutic modalities and outcome. Accumulating evidence indicates that nimbolide prevents the acquisition of cancer hallmarks such as sustained proliferation, apoptosis evasion, invasion, angiogenesis, metastasis, and inflammation by modulating kinase-driven oncogenic signaling networks. Nimbolide has been demonstrated to abrogate aberrant activation of cellular signaling by influencing the subcellular localization of transcription factors and phosphorylation of kinases in addition to influencing the epigenome. Nimbolide, with its ever-expanding repertoire of molecular targets, is a valuable addition to the anticancer drug arsenal.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer is the second most common cause of death worldwide and a major public health issue. Despite recent advances in treatment options, the morbidity and mortality due to cancer continue to increase.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Furthermore, toxicity and adverse side effects of chemotherapeutic agents as well as drug resistance pose serious challenges to oncologists. Recent research efforts on cancer drug discovery have therefore focused on natural products that exhibit high therapeutic efficacy with low toxicity and minimal side effects. A large number of phytochemicals from medicinal plants have emerged as promising anticancer drug candidates, and some of them have entered clinical trials.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Of late, limonoids from the neem tree have received increasing research attention for their potent antiproliferative effects.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a></div><div class="NLM_p">Neem (<i>Azadirachta indica</i> A. Juss) is an evergreen tree of the Meliaceae family, ubiquitously found in the Indian subcontinent and widely distributed in Asia, Africa, and America. Neem has gained enormous importance for its applications in the agricultural and pharmaceutical industry, as well as for its well-established ethnomedicinal value.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5â7)</a> Neem has been used as a food and folklore medicine to treat a variety of human ailments and has won epithets such as âheal allâ, âdivine treeâ, âvillage dispensaryâ, ânatureâs drug storeâ, and âtree of the 21<sup>st</sup> centuryâ. All parts of the neem tree have been documented to display a wide range of pharmacological properties including antiseptic, antiparasitic, analgesic, antimicrobial, antiulcer, hepatoprotective, antihyperglycaemic, orodental protection, anti-inflammatory, immunomodulatory, and anticancer effects. The antiproliferative effects of neem extracts and constituents have been extensively documented in a wide array of cancer cell lines <i>in vitro</i> and in preclinical animal tumor models <i>in vivo</i>. Neem is recognized to inhibit the development and progression of cancer by multiple mechanisms ranging from prevention of procarcinogen activation and oxidative DNA damage, upregulation of antioxidant and carcinogen detoxification systems, inhibition of tumor cell proliferation, invasion, and angiogenesis, and induction of apoptosis.<a onclick="showRef(event, 'ref5 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref8">(5,8)</a></div><div class="NLM_p last">The medicinal properties of neem have been attributed to the rich array of over 400 structurally diverse and chemically complex bioactive compounds, one-third of which are tetranortriterpenoids or limonoids.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> The major limonoids present in the neem tree include azadirachtin, azadiradione, epoxyazadiradione, gedunin, 6-desacetyl nimbinene, nimbidin, nimbin, nimolinone, and nimbolide. Nimbolide was found to be the major contributor to the antiproliferative effects of neem.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In this review, we provide an overview of the pharmacological properties of nimbolide with particular emphasis on the anticancer effects. We summarize the evidence for the modulatory effects of nimbolide on the acquisition of cancer hallmarks, oncogenic signaling pathways, and epigenetic modifications. Finally, we analyze the efficacy of nimbolide as a chemosensitizer and examine its pharmacokinetic and toxicity profile.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Nimbolide Structural Features</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78355" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78355" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nimbolide is a tetranortriterpenoid limonoid (mol formula C<sub>27</sub>H<sub>30</sub>O<sub>7</sub>), abundantly present in the leaves and flowers of the neem tree. Chemically, nimbolide is (4a,5a,6a,7a,15b,17a)-7,15:21,23-diepoxy-6-hydroxy-4,8-dimethyl-1-oxo-18,24-dinor-11,12-secochola-2,13,20,22-tetraene-4,11-dicarboxylic acid Î³-lactone methyl ester. Nimbolide contains a decalin skeleton and is a member of the tetranortriterpenoids known as C-secomeliacins. Two important structural features, the Î±,Î²-unsaturated ketone structural element and the Î³-lactone moiety, are believed to be responsible for the anticancer activity of nimbolide.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The 2D and 3D structures of nimbolide are shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. The amide derivatives of nimbolide have been demonstrated to display greater cytotoxicity against various cancer cell lines compared to the parent compound.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/medium/jm0c02239_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/large/jm0c02239_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Two-dimensional (A) and three-dimensional structure of nimbolide (IUPAC name: methyl 2-[(1<i>R</i>,2<i>S</i>,4<i>R</i>,9<i>R</i>,11<i>R</i>,15<i>R</i>,18<i>R</i>)-6-(furan-3-yl)-7,9,11,15-tetramethyl-12,16-dioxo 3,17dioxapentacyclo [9.6.1.0<sup>2,9</sup>.0<sup>4,8</sup>.0<sup>15,18</sup>] octadeca-7,13-dien-10-yl]acetate). (PubChem CID: 138115244. Molecular Formula: C<sub>27</sub>H<sub>30</sub>O<sub>7</sub>. Molecular Weight: 466.5 g/mol.)</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/large/jm0c02239_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02239&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3.  Pharmacological Properties of Nimbolide</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16423" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16423" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A growing body of evidence indicates that nimbolide exhibits a wide spectrum of pharmacological effects including antimalarial, antimicrobial, antifibrotic, anti-inflammatory, antioxidant, hepatoprotective, cardioprotective, and anticancer activities.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">3.1.  Antiparasitic and Antimicrobial Activities</h3><div class="NLM_p">The antimalarial activity of aqueous and ethanolic extracts of neem was attributed to the presence of nimbolide. Nimbolide was also shown to inhibit <i>Plasmodium falciparum</i> in culture with moderate potency.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Derivatives of nimbolide exhibited potent antitrypanosomal activity against <i>Trypanosomiasis brucei rhodesiense</i>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p last">Nimbolide exerts antibacterial effects against <i>Staphylococcus aureus</i> and <i>Staphylococcus coagulase</i>. A study by Sarkar et al.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> revealed the potential of nimbolide in the treatment of infections caused by multidrug-and meticillin-resistant strains of <i>Staphylococcus aureus</i> (MDR MRSA) implicated in nosocomial- and community-acquired infectious diseases. Nimbolide exerted its antibacterial effects by inducing membrane damage and lysis of <i>S. aureus</i> cells, disruption of biofilm structure and formation, and by reducing the viability of <i>S. aureus</i> in a manner similar to tetracycline and nalidixic acid. Molecular docking studies revealed inhibitory effects of nimbolide against New Delhi metallo-Î²-lactamase-1 (NDM-1), an enzyme produced by Gram-negative bacteria that hydrolyses Î²-lactam antibiotics. These findings suggest that nimbolide can be developed as a drug candidate against bacterial infections as well as bacterial resistance to antibiotics.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Using computational approaches, Vora et al.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> suggested that nimbolide is a promising target-specific drug candidate for human immunodeficiency virus (HIV).</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">3.2.  Antifibrotic and Anti-inflammatory Effects</h3><div class="NLM_p">Several studies have demonstrated the antifibrotic and anti-inflammatory potential of nimbolide. In a murine model of bleomycin-induced scleroderma, nimbolide administration induced regression of inflammation-driven fibrosis by abrogating the transforming growth factor-Î² (TGF-Î²)/Smad signaling axis and epithelial-to-mesenchymal transition (EMT), two major factors implicated in scleroderma. Furthermore, nimbolide reduced the levels of the collagen cross-linker, lysyl oxidase like-2 as well as extracellular matrix (ECM) deposition.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Nimbolide was demonstrated to regulate autophagy signaling in pulmonary fibrosis induced by TGF-Î²1 <i>in vitro</i> and bleomycin <i>in vivo</i>. The mechanism involved the downregulation of mesenchymal and fibrotic markers with increased expression of epithelial markers. Nimbolide regulated autophagy by reducing the expression of LC-3 (microtubule-associated protein 1A/1B-light chain 3) and p62 and enhancing Beclin 1 expression.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Annaldas et al.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> provided evidence for the antifibrotic activity of nimbolide in a mouse model of renal fibrosis induced by unilateral ureteral obstruction. Nimbolide prevented renal fibrogenesis and inflammation by reducing collagen deposition, oxidative stress, and the expression of TGF-Î²/p-Smad and ECM proteins.</div><div class="NLM_p">Nimbolide significantly suppressed the expression of the inflammatory cytokines, interleukins IL-6, IL-8, IL-12, and tumor necrosis factor-Î± (TNF-Î±) and inhibited nuclear factor-ÎºB (NF-ÎºB) signaling in IEC COLO 205 intestinal epithelial cells and in the murine macrophage cell line RAW 264.7 as well as in peritoneal macrophages from interleukin-10-deficient (IL-10<sup>â/â</sup>) mice stimulated with TNF-Î± or lipopolysaccharide (LPS). Additionally, nimbolide alleviated colitis in dextran sulfate sodium-induced acute and chronic colitis in IL-10<sup>â/â</sup> mice <i>in vivo</i> as reflected by disease activity, histopathologic scores, and abrogation of NF-ÎºB signaling.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Nimbolide exerted protective effects against cerulein-induced chronic pancreatitis in mice by significantly decreasing Î±-smooth muscle actin (Î±-SMA), matrix metalloproteinase-2 (MMP-2), collagen1a, and fibronectin via downregulation of Î²-catenin/TGF-Î²1/Smad signaling in a sirtuin1 (SIRT1) dependent manner.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Oral administration of nimbolide to arthritis-induced rats significantly reduced rheumatoid arthritic score, paw volume, edema formation, and proinflammatory cytokines.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p last">Pooladanda et al.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> investigated the protective effects of nimbolide in mitigating the complications associated with acute respiratory distress syndrome (ARDS) induced by bacterial LPS in RAW 264.7, THP-1, MLE-12, A549, and BEAS-2B cells <i>in vitro</i> and in C57BL/6 mice <i>in vivo</i>. Nimbolide significantly inhibited nitrosative-oxidative stress, as well as the expression of inflammatory cytokines, and chemokines. Nimbolide also suppressed the migration of neutrophils and mast cells, normalized LPS-induced hypothermia, and enhanced antioxidant defenses. Furthermore, nimbolide ameliorated TNF-Î±-regulated NF-ÎºB and histone deacetylase-3 (HDAC-3) crosstalk by preventing the nuclear translocation of NF-ÎºB and HDAC-3. These findings emphasize the potential use of nimbolide in the treatment of fibrosis and inflammatory diseases, besides underscoring its impact on cancer-related inflammation.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.3.  Cardioprotective and Hepatoprotective Effects</h3><div class="NLM_p last">Recently, Li et al.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> showed that nimbolide supplementation prevented doxorubicin-induced myocardial damage by modulating cardiac markers, ameliorating oxidative stress by enhancing antioxidants, and by suppressing apoptosis and inflammation. Nimbolide was reported to significantly lower the levels of cholesterol, free fatty acids and triglycerides, as well as lipid deposition-induced changes in primary hepatocytes. Additionally, nimbolide also improved hepatocyte function by multiple mechanisms including inhibition of reactive oxygen species (ROS)-induced oxidative DNA damage and lipid peroxidation, enhancement of antioxidant defenses, and by regulating the expression of liver X receptor-Î± (LXRÎ±), peroxisome proliferator-activated receptor-Î³ (PPAR-Î³), and sterol regulatory element-binding protein-1c (SREBP1c).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.4.  Detoxifying, Antioxidant, and Antigenotoxic Effects</h3><div class="NLM_p">Xenobiotics such as drugs, toxins, and carcinogens are effectively detoxified/metabolized by phase I, II, and III xenobiotic-metabolizing enzymes. Phase I reactions catalyzed by cytochrome P450 (CYP) monooxygenases involve the biotransformation of xenobiotics into more polar intermediates, which are then conjugated by the phase II enzymes such as glutathione S-transferase (GST), and finally excreted with the help of phase III transporters.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Nimbolide protects against the deleterious effects of carcinogens by repressing the phase I carcinogen activation enzyme CYP as well as its isoforms CYP1A1 1A2, 2B and CYP1B1, and cytochrome b5, while simultaneously enhancing the activities of the phase II detoxification enzymes- GST and DT diaphorase (NAD(P)H:quinone oxidoreductase).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Nimbolide fractionated from neem flowers was shown to enhance the activity of the detoxifying enzyme quinone reductase in mouse hepatoma Hepa 1c1c7 cells.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p last">Nimbolide displayed concentration-dependent radical scavenging activity on a panel of <i>in vitro</i> assays and was found to be a more potent antioxidant than ascorbic acid. Administration of nimbolide enhanced the activities of superoxide dismutase, catalase, and glutathione-dependent enzymes in the hamster buccal pouch (HBP) model of oral cancer.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Neem leaf fractions containing nimbolide as a primary constituent were found to exert protective effects against H<sub>2</sub>O<sub>2</sub>-induced oxidative damage to pBR322 DNA and erythrocytes.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Nimbolide administration ameliorated oxidative stress, chromosomal aberrations, and formation of micronucleated polychromatic erythrocytes (MnPCEs) induced by the chemotherapeutic drug hydroxyurea in Wistar rats.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">3.5.  Antiproliferative Effects</h3><div class="NLM_p">The antiproliferative effects of nimbolide have been extensively documented in a myriad of cancer cell lines. These include bladder cancer,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> breast cancer,<a onclick="showRef(event, 'ref32 ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35 ref36">(32â36)</a> cervical cancer,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> choriocarcinoma,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> colorectal cancer,<a onclick="showRef(event, 'ref39 ref40 ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42 ref43 ref44">(39â44)</a> glioblastoma,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> hematological malignancies,<a onclick="showRef(event, 'ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48 ref49">(46â49)</a> hepatocellular carcinoma,<a onclick="showRef(event, 'ref28 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref28 ref50 ref51">(28,50,51)</a> lung cancer,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> nasopharyngeal cancer,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> oral squamous cell carcinoma (OSCC),<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> osteosarcoma,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> pancreatic cancer,<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> prostate cancer,<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> and renal cell carcinoma.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Nimbolide was found to be effective both as a single agent as well as in combination with other anticancer agents such as 5-fluorouracil. Several studies have demonstrated the chemotherapeutic effects of nimbolide in preclinical carcinogen-induced animal tumor models<a onclick="showRef(event, 'ref27 ref62'); return false;" href="javascript:void(0);" class="ref ref27 ref62">(27,62)</a> as well as in tumor-xenografted<a onclick="showRef(event, 'ref41 ref45 ref48 ref51 ref54 ref57'); return false;" href="javascript:void(0);" class="ref ref41 ref45 ref48 ref51 ref54 ref57">(41,45,48,51,54,57)</a> and transgenic<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> mouse models. In the 7,12-dimethylbenz[<i>a</i>]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis model, nimbolide exhibited both chemopreventive and chemotherapeutic effects. In fact, nimbolide exerted significant chemotherapeutic efficacy at concentrations (100 Î¼g/kg bw) five times lower than that used for the reference compound wortmannin.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Nimbolide also induced significant tumor regression in the tumor xenografted and transgenic mouse models.</div><div class="NLM_p">Collectively, these results underscore the protective effects of nimbolide against various disorders. However, more detailed studies on the potential applications of nimbolide as an antimicrobial agent both alone and in combination, the reversal of antibiotic resistance, as well as mechanistic insights on the mode of action, and translational relevance, need to be evaluated. The antifibrotic and anti-inflammatory effects of nimbolide can spur investigations on its efficacy on premalignant conditions such as oral submucous fibrosis and the impact on cancer-related inflammation. The antiproliferative effects of nimbolide may be ascribed to its antioxidant, antigenotoxic, and detoxification activities. The protective effects of nimbolide against different classes of reactive oxygen and nitrogen species and carcinogens as well as its ability to modulate the complex signaling networks orchestrating the DNA damage response (DDR) remain to be elucidated.</div><div class="NLM_p last">The molecular mechanisms of the anticancer effects of nimbolide are discussed in detail in the subsequent sections.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">4.  Nimbolide Prevents the Acquisition of Cancer Hallmarks</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04150" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04150" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The development and progression of a malignant tumor involve the acquisition of ten essential attributes, collectively referred to as the hallmarks of cancer. These include sustaining proliferative signaling, insensitivity to growth suppressors, resisting cell death, enabling replicative immortality, evading immune surveillance, inducing angiogenesis, activating tissue invasion and metastasis, reprogramming of energy metabolism, genome instability, and inflammation.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Several studies have unraveled the inhibitory influence of nimbolide on the acquisition of cancer hallmarks that are described below and illustrated in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/medium/jm0c02239_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/large/jm0c02239_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Nimbolide prevents the acquisition of hallmark capabilities of cancer. Nimbolide inhibits cell proliferation, inflammation, EMT, invasion, migration, angiogenesis, and metastasis and induces apoptosis in cancer cells <i>in vitro</i> and <i>in vivo</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/large/jm0c02239_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02239&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">4.1.  Nimbolide Halts Cell Cycle Progression and Restrains Cell Proliferation</h3><div class="NLM_p">Dysregulation of the cell cycle with consequent uncontrolled cell proliferation is a defining feature of cancer cells. This is characterized by altered expression as well as phosphorylation of the cell cycle regulators, cyclins, cyclin-dependent kinases (CDKs), proliferating cell nuclear antigen (PCNA), retinoblastoma protein (Rb), p53, and p21.</div><div class="NLM_p">Nimbolide inhibited the growth of a panel of cancer cell lines in a concentration- and time-dependent manner by modulating the expression of cell cycle regulatory proteins and arresting the cell cycle. Roy et al.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> demonstrated that nimbolide suppressed the growth of HT-29 colon cancer cells by inducing cell cycle arrest at the G2/M and G0/G1 phases. Further, nimbolide-induced cell cycle arrest at G<sub>2</sub>/M phase was accompanied by upregulation of p21, cyclin D2, and Chk-2 with downregulation of cyclin-A, cyclin- E, cdk-2, and Rad-17. In a follow-up of this study, Roy et al.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> reported growth inhibitory effects of nimbolide on U937 lymphoma, HL-60 leukemia, THP1 leukemia monocytic, and B16 melanoma cell lines. U937 cells treated with nimbolide showed cell cycle disruption initially in S and G2/M phases and subsequently in G0/G1 phase. Exposure of cells to higher concentrations of nimbolide for a longer duration induced DNA damage with an increase in sub-G1 fraction accompanied by a decrease in the number of cells in all other phases of the cell cycle.</div><div class="NLM_p">Nimbolide was shown to suppress the growth of glioblastoma multiforme (GBM) cells by inhibiting CDK4/6 activity, with consequent hypophosphorylation of Rb and cell cycle arrest at the G1/S phase.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Nimbolide was reported to interfere with cell cycle kinetics in WiDr and HCT-116 colon cancer cells by repressing cyclin A/cyclin D1 leading to S phase arrest.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Flow cytometric analysis revealed that exposure of renal carcinoma cells to nimbolide induced G2/M phase arrest with increased expression of p53, cdc2, cdc25c and decreased the expression of cyclin A and cyclin B.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Treatment with nimbolide inhibited the proliferation of EJ and 5637 bladder cancer cells by inducing G2/M phase arrest through both Chk2-Cdc25C-Cdc2/cyclin B1-Wee1 and Chk2-p21WAF1-Cdc2/cyclin B1-Wee1 pathways.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p last">In BeWo choriocarcinoma cells, the cytotoxic effect of nimbolide was observed within 7 h of incubation accompanied by downregulation of PCNA, a cofactor for DNA polymerase that plays a pivotal role in the cell cycle.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Nimbolide suppressed the viability of the human cervical cancer HeLa cells and induced cell cycle arrest at G0/G1 phase associated with p53-dependent accumulation of p21 Cip1/waf1 and downregulation of cyclin B, cyclin D1, and PCNA.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In SCC131 and SCC4 oral cancer cells, nimbolide attenuated cell proliferation by increasing the expression of p21 with simultaneous downregulation of cyclin D1 resulting in accumulation of cells in subG0/G1. Notably, nimbolide stimulated glycogen synthase kinase-3Î² (GSK-3Î²)-mediated phosphorylation of cyclin D1 at Thr286 with consequent relocalization of cyclin D1 from the nucleus to the cytosol and subsequent degradation. Thus, nimbolide blocks cell cycle progression and drives cancer cells to apoptotic cell death.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Spradlin et al.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> demonstrated that nimbolide targets the N-terminal cysteine-8 (C8) of the E3 ubiquitin ligase RNF114 leading to impaired ubiquitination of RNF114 substrates such as p21 and p57, resulting in their accumulation with consequent inhibition of breast cancer cell proliferation.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">4.2.  Nimbolide Induces Cell Death by Apoptosis</h3><div class="NLM_p">One of the major hallmarks of cancer is the ability to resist the death of cells that have undergone DNA damage. Accumulating evidence indicates that apoptosis evasion by malignant tumors enables tumor progression besides blunting therapeutic response. Reinstating apoptosis in tumor cells is a promising approach for cancer prevention and therapeutics.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> An overwhelming body of evidence indicates that nimbolide exerts its antiproliferative effects by inducing apoptosis. The mechanism of apoptosis induction by nimbolide has been reviewed by us earlier.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Here, we summarize the literature on the effect of nimbolide on apoptosis pathways as well as the crosstalk between apoptosis and autophagy.</div><div class="NLM_p">Exposure of cancer cells to nimbolide induced stereotypical changes characteristic of apoptosis including alterations in nuclear morphology such as fragmentation and condensation, DNA fragmentation, subdiploid G1 peak, and annexin-V staining. Several studies by us and others have revealed that nimbolide transduces apoptosis via both the extrinsic (death receptor) and intrinsic (mitochondrial) pathways. Nimbolide also facilitates crosstalk between the two pathways of apoptosis by stimulating procaspase-8-catalyzed cleavage of BH3 interacting-domain death agonist (BID). The major mechanisms by which nimbolide induces apoptosis include some or a combination of the following: upregulation of death receptors, a shift in the expression of BCL2 family members to a proapoptotic phenotype, increased expression of p53, and downregulation of inhibitors of apoptosis (IAP) proteins, eventually culminating in the activation of caspases.<a onclick="showRef(event, 'ref66 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref66 ref67 ref68">(66â68)</a></div><div class="NLM_p">Nimbolide-induced mitochondria-mediated apoptotic cell death has attracted the major focus of research attention. Nimbolide has been demonstrated to induce the generation of ROS with consequent mitochondrial outer membrane permeabilization (MOMP), associated with increased expression of Opa-1, a dynamin-related mitochondrial protein involved in cristae remodeling and release of apoptogenic molecules such as cytochrome c and second mitochondria-derived activator of caspase (SMAC)/direct IAP binding protein with low pI (DIABLO) from the mitochondria into the cytosol resulting in activation of the caspase cascade and cleavage of poly(ADP ribose) polymerase (PARP).<a onclick="showRef(event, 'ref37 ref38 ref57 ref62'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref57 ref62">(37,38,57,62)</a> Kumar et al.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> provided evidence to show that nimbolide induced mitochondrial dysfunction, caspase activation, and apoptosis of pancreatic cancer cells with greater efficacy than the chemotherapeutic agents, gemcitabine and sorafenib. Nimbolide also reduced mutant p53 and enhanced mitochondrial ROS. In human Huh-7 and PLC/PRF/5 hepatocellular carcinoma cells, nimbolide induced mitochondrial dysfunction with downregulation of MCL-1 and BCL-2 and increased expression of BAX and activation of caspases.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> In osteosarcoma cells, nimbolide induced apoptosis by multiple mechanisms including increased ROS generation, mitochondrial dysfunction, endoplasmic reticulum stress, and caspase activation.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div class="NLM_p">Nimbolide has been reported to induce apoptosis in both T- and B-cell lymphomas. Recently, Jaiswara et al.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> demonstrated that nimbolide induced apoptosis of Daltonâs, HuT-78, and J6 lymphoma cells by enhancing ROS, p53, and Bax with cleavage of caspase-3. Interestingly, apoptosis induction by nimbolide was associated with the reversal of dysregulated cellular metabolism as revealed by downregulation of hypoxia-inducible factor-1Î±, glucose transporter-3, hexokinase II, and pyruvate dehydrogenase kinase-1, with consequent suppression of glycolysis and activation of oxidative phosphorylation. Nimbolide promotes apoptosis in B-cell cancer models such as multiple myeloma and non-Hodgkin lymphoma. WaldenstrÃ¶ms macroglobulinemia (WM), an indolent, non-Hodgkin B-cell lymphoma, was found to be highly sensitive to the cytotoxicity of nimbolide. WM cells including those that are drug-resistant (bortezomib or ibrutinib) undergo mitochondria-mediated apoptosis when exposed to nimbolide. Using cheminformatics-based approaches, BCL2 was identified as the preferential binding partner of nimbolide. This was validated <i>in vitro</i> wherein nimbolide-induced apoptosis in BCL2-dependent RS4;11 tumor cells was significantly higher than in BCL2 mutated Jurkat BCL2(Ser70-Ala) cells as well as <i>in vivo</i> in WM tumor xenografted mice.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">Nimbolide is believed to potentiate apoptosis by inhibiting the IAPs, IAP-1, IAP-2, neuronal apoptosis inhibitory protein (NAIP), I-FLICE, XIAP, and survivin in a wide variety of cancer cell lines by releasing the potent IAP inhibitors cytochrome c and SMAC/DIABLO into the cytosol. In addition, nimbolide also induced trafficking of survivin from the cytosol where it exerts IAP function, to the nucleus where it favors apoptosis by activation of proapoptotic BAX and p53.<a onclick="showRef(event, 'ref62 ref66'); return false;" href="javascript:void(0);" class="ref ref62 ref66">(62,66)</a> Using apoptosis antibody array, the IAP family proteins XIAP, c-IAP1, and c-IAP2, which are potent inhibitors of caspases as well as SMAC/DIABLO, were identified as the major targets of nimbolide.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><div class="NLM_p last">Nimbolide induced caspase-mediated apoptosis by both the extrinsic and intrinsic pathways in 786-O and A-498 renal cell carcinoma cells, human nasopharyngeal carcinoma HONE-1 cells as well as in DMBA-induced HBP carcinomas as reflected by increased activities of caspase-3, â8, and â9, associated with enhanced expression of death receptor 5 (DR5), C/EBP homologous protein (CHOP), Fas, FasL, and proapoptotic members of the BCL2 family.<a onclick="showRef(event, 'ref53 ref62'); return false;" href="javascript:void(0);" class="ref ref53 ref62">(53,62)</a> Likewise, the growth inhibitory effects of nimbolide on estrogen-dependent (MCF-7) and -independent (MDA-MB-231) human breast cancer cell lines were ascribed to both the intrinsic and extrinsic pathways.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Nimbolide, when administered in combination with TNF-Î±, significantly enhanced apoptosis of HT-29 colon adenocarcinoma cells by upregulating the expression of Bid and DR5 and caspase-3 via activation of the c-Jun N-terminal kinase (JNK) pathway.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Nimbolide-mediated apoptosis was associated with cleavage of PARP, a caspase-3 substrate. Additionally, treatment with caspase inhibitors rescued cancer cells from the cytotoxicity of nimbolide, confirming that nimbolide-mediated apoptosis is caspase-dependent.<a onclick="showRef(event, 'ref37 ref38 ref50'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref50">(37,38,50)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">4.3.  Nimbolide Regulates Autophagy to Induce Apoptosis</h3><div class="NLM_p">Although apoptosis is the major mechanism by which chemotherapeutic agents induce cell death, regulation of autophagy, a cytoprotective survival mechanism that tumor cells use to evade apoptosis has recently emerged as a promising strategy to improve therapeutic outcome.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Apoptosis and autophagy are intricately interconnected through protein networks mediated chiefly by ATG5, Bcl-2, and Beclin-1.<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71,72)</a></div><div class="NLM_p">Nimbolide has been documented to potentiate functional crosstalk between apoptosis and autophagy. In pancreatic cancer cells, nimbolide stimulates both apoptosis and autophagy. While autophagy serves as an adaptive stress response to prolong cell survival, mitochondria-mediated apoptosis induced by ROS generation is believed to be responsible for nimbolide-induced death of pancreatic cancer cells.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Nimbolide was shown to promote apoptosis via autophagy as evidenced by overexpression of Beclin 1 and LC3B with downregulation of p62, mechanistic target of rapamycin (mTOR), and BCL-2 in MCF-7 and MDA-MB-231 breast cancer cells.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Nimbolide was found to regulate autophagy signaling by enhancing the expression of Beclin 1 while simultaneously reducing the expression of LC-3 and p62 in TGF-Î²1-induced <i>in vitro</i> and bleomycin-induced <i>in vivo</i> models of pulmonary fibrosis.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p last">Studies from this laboratory provided proof-of-concept that nimbolide toggles between apoptosis and autophagy using SCC131 and SCC4 oral cancer cells and the HBP model of oral oncogenesis. Nimbolide induced classic hallmarks of autophagy such as accumulation of acidic vesicles, enhanced expression of Beclin-1, LC3-II, and truncated ATG5 associated with degradation of p62. Time-course experiments revealed that nimbolide initially promotes cytoprotective autophagy and subsequently switches over to apoptosis via modulation of the phosphatidylinositol 3-kinase (PI3K)/Akt/GSK3Î² signaling cascade. Pharmacological inhibition and siRNA ablation of ATG5 and Beclin-1 augmented apoptosis, further confirming that nimbolide stimulates autophagy-dependent apoptosis.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">4.4.  Nimbolide Inhibits Tumor Invasion, Angiogenesis, and Metastasis</h3><div class="NLM_p">Tumor metastasis, the major cause of cancer mortality, encompasses a complex series of alterations termed the metastatic cascade by which the tumor cells are disseminated from the primary site via circulation to distant sites or organs to establish secondary tumors. Invasion, a crucial step in metastasis involves EMT, followed by degradation of the ECM catalyzed by a family of zinc-dependent endopeptidases known as matrix metalloproteinases (MMPs) that are regulated by tissue inhibitors of MMPs (TIMPs) and reversion-inducing cysteine-rich protein with Kazal motifs (RECK). During ECM processing by MMPs, various proangiogenic molecules are released, predominantly the vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1Î± (HIF-1Î±), which promote angiogenesis, an essential prerequisite for tumor progression.<a onclick="showRef(event, 'ref73 ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref73 ref74 ref75">(73â75)</a></div><div class="NLM_p">Babykutty et al.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> demonstrated that nimbolide inhibits invasion, migration, and angiogenesis in WiDr and HCT-116 colon cancer cells by decreasing the expression of MMP-2 and â9 and VEGF via blockade of ERK1/2 and NF-ÎºB signaling. Nimbolide treatment suppressed the growth of colorectal cancer xenografts by downregulating the expression of proteins involved in invasion (MMP-9, ICAM-1), angiogenesis (VEGF), and metastasis (CXCR4) and modulated the proinflammatory microenvironment.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Nimbolide-treated nonsmall cell lung carcinoma (NSCLC) cells exhibited a significant decrease in the expression of MMP-3 and Snail with an increase in the expression of E-cadherin.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div class="NLM_p">Using the scratch assay, the migratory abilities of MIAPaCa-2, PANC-1, and HPAC pancreatic cancer cells were shown to be suppressed. Nimbolide prevented EMT in pancreatic cancer cells by increasing the expression of E-cadherin, an epithelial marker, while simultaneously decreasing the expression of the mesenchymal markers, vimentin, Î²-catenin, notch-2, N-cadherin, and the transcription factors Snail, Slug, and Zeb. Additionally, nimbolide also inhibited EMT and metastasis in a pancreatic cancer xenograft model.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Nimbolide inhibited the migration of osteosarcoma cells by decreasing the expression of integrin Î±vÎ²5 via modulation of PI3K/Akt and NF-ÎºB signaling.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Nimbolide blocked tumor invasion and metastasis by downregulating the expression of MMP-9, intercellular adhesion molecule-1 (ICAM-1), CXCR4 (chemokine receptor type 4), and VEGF via abrogation of NF-ÎºB signaling.<a onclick="showRef(event, 'ref41 ref47'); return false;" href="javascript:void(0);" class="ref ref41 ref47">(41,47)</a> The inhibitory effect of nimbolide on the invasion and migration of breast cancer cells was demonstrated by transwell invasion and wound healing assays. Nimbolide was found to downregulate the expression of urokinase plasminogen activator (uPA) and uPA receptor (uPAR) genes and chemokines as well as MMPs, VEGF, and NF-ÎºB signaling.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Nimbolide hampered wound healing, migration, and invasion in bladder cancer EJ and 5637 cells by inhibiting MMP-9 as well as the binding activity of the transcription factors NF-ÎºB, Sp-1, and AP-1, which regulate MMP-9.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p last">Extensive studies from this laboratory have provided compelling evidence for the anti-invasive, and antiangiogenic potential of nimbolide as reflected by the downregulation of MMPs, placental growth factor, VEGF, VEGF receptors, and HIF-1Î± accompanied by increased expression of TIMP-2 and RECK and reduced microvascular density, an independent marker of angiogenesis in the HBP carcinogenesis model.<a onclick="showRef(event, 'ref27 ref76'); return false;" href="javascript:void(0);" class="ref ref27 ref76">(27,76)</a> Nimbolide administration reversed âRECKlessnessâ, a hallmark of cancer and abrogated VEGF and Notch signaling in oral cancer cells <i>in vitro</i> and in HBP carcinomas <i>in vivo</i>. Upregulation of RECK, a common negative target of oncogenic signaling pathways, resulted in diminished activities of MMPs and a disintegrin and metalloproteinase-10 (ADAM-10). Nimbolide was found to activate RECK and inhibit proinvasive and proangiogenic molecules in SCC131 and SCC4 oral cancer and EAhy926 endothelial cells under hypoxic conditions. Transfection with RECK plasmid/siRNA indicated that nimbolide activated RECK by targeting HIF-1Î± and miR-21. HIF-1Î± knockdown and nimbolide administration led to RECK overexpression. Furthermore, molecular docking studies revealed that nimbolide interacts with Arg 33, His 98, Thr 99, and Ser 34 in the PAS-A domain of HIF-1Î±, suggesting HIF-1Î± as a likely target of nimbolide besides underscoring its antiangiogenic potential.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">4.5.  Nimbolide Inhibits Cancer-Related Inflammation</h3><div class="NLM_p">Chronic inflammation is recognized to potentiate tumorigenesis by releasing growth factors, cytokines, chemokines, chemokine receptors, and MMPs that promote a pro-growth microenvironment and facilitate the acquisition of cancer hallmarks. Increased synthesis and secretion of cytokines also activates the activity of transcription factors such as NF-ÎºB and signal transducer and activator of transcription3 (STAT3), triggering downstream signaling cascades that stimulate tumor development and progression.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><div class="NLM_p">Treatment of OSCC xenografted mouse models with a highly pure super critical CO<sub>2</sub> neem leaf extract (SCNE) as well as nimbolide, a primary component of SCNE, significantly reduced the serum levels of pro-tumor inflammatory cytokines involved in OSCC development and progression such as IL-1Î², IL-1Î±, IL-6, IL-10, TNFÎ±, and IFNÎ³. This was associated with inhibition of pro-tumor inflammatory signaling cascade as reflected by blockade of NFÎºB, STAT3, and cyclooxygenase2 (COX2) expression and/or activity in OSCC cell lines.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Likewise, treatment of HCT116 and HT29 human colon cancer cells with SCNE or nimbolide reduced the expression of the transcriptional factors, STAT3 and NF-ÎºB associated with downregulation of markers of inflammation (COX1, IL-6, and TNF-Î±) and invasion (MMP2 and MMP9).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The impact of nimbolide treatment on NF-ÎºB and STAT3 signaling are discussed in the next section.</div><div class="NLM_p last">The foregoing findings provide substantial evidence for the modulatory effects of nimbolide on major hallmarks of cancer. There is ample evidence in the literature to support the antiproliferative and apoptosis augmenting effects of nimbolide in diverse malignant cells <i>in vitro</i> as well as in animal tumor models. Given that apoptosis evasion enables cancer cell survival that facilitates the accumulation of mutations leading to tumor progression, the apoptosis-inducing potential of nimbolide can create a suitable environment to inhibit tumor invasion and angiogenesis, major drivers of metastasis, besides overcoming resistance to chemotherapeutic agents. There is, however, paucity of information on the effect of nimbolide on DNA repair systems that could mitigate DNA damage, a critical event in neoplastic transformation. It is also important to investigate whether nimbolide orchestrates other types of cell death; primarily immunogenic cell death that has received increasing attention as a useful therapeutic strategy.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> More systematic studies on the effect of nimbolide on the regulation of immune and inflammatory cells in the tumor microenvironment from a mechanistic perspective are warranted.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">5.  Nimbolide Abrogates Oncogenic Signaling</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51317" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51317" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cellular signaling pathways play a pivotal role in regulating various cellular processes such as cell division, differentiation, apoptosis, angiogenesis, among several others. These pathways are interconnected networks whose components include growth factors, growth factor receptors, kinases, cytoplasmic proteins, nuclear proteins, and transcription factors. Aberrant activation of signaling pathways enables the acquisition of cancer hallmarks.<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79,80)</a> Nimbolide exerts modulatory effects on oncogenic signaling, thereby preventing the acquisition of hallmark capabilities of cancer (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/medium/jm0c02239_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/large/jm0c02239_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Nimbolide abrogates key oncogenic signaling pathways. Nimbolide inhibits PI3K/Akt/MAPK signaling to activate GSK-3Î² with consequent trafficking of Î²-catenin away from the nucleus. Nimbolide inhibits multiple steps in the NF-ÎºB signaling cascade including IKKÎ² activation, IÎºB degradation, phosphorylation of IKKÎ±/Î², IÎºBÎ± and NF-ÎºB subunits, nuclear translocation, and DNA binding activity of NF-ÎºB. Nimbolide impedes aberrant activation of the JAK/STAT3 pathway by preventing phosphorylation of STAT3, a prerequisite for its nuclear translocation. Likewise, by activating RECK, nimbolide represses HIF-1Î±, preventing its nuclear translocation. Thus, nimbolide blocks DNA binding activity of oncogenic transcription factors such as Î²-catenin, NF-ÎºB, STAT3, and HIF1-Î± and transactivation of genes implicated in the acquisition of hallmark capabilities of cancer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/large/jm0c02239_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02239&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">5.1.  Nimbolide Modulates PI3K/Akt/MAPK Signaling Networks</h3><div class="NLM_p">GSK-3Î², a serine/threonine kinase, is a central hub in cellular signaling that elicits regulatory influences on metabolism, insulin signaling, differentiation, cell proliferation, apoptosis, EMT, cancer stemness, and chemoresistance. GSK3Î², a key suppressor of the Wnt/Î²-catenin pathway, undergoes activation/inactivation by site-specific phosphorylation at Tyr216/Ser9 residues. Several oncogenic signaling kinases inactivate GSK-3Î² including phosphatidylinositol 3-kinase (PI3K/Akt) and mitogen-activated protein kinase (MAPK)/extracellular signal-related kinases (ERK). GSK-3Î² interacts with multiple signaling pathways and noncoding RNAs (ncRNAs) to influence various hallmarks of cancer. Dysregulation of GSK-3Î² has been documented in diverse malignancies. GSK-3Î² is regarded as a potential therapeutic target in cancer.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><div class="NLM_p">Molecular docking studies revealed that nimbolide docks to key signaling kinases in the PI3K/Akt/MAPK/GSK3Î² signaling axis. Nimbolide forms hydrogen bonds with Tyr-134 and Gln-185 residues on the kinase domain of GSK-3Î² and with Gly 34, Lys 54, Arg 67, Glu 71, and Ser 153 in the kinase domain of ERK2, underscoring its kinase inhibitory effects. Nimbolide interacts with Gln 231 in the RAS binding domain of PI3KÎ³ that may inhibit RAS binding vital for activation of PI3KÎ³ and downstream signaling. Interaction of nimbolide with Glu 193, Asp 275, and Gly 295 residues in the kinase domain of Akt 2 may hinder translocation of Akt from the cytoplasm to the plasma membrane, thereby preventing PDK-1-catalyzed Ser473 phosphorylation essential for its activation.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p">Experimental studies <i>in vitro</i> and <i>in vivo</i> validated the <i>in silico</i> findings. In oral cancer cell lines and in HBP carcinomas, nimbolide inhibited cell proliferation and induced apoptosis by abrogating PI3K/Akt signaling with consequent activation of GSK-3Î². Additionally, nimbolide stimulated GSK-3Î² activity by decreasing p-GSK-3Î²Ser9, the inactive form of the enzyme, and upregulating miR-126 and let-7, well-known inducers of GSK-3Î². Nimbolide also induced cytoplasmic accumulation of Î²-catenin, facilitating its phosphorylation and degradation. PI3K overexpression promoted autophagy that was alleviated by nimbolide administration. Nimbolide was found to inhibit phosphorylation of Akt at Ser473 with a consequent increase in p-GSK3Î²Tyr216, the active form of GSK3Î² that inhibits autophagy and induces apoptosis.<a onclick="showRef(event, 'ref55 ref63'); return false;" href="javascript:void(0);" class="ref ref55 ref63">(55,63)</a> Subramani et al.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> demonstrated that nimbolide inhibited proliferation and metastasis of pancreatic cancer cells via blockade of PI3K/AKT/mTOR and ERK signaling. Further, using the autophagy inhibitors 3-methyladenine and chloroquine as well as the apoptosis inhibitor z-VAD-fmk, nimbolide was shown to mediate these effects through ROS-induced mitochondrial apoptosis but not via autophagy.</div><div class="NLM_p">Nimbolide suppressed the phosphorylation of the p85 subunit of PI3K and Akt at Ser473 in osteosarcoma cells that was blocked by pretreatment with inhibitors of PI3K (Ly294002) and Akt (Akti).<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Similarly, in GBM cells and in tumor xenografts, nimbolide was reported to impede growth factor-induced phosphorylation of Akt.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Nimbolide was shown to inhibit cell proliferation and induce apoptosis of breast and prostate cancer cell lines by restraining insulin growth factor (IGF) signaling via the PI3K/Akt and MAPK pathways.<a onclick="showRef(event, 'ref33 ref60 ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref33 ref60 ref82 ref83">(33,60,82,83)</a></div><div class="NLM_p last">Nimbolide exerted modulatory effects on the MAPK signaling pathway comprising ERK1/2, JNK1/2/3, and p38-MAPK. Nimbolide induced caspase-mediated apoptosis by inhibiting ERK1/2 and activating p38 and JNK1/2 in colon cancer cells.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Nimbolide inhibited TNF-Î±-mediated apoptosis by upregulation of DR5 expression via the JNK pathway in colon cancer. Chien et al.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> demonstrated that the apoptosis-inducing potential of nimbolide in HONE-1 nasopharyngeal cancer cells is mediated through ERK1/2 inhibition. Incubation with nimbolide prevented the invasion and migration of NSCLC cells by inactivation of ERK1/2. Knockdown of dual-specificity protein phosphatase 4 (DUSP4), a negative regulator of ERK1/2 attenuated nimbolide-mediated inhibition of NSCLC invasion and migration, confirming that nimbolide targets ERK1/2.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> In hepatocellular carcinoma cells, nimbolide effectively inhibited c-IAP1 expression and induced apoptosis via targeting the ERK pathway.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> In bladder cancer EJ and 5637 cells, nimbolide was shown to increase JNK phosphorylation and simultaneously decrease the phosphorylation of p38MAPK and AKT.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">5.2.  Nimbolide Abrogates NF-ÎºB Signaling</h3><div class="NLM_p">The Rel family transcription factor, nuclear factor Îº-light-chain-enhancer of activated B cells (NF-ÎºB), is present as an inactive heterodimer of p50 and p65 subunits complexed with the inhibitor of ÎºB (IÎºB) in the cytoplasm. Aberrant activation of NF-ÎºB documented in diverse malignant neoplasms, involves the release of the heterodimer from IÎºB, followed by nuclear translocation and transactivation of genes involved in the acquisition of cancer hallmarks such as cell proliferation, apoptosis avoidance, inflammation, invasion, angiogenesis, metastasis, and therapy resistance.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></div><div class="NLM_p last">Experiments by different research groups established that nimbolide inhibits multiple steps in the NF-ÎºB signaling cascade by blocking the activation of inhibitor of ÎºB kinaseÎ² (IKKÎ²), IÎºB degradation, phosphorylation of IKKÎ±/Î², IÎºBÎ± and NF-ÎºB subunits, nuclear translocation, and DNA binding activity of NF-ÎºB.<a onclick="showRef(event, 'ref37 ref40 ref41 ref56 ref62'); return false;" href="javascript:void(0);" class="ref ref37 ref40 ref41 ref56 ref62">(37,40,41,56,62)</a> Nimbolide induced mitochondria-mediated apoptosis by blocking both constitutive and TNF-Î±-induced NFÎºB activation in HepG2 hepatocellular carcinoma cells transfected with NFÎºB-responsive luciferase reporter plasmid.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Nimbolide treatment decreased the phosphorylation of IKKÎ±/Î², IÎºBÎ± and the p65 subunit of NF-ÎºB in osteosarcoma cells. Further, nimbolide-induced decrease in NF-ÎºB activity was confirmed using a ÎºB-luciferase activity assay. Pretreatment with the NF-ÎºB inhibitor TPCK blocked the effects of nimbolide in a migration assay and restored activity of the NF-ÎºB luciferase reporter, illustrating the modulatory effects of nimbolide on NF-ÎºB signaling.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Gupta et al.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> provided evidence for direct interaction of nimbolide with the Cys 179 of IKK-Î² that could prevent phosphorylation and degradation of IÎºBÎ±, leading to inactivation of NF-ÎºB and transactivation of NF-ÎºB responsive genes.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">5.3.  Nimbolide Targets the JAK/STAT-3 Pathway</h3><div class="NLM_p">The transcription factor, STAT3 when activated by cytokines and growth factors, undergoes phosphorylation by Janus kinase (JAK) followed by homodimerization and translocation to the nucleus, where it regulates the expression of genes vital for various cellular processes such as cell differentiation, proliferation, angiogenesis, and immune function. Aberrant activation of JAK/STAT3 signaling reported in diverse malignant tumors also occurs concurrently with other kinase-driven pathways.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><div class="NLM_p last">The anticancer effects of nimbolide on human PCa DU145 and LNCaP prostate cancer cells and in the transgenic adenocarcinoma of mouse prostate (TRAMP) model were found to be mediated via ROS-induced inhibition of both constitutive and IL-6 inducible STAT3 signaling.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> An ethanol-soluble fraction of <i>A. indica</i> leaves containing nimbolide as the principal cytotoxic constituent suppressed the proliferation of GBM cells <i>in vitro</i> and in tumor xenografts by downregulating BCL2 and blocking growth factor-induced phosphorylation of Akt, ERK1/2, and STAT3.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Morris et al.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> reported the anticancer effects of nimbolide in SCC4, Cal27, and HSC3 oral cancer cell lines and in xenografted nude mice generated from the three cell lines. Nimbolide displayed greater cytotoxicity on OSCC cell lines than the nonsteroidal anti-inflammatory drug (NSAID) celecoxib. Treatment with nimbolide decreased the expression of COX2 and nuclear NFÎºBp65 as well as pSTAT3, pAKT, and pERK1/2 in all three cell lines. In addition, cell migration was significantly reduced associated with downregulation of MMP-2 and MMP-9.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">5.4.  Nimbolide Pins Down Pin1</h3><div class="NLM_p">Peptidyl-prolyl cisâtrans isomerase NIMA-interacting 1 (Pin1), an enzyme that catalyzes the isomerization of phosphorylated serine/threonine-proline (pSer/Thr-Pro) motifs, activates a number of oncogenic proteins and signaling pathways involved in the acquisition of cancer hallmarks. Pin1 is aberrantly activated in diverse malignant tumors and has emerged as an attractive therapeutic target. da Costa et al.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> used various computational approaches such as molecular docking, pharmacophore filtering, and structural clustering allied to molecular dynamics simulations and binding free energy calculations to show that nimbolide interacts with high affinity with the Pin1 substrate peptide and destabilizes Pin1 structure.</div><div class="NLM_p last">Taken together, nimbolide apparently targets transcription factors that are the ultimate executors of oncogenic signaling. Transcription factors are vital components of complex signaling networks that regulate a plethora of diverse cellular processes including cell division, differentiation, migration, cell death, and homeostasis. The human transcription factor repertoire of over 1600 proteins acts individually or as an ensemble to recognize specific DNA sequences and regulate gene expression.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Aberrant expression of transcription factors contributes to dysregulated signaling and acquisition of hallmark capabilities of cancer. There is mounting evidence to indicate that transcription factors such as NF-ÎºB, Î²-catenin, HIF-1Î±, and STAT-3 are potential druggable targets of nimbolide. The use of three-dimensional cultures, cancer stem cells and cell-based reporter assays, and proteinâprotein interactions can shed light on the effects on specific signaling pathways and molecular targets. Studies that provide insights on the molecular mechanisms by which nimbolide targets transcription factors could impact cancer therapeutics as well as provide scope for designing analogues with higher efficacy.</div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">6.  Nimbolide Modulates the Epigenome</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30574" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30574" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Epigenetic alterations that play a critical role in tumor progression include DNA methylation, histone modifications, and changes in ncRNAs. While aberrant promoter hypermethylation can cause silencing of TSGs, global hypomethylation can activate protooncogenes leading to genomic instability. Likewise, histone acetylation enhances gene transcription, whereas deacetylation leads to gene repression. The ncRNAs, primarily microRNAs (miRs), and the long noncoding RNAs (lncRNAS) have gained increasing attention as important modulators of oncogenic signaling pathways and acquisition of cancer hallmarks.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><div class="NLM_p">Several studies have documented the modulatory effects of nimbolide on the epigenome. Nimbolide suppressed the proliferation of HCT116 and HT29 colon cancer cells by inhibiting the expression and activities of DNA methyltransferases (DNMT) and histone deacetylases (HDACs), thereby reducing methylation and stimulating the acetylation of the p16 gene promoter with consequent reexpression of the p16 tumor suppressor protein.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Nimbolide administration inhibited HDAC1 that plays a vital role in cell proliferation, apoptosis avoidance, and chemoresistance in a hamster model of oral carcinogenesis.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Nimbolide promoted acetylation of H3K27 by inhibiting HDAC2 to induce autophagy-driven apoptotic cell death of MDA-MB-231 and MCF-7 breast cancer cells.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">Nimbolide effectively modulated the expression of ncRNAs in oral cancer cells <i>in vitro</i> and in the HBP model <i>in vivo</i>. Administration of nimbolide significantly increased the expression of miR-126 and Let-7, which are known to induce GSK-3Î².<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The addition of nimbolide to SCC4 cells overexpressing miR-126 upregulated the expression of GSK-3Î² accompanied by downregulation of Homeobox transcript antisense intergenic RNA (HOTAIR), a lncRNA that sponges miR-126, indicating that nimbolide induces activation of GSK-3Î² via modulation of ncRNAs.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Nimbolide was shown to function as an antagonist of miR-21, an oncomiR that inhibits RECK expression to inhibit invasion and angiogenesis.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><div class="NLM_p last">To sum up, epigenetic remodelling by phytochemicals has opened up new opportunities and challenges in cancer therapy. There are very few reports on the epigenetic modifications induced by nimbolide. More intensive studies on global epigenetic changes, especially on those that influence oncogenic signaling networks, cancer hallmarks, and chemoresistance, are warranted to expand the molecular target repertoire of nimbolide.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">7.  Nimbolide Is an Effective Chemosensitizer</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84661" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84661" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Resistance to chemotherapeutic drugs remains a major challenge in cancer treatment. In particular, the development of multidrug resistance (MDR) has become a major contributor to chemotherapy failure and cancer mortality. Among the several mechanisms implicated in MDR, enhanced efflux of drugs by the ATP-binding cassette (ABC) transporters has assumed increased significance. Natural products that are able to reverse or overcome MDR have received growing attention in recent years as chemosensitizers.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></div><div class="NLM_p">Mahmoud et al.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> explored the cytotoxicity of nimbolide against the well-established MDR mechanisms ABCB1, ABCG2, ABCB5, TP53, and epidermal growth factor receptor. P-glycoprotein (ABCB1/MDR1)-overexpressing CEM/ADR5000 multidrug-resistant leukemic cells exhibited hypersensitivity to nimbolide compared to the CCRF-CEM drug-sensitive parental leukemia cells, a phenomenon known as collateral sensitivity. Nimbolide circumvented MDR by modulating the expressions of the tumor suppressor protein phosphatase and tensin homologue (PTEN), and the transcription factors, HIF1Î± and forkhead box O transcription factor1 (FOXO1). Upregulation of PTEN was suggested to inhibit PI3K/AKT/mTOR signaling with consequent negative regulation of IKK/NFÎºB signaling, degradation of HIF1Î±, and suppression of P-glycoprotein. Additionally, inhibition of PI3K/AKT/mTOR signaling can also lead to activation of FOXO1, which is known to antagonize MYC and reduce intracellular ROS levels. Alam et al.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> demonstrated that nimbolide in combination with Akt Inhibitor VIII synergistically induced Bax-dependent cell death by targeting the Akt pathway in SCC9/SCC4-cisplatin-resistant oral cancer cells that could be beneficial for chemosensitizing cisplatin-resistant human OSCC.</div><div class="NLM_p last">Cancer stem cells (CSCs) that have the ability to self-renew and differentiate into malignant cells are believed to be responsible for drug resistance as well as cancer relapse. Selective targeting of CSCs has emerged as a promising strategy to overcome drug resistance.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> In pancreatic cancer cells, nimbolide reduced the population of CD44<sup>+</sup> cells, thereby inhibiting the CSC population.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> However, more in-depth studies are required to establish the signaling pathways and cell surface markers through which nimbolide targets CSCs in a variety of malignant tumors.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">8.  Patents on Nimbolide</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56426" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56426" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Several patents have been granted for the anticancer activities of neem extracts. A US patent (US 7.179.927 B2) was granted for a method of extraction of neem components including azadirachtin and nimbolide. Patents specifically pertaining to nimbolide, although few are significant. A pharmaceutical formulation comprising nimbolide, nimbandiol, 2â²,3â²dihydronimbolide, and 28-dihydronimbolide was reported to modulate at least one of integrin Î²i activity, calreticulin activity, and focal adhesion kinase activity in cancer cells (WO/2015/035199A1). A recent patent publication relates to the synthesis and anticancer activities of nimbolide analogues (20190211027). One of the analogues, IM-1372-Kn-13 (A4), was found to inhibit the growth of pancreatic cells <i>in vitro</i> and in a xenograft model <i>in vivo</i>. Acute toxicity studies failed to show toxic effects up to 50 mg/kg.</div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">9.  Pharmacokinetic Profile of Nimbolide</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75458" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75458" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pharmacokinetics (PK) plays a vital role in various stages of the drug development process including generation of lead compounds, target identification and validation, preclinical pharmacological investigations and clinical trials. Most importantly, PK studies enable the determination of the bioavailability of a drug which facilitates optimization of dosage and route of administration to achieve therapeutic efficacy. Baira et al.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> reported the complete PK profile of oral as well as intravenously administered nimbolide in SpragueâDawley rats. The absolute bioavailability was found to be 2.72%, 1.76%, and 3.06% after oral administration of 10, 30, and 50 mg/kg nimbolide, respectively. The kinetic properties of nimbolide were characterized as slow absorption, middle-speed elimination, and very poor absolute bioavailability that could be attributed to its high lipophilicity. However, plasma levels were significantly elevated following intravenous administration of 10 mg/kg nimbolide.</div><div class="NLM_p">Wang et al.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> developed a sensitive and robust liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantitative analysis of nimbolide in mouse serum and for validation of preclinical PK studies. They demonstrated good linearity in the range 5â1000 ng/mL, with accuracy and precision in accordance with the Food and Drug Administration (FDA) guidelines of <15%. In the preclinical PK study, the peak concentration (<i>C</i><sub>max</sub>) of nimbolide (0.78 Î¼mol/L) was reached approximately 2 h after oral administration of 3 mg/kg indicating that nimbolide is rapidly and readily absorbed. Although the <i>C</i><sub>max</sub> of nimbolide was lower than the IC<sub>50</sub> values reported in breast and colorectal cancer,<a onclick="showRef(event, 'ref32 ref59'); return false;" href="javascript:void(0);" class="ref ref32 ref59">(32,59)</a> it was well within the <i>in vitro</i> effective concentration range of 0.5â10 Î¼mol/L. These results imply that it is possible to achieve effective therapeutic levels of nimbolide <i>in vivo</i>. In colorectal cancer xenografted mice administered 5 and 20 mg/kg intraperitoneal (ip) nimbolide, the bioavailability of nimbolide in blood plasma was found to be 222 and 409 ng/mL, whereas, in the tumor tissues, the bioavailability was 345 and 868 ng/g, respectively.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p last">Recently, nimbolide was demonstrated to fulfill Lipinskiâs drug-likeness ârule of fiveâ that includes criteria of molecular mass less than 500 Da molecular weight, less than 5 hydrogen bond donors, less than 10 hydrogen bond acceptors, and less than 5 partition coefficient (log<i>P</i>).<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Although predictions for ADMET properties indicated bloodâbrain barrier penetrating potential and inhibition of CYP3A4, rigorous laboratory investigations are essential. More robust and sensitive bioanalytical methods are required for estimating the effective plasma and tissue concentrations of nimbolide to evaluate bioavailability. Additionally, there is a gap in complete knowledge of other critical parameters including clearance, half-life, dose optimization, formulation, as well as route and schedule of administration that are roadblocks to initiating clinical trials.</div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">10.  Toxicity Profile of Nimbolide</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71266" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71266" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A large number of potential drug candidates fail to progress to clinical trials due to toxicity-based attrition. Acute toxicity studies revealed higher toxicity of nimbolide in mice compared to rats and hamsters. Nimbolide was found to be toxic to mice when administered by the ip and intravenous (iv) routes with median lethal dose (LD50) values of 225 mg/kg and 24 mg/kg, respectively. Lethal doses of nimbolide caused death in mice as a result of necrosis of the kidneys, liver, and pancreas as well as due to a sudden drop of arterial blood pressure. However, intragastric, oral, or subcutaneous administration of nimbolide was nontoxic with LD50 values greater than 600 mg/kg body weight. Furthermore, in rats and hamsters, nimbolide was well tolerated with LD50 values of 600 and 500 mg/kg body weight, respectively.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><div class="NLM_p">Nimbolide was not mutagenic in six strains of <i>Salmonella typhi</i>.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Studies on the spermicidal effects remain inconclusive. While one study failed to show significant spermicidal effects following <i>in vitro</i> exposure to 50 Î¼M nimbolide, in another study, significant depletion of antioxidants associated with oxidative stress was observed in rat epididymal sperms exposed to 0.5â2 Î¼M of nimbolide.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> In an <i>in vivo</i> study on Wistar rats, subcutaneous administration of graded doses of nimbolide reduced sperm functional parameters.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></div><div class="NLM_p last">Comprehensive, well-designed long-term toxicity studies on nimbolide in nonrodent species, doseâresponse relationship, and repeated-dose toxicity studies under different routes of administration are essential to understand the complete toxicology profile of nimbolide as well as to identify the no observed adverse effect level (NOAEL).</div></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">11.  Challenges in the Commercialization of Nimbolide</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66320" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66320" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Natural products have been the single largest source of anticancer drugs and novel lead compounds. However, there are several obstacles in the commercialization of phytochemicals such as nimbolide. These include extraction and characterization, bioavailability, analysis of ADMET, and high-throughput screening. Although simple and rapid methods have been devised for the isolation and purification of nimbolide from neem leaves, high yield, purity, and cost-effectiveness are major factors that influence product manufacture. In addition, procurement, authentication, quality assurance, and scale-up are time-consuming and labor-intensive. Recently, nimbolide was extracted using a simple, fast, and efficient microwave-assisted extraction method coupled with chromatography that yields 0.0336 g of nimbolide from 5 g of neem leaves within 3 h.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> More such technical initiatives are necessary to promote the potential pharmaceutical applications of nimbolide.</div><div class="NLM_p">Evaluation of different routes of administration, solubility, gastrointestinal absorption, and bioavailability are critical parameters to be considered in drug development from natural sources. Nimbolide is known to be only sparingly soluble in aqueous solutions. The poor bioavailability and high lipophilicity of nimbolide are major impediments in translating its anticancer potential to the clinical setting. Strategies such as combination with compounds that increase solubility and absorption as well as novel delivery systems such as microemulsions, phospholipid complexes, nanoparticles, or polymer micelles can enhance bioavailability. In this connection, poly(lactic-<i>co</i>-glycolic acid) (PLGA) nanoparticles of nimbolide that exhibit sustained release and enhanced cytotoxicity in breast and pancreatic cancer cell lines relative to free nimbolide raise hope for targeted delivery by conjugation with polyethylene glycol or receptor-binding ligands.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Conjugation of nimbolide liposomes conjugated with iRGD peptide (iRGD-NIMLip) was found to be a promising novel drug delivery system to target lung inflammation based on the significant inhibition of oxidative stress and cytokine storm associated with acute respiratory distress syndrome and COVID-19.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Further studies on targeted delivery will open up new possibilities for therapeutic intervention.</div><div class="NLM_p">The paucity of information on the ADMET of nimbolide is another bottleneck in the drug development pipeline. Moreover, a large majority of the investigations on the anticancer effects of nimbolide have been conducted in cellular models. Although some studies have been conducted in a few cell-line-derived tumor xenograft mouse models, chemotherapeutic efficacy needs to be firmly established on a range of malignant tumors as well as in patient-derived tumor xenograft (PDTX) models.</div><div class="NLM_p last">Commercialization of nimbolide requires validation of pharmacological, pharmacokinetic, toxicicological, and clinical studies. Although Gupta et al.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> confirmed the presence of nimbolide in plasma and tumor tissues of colorectal cancer xenografted mice, the method has not been fully validated by the FDA. The ability of nimbolide to cross the bloodâbrain barrier based on <i>in silico</i> predictions<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> and studies on GBM xenografted mice<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> needs further validation. Nimbolide must be thoroughly investigated in preclinical settings for safety, efficacy, and druggability standards before approval for clinical trials. High-throughput screening using a range of relevant cell-based and molecular bioassays, target validation, and examination of effects on specific physiological pathways can accelerate the evaluation of small molecules such as nimbolide for drug development.</div></div><div id="sec12" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">12.  Perspectives and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20757" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20757" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nimbolide that displays remarkable antiproliferative effects against numerous human cancer cells <i>in vitro</i> as well as in animal tumor models <i>in vivo</i> can be regarded as a âbroad-spectrumâ anticancer agent. Nimbolide influences all the steps in multistage carcinogenesis ranging from carcinogen metabolism, through genotoxicity, cell cycle progression, apoptosis evasion, angiogenesis, invasion, to metastasis as well as epigenetic modifications. Accumulating evidence has convincingly demonstrated that nimbolide targets a plethora of molecules and kinase-driven oncogenic signaling pathways to effectively prevent the acquisition of hallmark capabilities of cancer. Compelling evidence from various studies indicates that nimbolide abrogates oncogenic signaling by influencing the subcellular localization of transcription factors and phosphorylation of signaling kinases. Nimbolide also exerts modulatory effects on the epigenome and effectively overcomes MDR. The recent discovery of nimbolide as a covalent recruiter for the E3 ligase RNF114 underscores its broad utility for targeted protein degradation. Interestingly, a proteolysis-targeting chimera (PROTAC) linking nimbolide to the kinase and BCR-ABL fusion oncogene inhibitor dasatinib, BT1, was demonstrated to selectively degrade oncogenic BCR-ABL over c-ABL in leukemic cells.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> This has paved the way for the identification of EN219, a fully synthetic RNF114-based recruiter that mimics the mode of action of nimbolide.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> These findings further expand the arsenal of nimbolide and reinforce its potential as a promising anticancer drug candidate. It is noteworthy that nimbolide is listed among the ten potential compounds for oral cancer treatment based on large-scale mining as well as annotation of reliable compounds and bioactivity databases.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> A recent review by Agarwal et al.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> based on an extensive search using various literature databases revealed the preventive and therapeutic potential of neem in general and nimbolide in particular against oral cancer. <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> summarizes the mechanisms underlying the anticancer effects of nimbolide.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Mechanisms Underlying the Anticancer Effects of Nimbolide</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/medium/jm0c02239_0007.gif" alt="" id="GRAPHIC-d7e1121-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/medium/jm0c02239_0008.gif" alt="" id="GRAPHIC-d7e1122-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/medium/jm0c02239_0009.gif" alt="" id="GRAPHIC-d7e1123-autogenerated" /></img><div></div></div><div class="NLM_p last">Over the past several decades, anticancer drug design and discovery have focused on single-target agents that selectively target a single biological molecule, usually a protein. However, this approach is beset with certain drawbacks including low therapeutic efficacy and resistance. Given the multifactorial etiology and complexity of cancer, the use of multitarget drugs has emerged as a more pragmatic strategy resulting in the rational design of a large number of novel small molecule multitarget drugs in recent years with translational success in the clinic. The development of these drugs involves the integration of pharmacophores and is a daunting task.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Natural products like nimbolide, a small molecule with broad-spectrum and multitargeted activity, are attractive options for anticancer drug development. Extensive investigations on soluble nimbolide analogues, efficient delivery systems and nanoformulations that can enhance the bioavailability, as well as studies on subacute, acute, and chronic toxicity are, however, warranted before translating preclinical findings to the clinic.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c02239" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Siddavaram Nagini</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry & Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamil Nadu 608002, India</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8889-6013" title="Orcid link">http://orcid.org/0000-0001-8889-6013</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#45362b2924272430052228242c296b262a28"><span class="__cf_email__" data-cfemail="e0938e8c81828195a0878d81898cce838f8d">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramesh Nivetha</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry & Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamil Nadu 608002, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manikandan Palrasu</span> - <span class="hlFld-Affiliation affiliation">Department
of Surgery, University of Miami Miller School
of Medicine, Rosenstiel
Medical Sciences Building, Suite 4116, 1600 NW 10th Avenue, Miami, Florida 33136, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajakishore Mishra</span> - <span class="hlFld-Affiliation affiliation">Centre
for Life Sciences, School of
Natural Sciences, Central University of
Jharkhand, Ratu-Lohardaga Road, Brambe, Ranchi, Jharkhand 835205,  India</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>R.N. and M.P. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27883" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27883" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Siddavaram Nagini</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02239&amp;id=BIO-d7e1129-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Siddavaram Nagini</b> did her Masterâs in Biochemistry and started her journey in cancer biology with a Ph.D. from the Cancer Institute, Chennai, followed by postdoctoral training in the Molecular Oncology Group, University of Liverpool, on a Commonwealth Fellowship. She served as a Professor and Director of Research at Annamalai University, India. During her academic career, she has been a PI of several national and international research projects centered on the anticancer potential of natural products. Besides teaching and mentoring the next generation, she has been a prolific communicator, collaborator, rendered service on scientific panels, organizations, journal editorial boards, as well as public engagement with science. She is currently a Faculty Fellow at the Department of Biochemistry & Biotechnology, Annamalai University, India.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Ramesh Nivetha</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02239&amp;id=BIO-d7e1134-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ramesh Nivetha</b> is a Senior Research Fellow in the Department of Biochemistry & Biotechnology at Annamalai University, India. She completed her Masterâs Degree in Biochemistry from the University of Madras in 2015. Her doctoral thesis is focused on unravelling the molecular mechanisms underlying the modulatory effects of nimbolide on the PI3K/Akt/GSK3-Î² signaling network and the impact on tumor angiogenesis. Her current research interests include the evaluation of epigenetic marks as anticancer therapeutic targets using natural compounds.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Manikandan Palrasu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02239&amp;id=BIO-d7e1139-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Manikandan Palrasu</b> is an Assistant Scientist in the Department of Surgery at Millers School of Medicine, University of Miami, Miami, Florida. He graduated from Annamalai University in 2011, where he received his Ph.D. in Biochemistry. Dr. Palrasu has investigated the molecular mechanisms involved in the development and progression of chemically induced gastric and oral cancers. His research work at Annamalai University focused on the potential chemopreventive effect of medicinal plants (<i>Ocimum sanctum</i> and <i>Azadirachta indica</i>) and their constituent phytochemicals (eugenol, azadirachtin, nimbolide, and quercetin) on experimental oral and gastric animal tumor models. His current research interests include the mechanisms by which <i>Helicobacter pylori</i> infections promote gastric cancer development and progression. Based on the findings, he develops and tests novel plant-based chemopreventive agents against gastric cancer.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Rajakishore Mishra</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02239&amp;id=BIO-d7e1153-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Rajakishore Mishra</b> is presently working as an Assistant Professor in the Department of Life Sciences at the Central University of Jharkhand, India. He obtained his Ph.D. from the Institute of Life Sciences, India, in 2005 and soon after his Postdoctoral studies at Texas A&M University, USA (2005â2007), and Loyola University, Chicago (2007â2010). His doctoral and postdoctoral work mainly focused on understanding the underlying molecular mechanisms of oral and breast cancers. His current research interests include the identification of suitable biomarkers and designing novel therapeutics for effective treatment of oral cancer using natural products.</p></figure></div><div class="ack" id="ACK-d7e1482-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24738" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24738" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support from the University Grants Commission, Basic Science Research (F.18-1/2011(BSR)) and the Science and Engineering Research Board (EMR/2016/597 001984) of the Department of Science and Technology, New Delhi, India, to Siddavaram Nagini is gratefully acknowledged.</p></div><table summary="" class="NLM_def-list" id="dl2"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ABC</td><td class="NLM_def"><p class="first last">ATP-binding cassette</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, elimination, and toxicity</p></td></tr><tr><td class="NLM_term">Bid</td><td class="NLM_def"><p class="first last">BH3 interacting-domain death agonist</p></td></tr><tr><td class="NLM_term">CDK</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">DMBA</td><td class="NLM_def"><p class="first last">7,12-dimethylbenz[<i>a</i>]anthracene</p></td></tr><tr><td class="NLM_term">DNMT</td><td class="NLM_def"><p class="first last">DNA methyltransferase</p></td></tr><tr><td class="NLM_term">ECM</td><td class="NLM_def"><p class="first last">extracellular matrix</p></td></tr><tr><td class="NLM_term">EMT</td><td class="NLM_def"><p class="first last">epithelial-to-mesenchymal transition</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular signal-related kinase</p></td></tr><tr><td class="NLM_term">FOXO1</td><td class="NLM_def"><p class="first last">forkhead box O transcription factor1</p></td></tr><tr><td class="NLM_term">GBM</td><td class="NLM_def"><p class="first last">glioblastoma multiforme</p></td></tr><tr><td class="NLM_term">GSK-3Î²</td><td class="NLM_def"><p class="first last">glycogen synthase kinase-3Î²</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione S-transferase</p></td></tr><tr><td class="NLM_term">HBP</td><td class="NLM_def"><p class="first last">hamster buccal pouch</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">HIF-1Î±</td><td class="NLM_def"><p class="first last">hypoxia-inducible factor-1Î±</p></td></tr><tr><td class="NLM_term">IAP</td><td class="NLM_def"><p class="first last">inhibitor of apoptosis protein</p></td></tr><tr><td class="NLM_term">IKKÎ²</td><td class="NLM_def"><p class="first last">inhibitor of kappa B kinaseÎ²</p></td></tr><tr><td class="NLM_term">IÎºBÎ±</td><td class="NLM_def"><p class="first last">inhibitor of ÎºBÎ±</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">LC3</td><td class="NLM_def"><p class="first last">microtubule-associated protein 1A/1B-light chain 3</p></td></tr><tr><td class="NLM_term">LD50</td><td class="NLM_def"><p class="first last">median lethal dose</p></td></tr><tr><td class="NLM_term">lncRNA</td><td class="NLM_def"><p class="first last">long noncoding RNA</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matrix metalloproteinase</p></td></tr><tr><td class="NLM_term">MOMP</td><td class="NLM_def"><p class="first last">mitochondrial outer membrane permeabilization</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">ncRNA</td><td class="NLM_def"><p class="first last">noncoding RNA</p></td></tr><tr><td class="NLM_term">NF-ÎºB</td><td class="NLM_def"><p class="first last">nuclear factor Îº-light-chain-enhancer of activated B cells</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">nonsmall cell lung carcinoma</p></td></tr><tr><td class="NLM_term">OSCC</td><td class="NLM_def"><p class="first last">oral squamous cell carcinoma</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly(ADP ribose) polymerase</p></td></tr><tr><td class="NLM_term">PCNA</td><td class="NLM_def"><p class="first last">proliferating cell nuclear antigen</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-kinase</p></td></tr><tr><td class="NLM_term">Pin1</td><td class="NLM_def"><p class="first last">peptidyl-prolyl cisâtrans isomerase NIMA-interacting 1</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PTEN</td><td class="NLM_def"><p class="first last">phosphatase and Tensin homologue</p></td></tr><tr><td class="NLM_term">Rb</td><td class="NLM_def"><p class="first last">retinoblastoma protein</p></td></tr><tr><td class="NLM_term">RECK</td><td class="NLM_def"><p class="first last">reversion-inducing cysteine-rich protein with Kazal motifs</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">Smac/DIABLO</td><td class="NLM_def"><p class="first last">second mitochondria-derived activator of caspase/direct IAP binding protein with low pI</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription</p></td></tr><tr><td class="NLM_term">TGF-Î²</td><td class="NLM_def"><p class="first last">transforming growth factor-Î²</p></td></tr><tr><td class="NLM_term">TIMPs</td><td class="NLM_def"><p class="first last">tissue inhibitors of MMPs</p></td></tr><tr><td class="NLM_term">TNF-Î±</td><td class="NLM_def"><p class="first last">tumor necrosis factor-Î±</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr><tr><td class="NLM_term">WM</td><td class="NLM_def"><p class="first last">WaldenstrÃ¶ms macroglobulinemia</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51427" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51427" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 106 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferlay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soerjomataram, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PiÃ±eros, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Znaor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, F.</span></span> <span> </span><span class="NLM_article-title">Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">1941</span>â <span class="NLM_lpage">1953</span>, <span class="refDoi">Â DOI: 10.1002/ijc.31937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fijc.31937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=30350310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVaku77O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2019&pages=1941-1953&author=J.+Ferlayauthor=M.+Colombetauthor=I.+Soerjomataramauthor=C.+Mathersauthor=D.+M.+Parkinauthor=M.+Pi%C3%B1erosauthor=A.+Znaorauthor=F.+Bray&title=Estimating+the+global+cancer+incidence+and+mortality+in+2018%3A+GLOBOCAN+sources+and+methods&doi=10.1002%2Fijc.31937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods</span></div><div class="casAuthors">Ferlay, J.; Colombet, M.; Soerjomataram, I.; Mathers, C.; Parkin, D. M.; Pineros, M.; Znaor, A.; Bray, F.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1941-1953</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Ests. of the worldwide incidence and mortality from 36 cancers and for all cancers combined for the year 2018 are now available in the GLOBOCAN 2018 database, compiled and disseminated by the International Agency for Research on Cancer (IARC).  This paper reviews the sources and methods used in compiling the cancer statistics in 185 countries.  The validity of the national ests. depends upon the representativeness of the source information, and to take into account possible sources of bias, uncertainty intervals are now provided for the estd. sex- and site-specific all-ages no. of new cancer cases and cancer deaths.  We briefly describe the key results globally and by world region.  There were an estd. 18.1 million (95% UI: 17.5-18.7 million) new cases of cancer (17 million excluding non-melanoma skin cancer) and 9.6 million (95% UI: 9.3-9.8 million) deaths from cancer (9.5 million excluding non-melanoma skin cancer) worldwide in 2018.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFkXwTr-9_ibVg90H21EOLACvtfcHk0linnpSOzWVIig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVaku77O&md5=db8d895060c7770078fec16e2d9eb816</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fijc.31937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.31937%26sid%3Dliteratum%253Aachs%26aulast%3DFerlay%26aufirst%3DJ.%26aulast%3DColombet%26aufirst%3DM.%26aulast%3DSoerjomataram%26aufirst%3DI.%26aulast%3DMathers%26aufirst%3DC.%26aulast%3DParkin%26aufirst%3DD.%2BM.%26aulast%3DPi%25C3%25B1eros%26aufirst%3DM.%26aulast%3DZnaor%26aufirst%3DA.%26aulast%3DBray%26aufirst%3DF.%26atitle%3DEstimating%2520the%2520global%2520cancer%2520incidence%2520and%2520mortality%2520in%25202018%253A%2520GLOBOCAN%2520sources%2520and%2520methods%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2019%26volume%3D144%26spage%3D1941%26epage%3D1953%26doi%3D10.1002%2Fijc.31937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choudhari, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandave, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshpande, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranjekar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, O.</span></span> <span> </span><span class="NLM_article-title">Phytochemicals in cancer treatment: From preclinical studies to clinical practice</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1614</span>, <span class="refDoi">Â DOI: 10.3389/fphar.2019.01614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3389%2Ffphar.2019.01614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32116665" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=1614&author=A.+S.+Choudhariauthor=P.+C.+Mandaveauthor=M.+Deshpandeauthor=P.+Ranjekarauthor=O.+Prakash&title=Phytochemicals+in+cancer+treatment%3A+From+preclinical+studies+to+clinical+practice&doi=10.3389%2Ffphar.2019.01614"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.01614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.01614%26sid%3Dliteratum%253Aachs%26aulast%3DChoudhari%26aufirst%3DA.%2BS.%26aulast%3DMandave%26aufirst%3DP.%2BC.%26aulast%3DDeshpande%26aufirst%3DM.%26aulast%3DRanjekar%26aufirst%3DP.%26aulast%3DPrakash%26aufirst%3DO.%26atitle%3DPhytochemicals%2520in%2520cancer%2520treatment%253A%2520From%2520preclinical%2520studies%2520to%2520clinical%2520practice%26jtitle%3DFront.%2520Pharmacol.%26date%3D2020%26volume%3D10%26spage%3D1614%26doi%3D10.3389%2Ffphar.2019.01614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagulapalli Venkata, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharyya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishayee, A.</span></span> <span> </span><span class="NLM_article-title">Potential of neem (Azadirachta indica L.) for prevention and treatment of oncologic diseases</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>40â41</i></span>,  <span class="NLM_fpage">100</span>â <span class="NLM_lpage">115</span>, <span class="refDoi">Â DOI: 10.1016/j.semcancer.2016.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.semcancer.2016.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=27019417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28Xms1WktLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40%E2%80%9341&publication_year=2016&pages=100-115&author=S.+M.+Patelauthor=K.+C.+Nagulapalli+Venkataauthor=P.+Bhattacharyyaauthor=G.+Sethiauthor=A.+Bishayee&title=Potential+of+neem+%28Azadirachta+indica+L.%29+for+prevention+and+treatment+of+oncologic+diseases&doi=10.1016%2Fj.semcancer.2016.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Potential of neem (Azadirachta indica L.) for prevention and treatment of oncologic diseases</span></div><div class="casAuthors">Patel, Shradha M.; Nagulapalli Venkata, Kalyan C.; Bhattacharyya, Piyali; Sethi, Gautam; Bishayee, Anupam</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">40-41</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">100-115</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Throughout time, plants have often displayed medicinal properties that have been underscored.  We often derive medicines involved in treating cancer from components in plants.  Azadirachta indica, commonly known as "neem", has been used to treat different ailments in many Asian countries.  Due to its widespread beneficial uses, A. indica has often been referred to as "the wonder tree" or "nature's drug store".  Various parts of this plant, including, leaves, flowers, fruits, seeds, roots, bark and oil, produce a large no. of phytochems. with various biol. and pharmacol. activities.  The numerous biol. activities of the phytoconstituents of A. indica explain its beneficial uses for the prevention and therapy of cancer.  The chemopreventive and anticancer therapeutic efficacy of A. indica fractions and compds. could be explained by multiple cellular and mol. mechanisms, including free radical scavenging, carcinogen-detoxification, DNA repair, cell cycle alteration, programmed cell death (apoptosis) and autophagy, immune surveillance, anti-inflammatory, anti-angiogenic, anti-invasive and anti-metastatic activities as well as their ability to modulate several dysregulated oncogenic signaling pathways.  This article aims to present the collective and crit. anal. of multiple phytoconstituents of A. indica and their mol. mechanisms implicated in cancer chemopreventive and therapeutic effects based on published preclin. and clin. results.  Current limitations and future directions of research on this medicinal plant are also critically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9KcC7SJ3-YrVg90H21EOLACvtfcHk0linnpSOzWVIig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xms1WktLo%253D&md5=8d3c9362632987d6aeef9029498f942d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2016.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2016.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%2BM.%26aulast%3DNagulapalli%2BVenkata%26aufirst%3DK.%2BC.%26aulast%3DBhattacharyya%26aufirst%3DP.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DBishayee%26aufirst%3DA.%26atitle%3DPotential%2520of%2520neem%2520%2528Azadirachta%2520indica%2520L.%2529%2520for%2520prevention%2520and%2520treatment%2520of%2520oncologic%2520diseases%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2016%26volume%3D40%25E2%2580%259341%26spage%3D100%26epage%3D115%26doi%3D10.1016%2Fj.semcancer.2016.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Islas, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acosta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">G-Buentello, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado-Gallegos, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-TreviÃ±o, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escalante, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Cuevas, J. E.</span></span> <span> </span><span class="NLM_article-title">An overview of neem (Azadirachta indica) and its potential impact on health</span>. <i>J. Funct. Foods</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">104171</span>, <span class="refDoi">Â DOI: 10.1016/j.jff.2020.104171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.jff.2020.104171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVSmtLvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2020&pages=104171&author=J.+F.+Islasauthor=E.+Acostaauthor=Z.+G-Buentelloauthor=J.+L.+Delgado-Gallegosauthor=M.+G.+Moreno-Trevi%C3%B1oauthor=B.+Escalanteauthor=J.+E.+Moreno-Cuevas&title=An+overview+of+neem+%28Azadirachta+indica%29+and+its+potential+impact+on+health&doi=10.1016%2Fj.jff.2020.104171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of Neem (Azadirachta indica) and its potential impact on health</span></div><div class="casAuthors">Islas, Jose Francisco; Acosta, Ezeiza; G-Buentello, Zuca; Delgado-Gallegos, Juan Luis; Moreno-Trevino, Maria Guadalupe; Escalante, Bruno; Moreno-Cuevas, Jorge E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Functional Foods</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104171</span>CODEN:
                <span class="NLM_cas:coden">JFFOAX</span>;
        ISSN:<span class="NLM_cas:issn">1756-4646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Global health and medical practice seek to merge alternative medicine with evidence-based medicine for a better understanding of the metabolic process and its effects in the human body.  An example is the use of complementary medicine like phytotherapy.  Azadirachta indica (Neem), a tree originally from India and Myanmar, called by many "The village pharmacy" or "Divine tree" because of its many health properties.  In recent times, Neem-derived exts. have been shown to work from anywhere from insect repellent, to supplements to lower inflammation, diabetic control, and even to combat cancer.  Herein, we state the health benefits found in diverse compds. and exts. derived from Neem, highlighting the mechanisms and pathways in which Neem compds. produce their effects, while warning that the improper and unstandardized conditions to produce exts. can lead to health issues, particularly certain compds. might have damaging effects on the liver and kidneys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiw1_OFgHZcLVg90H21EOLACvtfcHk0liPL16bcy7nJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVSmtLvP&md5=78401485d482c2e1408f9f95af4fb3be</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jff.2020.104171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jff.2020.104171%26sid%3Dliteratum%253Aachs%26aulast%3DIslas%26aufirst%3DJ.%2BF.%26aulast%3DAcosta%26aufirst%3DE.%26aulast%3DG-Buentello%26aufirst%3DZ.%26aulast%3DDelgado-Gallegos%26aufirst%3DJ.%2BL.%26aulast%3DMoreno-Trevi%25C3%25B1o%26aufirst%3DM.%2BG.%26aulast%3DEscalante%26aufirst%3DB.%26aulast%3DMoreno-Cuevas%26aufirst%3DJ.%2BE.%26atitle%3DAn%2520overview%2520of%2520neem%2520%2528Azadirachta%2520indica%2529%2520and%2520its%2520potential%2520impact%2520on%2520health%26jtitle%3DJ.%2520Funct.%2520Foods%26date%3D2020%26volume%3D74%26spage%3D104171%26doi%3D10.1016%2Fj.jff.2020.104171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subapriya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Medicinal properties of neem leaves: A review</span>. <i>Curr. Med. Chem.: Anti-Cancer Agents</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">149</span>â <span class="NLM_lpage">156</span>, <span class="refDoi">Â DOI: 10.2174/1568011053174828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.2174%2F1568011053174828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=15777222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVCjurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=149-156&author=R.+Subapriyaauthor=S.+Nagini&title=Medicinal+properties+of+neem+leaves%3A+A+review&doi=10.2174%2F1568011053174828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal properties of neem leaves: a review</span></div><div class="casAuthors">Subapriya, R.; Nagini, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Cancer Agents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-156</span>CODEN:
                <span class="NLM_cas:coden">CMCACI</span>;
        ISSN:<span class="NLM_cas:issn">1568-0118</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Azadirachta indica, commonly known as neem, has attracted worldwide prominence in recent years, owing to its wide range of medicinal properties.  Neem was extensively used in Ayurveda, Unani and Homeopathic medicine and has become a cynosure of modern medicine.  Neem elaborates a vast array of biol. active compds. that are chem. diverse and structurally complex.  More than 140 compds. were isolated from different parts of neem.  All parts of the neem tree- leaves, flowers, seeds, fruits, roots and bark were used traditionally for the treatment of inflammation, infections, fever, skin diseases and dental disorders.  The medicinal utilities were described esp. for neem leaf.  Neem leaf and its constituents were demonstrated to exhibit immunomodulatory, anti-inflammatory, antihyperglycemic, antiulcer, antimalarial, antifungal, antibacterial, antiviral, antioxidant, antimutagenic and anticarcinogenic properties.  This review summarizes the wide range of pharmacol. activities of neem leaf.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU21nKb01Ku7Vg90H21EOLACvtfcHk0liPL16bcy7nJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVCjurY%253D&md5=25f2e5faf32afd520f605dc590c846c7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568011053174828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568011053174828%26sid%3Dliteratum%253Aachs%26aulast%3DSubapriya%26aufirst%3DR.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DMedicinal%2520properties%2520of%2520neem%2520leaves%253A%2520A%2520review%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Cancer%2520Agents%26date%3D2005%26volume%3D5%26spage%3D149%26epage%3D156%26doi%3D10.2174%2F1568011053174828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hummel, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langner, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leithold, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmutterer, H.</span></span> <span> </span><span class="NLM_article-title">Neem: Unusually versatile plant genus Azadirachta with many useful and so far insufficiently exploited properties for agriculture, medicine, and industry</span>. <i>Commun. Agric. Appl. Biol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">211</span>â <span class="NLM_lpage">228</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=26084100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC2Mbks1CrsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=211-228&author=H.+E.+Hummelauthor=S.+S.+Langnerauthor=G.+Leitholdauthor=H.+Schmutterer&title=Neem%3A+Unusually+versatile+plant+genus+Azadirachta+with+many+useful+and+so+far+insufficiently+exploited+properties+for+agriculture%2C+medicine%2C+and+industry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">NEEM: UNUSUALLY VERSATILE PLANT GENUS AZADIRACHTA WITH MANY USEFUL AND SO FAR INSUFFICIENTLY EXPLOITED PROPERTIES FOR AGRICULTURE, MEDICINE, AND INDUSTRY</span></div><div class="casAuthors">Hummel H E; Langner S S; Leithold G; Schmutterer H</div><div class="citationInfo"><span class="NLM_cas:title">Communications in agricultural and applied biological sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-28</span>
        ISSN:<span class="NLM_cas:issn">1379-1176</span>.
    </div><div class="casAbstract">Neem plants (Rutales: Meliaceae) are well known for their multitude of human benefits in various fields.  Specifically well investigated are the Indian neem tree Azadirachta indica A.  Juss., the Thai neem A. siamensis Val., the originally Malaysian/Philippinean neem A. excelsa (Jack) and, as a close relative, the Persian lilac, Melia azedarach.  The major and most active natural products are azadirachtin, salannin, nimbin and marrangin from Azadirachta species, and azadirachtin analogues like meliantriol from Melia species.  Neem fruits, leaves, bark, and roots have specific virtues.  They have been traditionally exploited for a considerable part of human history and are documented in Sanskrit texts.  Due to human activity in trade and travel both at land and sea, the plant species has been distributed around the globe and is cultivated in many tropical, and subtropical regions.  A multitude of natural products of neem have been isolated, chemically characterized or identified, and investigated for their properties in the management of insects, Acarina, Crustacea, nematodes, bacteria, fungi, viruses and soil fertility (for reviews see Kraus, 2002; Schmutterer, 2002A; Rembold, 2002; Koul, 2004; Schmutterer and Huber, 2005; Kleeberg and Strang, 2009; Hummel et al., 2008, 2011, 2012).  Neem products are virtually nontoxic, compatible with beneficial insects, pollinators and bees.  They are environmentally benign, sustainable, renewable, and of a price affordable for developed countries.  In conclusion, neem is a prime example of a natural resource with many beneficial applications in agriculture, human and veterinary medicine.  So far, its use is practically free of resistance problems which are frustratingly prevalent in many areas of synthetic insecticide and drug development.  Investigating more neem applications will increase future human welfare and health while being of general ecological benefit to the planet.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwQb8DoRSnI8yail4HZd-ifW6udTcc2eZqjPSQKHJcKLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mbks1CrsQ%253D%253D&md5=6b0a8185f092ca4c11299c8dd0e6907f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHummel%26aufirst%3DH.%2BE.%26aulast%3DLangner%26aufirst%3DS.%2BS.%26aulast%3DLeithold%26aufirst%3DG.%26aulast%3DSchmutterer%26aufirst%3DH.%26atitle%3DNeem%253A%2520Unusually%2520versatile%2520plant%2520genus%2520Azadirachta%2520with%2520many%2520useful%2520and%2520so%2520far%2520insufficiently%2520exploited%2520properties%2520for%2520agriculture%252C%2520medicine%252C%2520and%2520industry%26jtitle%3DCommun.%2520Agric.%2520Appl.%2520Biol.%2520Sci.%26date%3D2014%26volume%3D79%26spage%3D211%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kharwar, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gond, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaushik, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revuru, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusari, S.</span></span> <span> </span><span class="NLM_article-title">Harnessing the phytotherapeutic treasure troves of the ancient medicinal plant Azadirachta indica (neem) and associated endophytic microorganisms</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">906</span>â <span class="NLM_lpage">940</span>, <span class="refDoi">Â DOI: 10.1055/a-1107-9370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1055%2Fa-1107-9370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32126583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVynsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2020&pages=906-940&author=R.+N.+Kharwarauthor=V.+K.+Sharmaauthor=A.+Mishraauthor=J.+Kumarauthor=D.+K.+Singhauthor=S.+K.+Vermaauthor=S.+K.+Gondauthor=A.+Kumarauthor=N.+Kaushikauthor=B.+Revuruauthor=S.+Kusari&title=Harnessing+the+phytotherapeutic+treasure+troves+of+the+ancient+medicinal+plant+Azadirachta+indica+%28neem%29+and+associated+endophytic+microorganisms&doi=10.1055%2Fa-1107-9370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing the Phytotherapeutic Treasure Troves of the Ancient Medicinal Plant Azadirachta indica (Neem) and Associated Endophytic Microorganisms</span></div><div class="casAuthors">Kharwar, Ravindra N.; Sharma, Vijay K.; Mishra, Ashish; Kumar, Jitendra; Singh, Dheeraj K.; Verma, Satish K.; Gond, Surendra K.; Kumar, Anuj; Kaushik, Nutan; Revuru, Bharadwaj; Kusari, Souvik</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">13/14</span>),
    <span class="NLM_cas:pages">906-940</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Azadirachta indica, commonly known as neem, is an evergreen tree of the tropics and sub-tropics native to the Indian subcontinent with demonstrated ethnomedicinal value and importance in agriculture as well as in the pharmaceutical industry.  This ancient medicinal tree, often called the "wonder tree", is regarded as a chem. factory of diverse and complex compds. with a plethora of structural scaffolds that is very difficult to mimic by chem. synthesis.  Such multifaceted chem. diversity leads to a fantastic repertoire of functional traits, encompassing a wide variety of biol. activity and unique modes of action against specific and generalist pathogens and pests.  Until now, more than 400 compds. have been isolated from different parts of neem including important bioactive secondary metabolites such as azadirachtin, nimbidin, nimbin, nimbolide, gedunin, and many more.  In addn. to its insecticidal property, the plant is also known for antimicrobial, antimalarial, antiviral, anti-inflammatory, analgesic, antipyretic, hypoglycemic, antiulcer, antifertility, anticarcinogenic, hepatoprotective, antioxidant, anxiolytic, molluscicidal, acaricidal, and antifilarial properties.  Notwithstanding the chem. and biol. virtuosity of neem, it has also been extensively explored for assocd. microorganisms, esp. a class of mutualists called endophytic microorganisms (or endophytes).  More than 30 compds., including neem "mimetic" compds., have been reported from endophytes harbored in the neem trees in different ecol. niches.  In this review, we provide an informative and in-depth overview of the topic that can serve as a point of ref. for an understanding of the functions and applications of a medicinal plant such as neem, including assocd. endophytes, within the overall theme of phytopathol.  Our review further exemplifies the already-noted current surge of interest in plant and microbial natural products for implications both within the ecol. and clin. settings, for a more secure and sustainable future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAZ7LPziK8ObVg90H21EOLACvtfcHk0lhdIra7bl8arg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVynsb0%253D&md5=ae3f5614213b0569872de57e94e7d70f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1055%2Fa-1107-9370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fa-1107-9370%26sid%3Dliteratum%253Aachs%26aulast%3DKharwar%26aufirst%3DR.%2BN.%26aulast%3DSharma%26aufirst%3DV.%2BK.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DD.%2BK.%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DGond%26aufirst%3DS.%2BK.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DKaushik%26aufirst%3DN.%26aulast%3DRevuru%26aufirst%3DB.%26aulast%3DKusari%26aufirst%3DS.%26atitle%3DHarnessing%2520the%2520phytotherapeutic%2520treasure%2520troves%2520of%2520the%2520ancient%2520medicinal%2520plant%2520Azadirachta%2520indica%2520%2528neem%2529%2520and%2520associated%2520endophytic%2520microorganisms%26jtitle%3DPlanta%2520Med.%26date%3D2020%26volume%3D86%26spage%3D906%26epage%3D940%26doi%3D10.1055%2Fa-1107-9370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Neem limonoids as anticancer agents: Modulation of cancer hallmarks and oncogenic signaling</span>. <i>Enzymes</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">131</span>â <span class="NLM_lpage">147</span>, <span class="refDoi">Â DOI: 10.1016/B978-0-12-802215-3.00007-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2FB978-0-12-802215-3.00007-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=27102702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yru7rO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2014&pages=131-147&author=S.+Nagini&title=Neem+limonoids+as+anticancer+agents%3A+Modulation+of+cancer+hallmarks+and+oncogenic+signaling&doi=10.1016%2FB978-0-12-802215-3.00007-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Neem limonoids as anticancer agents: modulation of cancer hallmarks and oncogenic signaling</span></div><div class="casAuthors">Nagini, Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">Enzymes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">131-147</span>CODEN:
                <span class="NLM_cas:coden">25GLAS</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Neem (Azadirachta indica A. Juss) is one of the most versatile medicinal plants, widely distributed in the Indian subcontinent.  Neem is a rich source of limonoids that are endowed with potent medicinal properties predominantly antioxidant, anti-inflammatory, and anticancer activities.  Azadirachtin, gedunin, and nimbolide are more extensively investigated relative to other neem limonoids.  Accumulating evidence indicates that the anticancer effects of neem limonoids are mediated through the inhibition of hallmark capabilities of cancer such as cell proliferation, apoptosis evasion, inflammation, invasion, and angiogenesis.  The neem limonoids have been demonstrated to target oncogenic signaling kinases and transcription factors chiefly, NF-ÎºB, Wnt/Î²-catenin, PI3K/Akt, MAPK, and JAK/STAT signaling pathways.  Neem limonoids that target multiple pathways that are aberrant in cancer are ideal candidates for cancer chemoprevention and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpBKNV6Gh4K7Vg90H21EOLACvtfcHk0lhdIra7bl8arg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yru7rO&md5=6596df3ba46c91471d4eea739e3e0292</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-802215-3.00007-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-802215-3.00007-0%26sid%3Dliteratum%253Aachs%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DNeem%2520limonoids%2520as%2520anticancer%2520agents%253A%2520Modulation%2520of%2520cancer%2520hallmarks%2520and%2520oncogenic%2520signaling%26jtitle%3DEnzymes%26date%3D2014%26volume%3D36%26spage%3D131%26epage%3D147%26doi%3D10.1016%2FB978-0-12-802215-3.00007-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quistad, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casida, J. E.</span></span> <span> </span><span class="NLM_article-title">Cytotoxicity of nimbolide, epoxyazadiradione and other limonoids from neem insecticide</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1075</span>â <span class="NLM_lpage">1081</span>, <span class="refDoi">Â DOI: 10.1016/0024-3205(96)00061-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2F0024-3205%2896%2900061-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=8622560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADyaK28XhsVWrsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1996&pages=1075-1081&author=E.+Cohenauthor=G.+B.+Quistadauthor=J.+E.+Casida&title=Cytotoxicity+of+nimbolide%2C+epoxyazadiradione+and+other+limonoids+from+neem+insecticide&doi=10.1016%2F0024-3205%2896%2900061-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxicity of nimbolide, epoxyazadiradione and other limonoids from neem insecticide</span></div><div class="casAuthors">Cohen, Ephraim; Quistad, Gary B.; Casida, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1075-81</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Neem seed prepns. contain not only azadirachtin as the active insect antifeedant or growth regulator but also a variety of other limonoids, some of which are cytotoxic to N1E-115 neuroblastoma (mouse), 143B.TK- osteosarcoma (human) and Sf9 (insect) cultured cell lines.  The most potent of these limonoids is nimbolide with an IC50 ranging from 4 to 10 Î¼M and averaging 6 Î¼M for the three cell lines.  Other limonoids of decreasing potency and their av. IC50 values (Î¼M) are epoxyazadiradione 27 Î¼M, salannin 112 Î¼M, and nimbin, deacetylnimbin and azadirachtin each >200 Î¼M (practically nontoxic).  Nimbolide at 10 Î¼M acts rapidly in the neuroblastoma cells to induce blebbing assocd. with disruption of plasma membranes almost instantaneously and 50% loss of cell viability within 30 min.  At 5 Î¼M nimbolide, the cells become elongated and assume a neuronal shape accompanied by spikes and lamellipodia within 1-2 h followed shortly thereafter by extensive cytol. changes and vacuolization assocd. with irreversible processes leading to cell death.  Calcium is apparently not involved in the cytotoxic effect since a calcium-free medium, leading to profound morphol. changes, does not alter the sensitivity to nimbolide.  In contrast, epoxyazadiradione requires higher concns. and a few hours for 50% viability loss without major morphol. changes, indicating a difference in mode of action for nimbolide and epoxyazadiradione.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBbj736fCtirVg90H21EOLACvtfcHk0lhdIra7bl8arg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsVWrsLk%253D&md5=09405fc8e2475a4f25c71f0dd7de581e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2896%2900061-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252896%252900061-6%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DE.%26aulast%3DQuistad%26aufirst%3DG.%2BB.%26aulast%3DCasida%26aufirst%3DJ.%2BE.%26atitle%3DCytotoxicity%2520of%2520nimbolide%252C%2520epoxyazadiradione%2520and%2520other%2520limonoids%2520from%2520neem%2520insecticide%26jtitle%3DLife%2520Sci.%26date%3D1996%26volume%3D58%26spage%3D1075%26epage%3D1081%26doi%3D10.1016%2F0024-3205%2896%2900061-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anitha, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josepha Lourdu Raj, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand Solomon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajan, S. S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide and isonimbolide</span>. <i>J. Asian Nat. Prod. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">445</span>â <span class="NLM_lpage">449</span>, <span class="refDoi">Â DOI: 10.1080/10286020500173267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1080%2F10286020500173267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=16864461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVequr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=445-449&author=G.+Anithaauthor=J.+Josepha+Lourdu+Rajauthor=S.+Narasimhanauthor=K.+Anand+Solomonauthor=S.+S.+Rajan&title=Nimbolide+and+isonimbolide&doi=10.1080%2F10286020500173267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide and isonimbolide</span></div><div class="casAuthors">Anitha, G.; Raj, J. Josepha Lourdu; Narasimhan, S.; Solomon, K. Anand; Rajan, S. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Asian Natural Products Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">445-449</span>CODEN:
                <span class="NLM_cas:coden">JANRFI</span>;
        ISSN:<span class="NLM_cas:issn">1028-6020</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Nimbolide 1, a potent mol. of biol. significance, was isolated.  Attempts were made to cleave the ether linkage in nimbolide using boron trifluoride etherate in the presence of tetra-Bu ammonium bromide so as to generate a ring-opened structure akin to azadirachtins, which are known to possess excellent antifeedant properties.  However, a novel rearranged product was envisaged during the course of the reaction, which was detd. as isonimbolide 2-a structural isomer of nimbolide through spectroscopic methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvWPGkWUK3wbVg90H21EOLACvtfcHk0lgGTewbJU4nYw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVequr8%253D&md5=2fe43e1f62456c98761f125b2c468b36</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1080%2F10286020500173267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10286020500173267%26sid%3Dliteratum%253Aachs%26aulast%3DAnitha%26aufirst%3DG.%26aulast%3DJosepha%2BLourdu%2BRaj%26aufirst%3DJ.%26aulast%3DNarasimhan%26aufirst%3DS.%26aulast%3DAnand%2BSolomon%26aufirst%3DK.%26aulast%3DRajan%26aufirst%3DS.%2BS.%26atitle%3DNimbolide%2520and%2520isonimbolide%26jtitle%3DJ.%2520Asian%2520Nat.%2520Prod.%2520Res.%26date%3D2006%26volume%3D8%26spage%3D445%26epage%3D449%26doi%3D10.1080%2F10286020500173267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sastry, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh Babu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hari Babu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhusudana Rao, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of amide derivatives of nimbolide</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">4391</span>â <span class="NLM_lpage">4394</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2006.05.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.bmcl.2006.05.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=16793266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFertb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4391-4394&author=B.+S.+Sastryauthor=K.+Suresh+Babuauthor=T.+Hari+Babuauthor=S.+Chandrasekharauthor=P.+V.+Srinivasauthor=A.+K.+Saxenaauthor=J.+Madhusudana+Rao&title=Synthesis+and+biological+activity+of+amide+derivatives+of+nimbolide&doi=10.1016%2Fj.bmcl.2006.05.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activity of amide derivatives of nimbolide</span></div><div class="casAuthors">Sastry, B. S.; Babu, K. Suresh; Babu, T. Hari; Chandrasekhar, S.; Srinivas, P. V.; Saxena, A. K.; Rao, J. Madhusudana</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4391-4394</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nimbolide (I), a limonoid isolated from Azadirachta indica, is the chief cytotoxic principle in Neem leaves ext.  Using nimbolide as a lead compd. for anti-cancer analog design, a series of nimbolide derivs., e.g., II, have been synthesized by ring-opening of the lactone ring with amines, and evaluated for in vitro cytotoxic activity against a panel of human cancer cell lines.  Out of the 10 compds. screened, three of them, including II, showed potent activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpk1kkyld14rVg90H21EOLACvtfcHk0lgGTewbJU4nYw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFertb8%253D&md5=b391fbc6ba29c2d512226cf34259e605</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.05.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.05.105%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DB.%2BS.%26aulast%3DSuresh%2BBabu%26aufirst%3DK.%26aulast%3DHari%2BBabu%26aufirst%3DT.%26aulast%3DChandrasekhar%26aufirst%3DS.%26aulast%3DSrinivas%26aufirst%3DP.%2BV.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DMadhusudana%2BRao%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520amide%2520derivatives%2520of%2520nimbolide%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4391%26epage%3D4394%26doi%3D10.1016%2Fj.bmcl.2006.05.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rochanakij, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thebtaranonth, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yenjai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuthavong, Y.</span></span> <span> </span><span class="NLM_article-title">Nimbolide, a constituent of Azadirachta indica, inhibits Plasmodium falciparum in culture</span>. <i>Southeast Asian J. Trop. Med. Public Health</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">66</span>â <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=3895455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADyaL28Xis1U%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1985&pages=66-67&author=S.+Rochanakijauthor=Y.+Thebtaranonthauthor=C.+Yenjaiauthor=Y.+Yuthavong&title=Nimbolide%2C+a+constituent+of+Azadirachta+indica%2C+inhibits+Plasmodium+falciparum+in+culture"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide, a constituent of Azadirachta indica, inhibits Plasmodium falciparum in culture</span></div><div class="casAuthors">Rochanakij, Sudaratana; Thebtaranonth, Yodhathai; Yenjai, Chavi; Yuthavong, Yongyuth</div><div class="citationInfo"><span class="NLM_cas:title">Southeast Asian Journal of Tropical Medicine and Public Health</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-72</span>CODEN:
                <span class="NLM_cas:coden">SJTMAK</span>;
        ISSN:<span class="NLM_cas:issn">0125-1562</span>.
    </div><div class="casAbstract">The terpenoid lactone nimbolide (I)  [25990-37-8] inhibited P. falciparum in culture with a moderate potency.  The EC50 against the parasite line K1 from Thailand was approx. 2.0 Î¼M (0.95 Î¼g/m).  The EC50 of crude aq. ext. of Azadirachta indica siamensis (Sadao tree), was 115 Î¼g/mL, and of crude EtOH ext. was 5.0 Î¼g/mL.  Since I is a major constituent in these exts., it could account substantially for their inhibitory activity.  However, neither the crude exts. nor I showed any activity in vivo against P. berghei in the mouse either through ingestion (746 mg aq. ext., 62.5 mg EtOH ext. or 12.5 mg nimbolide/kg/day), or s.c. injection (93 mg aq. ext., 31 mg EtOH ext. or 12.5 mg I/kg/day).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodIQyjZzeCbrVg90H21EOLACvtfcHk0lgGTewbJU4nYw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xis1U%253D&md5=83b8daf0560b6de9ed42e589774d190e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRochanakij%26aufirst%3DS.%26aulast%3DThebtaranonth%26aufirst%3DY.%26aulast%3DYenjai%26aufirst%3DC.%26aulast%3DYuthavong%26aufirst%3DY.%26atitle%3DNimbolide%252C%2520a%2520constituent%2520of%2520Azadirachta%2520indica%252C%2520inhibits%2520Plasmodium%2520falciparum%2520in%2520culture%26jtitle%3DSoutheast%2520Asian%2520J.%2520Trop.%2520Med.%2520Public%2520Health%26date%3D1985%26volume%3D16%26spage%3D66%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Githua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassanali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keriko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murilla, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndungu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyagah, G.</span></span> <span> </span><span class="NLM_article-title">New antitrypanosomal tetranotriterpenoids from Azadirachta indica</span>. <i>Afr. J. Tradit. Complement Altern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">207</span>â <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.4314%2Fajtcam.v7i3.54776" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=21461147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlWnsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=207-213&author=M.+Githuaauthor=A.+Hassanaliauthor=J.+Kerikoauthor=G.+Murillaauthor=M.+Ndunguauthor=G.+Nyagah&title=New+antitrypanosomal+tetranotriterpenoids+from+Azadirachta+indica"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">New antitrypanosomal tetranotriterpenoids from Azadirachta indica</span></div><div class="casAuthors">Githua, Mercy; Hassanali, Ahmed; Keriko, Joseph; Murilla, Grace; Ndungu, Mary; Nyagah, Gathu</div><div class="citationInfo"><span class="NLM_cas:title">African Journal of Traditional, Complementary and Alternative Medicines</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-213</span>CODEN:
                <span class="NLM_cas:coden">AJTCAU</span>;
        ISSN:<span class="NLM_cas:issn">0189-6016</span>.
    
            (<span class="NLM_cas:orgname">African Networks on Ethnomedicines</span>)
        </div><div class="casAbstract">Org. exts. of the leaves of Azadirachta indica A. Juss. yielded ten antitrypanosomal terpenoids.  Three of these (1 - 3), are novel and are derivs. of nimbolide and nimbin.  They were extd. from chloroform fraction of methanol ext.  These compds. were found to exhibit strong antitrypanosomal activities against Trypanosoma brucei rhodesiense with MIC values ranging of 6.9, 15.6 and 7.8 Î¼g/mL resp. and were more active than Cymerlarsan (a std. drug), which had an MIC value of 187.5 Î¼g/mL when tested against T. b. rhodesiense.  The structures were elucidated by spectroscopic methods including; NMR, MS, UV and IR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok10RFUmB_ebVg90H21EOLACvtfcHk0liP9oguJz54mA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlWnsbc%253D&md5=c8f739a201ff53127dca4fbedfe42589</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4314%2Fajtcam.v7i3.54776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4314%252Fajtcam.v7i3.54776%26sid%3Dliteratum%253Aachs%26aulast%3DGithua%26aufirst%3DM.%26aulast%3DHassanali%26aufirst%3DA.%26aulast%3DKeriko%26aufirst%3DJ.%26aulast%3DMurilla%26aufirst%3DG.%26aulast%3DNdungu%26aufirst%3DM.%26aulast%3DNyagah%26aufirst%3DG.%26atitle%3DNew%2520antitrypanosomal%2520tetranotriterpenoids%2520from%2520Azadirachta%2520indica%26jtitle%3DAfr.%2520J.%2520Tradit.%2520Complement%2520Altern.%2520Med.%26date%3D2010%26volume%3D7%26spage%3D207%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharyya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thankamani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koley, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bag, P. K.</span></span> <span> </span><span class="NLM_article-title">Intracellular, biofilm-inhibitory and membrane-damaging activities of nimbolide isolated from Azadirachta indica A. Juss (Meliaceae) against meticillin-resistant Staphylococcus aureus</span>. <i>J. Med. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1205</span>â <span class="NLM_lpage">1214</span>, <span class="refDoi">Â DOI: 10.1099/jmm.0.000343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1099%2Fjmm.0.000343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=27553840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlSntb7K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1205-1214&author=P.+Sarkarauthor=S.+Acharyyaauthor=A.+Banerjeeauthor=A.+Patraauthor=K.+Thankamaniauthor=H.+Koleyauthor=P.+K.+Bag&title=Intracellular%2C+biofilm-inhibitory+and+membrane-damaging+activities+of+nimbolide+isolated+from+Azadirachta+indica+A.+Juss+%28Meliaceae%29+against+meticillin-resistant+Staphylococcus+aureus&doi=10.1099%2Fjmm.0.000343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular, biofilm-inhibitory and membrane-damaging activities of nimbolide isolated from Azadirachta indica A. Juss (Meliaceae) against meticillin-resistant Staphylococcus aureus</span></div><div class="casAuthors">Sarkar, Prodipta; Acharyya, Saurabh; Banerjee, Anirban; Patra, Amarendra; Thankamani, Karthika; Koley, Hemanta; Bag, Prasanta K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Microbiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1205-1214</span>CODEN:
                <span class="NLM_cas:coden">JMMIAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-2615</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Staphylococcus aureus is a leading etiol. agent of nosocomial- and community-acquired infectious diseases worldwide.  The public health concern regarding staphylococcal infections is inflated by the increasing occurrence of multidrug-resistant strains, e.g. multidrug- and meticillin-resistant S. aureus (MDR MRSA).  This study was designed to evaluate the intracellular killing, membrane-damaging and biofilm-inhibitory activities of nimbolide isolated from Azadirachta indica against MDR MRSA.  In vitro antibacterial activity of nimbolide was detd. by performing MIC, minimal bactericidal concn. (MBC) and time-kill kinetic studies.  Bacterial membrane-damaging activity was detd. by membrane perturbation and SEM (SEM) examn.  Biofilm-inhibitory activities were detd. by SEM.  Cellular drug accumulation and assessments of intracellular activities were performed using Vero cell culture.  SEM revealed that nimbolide caused significant membrane damage and lysis of the S. aureus cells.  The biofilm structure was disrupted, and the biofilm formation was greatly reduced in the presence of nimbolide as examd. by SEM.  The level of accumulation of nimbolide in Vero cells incubated for 24 h is relatively higher than that of ciprofloxacin and nalidixic acid (Cc/Ce for nimbolide > ciprofloxacin and nalidixic acid).  The viable no. of intracellular S. aureus was decreased [redn. of â¼2 log10 c.f.u. (mg Vero cell protein)-1] in a time-dependent manner in the presence of nimbolide (4Ã MBC) that was comparable to that of tetracycline and nalidixic acid.  The significant intracellular, biofilm-inhibitory and bacterial membrane-damaging activities of nimbolide demonstrated here suggested that it has potential as an effective antibacterial agent for the treatment of severe infections caused by MDR MRSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxtWG5beE2hrVg90H21EOLACvtfcHk0liP9oguJz54mA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlSntb7K&md5=3d371999538ec7bacf09dd663c45d844</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1099%2Fjmm.0.000343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fjmm.0.000343%26sid%3Dliteratum%253Aachs%26aulast%3DSarkar%26aufirst%3DP.%26aulast%3DAcharyya%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DPatra%26aufirst%3DA.%26aulast%3DThankamani%26aufirst%3DK.%26aulast%3DKoley%26aufirst%3DH.%26aulast%3DBag%26aufirst%3DP.%2BK.%26atitle%3DIntracellular%252C%2520biofilm-inhibitory%2520and%2520membrane-damaging%2520activities%2520of%2520nimbolide%2520isolated%2520from%2520Azadirachta%2520indica%2520A.%2520Juss%2520%2528Meliaceae%2529%2520against%2520meticillin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DJ.%2520Med.%2520Microbiol.%26date%3D2016%26volume%3D65%26spage%3D1205%26epage%3D1214%26doi%3D10.1099%2Fjmm.0.000343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anjum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassan, I. Md.</span></span> <span> </span><span class="NLM_article-title">Search of potential inhibitor against New Delhi metallo-beta-lactamase 1 from a series of antibacterial natural compounds</span>. <i>J. Nat. Sci. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">51</span>â <span class="NLM_lpage">56</span>, <span class="refDoi">Â DOI: 10.4103/0976-9668.107260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.4103%2F0976-9668.107260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=23633835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvV2iu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=51-56&author=P.+K.+Thakurauthor=J.+Kumarauthor=D.+Rayauthor=F.+Anjumauthor=I.+Md.+Hassan&title=Search+of+potential+inhibitor+against+New+Delhi+metallo-beta-lactamase+1+from+a+series+of+antibacterial+natural+compounds&doi=10.4103%2F0976-9668.107260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Search of potential inhibitor against New Delhi metallo-beta-lactamase 1 from a series of antibacterial natural compounds</span></div><div class="casAuthors">Thakur, Prasoon Kumar; Kumar, Jitender; Ray, Divya; Anjum, Farah; Hassan, Md. Imtaiyaz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Science, Biology and Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-56</span>CODEN:
                <span class="NLM_cas:coden">JNSBAD</span>;
        ISSN:<span class="NLM_cas:issn">2229-7707</span>.
    
            (<span class="NLM_cas:orgname">Medknow Publications and Media Pvt. Ltd.</span>)
        </div><div class="casAbstract">New Delhi metallo-Î²-lactamase-1 (NDM-1)-producing Gram-neg. bacteria are today's major worldwide health concern.  The enzyme NDM-1 provides bacterial resistance by its hydrolytic activity against the Î²-lactam ring of antibiotics.  Inhibition of NDM-1 may prevent the hydrolysis of Î²-lactam ring of the antibiotics, and therefore, plays an important role against antibacterial resistance.  Materials and Methods: Here we made an attempt to design suitable inhibitors against NDM-1 from different natural antibacterial compds. using mol. docking approach.  Results: We obsd. that natural compds. such as Nimbolide and Isomargololone are showing an appreciable IC50 value as well as significant binding energy value for NDM-1.  We further obsd. these compds. showing better affinity to NDM-1 on comparison with 14 Î²-lactam antibiotics.  Conclusion: Finally, our study provides a platform for the development of a potent inhibitor of NDM-1, which may be considered as a potential drug candidate against bacterial resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg1iu7-fKfhbVg90H21EOLACvtfcHk0liP9oguJz54mA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvV2iu7Y%253D&md5=c8f4650d012ed88b86d833fa1942a0a6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4103%2F0976-9668.107260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0976-9668.107260%26sid%3Dliteratum%253Aachs%26aulast%3DThakur%26aufirst%3DP.%2BK.%26aulast%3DKumar%26aufirst%3DJ.%26aulast%3DRay%26aufirst%3DD.%26aulast%3DAnjum%26aufirst%3DF.%26aulast%3DHassan%26aufirst%3DI.%2BMd.%26atitle%3DSearch%2520of%2520potential%2520inhibitor%2520against%2520New%2520Delhi%2520metallo-beta-lactamase%25201%2520from%2520a%2520series%2520of%2520antibacterial%2520natural%2520compounds%26jtitle%3DJ.%2520Nat.%2520Sci.%2520Biol.%2520Med.%26date%3D2013%26volume%3D4%26spage%3D51%26epage%3D56%26doi%3D10.4103%2F0976-9668.107260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vora, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chhabria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrivastava, N.</span></span> <span> </span><span class="NLM_article-title">Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV</span>. <i>J. Biomol. Struct. Dyn.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">131</span>â <span class="NLM_lpage">146</span>, <span class="refDoi">Â DOI: 10.1080/07391102.2017.1420489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1080%2F07391102.2017.1420489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29268664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWqt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=131-146&author=J.+Voraauthor=S.+Patelauthor=S.+Sinhaauthor=S.+Sharmaauthor=A.+Srivastavaauthor=M.+Chhabriaauthor=N.+Shrivastava&title=Molecular+docking%2C+QSAR+and+ADMET+based+mining+of+natural+compounds+against+prime+targets+of+HIV&doi=10.1080%2F07391102.2017.1420489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV</span></div><div class="casAuthors">Vora, Jaykant; Patel, Shivani; Sinha, Sonam; Sharma, Sonal; Srivastava, Anshu; Chhabria, Mahesh; Shrivastava, Neeta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Structure and Dynamics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-146</span>CODEN:
                <span class="NLM_cas:coden">JBSDD6</span>;
        ISSN:<span class="NLM_cas:issn">0739-1102</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">AIDS is one of the multifaceted diseases and this underlying complexity hampers its complete cure.  The toxicity of existing drugs and emergence of multidrug-resistant virus makes the treatment worse.  Development of effective, safe and low-cost anti-HIV drugs is among the top global priority.  Exploration of natural resources may give ray of hope to develop new anti-HIV leads.  Among the various therapeutic targets for HIV treatment, reverse transcriptase, protease, integrase, GP120, and RNase are the prime focus.  In the present study, we predicted potential plant-derived natural mols. for HIV treatment using computational approach, i.e. mol. docking, quant. structure activity relationship (QSAR), and ADMET studies.  Receptor-ligand binding studies were performed using three different software for precise prediction - Discovery studio 4.0, Schrodinger and Molegrow virtual docker.  Docking scores revealed that Mulberrosides, Anolignans, Curcumin and Chebulic acid are promising candidates that bind with multi targets of HIV, while Neo-andrographolide, Nimbolide and Punigluconin were target-specific candidates.  Subsequently, QSAR was performed using biol. proved compds. which predicted the biol. activity of compds.  We identified Anolignans, Curcumin, Mulberrosides, Chebulic acid and Neo-andrographolide as potential natural mols. for HIV treatment from results of mol. docking and 3D-QSAR.  In silico ADMET studies showed drug-likeness of these lead mols.  Structure similarities of identified lead mols. were compared with identified marketed drugs by superimposing both the mols.  Using in silico studies, we have identified few best fit mols. of natural origin against identified targets which may give new drugs to combat HIV infection after wet lab validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFAr9GeHPXCbVg90H21EOLACvtfcHk0liP9oguJz54mA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWqt7Y%253D&md5=f01b6e6fb4acd43fa1bd7759cc33234f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1080%2F07391102.2017.1420489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07391102.2017.1420489%26sid%3Dliteratum%253Aachs%26aulast%3DVora%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DChhabria%26aufirst%3DM.%26aulast%3DShrivastava%26aufirst%3DN.%26atitle%3DMolecular%2520docking%252C%2520QSAR%2520and%2520ADMET%2520based%2520mining%2520of%2520natural%2520compounds%2520against%2520prime%2520targets%2520of%2520HIV%26jtitle%3DJ.%2520Biomol.%2520Struct.%2520Dyn.%26date%3D2019%26volume%3D37%26spage%3D131%26epage%3D146%26doi%3D10.1080%2F07391102.2017.1420489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diddi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulivendala, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma</span>. <i>Inflammopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">139</span>â <span class="NLM_lpage">149</span>, <span class="refDoi">Â DOI: 10.1007/s10787-018-0527-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs10787-018-0527-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=30218238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslCjsLrP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=139-149&author=S.+Diddiauthor=S.+Baleauthor=G.+Pulivendalaauthor=C.+Godugu&title=Nimbolide+ameliorates+fibrosis+and+inflammation+in+experimental+murine+model+of+bleomycin-induced+scleroderma&doi=10.1007%2Fs10787-018-0527-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma</span></div><div class="casAuthors">Diddi, Snehalatha; Bale, Swarna; Pulivendala, Gauthami; Godugu, Chandraiah</div><div class="citationInfo"><span class="NLM_cas:title">Inflammopharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-149</span>CODEN:
                <span class="NLM_cas:coden">IAOAES</span>;
        ISSN:<span class="NLM_cas:issn">0925-4692</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Objective: Our current study is aimed at demonstrating the antifibrotic and anti-inflammatory potential of nimbolide, a triterpene derived from Indian traditional plant neem, in a murine model of Bleomycin-induced scleroderma.  Methods: Male C57BL/6 mice were administered with Bleomycin injections s.c., daily for 28 days, at a const. site on the dorsum of the mice.  Treatment with nimbolide lasted from day 1 to day 28.  At the time of study termination, the injected sites were collected and stored suitably to conduct further mol. expts. and protein expression studies.  Results and conclusion: The results of our study show that nimbolide can significantly intervene in the TGF-Î²/Smad signaling axis and the consequent EMT process, thus attenuating deposition of extracellular matrix.  Nimbolide also profoundly caused the regression of established inflammation-driven fibrosis, thus demonstrating both antifibrotic and anti-inflammatory activities.  Another commendable finding of this study is that nimbolide was able to decrease the levels of LOXL2, a collagen cross-linker, which is aberrantly expressed in scleroderma.  Although further mechanistic studies are required, our study displays nimbolide for the first time as a potent antifibrotic agent which can be used as a pharmacol. intervention for the treatment of scleroderma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgXhcAufdAl7Vg90H21EOLACvtfcHk0liSE-Xh6ZN4WQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslCjsLrP&md5=811a1fa4594a44fa123465bb1d4d3d23</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs10787-018-0527-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10787-018-0527-4%26sid%3Dliteratum%253Aachs%26aulast%3DDiddi%26aufirst%3DS.%26aulast%3DBale%26aufirst%3DS.%26aulast%3DPulivendala%26aufirst%3DG.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DNimbolide%2520ameliorates%2520fibrosis%2520and%2520inflammation%2520in%2520experimental%2520murine%2520model%2520of%2520bleomycin-induced%2520scleroderma%26jtitle%3DInflammopharmacology%26date%3D2019%26volume%3D27%26spage%3D139%26epage%3D149%26doi%3D10.1007%2Fs10787-018-0527-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prashanth
Goud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulivendala, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">Therapeutic effects of nimbolide, an autophagy regulator, in ameliorating pulmonary fibrosis through attenuation of TGF-Î²1 driven epithelial-to-mesenchymal transition</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">105755</span>, <span class="refDoi">Â DOI: 10.1016/j.intimp.2019.105755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.intimp.2019.105755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31377591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFamsLrN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2019&pages=105755&author=M.+Prashanth%0AGoudauthor=S.+Baleauthor=G.+Pulivendalaauthor=C.+Godugu&title=Therapeutic+effects+of+nimbolide%2C+an+autophagy+regulator%2C+in+ameliorating+pulmonary+fibrosis+through+attenuation+of+TGF-%CE%B21+driven+epithelial-to-mesenchymal+transition&doi=10.1016%2Fj.intimp.2019.105755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic effects of Nimbolide, an autophagy regulator, in ameliorating pulmonary fibrosis through attenuation of TGF-gamma1 driven epithelial-to-mesenchymal transition</span></div><div class="casAuthors">Prashanth Goud, M.; Bale, Swarna; Pulivendala, Gauthami; Godugu, Chandraiah</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105755</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pulmonary fibrosis is an irreversible lung disorder with predictable decline in lung function leading to respiratory insufficiency.  Incidence of pulmonary fibrosis has been apparently increasing worldwide.  Though etiol. of this disease remains unclear, potential roles of infection, disordered cell biol., genetic influence etc. have been proposed.  Pirfenidone and nintedanib are the only two US FDA approved drugs to treat pulmonary fibrosis.  Autophagy is a catabolic intracellular pathway that plays a crucial role in maintaining cellular homeostasis, which is involved in many disorders including fibrotic diseases.  The present study investigated the role of Nimbolide, an important active constituent of Neem in TGF-gamma1 induced in vitro and bleomycin induced in vivo model of pulmonary fibrosis, with a slight emphasis on regulation of fibrosis related autophagy.  Protein expression studies showed significant redn. in mesenchymal, fibrotic markers and a substantial up regulation of epithelial markers upon treatment with Nimbolide.  Nimbolide regulated autophagy signaling by dampening LC-3 and p-62 expression and increasing Beclin 1 expression as evidenced by immunohistochem. and confocal microscopy.  Our study demonstrates Nimbolide as a potent anti-fibrotic agent and its ability to regulate fibrosis assocd. autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU1w29I2OkFrVg90H21EOLACvtfcHk0liSE-Xh6ZN4WQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFamsLrN&md5=be71fe26c2afc0d4c07bb2c28ab12458</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2019.105755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2019.105755%26sid%3Dliteratum%253Aachs%26aulast%3DPrashanth%2BGoud%26aufirst%3DM.%26aulast%3DBale%26aufirst%3DS.%26aulast%3DPulivendala%26aufirst%3DG.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DTherapeutic%2520effects%2520of%2520nimbolide%252C%2520an%2520autophagy%2520regulator%252C%2520in%2520ameliorating%2520pulmonary%2520fibrosis%2520through%2520attenuation%2520of%2520TGF-%25CE%25B21%2520driven%2520epithelial-to-mesenchymal%2520transition%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2019%26volume%3D75%26spage%3D105755%26doi%3D10.1016%2Fj.intimp.2019.105755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Annaldas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saifi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khurana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">Nimbolide ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibition of TGF-beta and EMT/Slug signalling</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">247</span>â <span class="NLM_lpage">255</span>, <span class="refDoi">Â DOI: 10.1016/j.molimm.2019.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.molimm.2019.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31202101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFKjtLvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2019&pages=247-255&author=S.+Annaldasauthor=M.+A.+Saifiauthor=A.+Khuranaauthor=C.+Godugu&title=Nimbolide+ameliorates+unilateral+ureteral+obstruction-induced+renal+fibrosis+by+inhibition+of+TGF-beta+and+EMT%2FSlug+signalling&doi=10.1016%2Fj.molimm.2019.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibition of TGF-Î² and EMT/Slug signalling</span></div><div class="casAuthors">Annaldas, Shivaraju; Saifi, Mohd Aslam; Khurana, Amit; Godugu, Chandraiah</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247-255</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Chronic kidney disease (CKD) involves interstitial fibrosis as an underlying pathol. process assocd. with compromised renal function irresp. of etiol. cause of the injury.  The transforming growth factor-Î² (TGF-Î²) plays a pivotal role in progression of renal fibrosis.  TGF-Î² transduces its downstream signaling by phosphorylation of smad2/3 and also regulates epithelial-mesenchymal-transition (EMT), a program centrally involved in activation of fibroblasts.  Renal fibrosis was induced in Swiss albino mice by unilateral ureteral obstruction of animals.  Kidney tissues were evaluated for fibrotic protein expression by western blot and immunohistochem.  The administration of nimbolide (NB) to UUO animals reduced the oxidative stress, expression of ECM proteins, TGF-Î², p-smad and EMT program.  Further, NB administration also improved histoarchitecture of obstructed kidney and reduced the collagen deposition in kidney.  Our results provided compelling evidence to support antifibrotic activity of NB by redn. in oxidative stress, TGF-Î², and EMT program in fibrotic kidney.  The administration of NB in animals blunted the UUO-induced renal injury, inflammation and reduced fibrogenesis in obstructed kidney.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSsWMJ7mNpXrVg90H21EOLACvtfcHk0liSE-Xh6ZN4WQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFKjtLvM&md5=8009e4ea6d7b30e07710fd036247447c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2019.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2019.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DAnnaldas%26aufirst%3DS.%26aulast%3DSaifi%26aufirst%3DM.%2BA.%26aulast%3DKhurana%26aufirst%3DA.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DNimbolide%2520ameliorates%2520unilateral%2520ureteral%2520obstruction-induced%2520renal%2520fibrosis%2520by%2520inhibition%2520of%2520TGF-beta%2520and%2520EMT%252FSlug%2520signalling%26jtitle%3DMol.%2520Immunol.%26date%3D2019%26volume%3D112%26spage%3D247%26epage%3D255%26doi%3D10.1016%2Fj.molimm.2019.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide inhibits nuclear factor-ÎºB pathway in intestinal epithelial cells and macrophages and alleviates experimental colitis in mice</span>. <i>Phytother. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1605</span>â <span class="NLM_lpage">1614</span>, <span class="refDoi">Â DOI: 10.1002/ptr.5657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fptr.5657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=27270592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1SjtLrF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=1605-1614&author=J.+Y.+Seoauthor=C.+Leeauthor=S.+W.+Hwangauthor=J.+Chunauthor=J.+P.+Imauthor=J.+S.+Kim&title=Nimbolide+inhibits+nuclear+factor-%CE%BAB+pathway+in+intestinal+epithelial+cells+and+macrophages+and+alleviates+experimental+colitis+in+mice&doi=10.1002%2Fptr.5657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide Inhibits Nuclear Factor-ÎºB Pathway in Intestinal Epithelial Cells and Macrophages and Alleviates Experimental Colitis in Mice</span></div><div class="casAuthors">Seo, Ji Yeon; Lee, Changhyun; Hwang, Sung Wook; Chun, Jaeyoung; Im, Jong Pil; Kim, Joo Sung</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1605-1614</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Nimbolide is a limonoid extd. from neem tree (Azadirachta indica) that has antiinflammatory properties.  The effect of nimbolide on the nuclear factor-kappa B (NF-ÎºB) pathway in intestinal epithelial cells (IECs), macrophages and in murine colitis models was investigated.  The IEC COLO 205, the murine macrophage cell line RAW 264.7, and peritoneal macrophages from interleukin-10-deficient (IL-10-/-) mice were preconditioned with nimbolide and then stimulated with tumor necrosis factor-Î± (TNF-Î±) or lipopolysaccharide.  Dextran sulfate sodium-induced acute colitis model and chronic colitis model in IL-10-/- mice were used for in vivo expts.  Nimbolide significantly suppressed the expression of inflammatory cytokines (IL-6, IL-8, IL-12, and TNF-Î±) and inhibited the phosphorylation of IÎºBÎ± and the DNA-binding affinity of NF-ÎºB in IECs and macrophages.  Nimbolide ameliorated wt. loss, colon shortening, disease activity index score, and histol. scores in dextran sulfate sodium colitis.  It also improved histopathol. scores in the chronic colitis of IL-10-/- mice.  Staining for phosphorylated IÎºBÎ± was significantly decreased in the colon tissue after treatment with nimbolide in both models.  Nimbolide inhibits NF-ÎºB signaling in IECs and macrophages and ameliorates exptl. colitis in mice.  These results suggest nimbolide could be a potentially new treatment for inflammatory bowel disease.  Copyright Â© 2016 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo_ZH2rI3Sd7Vg90H21EOLACvtfcHk0lioz-P1S2AXLw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1SjtLrF&md5=0b41ee7dfc2978439e75b44a69d6012e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fptr.5657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.5657%26sid%3Dliteratum%253Aachs%26aulast%3DSeo%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DHwang%26aufirst%3DS.%2BW.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DIm%26aufirst%3DJ.%2BP.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DNimbolide%2520inhibits%2520nuclear%2520factor-%25CE%25BAB%2520pathway%2520in%2520intestinal%2520epithelial%2520cells%2520and%2520macrophages%2520and%2520alleviates%2520experimental%2520colitis%2520in%2520mice%26jtitle%3DPhytother.%2520Res.%26date%3D2016%26volume%3D30%26spage%3D1605%26epage%3D1614%26doi%3D10.1002%2Fptr.5657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bansod, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslam Saifi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khurana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">Nimbolide abrogates cerulein-induced chronic pancreatitis by modulating beta-catenin/Smad in a sirtuin-dependent way</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">104756</span>, <span class="refDoi">Â DOI: 10.1016/j.phrs.2020.104756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.phrs.2020.104756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32194177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlsFeqsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2020&pages=104756&author=S.+Bansodauthor=M.+Aslam+Saifiauthor=A.+Khuranaauthor=C.+Godugu&title=Nimbolide+abrogates+cerulein-induced+chronic+pancreatitis+by+modulating+beta-catenin%2FSmad+in+a+sirtuin-dependent+way&doi=10.1016%2Fj.phrs.2020.104756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide abrogates cerulein-induced chronic pancreatitis by modulating Î²-catenin/Smad in a sirtuin-dependent way</span></div><div class="casAuthors">Bansod, Sapana; Aslam Saifi, Mohd.; Khurana, Amit; Godugu, Chandraiah</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104756</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Chronic pancreatitis (CP) is one of the leading causes of mortality worldwide with no clin. approved therapeutic interventions.  The present study was designed to investigate the protective effect of nimbolide (NB), an active constituent of neem tree (Azadirachta indica), by targeting Î²-catenin/Smad/SIRT1 in caerulein-induced CP model.  The effects of NB was investigated on caerulein (50 Î¼g/kg/h*6 exposures /day, 3 days a week for 3 wk) induced CP in mice.  Amylase and lipase activity were measured and histopathol. evaluation was performed.  Collagen deposition in the pancreatic tissue was estd. by hydroxyproline assay, and collagen specific staining picrosirius red and Masson's trichrome.  Caerulein-induced CP was significantly controlled by NB treatment, as shown by the downregulation of Î²-catenin/Smad signaling in a SIRT1 dependent manner.  NB treatment significantly decreased Î±-SMA, MMP-2, collagen1a, fibronectin, TGF-Î²1, p-Smad-2/3 expression and extracellular matrix (ECM) deposition in pancreatic tissue.  However, the protective effects of NB on caerulein-induced CP were undermined by nicotinamide (NMD) or splitomicin, sirtuin 1 (SIRT1) inhibitors treatment.  NB treatment modulated protein expression by activating SIRT1 and decreasing the expression of Î²-catenin/Smad proteins in CP mice.  However, the expression of SIRT1 in pancreatic tissue was elevated by NB treatment and it was decreased by NMD or splitomicin treatment.  In summary, our results strongly suggest that NB exerted promising protective effects in caerulein-induced CP model by inhibiting Î²-catenin/Smad in a sirtuin-dependent manner, which could be attributed to its anti-inflammatory and antifibrotic effects.  Our study suggests that NB could be an effective therapeutic intervention for the treatment of CP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCWPzRrTvJu7Vg90H21EOLACvtfcHk0lioz-P1S2AXLw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlsFeqsb0%253D&md5=5a078f2269ce541fce8d409c3626c436</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2020.104756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2020.104756%26sid%3Dliteratum%253Aachs%26aulast%3DBansod%26aufirst%3DS.%26aulast%3DAslam%2BSaifi%26aufirst%3DM.%26aulast%3DKhurana%26aufirst%3DA.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DNimbolide%2520abrogates%2520cerulein-induced%2520chronic%2520pancreatitis%2520by%2520modulating%2520beta-catenin%252FSmad%2520in%2520a%2520sirtuin-dependent%2520way%26jtitle%3DPharmacol.%2520Res.%26date%3D2020%26volume%3D156%26spage%3D104756%26doi%3D10.1016%2Fj.phrs.2020.104756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seshadri, V. D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span> <span> </span><span class="NLM_article-title">Evaluation of antiarthritic activity of nimbolide against Freundâs adjuvant induced arthritis in rats</span>. <i>Artif. Cells, Nanomed., Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">3391</span>â <span class="NLM_lpage">3398</span>, <span class="refDoi">Â DOI: 10.1080/21691401.2019.1649269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1080%2F21691401.2019.1649269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31394949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFGgs7fK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=3391-3398&author=X.+Cuiauthor=R.+Wangauthor=P.+Bianauthor=Q.+Wuauthor=V.+D.+D.+Seshadriauthor=L.+Liu&title=Evaluation+of+antiarthritic+activity+of+nimbolide+against+Freund%E2%80%99s+adjuvant+induced+arthritis+in+rats&doi=10.1080%2F21691401.2019.1649269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of antiarthritic activity of nimbolide against Freund's adjuvant induced arthritis in rats</span></div><div class="casAuthors">Cui, Xin; Wang, Ruijing; Bian, Peimin; Wu, Qingke; Seshadri, Vidya Devanatha Desikan; Liu, Lun</div><div class="citationInfo"><span class="NLM_cas:title">Artificial Cells, Nanomedicine, and Biotechnology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3391-3398</span>CODEN:
                <span class="NLM_cas:coden">ACNBCI</span>;
        ISSN:<span class="NLM_cas:issn">2169-141X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Nimbolide, a triterpenoid isolated from flower of neem tree possess various therapeutic properties.  The objective of the study was to assess the anti-arthritic activity of nimbolide in arthritis induced rats.  Nimbolide (20 mg/kg per day) was given orally to arthritic rats induced with Complete Freund's Adjuvant and changes inpaw vol., body wt., organ indexes (thymus and spleen), arthritic score, biochem. parameters and proinflammatory cytokines levels were detd.  Histopathol. anal. was also performed.  Western blot anal. was also performed.  Rats treated with nimbolide displayed marked redn. in arthritic score, organ indexes, vol. of paw, edema formation, along with substantial enhancement in body wt.  Histopathol. findings showed significant redn. in destruction of joints and inflammation following nimbolide treatment.  The protective action of arthritic rats treated with nimbolide was also substantiated by mol. and biochem. studies.  The results of the study show that nimbolide treatment has markedly enhanced health and reduced inflammation via lessening the proinflammatory cytokines expression in arthritic rats.  Hence, nimbolide may be used as a potent therapeutic drug in treating rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTDYjQAyNNJLVg90H21EOLACvtfcHk0lioz-P1S2AXLw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFGgs7fK&md5=88dbf07b388ad7c5cb981c061fc73c67</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F21691401.2019.1649269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21691401.2019.1649269%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DBian%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DSeshadri%26aufirst%3DV.%2BD.%2BD.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DEvaluation%2520of%2520antiarthritic%2520activity%2520of%2520nimbolide%2520against%2520Freund%25E2%2580%2599s%2520adjuvant%2520induced%2520arthritis%2520in%2520rats%26jtitle%3DArtif.%2520Cells%252C%2520Nanomed.%252C%2520Biotechnol.%26date%3D2019%26volume%3D47%26spage%3D3391%26epage%3D3398%26doi%3D10.1080%2F21691401.2019.1649269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pooladanda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatikonda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattnaik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigalapalli, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathini, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-Î± mediated NF-ÎºB and HDAC-3 nuclear translocation</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">81</span>, <span class="refDoi">Â DOI: 10.1038/s41419-018-1247-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fs41419-018-1247-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=30692512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3cjmtleruw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=81&author=V.+Pooladandaauthor=S.+Thatikondaauthor=S.+Baleauthor=B.+Pattnaikauthor=D.+K.+Sigalapalliauthor=N.+B.+Bathiniauthor=S.+B.+Singhauthor=C.+Godugu&title=Nimbolide+protects+against+endotoxin-induced+acute+respiratory+distress+syndrome+by+inhibiting+TNF-%CE%B1+mediated+NF-%CE%BAB+and+HDAC-3+nuclear+translocation&doi=10.1038%2Fs41419-018-1247-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-Î± mediated NF-ÎºB and HDAC-3 nuclear translocation</span></div><div class="casAuthors">Pooladanda Venkatesh; Thatikonda Sowjanya; Bale Swarna; Singh Shashi Bala; Godugu Chandraiah; Pattnaik Bijay; Sigalapalli Dilep Kumar; Bathini Nagendra Babu</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acute respiratory distress syndrome (ARDS) is characterized by an excessive acute inflammatory response in lung parenchyma, which ultimately leads to refractory hypoxemia.  One of the earliest abnormalities seen in lung injury is the elevated levels of inflammatory cytokines, among them, the soluble tumor necrosis factor (TNF-Î±) has a key role, which exerts cytotoxicity in epithelial and endothelial cells thus exacerbates edema.  The bacterial lipopolysaccharide (LPS) was used both in vitro (RAW 264.7, THP-1, MLE-12, A549, and BEAS-2B) and in vivo (C57BL/6 mice), as it activates a plethora of overlapping inflammatory signaling pathways involved in ARDS.  Nimbolide is a chemical constituent of Azadirachta indica, which contains multiple biological properties, while its role in ARDS is elusive.  Herein, we have investigated the protective effects of nimbolide in abrogating the complications associated with ARDS.  We showed that nimbolide markedly suppressed the nitrosative-oxidative stress, inflammatory cytokines, and chemokines expression by suppressing iNOS, myeloperoxidase, and nitrotyrosine expression.  Moreover, nimbolide mitigated the migration of neutrophils and mast cells whilst normalizing the LPS-induced hypothermia.  Also, nimbolide modulated the expression of epigenetic regulators with multiple HDAC inhibitory activity by suppressing the nuclear translocation of NF-ÎºB and HDAC-3.  We extended our studies using molecular docking studies, which demonstrated a strong interaction between nimbolide and TNF-Î±.  Additionally, we showed that treatment with nimbolide increased GSH, Nrf-2, SOD-1, and HO-1 protein expression; concomitantly abrogated the LPS-triggered TNF-Î±, p38 MAPK, mTOR, and GSK-3Î² protein expression.  Collectively, these results indicate that TNF-Î±-regulated NF-ÎºB and HDAC-3 crosstalk was ameliorated by nimbolide with promising anti-nitrosative, antioxidant, and anti-inflammatory properties in LPS-induced ARDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkFD5PpqlwQz0SWnHPWbmmfW6udTcc2eaWx_YhtzM6Ubntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjmtleruw%253D%253D&md5=fa7f58b4c6a6ad4f29307e170ffe25a5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fs41419-018-1247-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-018-1247-9%26sid%3Dliteratum%253Aachs%26aulast%3DPooladanda%26aufirst%3DV.%26aulast%3DThatikonda%26aufirst%3DS.%26aulast%3DBale%26aufirst%3DS.%26aulast%3DPattnaik%26aufirst%3DB.%26aulast%3DSigalapalli%26aufirst%3DD.%2BK.%26aulast%3DBathini%26aufirst%3DN.%2BB.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DNimbolide%2520protects%2520against%2520endotoxin-induced%2520acute%2520respiratory%2520distress%2520syndrome%2520by%2520inhibiting%2520TNF-%25CE%25B1%2520mediated%2520NF-%25CE%25BAB%2520and%2520HDAC-3%2520nuclear%2520translocation%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2019%26volume%3D10%26spage%3D81%26doi%3D10.1038%2Fs41419-018-1247-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinnathambi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alharbi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">Nimbolide prevents myocardial damage by regulating cardiac biomarkers, antioxidant level, and apoptosis signaling against doxorubicin-induced cardiotoxicity in rats</span>. <i>J. Biochem. Mol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e22543</span>, <span class="refDoi">Â DOI: 10.1002/jbt.22543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fjbt.22543" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=e22543&author=H.+Liauthor=B.+Xiaauthor=W.+Chenauthor=Y.+Zhangauthor=X.+Gaoauthor=A.+Chinnathambiauthor=S.+A.+Alharbiauthor=Y.+Zhao&title=Nimbolide+prevents+myocardial+damage+by+regulating+cardiac+biomarkers%2C+antioxidant+level%2C+and+apoptosis+signaling+against+doxorubicin-induced+cardiotoxicity+in+rats&doi=10.1002%2Fjbt.22543"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fjbt.22543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbt.22543%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DXia%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DChinnathambi%26aufirst%3DA.%26aulast%3DAlharbi%26aufirst%3DS.%2BA.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DNimbolide%2520prevents%2520myocardial%2520damage%2520by%2520regulating%2520cardiac%2520biomarkers%252C%2520antioxidant%2520level%252C%2520and%2520apoptosis%2520signaling%2520against%2520doxorubicin-induced%2520cardiotoxicity%2520in%2520rats%26jtitle%3DJ.%2520Biochem.%2520Mol.%2520Toxicol.%26date%3D2020%26volume%3D6%26spage%3De22543%26doi%3D10.1002%2Fjbt.22543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alshammari, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinnasamy, T.</span></span> <span> </span><span class="NLM_article-title">Nimbolide attenuate the lipid accumulation, oxidative stress and antioxidant in primary hepatocytes</span>. <i>Mol. Biol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">463</span>â <span class="NLM_lpage">474</span>, <span class="refDoi">Â DOI: 10.1007/s11033-017-4132-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs11033-017-4132-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29185131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2isbrP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2017&pages=463-474&author=G.+M.+Alshammariauthor=A.+Balakrishnanauthor=T.+Chinnasamy&title=Nimbolide+attenuate+the+lipid+accumulation%2C+oxidative+stress+and+antioxidant+in+primary+hepatocytes&doi=10.1007%2Fs11033-017-4132-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide attenuate the lipid accumulation, oxidative stress and antioxidant in primary hepatocytes</span></div><div class="casAuthors">Alshammari, Ghedeir M.; Balakrishnan, Aristatile; Chinnasamy, Thirunavukkarasu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">463-474</span>CODEN:
                <span class="NLM_cas:coden">MLBRBU</span>;
        ISSN:<span class="NLM_cas:issn">0301-4851</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Nimbolide is a bioactive compd. found in Azadirachta indica.  This work was devised to investigate the potential effects of nimbolide on intracellular lipid deposition and its assocd. redox modulation in primary hepatocytes (Heps).  Lipid accumulation was induced in Heps by supplementing 1 mM oleic acid for 24 h which was marked by significant accumulation of lipids.  The results demonstrated that nimbolide can decrease intracellular cholesterol, free fatty acids and triglycerides.  Nimbolide may also improve hepatocytes function through its antioxidant effects by inhibiting oxidative DNA damage and lipid peroxidn. by curtailing the reactive oxygen species levels.  Further it also restore the mitochondrial potential, improving the endogenous antioxidant levels such as GSH and antioxidant enzyme activities.  Nimbolide increased (P < 0.05) liver X receptor-Î± (LXRÎ±), peroxisome proliferator-activated receptor-Î³ (PPARÎ³) and sterol regulatory element-binding protein-1c (SREBP1c) gene expression in Heps.  The biol. significance of nimbolide may involve hypolipidemic effect, lipid peroxidn. inhibition, DNA damage inhibition, ROS inhibition, restoring mitochondrial function, increases in GSH and SOD & CAT activities, and direct regulation of LXRÎ±, PPARÎ³ and SREBP1c gene expression.  Nimbolide may be used as effective lipid lowering compd. and lipid deposition-induced Heps changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_7jsirgw6K7Vg90H21EOLACvtfcHk0lgmSs06wKE_0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2isbrP&md5=bf0a2fd3fcff5c5adc52551e42fd93c2</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs11033-017-4132-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11033-017-4132-1%26sid%3Dliteratum%253Aachs%26aulast%3DAlshammari%26aufirst%3DG.%2BM.%26aulast%3DBalakrishnan%26aufirst%3DA.%26aulast%3DChinnasamy%26aufirst%3DT.%26atitle%3DNimbolide%2520attenuate%2520the%2520lipid%2520accumulation%252C%2520oxidative%2520stress%2520and%2520antioxidant%2520in%2520primary%2520hepatocytes%26jtitle%3DMol.%2520Biol.%2520Rep.%26date%3D2017%26volume%3D44%26spage%3D463%26epage%3D474%26doi%3D10.1007%2Fs11033-017-4132-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Omiecinski, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Heuvel, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdew, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">S49</span>â <span class="NLM_lpage">S75</span>, <span class="refDoi">Â DOI: 10.1093/toxsci/kfq338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1093%2Ftoxsci%2Fkfq338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=21059794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1Cgs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2011&pages=S49-S75&author=C.+J.+Omiecinskiauthor=J.+P.+Vanden+Heuvelauthor=G.+H.+Perdewauthor=J.+M.+Peters&title=Xenobiotic+metabolism%2C+disposition%2C+and+regulation+by+receptors%3A+from+biochemical+phenomenon+to+predictors+of+major+toxicities&doi=10.1093%2Ftoxsci%2Fkfq338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities</span></div><div class="casAuthors">Omiecinski, Curtis J.; Vanden Heuvel, John P.; Perdew, Gary H.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">S1</span>),
    <span class="NLM_cas:pages">S49-S75</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  To commemorate the 50th anniversary of the Society of Toxicol., this special edition article reviews the history and current scope of xenobiotic metab. and transport, with special emphasis on the discoveries and impact of selected "xenobiotic receptors.  " This overall research realm has witnessed dynamic development in the past 50 years, and several of the key milestone events that mark the impressive progress in these areas of toxicol. sciences are highlighted.  From the initial observations regarding aspects of drug metab. dating from the mid- to late 1800's, the area of biotransformation research witnessed seminal discoveries in the mid-1900's and onward that are remarkable in retrospect, including the discovery and characterization of the phase I monooxygenases, the cytochrome P450s.  Further research uncovered many aspects of the biochem. of xenobiotic metab., expanding to phase II conjugation and phase III xenobiotic transport.  This led to hallmark developments involving integration of genomic technologies to elucidate the basis for interindividual differences in response to xenobiotic exposures and discovery of nuclear and sol. receptor families that selectively "sense" the chem. milieu of the mammalian cell and orchestrate compensatory changes in gene expression programming to accommodate complex xenobiotic exposures.  This review will briefly summarize these developments and investigate the expanding roles of xenobiotic receptor biol. in the underlying basis of toxicol. response to chem. agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqposuXaLetvbVg90H21EOLACvtfcHk0lgmSs06wKE_0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1Cgs7Y%253D&md5=6e530678dc2bb6c3754268bbecb1560e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfq338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfq338%26sid%3Dliteratum%253Aachs%26aulast%3DOmiecinski%26aufirst%3DC.%2BJ.%26aulast%3DVanden%2BHeuvel%26aufirst%3DJ.%2BP.%26aulast%3DPerdew%26aufirst%3DG.%2BH.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DXenobiotic%2520metabolism%252C%2520disposition%252C%2520and%2520regulation%2520by%2520receptors%253A%2520from%2520biochemical%2520phenomenon%2520to%2520predictors%2520of%2520major%2520toxicities%26jtitle%3DToxicol.%2520Sci.%26date%3D2011%26volume%3D120%26spage%3DS49%26epage%3DS75%26doi%3D10.1093%2Ftoxsci%2Fkfq338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Priyadarsini, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manikandan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">The neem limonoids azadirachtin and nimbolide inhibit hamster cheek pouch carcinogenesis by modulating xenobiotic-metabolizing enzymes, DNA damage, antioxidants, invasion and angiogenesis</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">492</span>â <span class="NLM_lpage">504</span>, <span class="refDoi">Â DOI: 10.1080/10715760902870637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1080%2F10715760902870637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=19391054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvFKhs7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2009&pages=492-504&author=R.+V.+Priyadarsiniauthor=P.+Manikandanauthor=G.+H.+Kumarauthor=S.+Nagini&title=The+neem+limonoids+azadirachtin+and+nimbolide+inhibit+hamster+cheek+pouch+carcinogenesis+by+modulating+xenobiotic-metabolizing+enzymes%2C+DNA+damage%2C+antioxidants%2C+invasion+and+angiogenesis&doi=10.1080%2F10715760902870637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The neem limonoids azadirachtin and nimbolide inhibit hamster cheek pouch carcinogenesis by modulating xenobiotic-metabolizing enzymes, DNA damage, antioxidants, invasion and angiogenesis</span></div><div class="casAuthors">Priyadarsini, Ramamurthi Vidya; Manikandan, Palrasu; Kumar, Gurram Harish; Nagini, Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">492-504</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The neem tree has attracted considerable research attention as a rich source of limonoids that have potent antioxidant and anti-cancer properties.  The present study was designed to evaluate the chemopreventive potential of the neem limonoids azadirachtin and nimbolide based on in vitro antioxidant assays and in vivo inhibitory effects on 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis.  Both azadirachtin and nimbolide exhibited concn.-dependent anti-radical scavenging activity and reductive potential in the order: nimbolide > azadirachtin > ascorbate.  Administration of both azadirachtin and nimbolide inhibited the development of DMBA-induced HBP carcinomas by influencing multiple mechanisms including prevention of procarcinogen activation and oxidative DNA damage, upregulation of antioxidant and carcinogen detoxification enzymes and inhibition of tumor invasion and angiogenesis.  On a comparative basis, nimbolide was found to be a more potent antioxidant and chemopreventive agent and offers promise as a candidate agent in multitargeted prevention and treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdF8lJIsGfYLVg90H21EOLACvtfcHk0ljDeEP7EPC1ZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvFKhs7g%253D&md5=ba185fa75f8732a90a05047c44116cdb</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F10715760902870637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715760902870637%26sid%3Dliteratum%253Aachs%26aulast%3DPriyadarsini%26aufirst%3DR.%2BV.%26aulast%3DManikandan%26aufirst%3DP.%26aulast%3DKumar%26aufirst%3DG.%2BH.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DThe%2520neem%2520limonoids%2520azadirachtin%2520and%2520nimbolide%2520inhibit%2520hamster%2520cheek%2520pouch%2520carcinogenesis%2520by%2520modulating%2520xenobiotic-metabolizing%2520enzymes%252C%2520DNA%2520damage%252C%2520antioxidants%252C%2520invasion%2520and%2520angiogenesis%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2009%26volume%3D43%26spage%3D492%26epage%3D504%26doi%3D10.1080%2F10715760902870637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sritanaudomchai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusamran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuakulkiat, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunyapraphatsara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiransalee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tepsuwan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusamran, W. R.</span></span> <span> </span><span class="NLM_article-title">Quinone reductase inducers in Azadirachta indica A. Juss flowers, and their mechanisms of action</span>. <i>Asian Pac. J. Cancer Prev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">263</span>â <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=16235984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BD2MrlvFGksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=263-269&author=H.+Sritanaudomchaiauthor=T.+Kusamranauthor=W.+Kuakulkiatauthor=N.+Bunyapraphatsaraauthor=A.+Hiransaleeauthor=A.+Tepsuwanauthor=W.+R.+Kusamran&title=Quinone+reductase+inducers+in+Azadirachta+indica+A.+Juss+flowers%2C+and+their+mechanisms+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Quinone reductase inducers in Azadirachta indica A. Juss flowers, and their mechanisms of action</span></div><div class="casAuthors">Sritanaudomchai Hathaitip; Kusamran Thanit; Kuakulkiat Worapun; Bunyapraphatsara Nuntavan; Hiransalee Ankana; Tepsuwan Anong; Kusamran Wannee R</div><div class="citationInfo"><span class="NLM_cas:title">Asian Pacific journal of cancer prevention : APJCP</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-9</span>
        ISSN:<span class="NLM_cas:issn">1513-7368</span>.
    </div><div class="casAbstract">We have previously shown that the flowers of neem tree (Azadirachta indica A.  Juss, family Meliaceae), Thai variety, strongly induced the activity of glutathione S-transferase (GST) while resulting in a significant reduction in the activities of some cytochrome P(450)-dependent monooxygenases in rat liver, and possess cancer chemopreventive potential against chemically-induced mammary gland and liver carcinogenesis in rats.  In the present study, 2 chemicals possessing strong QR inducing activity were fractionated from neem flowers using a bioassay based on the induction of QR activity in mouse hepatoma Hepa 1c1c7 cultured cells.  Spectroscopic characteristics revealed that these compounds were nimbolide and chlorophylls, having CD (concentration required to double QR specific activity) values of 0.16 and 3.8 mug/ml, respectively.  Nimbolide is a known constituent of neem leaves, but was found for the first time here in the flowers.  Both nimbolide and chlorophylls strongly enhanced the level of QR mRNA in Hepa 1c1c7 cells, as monitored by northern blot hybridization, indicating that the mechanism by which these constituents of neem flowers induced QR activity is the induction of QR gene expression.  These findings may have implication on cancer chemopreventive potential of neem flowers in experimental rats previously reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwLFuv8uoqC2Gmni0r9GoKfW6udTcc2eZUMsm1z9tyiLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrlvFGksg%253D%253D&md5=af625dd87148d6c7fa312a260174dc29</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSritanaudomchai%26aufirst%3DH.%26aulast%3DKusamran%26aufirst%3DT.%26aulast%3DKuakulkiat%26aufirst%3DW.%26aulast%3DBunyapraphatsara%26aufirst%3DN.%26aulast%3DHiransalee%26aufirst%3DA.%26aulast%3DTepsuwan%26aufirst%3DA.%26aulast%3DKusamran%26aufirst%3DW.%2BR.%26atitle%3DQuinone%2520reductase%2520inducers%2520in%2520Azadirachta%2520indica%2520A.%2520Juss%2520flowers%252C%2520and%2520their%2520mechanisms%2520of%2520action%26jtitle%3DAsian%2520Pac.%2520J.%2520Cancer%2520Prev.%26date%3D2005%26volume%3D6%26spage%3D263%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manikandan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anandan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Azadirachta indica leaf fractions for in vitro antioxidant potential and protective effects against H2O2-induced oxidative damage to pBR322 DNA and red blood cells</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6990</span>â <span class="NLM_lpage">6996</span>, <span class="refDoi">Â DOI: 10.1021/jf901351n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf901351n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD1MXot1egsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2009&pages=6990-6996&author=P.+Manikandanauthor=R.+Anandanauthor=S.+Nagini&title=Evaluation+of+Azadirachta+indica+leaf+fractions+for+in+vitro+antioxidant+potential+and+protective+effects+against+H2O2-induced+oxidative+damage+to+pBR322+DNA+and+red+blood+cells&doi=10.1021%2Fjf901351n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Azadirachta indica Leaf Fractions for in Vitro Antioxidant Potential and Protective Effects against H2O2-Induced Oxidative Damage to pBR322 DNA and Red Blood Cells</span></div><div class="casAuthors">Manikandan, P.; Anandan, R.; Nagini, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6990-6996</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We evaluated the protective effects of subfractions of the Et acetate fraction (EAF) and the methanolic fraction (MF) from the crude ethanolic ext. (CEE) of Azadirachta indica A. Juss (neem) leaves against various free radicals and hydrogen peroxide (H2O2)-induced oxidative damage to red blood cells (RBCs) and pBR322 DNA.  Neem leaf fractions reduced DPPHÂ·, ABTSÂ·+, superoxide (OÂ·-), hydroxyl (OHÂ·), and nitric oxide radicals to nonradical forms in a concn.-dependent manner.  Treatment with the benzene insol. fraction from EAF (EBIF), the chloroform insol. fraction from EAF (ECIF), the chloroform insol. fraction from MF (MCIF), and the Et acetate insol. fraction from MF (MEIF) significantly mitigated H2O2-induced oxidative damage to RBCs and pBR322 DNA.  Although we found low in vitro free radical scavenging activity for the benzene insol. fraction from EAF (EBSF), the chloroform sol. fraction from EAF (ECSF), the chloroform sol. fraction from MF (MCSF), and the Et acetate sol. fraction from MF (MESF), these fractions showed no effect on H2O2-induced lipid peroxidn. and pBR322 DNA damage.  High-performance liq. chromatog. (HPLC) and TLC-Iatroscan anal. revealed that the greater efficacy of EBIF, ECIF, MCIF, and MEIF may be due to the presence of more polar compds. such as nimbolide and quercetin.  Our studies suggest that the antioxidant and protective effects of active neem leaf fractions against H2O2-induced lipid peroxidn. and pBR322 DNA damage can be attributed to their ability to inhibit various free radicals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdo7rLKD2dCbVg90H21EOLACvtfcHk0ljbRsQROlH4PA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXot1egsLw%253D&md5=03b0ba26aae2ee6ac5b23b4e3c2e9d33</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjf901351n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf901351n%26sid%3Dliteratum%253Aachs%26aulast%3DManikandan%26aufirst%3DP.%26aulast%3DAnandan%26aufirst%3DR.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DEvaluation%2520of%2520Azadirachta%2520indica%2520leaf%2520fractions%2520for%2520in%2520vitro%2520antioxidant%2520potential%2520and%2520protective%2520effects%2520against%2520H2O2-induced%2520oxidative%2520damage%2520to%2520pBR322%2520DNA%2520and%2520red%2520blood%2520cells%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2009%26volume%3D57%26spage%3D6990%26epage%3D6996%26doi%3D10.1021%2Fjf901351n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansari, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jameel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parveen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddique, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shadab, G. G. H. A.</span></span> <span> </span><span class="NLM_article-title">Protective role of nimbolide against chemotherapeutic drug hydroxyurea induced genetic and oxidative damage in an animal model</span>. <i>Environ. Toxicol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">91</span>â <span class="NLM_lpage">99</span>, <span class="refDoi">Â DOI: 10.1016/j.etap.2018.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.etap.2018.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29679812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVSms7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2018&pages=91-99&author=M.+F.+Ahmadauthor=M.+O.+Ansariauthor=S.+Jameelauthor=A.+L.+Waniauthor=N.+Parveenauthor=H.+R.+Siddiqueauthor=G.+G.+H.+A.+Shadab&title=Protective+role+of+nimbolide+against+chemotherapeutic+drug+hydroxyurea+induced+genetic+and+oxidative+damage+in+an+animal+model&doi=10.1016%2Fj.etap.2018.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Protective role of nimbolide against chemotherapeutic drug hydroxyurea induced genetic and oxidative damage in an animal model</span></div><div class="casAuthors">Ahmad, Md. Fahim; Ansari, Mohd. Owais; Jameel, Sana; Wani, Ab Latif; Parveen, Nuzhat; Siddique, Hifzur R.; Shadab, G. G. H. A.</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Toxicology and Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">91-99</span>CODEN:
                <span class="NLM_cas:coden">ETOPFR</span>;
        ISSN:<span class="NLM_cas:issn">1382-6689</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nimbolide is known to be an antioxidant found in neem plant.  Hydroxyurea is a medication frequently used in sickle-cell disease, different cancers and HIV infection.  The present study aimed to evaluate the adverse effect of HU and possible amelioration by nimbolide in Wistar rats.  To test the authors' hypothesis, the authors performed genotoxicity tests, biochem. assays, and histopathol. studies.  The authors obsd. that HU caused higher levels of genotoxicity in the treated animals.  The obsd. genetic and oxidative damage might be due to the presence of reactive species as HU increased the level of the malondialdehyde-a biomarker of oxidative damage.  Interestingly, co-treatment of animals with HU and nimbolide showed a lower level of damage.  The authors conclude that nimbolide significantly protects the cells from the adverse effect of HU and could be considered as a potential adjuvant for the patients under HU therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprHcUvw3gh77Vg90H21EOLACvtfcHk0ljbRsQROlH4PA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVSms7k%253D&md5=f523b8c2711e33fe58e0810e8eaf4a6e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.etap.2018.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.etap.2018.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DM.%2BF.%26aulast%3DAnsari%26aufirst%3DM.%2BO.%26aulast%3DJameel%26aufirst%3DS.%26aulast%3DWani%26aufirst%3DA.%2BL.%26aulast%3DParveen%26aufirst%3DN.%26aulast%3DSiddique%26aufirst%3DH.%2BR.%26aulast%3DShadab%26aufirst%3DG.%2BG.%2BH.%2BA.%26atitle%3DProtective%2520role%2520of%2520nimbolide%2520against%2520chemotherapeutic%2520drug%2520hydroxyurea%2520induced%2520genetic%2520and%2520oxidative%2520damage%2520in%2520an%2520animal%2520model%26jtitle%3DEnviron.%2520Toxicol.%2520Pharmacol.%26date%3D2018%26volume%3D60%26spage%3D91%26epage%3D99%26doi%3D10.1016%2Fj.etap.2018.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhammad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gho, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, S. K.</span></span> <span> </span><span class="NLM_article-title">Nimbolide represses the proliferation, migration, and invasion of bladder carcinoma cells via Chk2-mediated G2/M phase cell cycle arrest, altered signaling pathways, and reduced transcription factors-associated MMP-9 expression</span>. <i>Evid. Based Complement Alternat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2019</i></span>,  <span class="NLM_fpage">3753587</span>, <span class="refDoi">Â DOI: 10.1155/2019/3753587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1155%2F2019%2F3753587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31391858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3MvlvFSqtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&pages=3753587&author=S.+S.+Shinauthor=B.+Hwangauthor=K.+Muhammadauthor=Y.+Ghoauthor=J.+H.+Songauthor=W.+J.+Kimauthor=G.+Kimauthor=S.+K.+Moon&title=Nimbolide+represses+the+proliferation%2C+migration%2C+and+invasion+of+bladder+carcinoma+cells+via+Chk2-mediated+G2%2FM+phase+cell+cycle+arrest%2C+altered+signaling+pathways%2C+and+reduced+transcription+factors-associated+MMP-9+expression&doi=10.1155%2F2019%2F3753587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide Represses the Proliferation, Migration, and Invasion of Bladder Carcinoma Cells via Chk2-Mediated G2/M Phase Cell Cycle Arrest, Altered Signaling Pathways, and Reduced Transcription Factors-Associated MMP-9 Expression</span></div><div class="casAuthors">Shin Seung-Shick; Hwang Byungdoo; Gho Yujeong; Song Jun-Hui; Moon Sung-Kwon; Muhammad Kashif; Kim Gonhyung; Kim Wun-Jae</div><div class="citationInfo"><span class="NLM_cas:title">Evidence-based complementary and alternative medicine : eCAM</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2019</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3753587</span>
        ISSN:<span class="NLM_cas:issn">1741-427X</span>.
    </div><div class="casAbstract">Nimbolide, an active chemical constituent of Azadirachta indica, reportedly has several physiological effects.  Here, we assessed novel anticancer effects of nimbolide against bladder cancer EJ and 5637 cells.  Nimbolide treatment inhibited the proliferation of both bladder cancer cell lines with an IC50 value of 3 Î¼M.  Treatment of cells with nimbolide induced G2/M phase cell cycle arrest via both Chk2-Cdc25C-Cdc2/cyclin B1-Wee1 pathway and Chk2-p21WAF1-Cdc2/cyclin B1-Wee1 pathway.  Nimbolide increased JNK phosphorylation and decreased p38MAPK and AKT phosphorylation.  Additionally, nimbolide impeded both wound healing migration and invasion abilities by suppressing matrix metalloproteinase-9 (MMP-9) activity.  Finally, nimbolide repressed the binding activity of NF-ÎºB, Sp-1, and AP-1 motifs, which are key transcription factors for MMP-9 activity regulation.  Overall, our study indicates that nimbolide is a potential chemotherapeutic agent for bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSq3560K0J4HtNTrvPZP1IpfW6udTcc2eYWpQ7S3g-q7Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvlvFSqtw%253D%253D&md5=a84a3a5ccf89bab120232869a4946745</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1155%2F2019%2F3753587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2019%252F3753587%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DS.%2BS.%26aulast%3DHwang%26aufirst%3DB.%26aulast%3DMuhammad%26aufirst%3DK.%26aulast%3DGho%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DW.%2BJ.%26aulast%3DKim%26aufirst%3DG.%26aulast%3DMoon%26aufirst%3DS.%2BK.%26atitle%3DNimbolide%2520represses%2520the%2520proliferation%252C%2520migration%252C%2520and%2520invasion%2520of%2520bladder%2520carcinoma%2520cells%2520via%2520Chk2-mediated%2520G2%252FM%2520phase%2520cell%2520cycle%2520arrest%252C%2520altered%2520signaling%2520pathways%252C%2520and%2520reduced%2520transcription%2520factors-associated%2520MMP-9%2520expression%26jtitle%3DEvid.%2520Based%2520Complement%2520Alternat.%2520Med.%26date%3D2019%26volume%3D2019%26spage%3D3753587%26doi%3D10.1155%2F2019%2F3753587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elumalai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunadharini, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senthilkumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banudevi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunkumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharmila, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunakaran, J.</span></span> <span> </span><span class="NLM_article-title">Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>215</i></span>,  <span class="NLM_fpage">131</span>â <span class="NLM_lpage">142</span>, <span class="refDoi">Â DOI: 10.1016/j.toxlet.2012.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.toxlet.2012.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=23089555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7nJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2012&pages=131-142&author=P.+Elumalaiauthor=D.+N.+Gunadhariniauthor=K.+Senthilkumarauthor=S.+Banudeviauthor=R.+Arunkumarauthor=C.+S.+Bensonauthor=G.+Sharmilaauthor=J.+Arunakaran&title=Induction+of+apoptosis+in+human+breast+cancer+cells+by+nimbolide+through+extrinsic+and+intrinsic+pathway&doi=10.1016%2Fj.toxlet.2012.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway</span></div><div class="casAuthors">Elumalai, P.; Gunadharini, D. N.; Senthilkumar, K.; Banudevi, S.; Arunkumar, R.; Benson, C. S.; Sharmila, G.; Arunakaran, J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-142</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">We aimed to investigate the cytotoxic effects of nimbolide, a limonoid present in leaves and flowers of the neem tree (Azadirachta indica) on human breast cancer cells.  The mol. mechanisms involved in the apoptotic activity exerted by nimbolide were studied on the estrogen dependent (MCF-7) and estrogen independent (MDA-MB-231) human breast cancer cell lines.  The growth inhibitory effect of nimbolide was assessed by MTT assay.  Apoptosis induction by nimbolide treatment was detd. by JC-1 mitochondrial membrane potential staining, cytochrome c release, caspase activation, cleavage of PARP and AO/EtBr dual staining.  The modulation of apoptotic proteins (intrinsic pathway: Bax, bad, Bcl-2, Bcl-xL, Mcl-1, XIAP-1 and caspase-3, 9; extrinsic pathway: TRAIL, FasL, FADDR and Caspase-8) were studied by western blot and real time PCR anal.  Treatment with nimbolide resulted in dose and time-dependent inhibition of growth of MCF-7 and MDA-MB-231 cells.  The occurrence of apoptosis in these cells was indicated by JC-1 staining, modulation of both intrinsic and extrinsic apoptotic signaling mols. expression and further apoptosis was confirmed by AO/EtBr dual staining.  These events were assocd. with: increased levels of proapoptotic proteins Bax, Bad, Fas-L, TRAIL, FADDR, cytochrome c and reduced levels of the anti-apoptotic proteins Bcl-2, Bcl-xL, Mcl-1 and XIAP-1.  Nimbolide induces the cleavage of pro-caspase-8, pro-caspase-3 and PARP.  The above data suggest that nimbolide induces apoptosis by both the intrinsic and extrinsic pathways.  With evidence of above data it is suggested that nimbolide exhibit anticancer effect through its apoptosis-inducing property.  Thus, nimbolide raises new hope for its use in anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbu-R8QusMprVg90H21EOLACvtfcHk0ljp3-xB1ZCXBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7nJ&md5=39fb463162d9c9fb21e707b2af5b2b1a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2012.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2012.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DElumalai%26aufirst%3DP.%26aulast%3DGunadharini%26aufirst%3DD.%2BN.%26aulast%3DSenthilkumar%26aufirst%3DK.%26aulast%3DBanudevi%26aufirst%3DS.%26aulast%3DArunkumar%26aufirst%3DR.%26aulast%3DBenson%26aufirst%3DC.%2BS.%26aulast%3DSharmila%26aufirst%3DG.%26aulast%3DArunakaran%26aufirst%3DJ.%26atitle%3DInduction%2520of%2520apoptosis%2520in%2520human%2520breast%2520cancer%2520cells%2520by%2520nimbolide%2520through%2520extrinsic%2520and%2520intrinsic%2520pathway%26jtitle%3DToxicol.%2520Lett.%26date%3D2012%26volume%3D215%26spage%3D131%26epage%3D142%26doi%3D10.1016%2Fj.toxlet.2012.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elumalai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunkumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharmila, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunakaran, J.</span></span> <span> </span><span class="NLM_article-title">Nimbolide inhibits IGF-I-mediated PI3K/Akt and MAPK signalling in human breast cancer cell lines (MCF-7 and MDA-MB-231)</span>. <i>Cell Biochem.Funct.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">476</span>â <span class="NLM_lpage">484</span>, <span class="refDoi">Â DOI: 10.1002/cbf.3040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fcbf.3040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=24888707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOgtrfM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=476-484&author=P.+Elumalaiauthor=R.+Arunkumarauthor=C.+S.+Bensonauthor=G.+Sharmilaauthor=J.+Arunakaran&title=Nimbolide+inhibits+IGF-I-mediated+PI3K%2FAkt+and+MAPK+signalling+in+human+breast+cancer+cell+lines+%28MCF-7+and+MDA-MB-231%29&doi=10.1002%2Fcbf.3040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide inhibits IGF-I-mediated PI3K/Akt and MAPK signalling in human breast cancer cell lines (MCF-7 and MDA-MB-231)</span></div><div class="casAuthors">Elumalai, Perumal; Arunkumar, Ramachandran; Benson, Chellakkan Selvanesan; Sharmila, Govindaraj; Arunakaran, Jagadeesan</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Function</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">476-484</span>CODEN:
                <span class="NLM_cas:coden">CBFUDH</span>;
        ISSN:<span class="NLM_cas:issn">1099-0844</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The insulin-like growth factor I (IGF-I) signalling pathway contributes a major role on various cancer cell proliferation, survival and cell cycle.  The present study was aimed to investigate the effect of nimbolide on IGF signalling and cell cycle arrest in MCF-7 and MDA-MB-231 breast cancer cell lines.  The protein expression of IGF signalling mols. and cell cycle protein levels was assessed by western blot anal.  In order to study the interaction of nimbolide on IGF-1 signalling pathway, IGF-I and phosphoinositide 3-kinase (PI3K) inhibitor (LY294002) were used to treat MCF-7 and MDA-MB-231 cells.  Further, the cell cycle arrest was analyzed by flow cytometry.  The protein expression of IGF signalling mols. was significantly decreased in nimbolide-treated breast cancer cells.  PI3K inhibitor and IGF-I with nimbolide treatment notably inhibited phosphorylated Akt.  The cell cycle arrest was obsd. at the G0/G1 phase, and accumulation of apoptotic cells was obsd. in nimbolide-treated breast cancer cell lines.  Nimbolide also increased the protein expression of p21 and decreased the cyclins in both the cell lines.  Nimbolide decreases the proliferation of breast cancer cells by modulating the IGF signalling mols., which could be very useful for the breast cancer treatment.  Copyright 2014 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9883XOzRxSbVg90H21EOLACvtfcHk0ljp3-xB1ZCXBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOgtrfM&md5=c3bb5fab0647b6d2fac5dce2f87218df</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fcbf.3040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbf.3040%26sid%3Dliteratum%253Aachs%26aulast%3DElumalai%26aufirst%3DP.%26aulast%3DArunkumar%26aufirst%3DR.%26aulast%3DBenson%26aufirst%3DC.%2BS.%26aulast%3DSharmila%26aufirst%3DG.%26aulast%3DArunakaran%26aufirst%3DJ.%26atitle%3DNimbolide%2520inhibits%2520IGF-I-mediated%2520PI3K%252FAkt%2520and%2520MAPK%2520signalling%2520in%2520human%2520breast%2520cancer%2520cell%2520lines%2520%2528MCF-7%2520and%2520MDA-MB-231%2529%26jtitle%3DCell%2520Biochem.Funct.%26date%3D2014%26volume%3D32%26spage%3D476%26epage%3D484%26doi%3D10.1002%2Fcbf.3040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elumalai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindha Mercy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunkamar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharmila, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunakaran, J.</span></span> <span> </span><span class="NLM_article-title">Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines</span>. <i>Cell Proliferation</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">540</span>â <span class="NLM_lpage">552</span>, <span class="refDoi">Â DOI: 10.1111/cpr.12148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1111%2Fcpr.12148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=25377085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2ht7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2014&pages=540-552&author=P.+Elumalaiauthor=A.+Brindha+Mercyauthor=R.+Arunkamarauthor=G.+Sharmilaauthor=F.+A.+Bhatauthor=S.+Balakrishnanauthor=P.+Raja+Singhauthor=J.+Arunakaran&title=Nimbolide+inhibits+invasion+and+migration%2C+and+down-regulates+uPAR+chemokine+gene+expression%2C+in+two+breast+cancer+cell+lines&doi=10.1111%2Fcpr.12148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines</span></div><div class="casAuthors">Elumalai, P.; Brindha Mercy, A.; Arunkamar, R.; Sharmila, G.; Bhat, F. A.; Balakrishnan, S.; Raja Singh, P.; Arunakaran, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Proliferation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">540-552</span>CODEN:
                <span class="NLM_cas:coden">CPROEM</span>;
        ISSN:<span class="NLM_cas:issn">0960-7722</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Objectives : Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women, worldwide.  Urokinase type plasminogen activator (uPA) is a serine protease that is involved in cancer progression, esp. invasion and metastasis of breast cancer.  Nimbolide is a potent cytotoxic limnoid isolated from Azadirachta indica.  Our previous studies have shown that nimbolide elicits pleiotropic effects on breast cancer cells; however, its roles in invasion and migration have not previously been fully elucidated.  Materials and methods : Protein expression of pEGFR, VEGFR, NFÎºB, IKKÎ±, IKKÎ², MMP-2, MMP-9 and TIMP-2 were analyzed by western blotting.  We also analyzed expressions of uPA, uPAR genes and chemokines by real-time PCR.  Breast cancer cell invasion was assessed by transwell invasion assay and cell migration analyzed by scratch wound healing assay.  Results : Our results showed that reduced protein expression of pEGFR, VEGFR, NFÎºB, IKKÎ±, Î², MMP-2, MMP-9 and TIMP-2 was higher in nimbolide-treated breast cancer cells. mRNA expression of uPA, uPAR, chemokines and their receptors were also significantly reduced in response to nimbolide treatment.  Nimbolide inhibited breast cancer cell migration and invasion as shown in transwell invasion and wound healing assays.  Conclusion : These results clearly proved inhibitory effects of nimbolide on tumor cell invasion and migration by down-regulating proteins critically involved in regulation of cell invasion and metastasis, suggesting a possible therapeutic role of nimbolide for breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy0lYpf5X9u7Vg90H21EOLACvtfcHk0licnAXlAMO8Bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2ht7nK&md5=3a3da381493a25678173aaaddbda9eae</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fcpr.12148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcpr.12148%26sid%3Dliteratum%253Aachs%26aulast%3DElumalai%26aufirst%3DP.%26aulast%3DBrindha%2BMercy%26aufirst%3DA.%26aulast%3DArunkamar%26aufirst%3DR.%26aulast%3DSharmila%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DF.%2BA.%26aulast%3DBalakrishnan%26aufirst%3DS.%26aulast%3DRaja%2BSingh%26aufirst%3DP.%26aulast%3DArunakaran%26aufirst%3DJ.%26atitle%3DNimbolide%2520inhibits%2520invasion%2520and%2520migration%252C%2520and%2520down-regulates%2520uPAR%2520chemokine%2520gene%2520expression%252C%2520in%2520two%2520breast%2520cancer%2520cell%2520lines%26jtitle%3DCell%2520Proliferation%26date%3D2014%26volume%3D47%26spage%3D540%26epage%3D552%26doi%3D10.1111%2Fcpr.12148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pooladanda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondi, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottumukkala, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">Nimbolide epigenetically regulates autophagy and apoptosis in breast cancer</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">114</span>â <span class="NLM_lpage">128</span>, <span class="refDoi">Â DOI: 10.1016/j.tiv.2018.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.tiv.2018.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29778718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVSgu7vM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2018&pages=114-128&author=V.+Pooladandaauthor=S.+Bandiauthor=S.+R.+Mondiauthor=K.+M.+Gottumukkalaauthor=C.+Godugu&title=Nimbolide+epigenetically+regulates+autophagy+and+apoptosis+in+breast+cancer&doi=10.1016%2Fj.tiv.2018.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide epigenetically regulates autophagy and apoptosis in breast cancer</span></div><div class="casAuthors">Pooladanda, Venkatesh; Bandi, Soumya; Mondi, Sandhya Rani; Gottumukkala, Krishna Mohan; Godugu, Chandraiah</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology In Vitro</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114-128</span>CODEN:
                <span class="NLM_cas:coden">TIVIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0887-2333</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Autophagy is a crit. regulator of cellular homeostasis and its dysregulation often results in various disease manifestations, including cancer.  Nimbolide, an active chem. constituent of neem (Azadirachta indica) exhibits potent anticancer effects.  Although, nimbolide mediated apoptosis activation in breast cancer cells is well known.  Nevertheless, its role in autophagy induction mechanism and epigenetic alteration is not explored previously.  The authors' current study intended to bridge the gaps in the existing research by exploring the potential of nimbolide in inducing autophagy, which could counter regulate the transformations in breast cancer.  In the authors' studies, nimbolide significantly inhibited the cell proliferation of MDA-MB-231 and MCF-7 cells with IC50 values of 1.97 and 5.04 Î¼M, resp.  Nimbolide markedly arrested the cell cycle progression and cell survival with loss of mitochondrial membrane potential by reducing Bcl-2 concomitantly inducing Bax and caspases protein expression with modulation of HDAC-2 and H3K27Ac expression.  Consequently, characteristic autophagolysosome accumulation was obsd. by acridine orange, monodansylcadaverine (MDC) and Lysotracker Red staining.  Moreover, nimbolide induced autophagy signaling by increasing Beclin 1 and LC3B along with decreased p62 and mTOR protein expression.  Thus, the authors' findings imply that nimbolide induces autophagy mediated apoptotic cell death in breast cancer with epigenetic modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEtzXopBYiOLVg90H21EOLACvtfcHk0licnAXlAMO8Bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVSgu7vM&md5=0585d8ebe91341dec1d41a27416e657b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2018.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2018.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DPooladanda%26aufirst%3DV.%26aulast%3DBandi%26aufirst%3DS.%26aulast%3DMondi%26aufirst%3DS.%2BR.%26aulast%3DGottumukkala%26aufirst%3DK.%2BM.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DNimbolide%2520epigenetically%2520regulates%2520autophagy%2520and%2520apoptosis%2520in%2520breast%2520cancer%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2018%26volume%3D51%26spage%3D114%26epage%3D128%26doi%3D10.1016%2Fj.tiv.2018.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spradlin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brittain, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proudfoot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornelas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woldegiorgis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olzmann, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bussiere, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maimone, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span> <span> </span><span class="NLM_article-title">Harnessing the anti-cancer natural product nimbolide for targeted protein degradation</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">747</span>â <span class="NLM_lpage">755</span>, <span class="refDoi">Â DOI: 10.1038/s41589-019-0304-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fs41589-019-0304-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31209351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFymtbjJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=747-755&author=J.+N.+Spradlinauthor=X.+Huauthor=C.+C.+Wardauthor=S.+M.+Brittainauthor=M.+D.+Jonesauthor=L.+Ouauthor=M.+Toauthor=A.+Proudfootauthor=E.+Ornelasauthor=M.+Woldegiorgisauthor=J.+A.+Olzmannauthor=D.+E.+Bussiereauthor=J.+Thomasauthor=J.+A.+Tallaricoauthor=J.+M.+McKennaauthor=M.+Schirleauthor=T.+J.+Maimoneauthor=D.+K.+Nomura&title=Harnessing+the+anti-cancer+natural+product+nimbolide+for+targeted+protein+degradation&doi=10.1038%2Fs41589-019-0304-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing the anti-cancer natural product nimbolide for targeted protein degradation</span></div><div class="casAuthors">Spradlin, Jessica N.; Hu, Xirui; Ward, Carl C.; Brittain, Scott M.; Jones, Michael D.; Ou, Lisha; To, Milton; Proudfoot, Andrew; Ornelas, Elizabeth; Woldegiorgis, Mikias; Olzmann, James A.; Bussiere, Dirksen E.; Thomas, Jason R.; Tallarico, John A.; McKenna, Jeffrey M.; Schirle, Markus; Maimone, Thomas J.; Nomura, Daniel K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">747-755</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Nimbolide, a terpenoid natural product derived from the Neem tree, impairs cancer pathogenicity; however, the direct targets and mechanisms by which nimbolide exerts its effects are poorly understood.  Here, we used activity-based protein profiling (ABPP) chemoproteomic platforms to discover that nimbolide reacts with a novel functional cysteine crucial for substrate recognition in the E3 ubiquitin ligase RNF114.  Nimbolide impairs breast cancer cell proliferation in-part by disrupting RNF114-substrate recognition, leading to inhibition of ubiquitination and degrdn. of tumor suppressors such as p21, resulting in their rapid stabilization.  We further demonstrate that nimbolide can be harnessed to recruit RNF114 as an E3 ligase in targeted protein degrdn. applications and show that synthetically simpler scaffolds are also capable of accessing this unique reactive site.  Our study highlights the use of ABPP platforms in uncovering unique druggable modalities accessed by natural products for cancer therapy and targeted protein degrdn. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5pXgwBOxeG7Vg90H21EOLACvtfcHk0licnAXlAMO8Bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFymtbjJ&md5=02b64cab829d7307b6dd6555617aa796</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fs41589-019-0304-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41589-019-0304-8%26sid%3Dliteratum%253Aachs%26aulast%3DSpradlin%26aufirst%3DJ.%2BN.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DWard%26aufirst%3DC.%2BC.%26aulast%3DBrittain%26aufirst%3DS.%2BM.%26aulast%3DJones%26aufirst%3DM.%2BD.%26aulast%3DOu%26aufirst%3DL.%26aulast%3DTo%26aufirst%3DM.%26aulast%3DProudfoot%26aufirst%3DA.%26aulast%3DOrnelas%26aufirst%3DE.%26aulast%3DWoldegiorgis%26aufirst%3DM.%26aulast%3DOlzmann%26aufirst%3DJ.%2BA.%26aulast%3DBussiere%26aufirst%3DD.%2BE.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DMcKenna%26aufirst%3DJ.%2BM.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DMaimone%26aufirst%3DT.%2BJ.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26atitle%3DHarnessing%2520the%2520anti-cancer%2520natural%2520product%2520nimbolide%2520for%2520targeted%2520protein%2520degradation%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D15%26spage%3D747%26epage%3D755%26doi%3D10.1038%2Fs41589-019-0304-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Priyadarsini, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugan, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sripriya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karunagaran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">The neem limonoids azadirachtin and nimbolide induce cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">624</span>â <span class="NLM_lpage">634</span>, <span class="refDoi">Â DOI: 10.3109/10715761003692503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3109%2F10715761003692503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=20429769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVWis7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2010&pages=624-634&author=R.+V.+Priyadarsiniauthor=R.+S.+Muruganauthor=P.+Sripriyaauthor=D.+Karunagaranauthor=S.+Nagini&title=The+neem+limonoids+azadirachtin+and+nimbolide+induce+cell+cycle+arrest+and+mitochondria-mediated+apoptosis+in+human+cervical+cancer+%28HeLa%29+cells&doi=10.3109%2F10715761003692503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The neem limonoids azadirachtin and nimbolide induce cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells</span></div><div class="casAuthors">Priyadarsini, R. Vidya; Murugan, R. Senthil; Sripriya, P.; Karunagaran, D.; Nagini, S.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">624-634</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Limonoids from the neem tree (Azadirachta indica) have attracted considerable research attention in recent years owing to their potent antioxidant and anti-proliferative effects.  The present study was designed to investigate the cellular and mol. mechanisms by which azadirachtin and nimbolide exert cytotoxic effects in the human cervical cancer (HeLa) cell line.  Both azadirachtin and nimbolide significantly suppressed the viability of HeLa cells in a dose-dependent manner by inducing cell cycle arrest at G0/G1 phase accompanied by p53-dependent p21 accumulation and down-regulation of the cell cycle regulatory proteins cyclin B, cyclin D1 and PCNA.  Characteristic changes in nuclear morphol., presence of a subdiploid peak and annexin-V staining pointed to apoptosis as the mode of cell death.  Increased generation of reactive oxygen species with decline in the mitochondrial transmembrane potential and release of cytochrome c confirmed that the neem limonoids transduced the apoptotic signal via the mitochondrial pathway.  Altered expression of the Bcl-2 family of proteins, inhibition of NF-ÎºB activation and over-expression of caspases and survivin provide compelling evidence that azadirachtin and nimbolide induce a shift of balance toward a pro-apoptotic phenotype.  Antioxidants such as azadirachtin and nimbolide that can simultaneously arrest the cell cycle and target multiple mols. involved in mitochondrial apoptosis offer immense potential as anti-cancer therapeutic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPK8XWd7ubObVg90H21EOLACvtfcHk0ljQTtPGyP7-vQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVWis7s%253D&md5=c1e644d072998b475796951be6e91456</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.3109%2F10715761003692503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10715761003692503%26sid%3Dliteratum%253Aachs%26aulast%3DPriyadarsini%26aufirst%3DR.%2BV.%26aulast%3DMurugan%26aufirst%3DR.%2BS.%26aulast%3DSripriya%26aufirst%3DP.%26aulast%3DKarunagaran%26aufirst%3DD.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DThe%2520neem%2520limonoids%2520azadirachtin%2520and%2520nimbolide%2520induce%2520cell%2520cycle%2520arrest%2520and%2520mitochondria-mediated%2520apoptosis%2520in%2520human%2520cervical%2520cancer%2520%2528HeLa%2529%2520cells%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2010%26volume%3D44%26spage%3D624%26epage%3D634%26doi%3D10.3109%2F10715761003692503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harish
Kumar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra Mohan, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagannadha Rao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide a limonoid from Azadirachta indica inhibits proliferation and induces apoptosis of human choriocarcinoma (BeWo) cells</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">246</span>â <span class="NLM_lpage">252</span>, <span class="refDoi">Â DOI: 10.1007/s10637-008-9170-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs10637-008-9170-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=18719855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1yhs7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=246-252&author=G.+Harish%0AKumarauthor=K.+V.+Chandra+Mohanauthor=A.+Jagannadha+Raoauthor=S.+Nagini&title=Nimbolide+a+limonoid+from+Azadirachta+indica+inhibits+proliferation+and+induces+apoptosis+of+human+choriocarcinoma+%28BeWo%29+cells&doi=10.1007%2Fs10637-008-9170-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide a limonoid from Azadirachta indica inhibits proliferation and induces apoptosis of human choriocarcinoma (BeWo) cells</span></div><div class="casAuthors">Harish Kumar, G.; Chandra Mohan, K. V. P.; Jagannadha Rao, A.; Nagini, S.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">246-252</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We investigated the cytotoxic effects of nimbolide, a limonoid present in leaves and flowers of the neem tree (Azadirachta indica) on human choriocarcinoma (BeWo) cells.  Treatment with nimbolide resulted in dose- and time-dependent inhibition of growth of BeWo cells with IC50 values of 2.01 and 1.19 Î¼M for 7 and 24 h resp., accompanied by downregulation of proliferating cell nuclear antigen.  Examn. of nuclear morphol. revealed fragmentation and condensation indicating apoptosis.  Increase in the generation of reactive oxygen species (ROS) that was reversed by addn. of reduced glutathione suggested ROS involvement in the cytotoxicity of nimbolide.  A decrease in Bcl-2/Bax ratio with increased expression of Apaf-1 and caspase-3, and cleavage of poly(ADP-ribose) polymerase provide compelling evidence that nimbolide-induced apoptosis is mediated by the mitochondrial pathway.  The results of the present study suggest that nimbolide has immense potential in cancer prevention and therapy based on its antiproliferative and apoptosis inducing effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxaV-0ZNVbtrVg90H21EOLACvtfcHk0ljQTtPGyP7-vQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1yhs7k%253D&md5=128c967901626a7f4492588664edb5da</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs10637-008-9170-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-008-9170-z%26sid%3Dliteratum%253Aachs%26aulast%3DHarish%2BKumar%26aufirst%3DG.%26aulast%3DChandra%2BMohan%26aufirst%3DK.%2BV.%26aulast%3DJagannadha%2BRao%26aufirst%3DA.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DNimbolide%2520a%2520limonoid%2520from%2520Azadirachta%2520indica%2520inhibits%2520proliferation%2520and%2520induces%2520apoptosis%2520of%2520human%2520choriocarcinoma%2520%2528BeWo%2529%2520cells%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2009%26volume%3D27%26spage%3D246%26epage%3D252%26doi%3D10.1007%2Fs10637-008-9170-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takenaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinmoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsushida, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of colon cancer (HT-29) cell proliferation by a triterpenoid isolated from Azadirachta indica is accompanied by cell cycle arrest and up-regulation of p21</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">917</span>â <span class="NLM_lpage">923</span>, <span class="refDoi">Â DOI: 10.1055/s-2006-946694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1055%2Fs-2006-946694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=16858664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpsl2itbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=917-923&author=M.+K.+Royauthor=M.+Koboriauthor=M.+Takenakaauthor=K.+Nakaharaauthor=H.+Shinmotoauthor=T.+Tsushida&title=Inhibition+of+colon+cancer+%28HT-29%29+cell+proliferation+by+a+triterpenoid+isolated+from+Azadirachta+indica+is+accompanied+by+cell+cycle+arrest+and+up-regulation+of+p21&doi=10.1055%2Fs-2006-946694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of colon cancer (HT-29) cell proliferation by a triterpenoid isolated from Azadirachta indica is accompanied by cell cycle arrest and up-regulation of p21</span></div><div class="casAuthors">Roy, Molay Kumar; Kobori, Masuko; Takenaka, Makiko; Nakahara, Kazuhiko; Shinmoto, Hiroshi; Tsushida, Tojiro</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">917-923</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Nimbolide, a natural triterpenoid present in the edible parts of the neem tree (Azadirachta indica), was found to be growth-inhibitory in human colon carcinoma HT-29 cells.  Nimbolide treatment of cells at 2.5 - 10 Î¼M resulted in moderate to very strong growth inhibition.  Flow cytometric anal. of HT-29 cells showed that nimbolide treatment (2.5 Î¼M, 12 h) caused a 6.5-fold increase in the no. of cells (55.6%) in the G2/M phase compared with the control cells (8.8%).  At 48 h, the cell population in the G2/M phase decreased to 18%, while that in the G0/G1 phase increased to 52.3%.  Western blot anal. revealed that nimbolide-mediated G2/M arrest was accompanied by the up-regulation of p21, cyclin D2, Chk2; and down-regulation of cyclin A, cyclin E, Cdk2, Rad17.  At G0/G1 cell cycle arrest, modulation in the expression of the cell cycle regulatory mols. was also obsd.  We found that nimbolide-induced growth inhibition and cell cycle arrest were not assocd. with cellular differentiation.  Quantification of cells with respect to the expression of phosphatidylserine in the outer cell membrane showed an increase in apoptotic cells by about 13% after 48 h of nimbolide treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJUcwlDjsuQbVg90H21EOLACvtfcHk0ljQTtPGyP7-vQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpsl2itbw%253D&md5=41b9a8fc6f7060b3bb66698163cf47f9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-946694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-946694%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DM.%2BK.%26aulast%3DKobori%26aufirst%3DM.%26aulast%3DTakenaka%26aufirst%3DM.%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DShinmoto%26aufirst%3DH.%26aulast%3DTsushida%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520colon%2520cancer%2520%2528HT-29%2529%2520cell%2520proliferation%2520by%2520a%2520triterpenoid%2520isolated%2520from%2520Azadirachta%2520indica%2520is%2520accompanied%2520by%2520cell%2520cycle%2520arrest%2520and%2520up-regulation%2520of%2520p21%26jtitle%3DPlanta%2520Med.%26date%3D2006%26volume%3D72%26spage%3D917%26epage%3D923%26doi%3D10.1055%2Fs-2006-946694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babykutty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">S, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">J, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopala, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide retards tumor cell migration, invasion, and angiogenesis by downregulating MMP-2/9 expression via inhibiting ERK1/2 and reducing DNA-binding activity of NF-ÎºB in colon cancer cells</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">475</span>â <span class="NLM_lpage">490</span>, <span class="refDoi">Â DOI: 10.1002/mc.20812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fmc.20812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=21678498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFyhtrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=475-490&author=S.+Babykuttyauthor=P.+P.+Sauthor=N.+R.+Jauthor=M.+A.+Kumarauthor=M.+S.+Nairauthor=P.+Srinivasauthor=S.+Gopala&title=Nimbolide+retards+tumor+cell+migration%2C+invasion%2C+and+angiogenesis+by+downregulating+MMP-2%2F9+expression+via+inhibiting+ERK1%2F2+and+reducing+DNA-binding+activity+of+NF-%CE%BAB+in+colon+cancer+cells&doi=10.1002%2Fmc.20812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide retards tumor cell migration, invasion, and angiogenesis by downregulating MMP-2/9 expression via inhibiting ERK1/2 and reducing DNA-binding activity of NF-ÎºB in colon cancer cells</span></div><div class="casAuthors">Babykutty, Suboj; Priya, P. S.; Nandini, R. J.; Kumar, M. A. Suresh; Nair, Mangalam S.; Srinivas, Priya; Gopala, Srinivas</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">475-490</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Nimbolide, a plant-derived limonoid has been shown to exert its antiproliferative effects in various cell lines.  We demonstrate that nimbolide effectively inhibited proliferation of WiDr colon cancer cells through inhibition of cyclin A leading to S phase arrest.  It also caused activation of caspase-mediated apoptosis through the inhibition of ERK1/2 and activation of p38 and JNK1/2.  Further nimbolide effectively retarded tumor cell migration and invasion through inhibition of metalloproteinase-2/9 (MMP-2/9) expression, both at the mRNA and protein level.  It was also a strong inhibitor of VEGF expression, promoter activity, and in vitro angiogenesis.  Finally, nimbolide suppressed the nuclear translocation of p65/p50 and DNA binding of NF-ÎºB, which is an important transcription factor for controlling MMP-2/9 and VEGF gene expression. Â© 2011 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjjfdRwRjx0LVg90H21EOLACvtfcHk0lgpENtb6PMb1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFyhtrg%253D&md5=9f055b666e384b7ee450391aa8595b5b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fmc.20812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.20812%26sid%3Dliteratum%253Aachs%26aulast%3DBabykutty%26aufirst%3DS.%26aulast%3DS%26aufirst%3DP.%2BP.%26aulast%3DJ%26aufirst%3DN.%2BR.%26aulast%3DKumar%26aufirst%3DM.%2BA.%26aulast%3DNair%26aufirst%3DM.%2BS.%26aulast%3DSrinivas%26aufirst%3DP.%26aulast%3DGopala%26aufirst%3DS.%26atitle%3DNimbolide%2520retards%2520tumor%2520cell%2520migration%252C%2520invasion%252C%2520and%2520angiogenesis%2520by%2520downregulating%2520MMP-2%252F9%2520expression%2520via%2520inhibiting%2520ERK1%252F2%2520and%2520reducing%2520DNA-binding%2520activity%2520of%2520NF-%25CE%25BAB%2520in%2520colon%2520cancer%2520cells%26jtitle%3DMol.%2520Carcinog.%26date%3D2012%26volume%3D51%26spage%3D475%26epage%3D490%26doi%3D10.1002%2Fmc.20812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethumadhavan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, B. B.</span></span> <span> </span><span class="NLM_article-title">Nimbolide, a limonoid triterpene, inhibits growth of human colorectal cancer xenografts by suppressing the proinflammatory microenvironment</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4465</span>â <span class="NLM_lpage">4476</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-13-0080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1158%2F1078-0432.CCR-13-0080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=23766363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSitrzP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=4465-4476&author=S.+C.+Guptaauthor=S.+Prasadauthor=D.+R.+Sethumadhavanauthor=M.+S.+Nairauthor=Y.+Y.+Moauthor=B.+B.+Aggarwal&title=Nimbolide%2C+a+limonoid+triterpene%2C+inhibits+growth+of+human+colorectal+cancer+xenografts+by+suppressing+the+proinflammatory+microenvironment&doi=10.1158%2F1078-0432.CCR-13-0080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide, a Limonoid Triterpene, Inhibits Growth of Human Colorectal Cancer Xenografts by Suppressing the Proinflammatory Microenvironment</span></div><div class="casAuthors">Gupta, Subash C.; Prasad, Sahdeo; Sethumadhavan, Dhanya R.; Nair, Mangalam S.; Mo, Yin-Yuan; Aggarwal, Bharat B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4465-4476</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Extensive research over the past decade has revealed that the proinflammatory microenvironment plays a crit. role in the development of colorectal cancer.  Whether nimbolide, a limonoid triterpene, can inhibit the growth of colorectal cancer was investigated in the present study.  Exptl. Design: The effect of nimbolide on proliferation of colorectal cancer cell lines was examd. by MTT assay, apoptosis by caspase activation and poly-ADP ribose polymerase cleavage, NF-ÎºB activation by DNA-binding assay, and protein expression by Western blotting.  The effect of nimbolide on the tumor growth in vivo was examd. in colorectal cancer xenografts in a nude mouse model.  Results: Nimbolide inhibited proliferation, induced apoptosis, and suppressed NF-ÎºB activation and NF-ÎºB-regulated tumorigenic proteins in colorectal cancer cells.  The suppression of NF-ÎºB activation by nimbolide was caused by sequential inhibition of IÎºB kinase (IKK) activation, IÎºBÎ± phosphorylation, and p65 nuclear translocation.  Furthermore, the effect of nimbolide on IKK activity was found to be direct.  In vivo, nimbolide (at 5 and 20 mg/kg body wt.), injected i.p. after tumor inoculation, significantly decreased the vol. of colorectal cancer xenografts.  The limonoid-treated xenografts exhibited significant downregulation in the expression of proteins involved in tumor cell survival (Bcl-2, Bcl-xL, c-IAP-1, survivin, and Mcl-1), proliferation (c-Myc and cyclin D1), invasion (MMP-9, ICAM-1), metastasis (CXCR4), and angiogenesis (VEGF).  The limonoid was found to be bioavailable in the blood plasma and tumor tissues of treated mice.  Conclusions: Our studies provide evidence that nimbolide can suppress the growth of human colorectal cancer through modulation of the proinflammatory microenvironment.  Clin Cancer Res; 19(16); 4465-76. Â©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp30IQjfm0ztrVg90H21EOLACvtfcHk0lgpENtb6PMb1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSitrzP&md5=3d2f0873757d724a55912403c5647464</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-0080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-0080%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DSethumadhavan%26aufirst%3DD.%2BR.%26aulast%3DNair%26aufirst%3DM.%2BS.%26aulast%3DMo%26aufirst%3DY.%2BY.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DNimbolide%252C%2520a%2520limonoid%2520triterpene%252C%2520inhibits%2520growth%2520of%2520human%2520colorectal%2520cancer%2520xenografts%2520by%2520suppressing%2520the%2520proinflammatory%2520microenvironment%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D4465%26epage%3D4476%26doi%3D10.1158%2F1078-0432.CCR-13-0080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chantana, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yenjai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubroycharoen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waiwut, P.</span></span> <span> </span><span class="NLM_article-title">Combination of nimbolide and TNF-alpha-increases human colon adenocarcinoma cell death through JNK-mediated DR5 up-regulation</span>. <i>Asian Pac. J. Cancer Prev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2637</span>â <span class="NLM_lpage">2641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=27268643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FnvVKhtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=2637-2641&author=C.+Chantanaauthor=C.+Yenjaiauthor=P.+Reubroycharoenauthor=P.+Waiwut&title=Combination+of+nimbolide+and+TNF-alpha-increases+human+colon+adenocarcinoma+cell+death+through+JNK-mediated+DR5+up-regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of Nimbolide and TNF-Î±-Increases Human Colon Adenocarcinoma Cell Death through JNK-mediated DR5 Up- regulation</span></div><div class="casAuthors">Chantana Chantana; Yenjai Chavi; Reubroycharoen Prasert; Waiwut Pornthip</div><div class="citationInfo"><span class="NLM_cas:title">Asian Pacific journal of cancer prevention : APJCP</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2637-41</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tumor necrosis factor (TNF-Î±), an inflammatory cytokine that plays an important role in the control of cell proliferation, differentiation, and apoptosis, has previously been used in anti-cancer therapy.  However, the therapeutic applications of TNF-Î± are largely limited due to its general toxicity and anti-apoptotic influence.  To overcome this problem, the present study focused on the effect of active constituents isolated from a medicinal plant on TNF-Î±-induced apoptosis in human colon adenocarcinoma (HT-29) cells.  Nimbolide from Azadirachta indica was evaluated for cytotoxicity by methyl tetrazolium 3-[4,5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide (MTT) assay and phase contrast microscopy.  Effects on apoptotic signaling proteins were investigated using Western blot analysis.  Nimbolide showed cytotoxicity against HT-29 cells that was significantly different from the control group (<0.01), a concentration of 10 Î¼M significantly inducing cell death (<0.01).  In combination with TNF-Î±, nimbolide significantly enhanced-induced cell death.  In apoptotic pathway, nimbolide activated c-Jun N-terminal kinase (JNK) phosphorylation, BH3 interacting-domain death agonist (Bid) and up-regulated the death receptor 5 (DR5) level.  In the combination group, nimbolide markedly sensitized TNF-Î±-induced JNK, Bid, caspase-3 activation and the up-regulation of DR5.  Our findings overall indicate that nimbolide may enhance TNF-Î±-mediated cellular proliferation inhibition through increasing cell apoptosis of HT-29 cells by up-reglation of DR5 expression via the JNK pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgbnNXk6v3a9-cVm4E2RlLfW6udTcc2ebrcs6AJbKfnLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FnvVKhtg%253D%253D&md5=70cae3a4768978f5b06ebd6c149cc210</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChantana%26aufirst%3DC.%26aulast%3DYenjai%26aufirst%3DC.%26aulast%3DReubroycharoen%26aufirst%3DP.%26aulast%3DWaiwut%26aufirst%3DP.%26atitle%3DCombination%2520of%2520nimbolide%2520and%2520TNF-alpha-increases%2520human%2520colon%2520adenocarcinoma%2520cell%2520death%2520through%2520JNK-mediated%2520DR5%2520up-regulation%26jtitle%3DAsian%2520Pac.%2520J.%2520Cancer%2520Prev.%26date%3D2016%26volume%3D17%26spage%3D2637%26epage%3D2641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wangjam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabang, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wargovich, M. J.</span></span> <span> </span><span class="NLM_article-title">A supercritical CO2 extract of neem leaf (A. indica) and its bioactive liminoid, nimbolide, suppresses colon cancer in preclinical models by modulating pro-inflammatory pathways</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1156</span>â <span class="NLM_lpage">1165</span>, <span class="refDoi">Â DOI: 10.1002/mc.22832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fmc.22832" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29697164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt1alur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=1156-1165&author=M.+J.+Patelauthor=S.+Tripathyauthor=K.+D.+Mukhopadhyayauthor=T.+Wangjamauthor=A.+B.+Cabangauthor=J.+Morrisauthor=M.+J.+Wargovich&title=A+supercritical+CO2+extract+of+neem+leaf+%28A.+indica%29+and+its+bioactive+liminoid%2C+nimbolide%2C+suppresses+colon+cancer+in+preclinical+models+by+modulating+pro-inflammatory+pathways&doi=10.1002%2Fmc.22832"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A supercritical CO2 extract of neem leaf (A. indica) and its bioactive liminoid, nimbolide, suppresses colon cancer in preclinical models by modulating pro-inflammatory pathways</span></div><div class="casAuthors">Patel, Mandakini J.; Tripathy, Shreya; Mukhopadhyay, Keya D.; Wangjam, Tamna; Cabang, April B.; Morris, Jay; Wargovich, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1156-1165</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second leading cause of cancer death in men and women in the United States.  Anti-inflammatory blockade has been proven to be a promising avenue of colorectal cancer prevention.  However, NSAIDs while effective in curbing CRC risk are too toxic for long-term use in cancer prevention.  The Neem tree (Azadirachta indica) is rich in liminoid terpenoids, collectively known as azadiractoids and has been shown to have anti-inflammatory effects.  To explore a role of neem in CRC, human colon cancer cell lines HCT116 and HT29 cells were treated with purified Super Crit. Neem Ext. (SCNE) or the neem liminoid, nimbolide.  SCNE treatment resulted in a dose dependent inhibition of CRC cell proliferation and an increase in apoptosis.  Treatment with SCNE and nimbolide decreased the expression of transcriptional factors, STAT3 and NF-ÎºB which plays a major role in gene regulation of multiple cellular processes.  Protein expression of COX1, IL-6, and TNF-Î± were decreased on treatment with SCNE in CRC cells.  Western blots and Zymogram assays results revealed anti-invasive effect by decreased expression of MMP2 and MMP9 proteins in CRC cells.  Overall, these data confirm a potential anti-cancer effect of SCNE, reducing cell proliferation, inflammation, migration, and invasion in human colon cancer cells.  Confirming these indications, we found that treatment of mice bearing HT29 and HCT116 xenografted tumors exhibited striking inhibition of colon tumor growth.  Clearly we must explore the effect of neem in preclin. animal models for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU-Gy1oPlXCbVg90H21EOLACvtfcHk0lgpENtb6PMb1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt1alur8%253D&md5=40bc7e1e2c7b31b26f2283300a6306c7</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fmc.22832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.22832%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%2BJ.%26aulast%3DTripathy%26aufirst%3DS.%26aulast%3DMukhopadhyay%26aufirst%3DK.%2BD.%26aulast%3DWangjam%26aufirst%3DT.%26aulast%3DCabang%26aufirst%3DA.%2BB.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DWargovich%26aufirst%3DM.%2BJ.%26atitle%3DA%2520supercritical%2520CO2%2520extract%2520of%2520neem%2520leaf%2520%2528A.%2520indica%2529%2520and%2520its%2520bioactive%2520liminoid%252C%2520nimbolide%252C%2520suppresses%2520colon%2520cancer%2520in%2520preclinical%2520models%2520by%2520modulating%2520pro-inflammatory%2520pathways%26jtitle%3DMol.%2520Carcinog.%26date%3D2018%26volume%3D57%26spage%3D1156%26epage%3D1165%26doi%3D10.1002%2Fmc.22832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrijauskaite, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wargovich, M. J.</span></span> <span> </span><span class="NLM_article-title">Disruption of epigenetic silencing in human colon cancer cells lines utilizing a novel supercritical CO2 extract of neem leaf (Azadirachta indica)</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">5473</span>â <span class="NLM_lpage">5481</span>, <span class="refDoi">Â DOI: 10.21873/anticanres.13740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.21873%2Fanticanres.13740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31570441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1OhtL%252FP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=5473-5481&author=Z.+Qiuauthor=K.+Andrijauskaiteauthor=J.+Morrisauthor=M.+J.+Wargovich&title=Disruption+of+epigenetic+silencing+in+human+colon+cancer+cells+lines+utilizing+a+novel+supercritical+CO2+extract+of+neem+leaf+%28Azadirachta+indica%29&doi=10.21873%2Fanticanres.13740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of epigenetic silencing in human colon cancer cells lines utilizing a novel supercritical CO2 Extract of Neem Leaf (Azadirachta indica)</span></div><div class="casAuthors">Qiu, Zhifang; Andruauskaite, Kristina; Morris, Jay; Wargovich, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5473-5481</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background!Aim: Aerial parts and seeds of the neem tree (Azadirachta indica) have long been used in traditional medicine such as Ayurveda for health-related purposes.  Our interest in neem bioactives lies in their potential use as standalone anticancer agents, or as adjuvants to std. therapy.  The aim of the present study was to explore a supercrit. CO2 ext. (SCNE) of neem leaf and a prominent Iiminoid in neem leaf, nimbolide, for epigenetic activity.  Materials and Methods: Human colorectal cancer cell lines (HCTIJ6 and HT29) were cultured for 48 h in the presence of neem ext. or nimbolide and evaluatedfor growth inhibition and evidence of suppression of histone deacetylation and DNA methylation.  Results: Both SCNE and nimbolide suppressed the proliferation of colon cancer cells by inducing epigenetic modifications.  Conclusion: Neem leaf contains bioactive constituents which modify epigenetic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_S8So1gu1q7Vg90H21EOLACvtfcHk0livtUT4sg26IQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1OhtL%252FP&md5=29923eb27f0c13c1087972a93ee50a4c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.21873%2Fanticanres.13740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21873%252Fanticanres.13740%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DZ.%26aulast%3DAndrijauskaite%26aufirst%3DK.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DWargovich%26aufirst%3DM.%2BJ.%26atitle%3DDisruption%2520of%2520epigenetic%2520silencing%2520in%2520human%2520colon%2520cancer%2520cells%2520lines%2520utilizing%2520a%2520novel%2520supercritical%2520CO2%2520extract%2520of%2520neem%2520leaf%2520%2528Azadirachta%2520indica%2529%26jtitle%3DAnticancer%2520Res.%26date%3D2019%26volume%3D39%26spage%3D5473%26epage%3D5481%26doi%3D10.21873%2Fanticanres.13740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karkare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chhipa, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasilina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nassar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roychoudhury, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. P</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauletti, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, B.</span></span> <span> </span><span class="NLM_article-title">Direct inhibition of retinoblastoma phosphorylation by nimbolide causes cell-cycle arrest and suppresses glioblastoma growth</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">199</span>â <span class="NLM_lpage">212</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-13-0762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1158%2F1078-0432.CCR-13-0762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=24170547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislKluw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=199-212&author=S.+Karkareauthor=R.+R.+Chhipaauthor=J.+Andersonauthor=X.+Liuauthor=H.+Henryauthor=A.+Gasilinaauthor=N.+Nassarauthor=J.+Roychoudhuryauthor=J.+P+Clarkauthor=A.+Kumarauthor=G.+M.+Paulettiauthor=P.+K.+Ghoshauthor=B.+Dasgupta&title=Direct+inhibition+of+retinoblastoma+phosphorylation+by+nimbolide+causes+cell-cycle+arrest+and+suppresses+glioblastoma+growth&doi=10.1158%2F1078-0432.CCR-13-0762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Inhibition of Retinoblastoma Phosphorylation by Nimbolide Causes Cell-Cycle Arrest and Suppresses Glioblastoma Growth</span></div><div class="casAuthors">Karkare, Swagata; Chhipa, Rishi Raj; Anderson, Jane; Liu, Xiaona; Henry, Heather; Gasilina, Anjelika; Nassar, Nicholas; Roychoudhury, Jayeeta; Clark, Jason P.; Kumar, Ashish; Pauletti, Giovanni M.; Ghosh, Pradip K.; Dasgupta, Biplab</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-212</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Classical pharmacol. allows the use and development of conventional phytomedicine faster and more economically than conventional drugs.  This approach should be tested for their efficacy in terms of complementarity and disease control.  The purpose of this study was to det. the mol. mechanisms by which nimbolide, a triterpenoid found in the well-known medicinal plant Azadirachta indica, controls glioblastoma growth.  Exptl. Design: Using in vitro signaling, anchorage-independent growth, kinase assays, and xenograft models, we investigated the mechanisms of its growth inhibition in glioblastoma.  Results: We show that nimbolide or an ethanol sol. fraction of A. indica leaves (Azt) that contains nimbolide as the principal cytotoxic agent is highly cytotoxic against glioblastoma multiforme in vitro and in vivo.  Azt caused cell-cycle arrest, most prominently at the G1-S stage in glioblastoma multiforme cells expressing EGFRvIII, an oncogene present in about 20% to 25% of glioblastoma multiformes.  Azt/nimbolide directly inhibited CDK4/CDK6 kinase activity leading to hypophosphorylation of the retinoblastoma protein, cell-cycle arrest at G1-S, and cell death.  Independent of retinoblastoma hypophosphorylation, Azt also significantly reduced proliferative and survival advantage of glioblastoma multiforme cells in vitro and in tumor xenografts by downregulating Bcl2 and blocking growth factor-induced phosphorylation of Akt, extracellular signal-regulated kinase 1/2, and STAT3.  These effects were specific because Azt did not affect mTOR or other cell-cycle regulators.  In vivo, Azt completely prevented initiation and inhibited progression of glioblastoma multiforme growth.  Conclusions: Our preclin. findings demonstrate nimbolide as a potent anti-glioma agent that blocks cell cycle and inhibits glioma growth in vitro and in vivo.  Clin Cancer Res; 20(1); 199-212. Â©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSCkKL-3wHz7Vg90H21EOLACvtfcHk0livtUT4sg26IQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislKluw%253D%253D&md5=857bedb8c580c61101ca0a4e4f2f3ef4</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-0762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-0762%26sid%3Dliteratum%253Aachs%26aulast%3DKarkare%26aufirst%3DS.%26aulast%3DChhipa%26aufirst%3DR.%2BR.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHenry%26aufirst%3DH.%26aulast%3DGasilina%26aufirst%3DA.%26aulast%3DNassar%26aufirst%3DN.%26aulast%3DRoychoudhury%26aufirst%3DJ.%26aulast%3DClark%26aufirst%3DJ.%2BP%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DPauletti%26aufirst%3DG.%2BM.%26aulast%3DGhosh%26aufirst%3DP.%2BK.%26aulast%3DDasgupta%26aufirst%3DB.%26atitle%3DDirect%2520inhibition%2520of%2520retinoblastoma%2520phosphorylation%2520by%2520nimbolide%2520causes%2520cell-cycle%2520arrest%2520and%2520suppresses%2520glioblastoma%2520growth%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D199%26epage%3D212%26doi%3D10.1158%2F1078-0432.CCR-13-0762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takenaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinmoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsushida, T.</span></span> <span> </span><span class="NLM_article-title">Antiproliferative effect on human cancer cell lines after treatment with nimbolide extracted from an edible part of the neem tree (Azadirachta indica)</span>. <i>Phytother. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">245</span>â <span class="NLM_lpage">250</span>, <span class="refDoi">Â DOI: 10.1002/ptr.2058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fptr.2058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=17163581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlSgt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=245-250&author=M.+K.+Royauthor=M.+Koboriauthor=M.+Takenakaauthor=K.+Nakaharaauthor=H.+Shinmotoauthor=S.+Isobeauthor=T.+Tsushida&title=Antiproliferative+effect+on+human+cancer+cell+lines+after+treatment+with+nimbolide+extracted+from+an+edible+part+of+the+neem+tree+%28Azadirachta+indica%29&doi=10.1002%2Fptr.2058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative effect on human cancer cell lines after treatment with nimbolide extracted from an edible part of the neem tree (Azadirachta indica)</span></div><div class="casAuthors">Roy, Molay Kumar; Kobori, Masuko; Takenaka, Makiko; Nakahara, Kazuhiko; Shinmoto, Hiroshi; Isobe, Seiichiro; Tsushida, Tojiro</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">245-250</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Nimbolide, a triterpenoid extd. from the flowers of the neem tree (Azadirachta indica), was found to have antiproliferative activity against some cancer cell lines.  Treatment of cells with 0.5-5.0 Î¼m concns. of nimbolide resulted in moderate to very strong growth inhibition in U937, HL-60, THP1 and B16 cell lines.  Flow cytometric anal. of U937 cells showed that nimbolide treatment (1-2.5 Î¼m) resulted in cell cycle disruption by decreasing the no. of cells in G0/G1 phase, with initial increases in S and G2/M phases.  Cells exposed to a higher dose of nimbolide for a longer period displayed a severely damaged DNA profile, resulting in a remarkable increase in the no. of cells in the sub-G1 fraction, with a reciprocal decrease of cells in all phases.  Quantification of the expression of phosphatidylserine in the outer cell membrane showed that doses of nimbolide higher than 0.4 Î¼m exerted remarkable lethality, with over 60% of cells exhibiting apoptotic features after exposure to 1.2 Î¼m nimbolide.  The antiproliferative effect of nimbolide and its apoptosis-inducing property raise hope for its use in anticancer therapy by enhancing the effectiveness of cell cycle disruption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU8l75KPgH67Vg90H21EOLACvtfcHk0livtUT4sg26IQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlSgt78%253D&md5=bd927805400598e0ece9d1d929ac68e0</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fptr.2058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.2058%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DM.%2BK.%26aulast%3DKobori%26aufirst%3DM.%26aulast%3DTakenaka%26aufirst%3DM.%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DShinmoto%26aufirst%3DH.%26aulast%3DIsobe%26aufirst%3DS.%26aulast%3DTsushida%26aufirst%3DT.%26atitle%3DAntiproliferative%2520effect%2520on%2520human%2520cancer%2520cell%2520lines%2520after%2520treatment%2520with%2520nimbolide%2520extracted%2520from%2520an%2520edible%2520part%2520of%2520the%2520neem%2520tree%2520%2528Azadirachta%2520indica%2529%26jtitle%3DPhytother.%2520Res.%26date%3D2007%26volume%3D21%26spage%3D245%26epage%3D250%26doi%3D10.1002%2Fptr.2058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannappan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravindran, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hema, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, B. B.</span></span> <span> </span><span class="NLM_article-title">Modification of cysteine 179 of IkappaBalpha kinase by nimbolide leads to down-regulation of NF-kappaB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">35406</span>â <span class="NLM_lpage">35417</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M110.161984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1074%2Fjbc.M110.161984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=20829362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyntLvO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=35406-35417&author=S.+C.+Guptaauthor=S.+Prasadauthor=S.+Reuterauthor=R.+Kannappanauthor=V.+R.+Yadavauthor=J.+Ravindranauthor=P.+S.+Hemaauthor=M.+M.+Chaturvediauthor=M.+Nairauthor=B.+B.+Aggarwal&title=Modification+of+cysteine+179+of+IkappaBalpha+kinase+by+nimbolide+leads+to+down-regulation+of+NF-kappaB-regulated+cell+survival+and+proliferative+proteins+and+sensitization+of+tumor+cells+to+chemotherapeutic+agents&doi=10.1074%2Fjbc.M110.161984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of Cysteine 179 of IÎºBÎ± Kinase by Nimbolide Leads to Down-regulation of NF-ÎºB-regulated Cell Survival and Proliferative Proteins and Sensitization of Tumor Cells to Chemotherapeutic Agents</span></div><div class="casAuthors">Gupta, Subash C.; Prasad, Sahdeo; Reuter, Simone; Kannappan, Ramaswamy; Yadav, Vivek R.; Ravindran, Jayaraj; Hema, Padmanabhan S.; Chaturvedi, Madan M.; Nair, Mangalam; Aggarwal, Bharat B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">35406-35417</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Reverse pharmacol., also called the "bedside to bench" approach, that deals with new uses for a well known mol. entity has been used extensively in cancer drug development to identify novel compds. and delineate their mechanisms of action.  Here, we show that nimbolide, a triterpenoid isolated from Azadirachta indica, enhanced the apoptosis induced by inflammatory cytokines and chemotherapeutic agents in tumor cells.  This limonoid abrogated the expression of proteins assocd. with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-ÎºB.  Nimbolide inhibited the activation of NF-ÎºB induced by carcinogens and inflammatory stimuli.  Constitutively active NF-ÎºB found in most tumor cells was also inhibited.  We found that suppression of NF-ÎºB activation by nimbolide was caused by inhibition of IÎºB kinase (IKK), which led to suppression of IÎºBÎ± phosphorylation and degrdn., nuclear translocation, DNA binding, and gene transcription.  Reducing agent reversed the action of the limonoid, suggesting the involvement of a cysteine residue.  Replacement of Cys179 of IKK-Î² with alanine abolished the effect of nimbolide, suggesting that Cys179 plays a crit. role in inhibiting the NF-ÎºB activation.  Overall, our results indicate that nimbolide can sensitize tumor cells to chemotherapeutic agents through interaction with IKK, leading to inhibition of NF-ÎºB-regulated proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEICPSk2cC7rVg90H21EOLACvtfcHk0liI8xZ_um0gAA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyntLvO&md5=98f883ffc274ce0d75d81b823c313804</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.161984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.161984%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DReuter%26aufirst%3DS.%26aulast%3DKannappan%26aufirst%3DR.%26aulast%3DYadav%26aufirst%3DV.%2BR.%26aulast%3DRavindran%26aufirst%3DJ.%26aulast%3DHema%26aufirst%3DP.%2BS.%26aulast%3DChaturvedi%26aufirst%3DM.%2BM.%26aulast%3DNair%26aufirst%3DM.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DModification%2520of%2520cysteine%2520179%2520of%2520IkappaBalpha%2520kinase%2520by%2520nimbolide%2520leads%2520to%2520down-regulation%2520of%2520NF-kappaB-regulated%2520cell%2520survival%2520and%2520proliferative%2520proteins%2520and%2520sensitization%2520of%2520tumor%2520cells%2520to%2520chemotherapeutic%2520agents%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D35406%26epage%3D35417%26doi%3D10.1074%2Fjbc.M110.161984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chitta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caulfield, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhtar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ailawadhi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckman, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanan-Khan, A.</span></span> <span> </span><span class="NLM_article-title">Nimbolide targets BCL2 and induces apoptosis in preclinical models of WaldenstrÃ¶ms macroglobulinemia</span>. <i>Blood Cancer J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e260</span>, <span class="refDoi">Â DOI: 10.1038/bcj.2014.74</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fbcj.2014.74" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=25382610" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=e260&author=K.+Chittaauthor=A.+Paulusauthor=T.+R.+Caulfieldauthor=S.+Akhtarauthor=M.+K.+Blakeauthor=S.+Ailawadhiauthor=J.+Knightauthor=M.+G.+Heckmanauthor=A.+Pinkertonauthor=A.+Chanan-Khan&title=Nimbolide+targets+BCL2+and+induces+apoptosis+in+preclinical+models+of+Waldenstr%C3%B6ms+macroglobulinemia&doi=10.1038%2Fbcj.2014.74"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fbcj.2014.74&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbcj.2014.74%26sid%3Dliteratum%253Aachs%26aulast%3DChitta%26aufirst%3DK.%26aulast%3DPaulus%26aufirst%3DA.%26aulast%3DCaulfield%26aufirst%3DT.%2BR.%26aulast%3DAkhtar%26aufirst%3DS.%26aulast%3DBlake%26aufirst%3DM.%2BK.%26aulast%3DAilawadhi%26aufirst%3DS.%26aulast%3DKnight%26aufirst%3DJ.%26aulast%3DHeckman%26aufirst%3DM.%2BG.%26aulast%3DPinkerton%26aufirst%3DA.%26aulast%3DChanan-Khan%26aufirst%3DA.%26atitle%3DNimbolide%2520targets%2520BCL2%2520and%2520induces%2520apoptosis%2520in%2520preclinical%2520models%2520of%2520Waldenstr%25C3%25B6ms%2520macroglobulinemia%26jtitle%3DBlood%2520Cancer%2520J.%26date%3D2014%26volume%3D4%26spage%3De260%26doi%3D10.1038%2Fbcj.2014.74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahmoud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, M. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klauck, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greten, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efferth, T.</span></span> <span> </span><span class="NLM_article-title">Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">35762</span>â <span class="NLM_lpage">35779</span>, <span class="refDoi">Â DOI: 10.18632/oncotarget.26299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.18632%2Foncotarget.26299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=30515268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3cros1KgtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=35762-35779&author=N.+Mahmoudauthor=M.+E.+M.+Saeedauthor=Y.+Sugimotoauthor=S.+M.+Klauckauthor=H.+J.+Gretenauthor=T.+Efferth&title=Cytotoxicity+of+nimbolide+towards+multidrug-resistant+tumor+cells+and+hypersensitivity+via+cellular+metabolic+modulation&doi=10.18632%2Foncotarget.26299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation</span></div><div class="casAuthors">Mahmoud Nuha; Saeed Mohamed E M; Efferth Thomas; Sugimoto Yoshikazu; Klauck Sabine M; Greten Henry J; Greten Henry J</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">87</span>),
    <span class="NLM_cas:pages">35762-35779</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nimbolide is considered a promising natural product in cancer prevention and treatment.  However, it is not known yet, whether the different mechanisms of multidrug resistance (MDR) influence its anticancer activity.  In this study, well-known MDR mechanisms (ABCB1, ABCG2, ABCB5, TP53, EGFR) were evaluated against nimbolide.  The P-glycoprotein (ABCB1/MDR1)-overexpressing CEM/ADR5000 cell line displayed remarkable hypersensitivity to nimbolide, which was mediated through upregulation of the tumor suppressor, PTEN, and its downstream components resulted in significant downregulation in ABCB1/MDR1 mRNA and P-glycoprotein.  In addition, nimbolide targeted essential cellular metabolic-regulating elements including HIF1Î±, FoxO1, MYC and reactive oxygen species.  The expression of breast cancer resistance protein (BCRP) as well as epidermal growth factor receptor (EGFR) and mutant tumor suppressor TP53 did not correlate to nimbolide's activity.  Furthermore, this paper looked for other molecular determinants that might determine tumor cellular response towards nimbolide.  COMPARE and hierarchical cluster analyses of transcriptome-wide microarray-based mRNA expressions of the NCI 60 cell line panel were performed, and a set of 40 genes from different functional groups was identified.  The data suggested NF-ÎºB as master regulator of nimbolide's activity.  Interestingly, HIF1Î± was determined by COMPARE analysis to mediate sensitivity to nimbolide, which would be of great benefit in targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4op8c3dWl04JKJbLTgsvCfW6udTcc2eaa6iazZ2_ek7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cros1KgtQ%253D%253D&md5=e872fa8f385268f0f34e6054746fc585</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.26299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.26299%26sid%3Dliteratum%253Aachs%26aulast%3DMahmoud%26aufirst%3DN.%26aulast%3DSaeed%26aufirst%3DM.%2BE.%2BM.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DKlauck%26aufirst%3DS.%2BM.%26aulast%3DGreten%26aufirst%3DH.%2BJ.%26aulast%3DEfferth%26aufirst%3DT.%26atitle%3DCytotoxicity%2520of%2520nimbolide%2520towards%2520multidrug-resistant%2520tumor%2520cells%2520and%2520hypersensitivity%2520via%2520cellular%2520metabolic%2520modulation%26jtitle%3DOncotarget%26date%3D2018%26volume%3D9%26spage%3D35762%26epage%3D35779%26doi%3D10.18632%2Foncotarget.26299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kavitha, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidya Priyadarsini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anitha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramalingam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakthivel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purushothaman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karunagaran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide, a neem limonoid abrogates canonical NF-ÎºB and Wnt signaling to induce caspase-dependent apoptosis in human hepatocarcinoma (HepG2) cells</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>681</i></span>,  <span class="NLM_fpage">6</span>â <span class="NLM_lpage">14</span>, <span class="refDoi">Â DOI: 10.1016/j.ejphar.2012.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.ejphar.2012.01.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=22327045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC38XivFygtro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=681&publication_year=2012&pages=6-14&author=K.+Kavithaauthor=R.+Vidya+Priyadarsiniauthor=P.+Anithaauthor=K.+Ramalingamauthor=R.+Sakthivelauthor=G.+Purushothamanauthor=A.+K.+Singhauthor=D.+Karunagaranauthor=S.+Nagini&title=Nimbolide%2C+a+neem+limonoid+abrogates+canonical+NF-%CE%BAB+and+Wnt+signaling+to+induce+caspase-dependent+apoptosis+in+human+hepatocarcinoma+%28HepG2%29+cells&doi=10.1016%2Fj.ejphar.2012.01.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide, a neem limonoid abrogates canonical NF-ÎºB and Wnt signaling to induce caspase-dependent apoptosis in human hepatocarcinoma (HepG2) cells</span></div><div class="casAuthors">Kavitha, Krishnamurthy; Vidya Priyadarsini, Ramamurthi; Anitha, Prabukumar; Ramalingam, Krishnan; Sakthivel, Ramasamy; Purushothaman, Gempuraj; Singh, Abhishek Kumar; Karunagaran, Devarajan; Nagini, Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">681</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">6-14</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nuclear factor kappa B (NF-ÎºB), an oncogenic signaling factor plays a crit. role in the development and progression of various cancers.  The objective of this study was to investigate the effect of nimbolide, a neem derived tetranortriterpenoid on NF-ÎºB signaling and its downstream events - Wnt/Î²-catenin activation and apoptosis evasion in human hepatocarcinoma (HepG2) cells by evaluating NF-ÎºB family members (NF-ÎºB-p50, p65, IÎºB-Î±, p-IÎºB-Î±, and IKKÎ²), members of Wnt signaling (GSK-3Î² and Î²-catenin), and intrinsic apoptosis (Bcl-2, Bax, cytochrome c, Smac/DIABLO, caspase-3, and caspase-9).  Our results demonstrate that nimbolide concurrently abrogates canonical NF-ÎºB and Wnt signaling and induces intrinsic apoptosis in HepG2 cells.  These data suggest that phytochems. such as nimbolide that can target multiple steps along the NF-ÎºB signaling circuit are promising candidates for future phytochem.-based mechanistic pathway targeted anticancer regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEREiaPxfMnLVg90H21EOLACvtfcHk0lgYcFX5KrRSVw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivFygtro%253D&md5=8c22dff348b4ffe6eed4dc3a78cd5521</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DKavitha%26aufirst%3DK.%26aulast%3DVidya%2BPriyadarsini%26aufirst%3DR.%26aulast%3DAnitha%26aufirst%3DP.%26aulast%3DRamalingam%26aufirst%3DK.%26aulast%3DSakthivel%26aufirst%3DR.%26aulast%3DPurushothaman%26aufirst%3DG.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DKarunagaran%26aufirst%3DD.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DNimbolide%252C%2520a%2520neem%2520limonoid%2520abrogates%2520canonical%2520NF-%25CE%25BAB%2520and%2520Wnt%2520signaling%2520to%2520induce%2520caspase-dependent%2520apoptosis%2520in%2520human%2520hepatocarcinoma%2520%2528HepG2%2529%2520cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D681%26spage%3D6%26epage%3D14%26doi%3D10.1016%2Fj.ejphar.2012.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsueh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, Y. H.</span></span> <span> </span><span class="NLM_article-title">Nimbolide induced apoptosis by activating ERK-mediated inhibition of c-IAP1 expression in human hepatocellular carcinoma cells</span>. <i>Environ. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">913</span>â <span class="NLM_lpage">922</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29962003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1eisLjL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=913-922&author=K.+C.+Hsuehauthor=C.+L.+Linauthor=J.+N.+Tungauthor=S.+F.+Yangauthor=Y.+H.+Hsieh&title=Nimbolide+induced+apoptosis+by+activating+ERK-mediated+inhibition+of+c-IAP1+expression+in+human+hepatocellular+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide induced apoptosis by activating ERK-mediated inhibition of c-IAP1 expression in human hepatocellular carcinoma cells</span></div><div class="casAuthors">Hsueh, Kuan-Chun; Lin, Chia-Liang; Tung, Jai-Nien; Yang, Shun-Fa; Hsieh, Yi-Hsien</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">913-922</span>CODEN:
                <span class="NLM_cas:coden">ETOXFH</span>;
        ISSN:<span class="NLM_cas:issn">1520-4081</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Nimbolide is one of the major compds. from the leaves and flowers of the neem tree and exhibits antitumor properties on various cancer cells.  However, no report has shown that nimbolide induces apoptosis in vitro and in vivo in human hepatocellular carcinoma cells.  Our results indicated that it inhibited cell growth in Huh-7 and PLC/PRF/5 cells.  We also found that nimbolide induced cell death through the induction of G2/M phase arrest and mitochondrial dysfunction, accompanied by the increased expression of cleaved caspase-7, caspase-9, caspase-3, caspase-PARP, and Bax and decreased expression of Mcl-1 and Bcl-2.  A human apoptosis antibody array anal. demonstrated that inhibition of the apoptosis family proteins (XIAP, c-IAP1, and c-IAP2) was one of the major targets of nimbolide.  Addnl., nimbolide sustained activation of ERK expression.  Moreover, pretreatment with U0126 (MEK inhibitor) markedly abolished nimbolide-inhibited cell viability, induced cell apoptosis, ERK phosphorylation, cleaved caspase-9, caspase-3, cleaved-PARP activation, and increased c-IAP1 expression in Huh-7 cells.  An in vivo study showed that nimbolide significantly reduced Huh-7 tumor growth and wt. in a xenograft mouse model.  This study indicated the antitumor potential of nimbolide in human hepatocellular carcinoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolM-4DfaR-WrVg90H21EOLACvtfcHk0lgYcFX5KrRSVw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1eisLjL&md5=31599c2e87b293209bd66ec7c9f970b5</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsueh%26aufirst%3DK.%2BC.%26aulast%3DLin%26aufirst%3DC.%2BL.%26aulast%3DTung%26aufirst%3DJ.%2BN.%26aulast%3DYang%26aufirst%3DS.%2BF.%26aulast%3DHsieh%26aufirst%3DY.%2BH.%26atitle%3DNimbolide%2520induced%2520apoptosis%2520by%2520activating%2520ERK-mediated%2520inhibition%2520of%2520c-IAP1%2520expression%2520in%2520human%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DEnviron.%2520Toxicol.%26date%3D2018%26volume%3D33%26spage%3D913%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide suppresses non-small cell lung cancer cell invasion and migration via manipulation of DUSP4 expression and ERK1/2 signaling</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">340</span>â <span class="NLM_lpage">346</span>, <span class="refDoi">Â DOI: 10.1016/j.biopha.2017.05.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.biopha.2017.05.072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=28554129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1entbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2017&pages=340-346&author=H.+Linauthor=S.+Qiuauthor=L.+Xieauthor=C.+Liuauthor=S.+Sun&title=Nimbolide+suppresses+non-small+cell+lung+cancer+cell+invasion+and+migration+via+manipulation+of+DUSP4+expression+and+ERK1%2F2+signaling&doi=10.1016%2Fj.biopha.2017.05.072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide suppresses non-small cell lung cancer cell invasion and migration via manipulation of DUSP4 expression and ERK1/2 signaling</span></div><div class="casAuthors">Lin, Hua; Qiu, Shiyang; Xie, Lihua; Liu, Chun; Sun, Shenghua</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">340-346</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Nimbolide plays an important role in treating human diseases.  In these years, the anticancer property of nimbolide has been paid more and more attention.  However, the role of nimbolide in non-small cell lung cancer (NSCLC) remains unclear.  In this study, we found that nimbolide treatment suppressed the invasion and migration of NSCLC cells, in a dose-dependent manner.  Moreover, nimbolide treatment dose-dependently inhibited ERK1/2 activation, decreased Snail and MMP-3 expression, and increased E-cadherin expression.  Further, we found that nimbolide treatment upregulated DUSP4 expression.  DUSP4 knockdown attenuated nimbolide-mediated inhibition of cell invasion, migration and ERK1/2 activation.  We also found that DUSP4 knockdown suppressed the effect of nimbolide on MMP-3, Snail and E-cadherin expression.  Taken together, our study demonstrates that nimbolide treatment can upregulate the expression of DUSP4, thus inhibiting ERK1/2 activation.  Inhibition of ERK1/2 pathway by nimbolide decreases MMP-3 and Snail expression, and increases E-cadherin expression, which finally inhibits NSCLC cell invasion and migration.  Therefore, nimbolide may act as a novel drug to inhibit NSCLC invasion and metastasis through manipulation of ERK1/2 signaling and DUSP4 expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPYq8X7vmnXrVg90H21EOLACvtfcHk0lgYcFX5KrRSVw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1entbo%253D&md5=a2c02d252e3aeaf8b5089f5b2237f1fb</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2017.05.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2017.05.072%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DH.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DS.%26atitle%3DNimbolide%2520suppresses%2520non-small%2520cell%2520lung%2520cancer%2520cell%2520invasion%2520and%2520migration%2520via%2520manipulation%2520of%2520DUSP4%2520expression%2520and%2520ERK1%252F2%2520signaling%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D92%26spage%3D340%26epage%3D346%26doi%3D10.1016%2Fj.biopha.2017.05.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsi, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.-K.</span></span> <span> </span><span class="NLM_article-title">Nimbolide induces apoptosis in human nasopharyngeal cancer cells</span>. <i>Environ. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2085</span>â <span class="NLM_lpage">2092</span>, <span class="refDoi">Â DOI: 10.1002/tox.22423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Ftox.22423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=28383207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1Wis7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=2085-2092&author=S.-Y.+Chienauthor=C.-H.+Hsuauthor=C.-C.+Linauthor=Y.-C.+Chuangauthor=Y.-S.+Loauthor=Y.-T.+Hsiauthor=M.-J.+Hsiehauthor=M.-K.+Chen&title=Nimbolide+induces+apoptosis+in+human+nasopharyngeal+cancer+cells&doi=10.1002%2Ftox.22423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide induces apoptosis in human nasopharyngeal cancer cells</span></div><div class="casAuthors">Chien, Su-Yu; Hsu, Ching-Hui; Lin, Chia-Chieh; Chuang, Yi-Ching; Lo, Yu-Sheng; Hsi, Yi-Ting; Hsieh, Ming-Ju; Chen, Mu-Kuan</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2085-2092</span>CODEN:
                <span class="NLM_cas:coden">ETOXFH</span>;
        ISSN:<span class="NLM_cas:issn">1520-4081</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Nasopharyngeal carcinoma (NPC), a tumor arising from epithelial cells that cover the surface and line the nasopharynx, is a rare malignancy worldwide but is prevalent in certain geog. areas, such as Southern Asia (Taiwan, Hong Kong, Singapore, Malaysia, and Southern China) and North Africa.  Despite advances in diagnostic techniques and improvements in treatment modalities, the prognosis of NPC remains poor.  Therefore, an effective chemotherapy regimen that enhances tumor sensitivity to chemotherapeutics is urgently required.  Nimbolide, derived from Azadirachta indica, has a wide range of beneficial effects, including anti-inflammatory and anticancer properties.  The present study evaluated the antitumor activity of nimbolide in NPC cells and its underlying mechanisms.  Our results revealed that the treatment of HONE-1 cells with nimbolide potently inhibited cell viability.  Moreover, nimbolide led to cell cycle arrest, which subsequently activated caspase-3, -8, and -9 and poly (ADP-ribose) polymerase to induce cell apoptosis.  Moreover, nimbolide induced Bik, Bax, and t-Bid expression in HONE-1 cells.  The results indicated that nimbolide induces apoptosis through the modulation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) pathways.  Nimbolide induces apoptosis in human NPC cells and is a potential chemopreventive agent against NPC proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzzosvPwV0dLVg90H21EOLACvtfcHk0lgYcFX5KrRSVw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1Wis7g%253D&md5=47ced1f67e83924318b7314d521c2637</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Ftox.22423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Ftox.22423%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DS.-Y.%26aulast%3DHsu%26aufirst%3DC.-H.%26aulast%3DLin%26aufirst%3DC.-C.%26aulast%3DChuang%26aufirst%3DY.-C.%26aulast%3DLo%26aufirst%3DY.-S.%26aulast%3DHsi%26aufirst%3DY.-T.%26aulast%3DHsieh%26aufirst%3DM.-J.%26aulast%3DChen%26aufirst%3DM.-K.%26atitle%3DNimbolide%2520induces%2520apoptosis%2520in%2520human%2520nasopharyngeal%2520cancer%2520cells%26jtitle%3DEnviron.%2520Toxicol.%26date%3D2017%26volume%3D32%26spage%3D2085%26epage%3D2092%26doi%3D10.1002%2Ftox.22423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De La, Chapa J.J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabang, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fountzilas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wargovich, M. J.</span></span> <span> </span><span class="NLM_article-title">The highly pure neem leaf extract, SCNE, inhibits tumorigenesis in oral squamous cell carcinoma via disruption of pro-tumor inflammatory cytokines and cell signaling</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">890</span>, <span class="refDoi">Â DOI: 10.3389/fonc.2019.00890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3389%2Ffonc.2019.00890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31572681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3MnjvFSnuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=890&author=J.+Morrisauthor=C.+B.+Gonzalesauthor=Chapa+J.J.+De+Laauthor=A.+B.+Cabangauthor=C.+Fountzilasauthor=M.+Patelauthor=S.+Orozcoauthor=M.+J.+Wargovich&title=The+highly+pure+neem+leaf+extract%2C+SCNE%2C+inhibits+tumorigenesis+in+oral+squamous+cell+carcinoma+via+disruption+of+pro-tumor+inflammatory+cytokines+and+cell+signaling&doi=10.3389%2Ffonc.2019.00890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The Highly Pure Neem Leaf Extract, SCNE, Inhibits Tumorigenesis in Oral Squamous Cell Carcinoma via Disruption of Pro-tumor Inflammatory Cytokines and Cell Signaling</span></div><div class="casAuthors">Morris Jay; Cabang April B; Patel Mandakini; Orozco Stephanie; Wargovich Michael J; Gonzales Cara B; De La Chapa Jorge J; Fountzilas Christos</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">890</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Oral squamous cell carcinoma (OSCC) is a deadly disease that comprises 60% of all head and neck squamous cell cancers.  The leaves of the Neem tree (Azadirachta indica) have been used in traditional Ayurvedic medicine for centuries to treat numerous oral maladies and are known to have significant anti-inflammatory properties.  We hypothesize that a highly pure super critical CO2 Neem leaf extract (SCNE) prevents initiation and progression of OSCC via downregulation of intra-tumor pro-inflammatory pathways, which promote tumorigenesis.  Hence, we investigated the anticancer effects of SCNE using in vitro and in vivo platforms.  OSCC cell lines (SCC4, Cal27, and HSC3) were treated with SCNE while inflammation, proliferation, and migration were analyzed over time.  SCNE treatment significantly inhibited OSCC cell proliferation and migration and reduced MMP activity in vitro, suggesting its potential to inhibit tumor growth and metastasis.  The preventive effects of SCNE in ectopic xenograft and 4NQO-1 (4-Nitroquinoline-1-oxide) carcinogen-induced mouse models of OSCC were also evaluated.  Indeed, xenografted nude mice showed significant reduction of OSCC tumor volumes.  Likewise, SCNE significantly reduced the incidence of tongue dysplasia in the 4NQO-1 OSCC initiation model.  In both OSCC animal models, SCNE significantly depressed circulating pro-cancer inflammatory cytokines (host and tumor-secreted) including NFkB, COX2, IL-1, IL-6, TNFÎ±, and IFNÎ³.  In addition, we demonstrate that SCNE downregulates STAT3 and AKT expression and activity in vitro.  We also demonstrate that the primary active component, nimbolide (NIM), has significant anticancer activity in established OSCC xenografts.  Lastly, we show that SCNE induces an M1 phenotype in tumor associated macrophages (TAMS) in vivo.  Taken together, these data strongly support SCNE as means of preventing OSCC via downregulation of pro-cancer inflammatory cascades and NIM as a potential new therapy for existing OSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlkAoUFo4KjZagfuraLLzSfW6udTcc2eY-FLEp_Z4AZLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MnjvFSnuw%253D%253D&md5=d42008f722c4e68e5ce7359e52a1c620</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2019.00890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2019.00890%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DGonzales%26aufirst%3DC.%2BB.%26aulast%3DDe%2BLa%26aufirst%3DChapa%2BJ.J.%26aulast%3DCabang%26aufirst%3DA.%2BB.%26aulast%3DFountzilas%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DOrozco%26aufirst%3DS.%26aulast%3DWargovich%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520highly%2520pure%2520neem%2520leaf%2520extract%252C%2520SCNE%252C%2520inhibits%2520tumorigenesis%2520in%2520oral%2520squamous%2520cell%2520carcinoma%2520via%2520disruption%2520of%2520pro-tumor%2520inflammatory%2520cytokines%2520and%2520cell%2520signaling%26jtitle%3DFront.%2520Oncol.%26date%3D2019%26volume%3D9%26spage%3D890%26doi%3D10.3389%2Ffonc.2019.00890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sophia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowshik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwivedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhutia, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manavathi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3Î² signalling pathway in oral cancer</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1087</span>, <span class="refDoi">Â DOI: 10.1038/s41419-018-1126-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fs41419-018-1126-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=30352996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3cvisFSltA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1087&author=J.+Sophiaauthor=J.+Kowshikauthor=A.+Dwivediauthor=S.+K.+Bhutiaauthor=B.+Manavathiauthor=R.+Mishraauthor=S.+Nagini&title=Nimbolide%2C+a+neem+limonoid+inhibits+cytoprotective+autophagy+to+activate+apoptosis+via+modulation+of+the+PI3K%2FAkt%2FGSK-3%CE%B2+signalling+pathway+in+oral+cancer&doi=10.1038%2Fs41419-018-1126-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3Î² signalling pathway in oral cancer</span></div><div class="casAuthors">Sophia Josephraj; Kowshik Jaganathan; Nagini Siddavaram; Dwivedi Anju; Manavathi Bramanandam; Bhutia Sujit K; Mishra Rajakishore</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1087</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Of late, nimbolide, a limonoid from the neem tree (Azadirachta indica) has gained increasing research attention owing to its potent antiproliferative and apoptosis-inducing effects.  The present study was designed to investigate the effect of nimbolide on autophagy and the time point at which the phosphorylation status of GSK-3Î² and PI3K dictate the choice between autophagy and apoptosis in SCC131 and SCC4 oral cancer cells.  Additionally, we analysed changes in the expression of proteins involved in autophagy and apoptosis after therapeutic intervention with nimbolide in a hamster model of oral oncogenesis.  Furthermore, we also demonstrate changes in the expression of key genes involved in apoptosis and autophagy during the stepwise evolution of hamster and human OSCCs.  Nimbolide-induced stereotypical changes in oral cancer cells characteristic of both apoptosis and autophagy.  Time-course experiments revealed that nimbolide induces autophagy as an early event and then switches over to apoptosis.  Nimbolide negatively regulates PI3K/Akt signalling with consequent increase in p-GSK-3Î²(Tyr216), the active form of GSK-3Î² that inhibits autophagy.  Downregulation of HOTAIR, a competing endogenous RNA that sponges miR-126 may be a major contributor to the inactivation of PI3K/Akt/GSK3 signalling by nimbolide.  Analysis of key markers of apoptosis and autophagy as well as p-Akt(Ser473) during sequential progression of hamster and human OSCC revealed a gradual evolution to a pro-autophagic and antiapoptotic phenotype that could confer a survival advantage to tumors.  In summary, the results of the present study provide insights into the molecular mechanisms by which nimbolide augments apoptosis by overcoming the shielding effects of cytoprotective autophagy through modulation of the phosphorylation status of Akt and GSK-3Î² as well as the ncRNAs miR-126 and HOTAIR.  Development of phytochemicals such as nimbolide that target the complex interaction between proteins and ncRNAs that regulate the autophagy/apoptosis flux is of paramount importance in cancer prevention and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScmbQ8u9AhUFUIs6wFK5xJfW6udTcc2eY-FLEp_Z4AZLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvisFSltA%253D%253D&md5=dca3631d9b3de9fa6c58e5c843002d63</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fs41419-018-1126-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-018-1126-4%26sid%3Dliteratum%253Aachs%26aulast%3DSophia%26aufirst%3DJ.%26aulast%3DKowshik%26aufirst%3DJ.%26aulast%3DDwivedi%26aufirst%3DA.%26aulast%3DBhutia%26aufirst%3DS.%2BK.%26aulast%3DManavathi%26aufirst%3DB.%26aulast%3DMishra%26aufirst%3DR.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DNimbolide%252C%2520a%2520neem%2520limonoid%2520inhibits%2520cytoprotective%2520autophagy%2520to%2520activate%2520apoptosis%2520via%2520modulation%2520of%2520the%2520PI3K%252FAkt%252FGSK-3%25CE%25B2%2520signalling%2520pathway%2520in%2520oral%2520cancer%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2018%26volume%3D9%26spage%3D1087%26doi%3D10.1038%2Fs41419-018-1126-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, S. M.</span></span> <span> </span><span class="NLM_article-title">Nimbolide induces ROS-regulated apoptosis and inhibits cell migration in osteosarcoma</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">23405</span>â <span class="NLM_lpage">23424</span>, <span class="refDoi">Â DOI: 10.3390/ijms161023405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3390%2Fijms161023405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=26426012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCrsb7I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=23405-23424&author=J.+F.+Liuauthor=C.+H.+Houauthor=F.+L.+Linauthor=Y.+T.+Tsaoauthor=S.+M.+Hou&title=Nimbolide+induces+ROS-regulated+apoptosis+and+inhibits+cell+migration+in+osteosarcoma&doi=10.3390%2Fijms161023405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide induces ROS-regulated apoptosis and inhibits cell migration in osteosarcoma</span></div><div class="casAuthors">Liu, Ju-Fang; Hou, Chun-Han; Lin, Feng-Ling; Tsao, Ya-Ting; Hou, Sheng-Mou</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">23405-23424</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Osteosarcoma (OS) is a primary malignant tumor of bone and is most prevalent in children and adolescents.  OS is frequently assocd. with pulmonary metastasis, which is the main cause of OS-related mortality.  OS has a poor prognosis and is often unresponsive to conventional chemotherapy.  In this study, we detd. that Nimbolide, a novel anti-cancer therapy, acts by modulating multiple mechanisms in osteosarcoma cells.  Nimbolide induces apoptosis by increasing endoplasmic reticulum (ER) stress, mitochondrial dysfunction, accumulation of reactive oxygen species (ROS), and finally, caspase activation.  We also detd. that Nimbolide inhibits cell migration, which is crucial for metastasis, by reducing the expression of integrin Î±vÎ²5.  In addn., our results demonstrate that integrin Î±vÎ²5 expression is modulated by the PI3K/Akt and NF-ÎºB signaling cascade.  Nimbolide has potential as an anti-tumor drug given its multifunctional effects in OS.  Collectively, these results help us to understand the mechanisms of action of Nimbolide and will aid in the development of effective therapies for OS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeDYElEE8xBrVg90H21EOLACvtfcHk0lhV7ycuNFQC2w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCrsb7I&md5=a32a8269c5113118661584de960cf49f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.3390%2Fijms161023405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms161023405%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DHou%26aufirst%3DC.%2BH.%26aulast%3DLin%26aufirst%3DF.%2BL.%26aulast%3DTsao%26aufirst%3DY.%2BT.%26aulast%3DHou%26aufirst%3DS.%2BM.%26atitle%3DNimbolide%2520induces%2520ROS-regulated%2520apoptosis%2520and%2520inhibits%2520cell%2520migration%2520in%2520osteosarcoma%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2015%26volume%3D16%26spage%3D23405%26epage%3D23424%26doi%3D10.3390%2Fijms161023405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subramani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arumugam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonkoungou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwivedi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmanaswamy, R.</span></span> <span> </span><span class="NLM_article-title">Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">19819</span>, <span class="refDoi">Â DOI: 10.1038/srep19819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fsrep19819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=26804739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtl2lurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=19819&author=R.+Subramaniauthor=E.+Gonzalezauthor=A.+Arumugamauthor=S.+Nandyauthor=V.+Gonzalezauthor=J.+Medelauthor=F.+Camachoauthor=A.+Ortegaauthor=S.+Bonkoungouauthor=M.+Narayanauthor=A.+K.+Dwivediauthor=R.+Lakshmanaswamy&title=Nimbolide+inhibits+pancreatic+cancer+growth+and+metastasis+through+ROS-mediated+apoptosis+and+inhibition+of+epithelial-to-mesenchymal+transition&doi=10.1038%2Fsrep19819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition</span></div><div class="casAuthors">Subramani, Ramadevi; Gonzalez, Elizabeth; Arumugam, Arunkumar; Nandy, Sushmita; Gonzalez, Viviana; Medel, Joshua; Camacho, Fernando; Ortega, Andrew; Bonkoungou, Sandrine; Narayan, Mahesh; Dwivedi, Alok kumar; Lakshmanaswamy, Rajkumar</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19819</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mortality and morbidity rates of pancreatic cancer are high because of its extremely invasive and metastatic nature.  Its lack of symptoms, late diagnosis and chemo-resistance and the ineffective treatment modalities warrant the development of new chemo-therapeutic agents for pancreatic cancer.  Agents from medicinal plants have demonstrated therapeutic benefits in various human cancers.  Nimbolide, an active mol. isolated from Azadirachta indica, has been reported to exhibit several medicinal properties.  This study assessed the anticancer properties of nimbolide against pancreatic cancer.  Our data reveal that nimbolide induces excessive generation of reactive oxygen species (ROS), thereby regulating both apoptosis and autophagy in pancreatic cancer cells.  Expts. with the autophagy inhibitors 3-methyladenine and chloroquine diphosphate salt and the apoptosis inhibitor z-VAD-fmk demonstrated that nimbolide-mediated ROS generation inhibited proliferation (through reduced PI3K/AKT/mTOR and ERK signaling) and metastasis (through decreased EMT, invasion, migration and colony forming abilities) via mitochondrial-mediated apoptotic cell death but not via autophagy.  In vivo expts. also demonstrated that nimbolide was effective in inhibiting pancreatic cancer growth and metastasis.  Overall, our data suggest that nimbolide can serve as a potential chemo-therapeutic agent for pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTlJpQ_WHLP7Vg90H21EOLACvtfcHk0lhV7ycuNFQC2w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtl2lurY%253D&md5=6664989670a7451c627354e1aacbc6df</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fsrep19819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep19819%26sid%3Dliteratum%253Aachs%26aulast%3DSubramani%26aufirst%3DR.%26aulast%3DGonzalez%26aufirst%3DE.%26aulast%3DArumugam%26aufirst%3DA.%26aulast%3DNandy%26aufirst%3DS.%26aulast%3DGonzalez%26aufirst%3DV.%26aulast%3DMedel%26aufirst%3DJ.%26aulast%3DCamacho%26aufirst%3DF.%26aulast%3DOrtega%26aufirst%3DA.%26aulast%3DBonkoungou%26aufirst%3DS.%26aulast%3DNarayan%26aufirst%3DM.%26aulast%3DDwivedi%26aufirst%3DA.%2BK.%26aulast%3DLakshmanaswamy%26aufirst%3DR.%26atitle%3DNimbolide%2520inhibits%2520pancreatic%2520cancer%2520growth%2520and%2520metastasis%2520through%2520ROS-mediated%2520apoptosis%2520and%2520inhibition%2520of%2520epithelial-to-mesenchymal%2520transition%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D19819%26doi%3D10.1038%2Fsrep19819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inigo, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâMalley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balachandar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attwood, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochwald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, D.</span></span> <span> </span><span class="NLM_article-title">Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>413</i></span>,  <span class="NLM_fpage">82</span>â <span class="NLM_lpage">93</span>, <span class="refDoi">Â DOI: 10.1016/j.canlet.2017.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.canlet.2017.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29107110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2lsL7I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2018&pages=82-93&author=S.+Kumarauthor=J.+R.+Inigoauthor=R.+Kumarauthor=A.+K.+Chaudharyauthor=J.+O%E2%80%99Malleyauthor=S.+Balachandarauthor=J.+Wangauthor=K.+Attwoodauthor=N.+Yadavauthor=S.+Hochwaldauthor=X.+Wangauthor=D.+Chandra&title=Nimbolide+reduces+CD44+positive+cell+population+and+induces+mitochondrial+apoptosis+in+pancreatic+cancer+cells&doi=10.1016%2Fj.canlet.2017.10.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells</span></div><div class="casAuthors">Kumar, Sandeep; Inigo, Joseph R.; Kumar, Rahul; Chaudhary, Ajay K.; O'Malley, Jordan; Balachandar, Srimmitha; Wang, Jianmin; Attwood, Kristopher; Yadav, Neelu; Hochwald, Steven; Wang, Xinjiang; Chandra, Dhyan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">413</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-93</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is highly aggressive disease and current treatment regimens fail to effectively cure PDAC.  Development of resistance to current therapy is one of the key reasons for this outcome.  Nimbolide (NL), a triterpenoid obtained from Azadirachta indica, exhibits anticancer properties in various cancer including PDAC cells.  However, the underlying mechanism of this anticancer agent in PDAC cells remains undefined.  We show that NL exerts a higher level of apoptotic cell death compared to the first-line agent gemcitabine for PDAC, as well as other anticancer agents including sorafenib and curcumin.  The anticancer efficacy of NL was further evidenced by a redn. in the CD44+ as well as cancer stem-like cell (CSC) population, as it causes decreased sphere formation.  Mechanistically, the anticancer efficacy of NL assocs. with reduced mutant p53 as well as increased mitochondrial activity in the form of increased mitochondrial reactive oxygen species and mitochondrial mass.  Together, this study highlights the therapeutic potential of NL in mutant p53 expressing pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWaM4J0Gt34LVg90H21EOLACvtfcHk0lhV7ycuNFQC2w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2lsL7I&md5=200e394249c261cc9bce68f32d88cc2c</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DInigo%26aufirst%3DJ.%2BR.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DChaudhary%26aufirst%3DA.%2BK.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DJ.%26aulast%3DBalachandar%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAttwood%26aufirst%3DK.%26aulast%3DYadav%26aufirst%3DN.%26aulast%3DHochwald%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChandra%26aufirst%3DD.%26atitle%3DNimbolide%2520reduces%2520CD44%2520positive%2520cell%2520population%2520and%2520induces%2520mitochondrial%2520apoptosis%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D413%26spage%3D82%26epage%3D93%26doi%3D10.1016%2Fj.canlet.2017.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugam, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siveen, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arfuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samym, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deivasigamanim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span> <span> </span><span class="NLM_article-title">Nimbolide-induced oxidative stress abrogates STAT3 signaling cascade and inhibits tumor growth in transgenic adenocarcinoma of mouse prostate model</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">575</span>â <span class="NLM_lpage">589</span>, <span class="refDoi">Â DOI: 10.1089/ars.2015.6418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1089%2Fars.2015.6418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=26649526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVeis7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=575-589&author=J.+Zhangauthor=K.+S.+Ahnauthor=C.+Kimauthor=M.+K.+Shanmugamauthor=K.+S.+Siveenauthor=F.+Arfusoauthor=R.+P.+Samymauthor=A.+Deivasigamanimauthor=L.+H.+Limauthor=L.+Wangauthor=B.+C.+Gohauthor=A.+P.+Kumarauthor=K.+M.+Huiauthor=G.+Sethi&title=Nimbolide-induced+oxidative+stress+abrogates+STAT3+signaling+cascade+and+inhibits+tumor+growth+in+transgenic+adenocarcinoma+of+mouse+prostate+model&doi=10.1089%2Fars.2015.6418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model</span></div><div class="casAuthors">Zhang, Jingwen; Ahn, Kwang Seok; Kim, Chulwon; Shanmugam, Muthu K.; Siveen, Kodappully Sivaraman; Arfuso, Frank; Samym, Ramar Perumal; Deivasigamanim, Amudha; Lim, Lina Hsiu Kim; Wang, Lingzhi; Goh, Boon Cher; Kumar, Alan Prem; Hui, Kam Man; Sethi, Gautam</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">575-589</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: Prostate cancer (PCa) is one of the most commonly diagnosed cancers worldwide.  Currently available therapies for metastatic PCa are only marginally effective, hence novel treatment modalities are urgently required.  Considerable evidence(s) suggest that deregulated activation of oncogenic transcription factor, signal transducer and activator of transcription 3 (STAT3) plays a pivotal role in the development and progression of PCa.  Thus, agents that can abrogate STAT3 activation could form the basis of novel therapy for PCa patients.  In the present study, we analyzed whether the potential anticancer effects of nimbolide (NL), a limonoid triterpene derived from Azadirachta indica, against PCa cell lines and transgenic adenocarcinoma of mouse prostate (TRAMP) model are mediated through the neg. regulation of STAT3 pathway.  Results: Data from the in vitro studies indicated that NL could significantly inhibit cell viability, induce apoptosis, and suppress cellular invasion and migration.  Interestingly, NL also abrogated STAT3 activation and this effect was found to be mediated via an increased prodn. of reactive oxygen species (ROS) due to GSH/GSSG imbalance.  Oral administration of NL significantly suppressed the tumor growth and metastasis in TRAMP mouse model without exhibiting any significant adverse effects.  Innovation: The present study demonstrates the crit. role of GSH/GSSG imbalance-mediated ROS prodn. contributing to the STAT3 inhibitory and tumor-suppressive effect of NL in PCa.  Conclusion: Overall, our findings indicate that NL exhibits significant anticancer effects in PCa that may be primarily mediated through the ROS-regulated inhibition of STAT3 signaling cascade.  Antioxid. Redox Signal. 24, 575-589.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGYSso-6wEnLVg90H21EOLACvtfcHk0lj9aKIjfyXVdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVeis7o%253D&md5=07b23bd2354fda2208198132f6de2d77</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1089%2Fars.2015.6418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2015.6418%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DShanmugam%26aufirst%3DM.%2BK.%26aulast%3DSiveen%26aufirst%3DK.%2BS.%26aulast%3DArfuso%26aufirst%3DF.%26aulast%3DSamym%26aufirst%3DR.%2BP.%26aulast%3DDeivasigamanim%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DL.%2BH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGoh%26aufirst%3DB.%2BC.%26aulast%3DKumar%26aufirst%3DA.%2BP.%26aulast%3DHui%26aufirst%3DK.%2BM.%26aulast%3DSethi%26aufirst%3DG.%26atitle%3DNimbolide-induced%2520oxidative%2520stress%2520abrogates%2520STAT3%2520signaling%2520cascade%2520and%2520inhibits%2520tumor%2520growth%2520in%2520transgenic%2520adenocarcinoma%2520of%2520mouse%2520prostate%2520model%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2016%26volume%3D24%26spage%3D575%26epage%3D589%26doi%3D10.1089%2Fars.2015.6418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priya, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunkumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharmila, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajalakshmi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunakaran, J.</span></span> <span> </span><span class="NLM_article-title">Nimbolide inhibits androgen independent prostate cancer cells survival and proliferation by modulating multiple pro-survival signaling pathways</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1623</span>â <span class="NLM_lpage">1634</span>, <span class="refDoi">Â DOI: 10.1016/j.biopha.2016.10.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.biopha.2016.10.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=27889231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGjsL7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2016&pages=1623-1634&author=P.+R.+Singhauthor=E.+S.+Priyaauthor=S.+Balakrishnanauthor=R.+Arunkumarauthor=G.+Sharmilaauthor=M.+Rajalakshmiauthor=J.+Arunakaran&title=Nimbolide+inhibits+androgen+independent+prostate+cancer+cells+survival+and+proliferation+by+modulating+multiple+pro-survival+signaling+pathways&doi=10.1016%2Fj.biopha.2016.10.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide inhibits androgen independent prostate cancer cells survival and proliferation by modulating multiple pro-survival signaling pathways</span></div><div class="casAuthors">Singh, P. Raja; Priya, E. Sugantha; Balakrishnan, S.; Arunkumar, R.; Sharmila, G.; Rajalakshmi, M.; Arunakaran, J.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1623-1634</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Prostate cancer is the most prominent cancer in men, experiencing a relapse in disease often express high serum TNF-Î± levels.  It has been correlated with increased cell survival and proliferation of prostate cancer cells.  Previous studies reported that nimbolide, a terpenoid derived from the leaves and flowers of neem tree inhibits cancer growth through selective modulation of cell signaling pathways linked to inflammation, survival, proliferation, angiogenesis and metastasis.  The present study aimed to examine the effect of nimbolide at 1 and 2 Î¼M concns. on TNF-Î±/TNFR1 mediated signaling mols. involved in cell survival and proliferation in PC-3 cell line via NF-ÎºB and MAPK pathways by real time PCR and western blot.  Protein and compd. interaction were performed by Mol. docking anal.  Our results indicate that nimbolide treatment suppressed expression of TNF-Î±, SODD, Grb2, SOS mRNA and modulated TNF-Î±/TNFR1 regulated NF-ÎºB and MAPK signaling mols. in PC-3 cells.  Addnl. mol. dynamics simulation studies confirmed the stability of nimbolide and signaling mols. binding interactions.  Binding pose anal. revealed the significance of hydrogen bond interactions for effective stabilization of virtual ligand protein complexes.  Nimbolide inhibited prostate cancer cell survival and proliferation via NF-ÎºB and MAPK pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCM5EtWSIV2LVg90H21EOLACvtfcHk0lj9aKIjfyXVdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGjsL7M&md5=6cf4c4a60aaafcb414da05784e776998</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2016.10.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2016.10.076%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DP.%2BR.%26aulast%3DPriya%26aufirst%3DE.%2BS.%26aulast%3DBalakrishnan%26aufirst%3DS.%26aulast%3DArunkumar%26aufirst%3DR.%26aulast%3DSharmila%26aufirst%3DG.%26aulast%3DRajalakshmi%26aufirst%3DM.%26aulast%3DArunakaran%26aufirst%3DJ.%26atitle%3DNimbolide%2520inhibits%2520androgen%2520independent%2520prostate%2520cancer%2520cells%2520survival%2520and%2520proliferation%2520by%2520modulating%2520multiple%2520pro-survival%2520signaling%2520pathways%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2016%26volume%3D84%26spage%3D1623%26epage%3D1634%26doi%3D10.1016%2Fj.biopha.2016.10.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, J. P.</span></span> <span> </span><span class="NLM_article-title">Induction of cell cycle arrest, DNA damage, and apoptosis by nimbolide in human renal cell carcinoma cells</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">7539</span>â <span class="NLM_lpage">7547</span>, <span class="refDoi">Â DOI: 10.1007/s13277-015-3477-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs13277-015-3477-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovVemur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=7539-7547&author=Y.+H.+Hsiehauthor=C.+H.+Leeauthor=H.+Y.+Chenauthor=S.+C.+Hsiehauthor=C.+L.+Linauthor=J.+P.+Tsai&title=Induction+of+cell+cycle+arrest%2C+DNA+damage%2C+and+apoptosis+by+nimbolide+in+human+renal+cell+carcinoma+cells&doi=10.1007%2Fs13277-015-3477-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of cell cycle arrest, DNA damage, and apoptosis by nimbolide in human renal cell carcinoma cells</span></div><div class="casAuthors">Hsieh, Yi-Hsien; Lee, Chien-Hsing; Chen, Hsiao-Yun; Hsieh, Shu-Ching; Lin, Chia-Liang; Tsai, Jen-Pi</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">7539-7547</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Nimbolide is a tetranortriterpenoid isolated from the leaves and flowers of Azadirachta indica which has been shown to exhibit anticancer, antioxidant, anti-inflammatory, and anti-invasive properties in a variety of cancer cells.  However, the anti-tumor effect on human renal cell carcinoma (RCC) cells is unknown.  In this study, we found that nimbolide treatment had a cytotoxic effect on 786-O and A-498 RCC cells in a dose-dependent manner.  According to flow cytometric anal., nimbolide treatment resulted in G2/M arrest in 786-O and A-498 cells accompanied with an increase in the phosphorylation status of p53, cdc2, cdc25c, and decreased expressions of cyclin A, cyclin B, cdc2, and cdc25c.  Nimbolide also caused DNA damage in a dose-dependent manner as detd. by comet assay and measurement of Î³-H2AX.  In addn., apoptotic cells were obsd. in an Annexin V-FITC/propidium iodide double-stained assay.  The activities of caspase-3, -9, and poly ADP-ribose polymerase (PARP) were increased, and the expression of pro-caspase-8 was decreased in nimbolide-treated 786-O and A-498 cells.  Western blot anal. revealed that the levels of intrinsic-related apoptotic proteins Bax and extrinsic-related proteins (DR5, CHOP) were significantly increased in nimbolide-treated 786-O and A-498 cells.  In addn., the expressions of Bcl-2 and Mcl-1 were decreased in 786-O and A-498 cells after nimbolide treatment.  We conclude that nimbolide can inhibit the growth of human RCC cells by inducing G2/M phase arrest by modulating cell cycle-related proteins and cell apoptosis by regulating intrinsic and extrinsic caspase signaling pathways.  Nimbolide may be a promising therapeutic strategy for the treatment of RCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocpLCQZIlxmrVg90H21EOLACvtfcHk0lj9aKIjfyXVdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovVemur4%253D&md5=bfab244db64b685bdba2fea57e58eba6</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2Fs13277-015-3477-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-015-3477-0%26sid%3Dliteratum%253Aachs%26aulast%3DHsieh%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DH.%2BY.%26aulast%3DHsieh%26aufirst%3DS.%2BC.%26aulast%3DLin%26aufirst%3DC.%2BL.%26aulast%3DTsai%26aufirst%3DJ.%2BP.%26atitle%3DInduction%2520of%2520cell%2520cycle%2520arrest%252C%2520DNA%2520damage%252C%2520and%2520apoptosis%2520by%2520nimbolide%2520in%2520human%2520renal%2520cell%2520carcinoma%2520cells%26jtitle%3DTumor%2520Biol.%26date%3D2015%26volume%3D36%26spage%3D7539%26epage%3D7547%26doi%3D10.1007%2Fs13277-015-3477-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harish
Kumar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidya Priyadarsini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinothini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VidjayaLetchoumy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">392</span>â <span class="NLM_lpage">401</span>, <span class="refDoi">Â DOI: 10.1007/s10637-009-9263-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs10637-009-9263-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=19458912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlyhu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=392-401&author=G.+Harish%0AKumarauthor=R.+Vidya+Priyadarsiniauthor=G.+Vinothiniauthor=P.+VidjayaLetchoumyauthor=S.+Nagini&title=The+neem+limonoids+azadirachtin+and+nimbolide+inhibit+cell+proliferation+and+induce+apoptosis+in+an+animal+model+of+oral+oncogenesis&doi=10.1007%2Fs10637-009-9263-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis</span></div><div class="casAuthors">Harish Kumar, G.; Vidya Priyadarsini, R.; Vinothini, G.; Vidjaya Letchoumy, P.; Nagini, S.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">392-401</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Limonoids from the neem tree (Azadirachta indica) have attracted considerable research attention for their cytotoxicity against human cancer cell lines.  However, the antiproliferative and apoptosis inducing effects of neem limonoids have not been tested in animal tumor models.  The present study was therefore designed to evaluate the relative chemopreventive potential of the neem limonoids azadirachtin and nimbolide in the hamster buccal pouch (HBP) carcinogenesis model by analyzing the expression of proliferating cell nuclear antigen (PCNA), p21waf1, cyclin D1, glutathione S-transferase pi (GST-P), NF-ÎºB, inhibitor of ÎºB (IÎºB), p53, Fas, Bcl-2, Bax, Bid, Apaf-1, cytochrome C, survivin, caspases-3, -6, -8 and -9, and poly(ADP-ribose) polymerase (PARP) by RT-PCR, immunohistochem., and Western blot analyses.  The results provide compelling evidence that azadirachtin and nimbolide mediate their antiproliferative effects by downregulating proteins involved in cell cycle progression and transduce apoptosis by both the intrinsic and extrinsic pathways.  On a comparative basis, nimbolide was found to be a more potent antiproliferative and apoptosis inducing agent and offers promise as a candidate agent in multitargeted prevention and treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql8dp_iMI_arVg90H21EOLACvtfcHk0ljrtptjnud1FA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlyhu7o%253D&md5=2245bc4172b2ca9498514592552c86ef</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs10637-009-9263-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-009-9263-3%26sid%3Dliteratum%253Aachs%26aulast%3DHarish%2BKumar%26aufirst%3DG.%26aulast%3DVidya%2BPriyadarsini%26aufirst%3DR.%26aulast%3DVinothini%26aufirst%3DG.%26aulast%3DVidjayaLetchoumy%26aufirst%3DP.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DThe%2520neem%2520limonoids%2520azadirachtin%2520and%2520nimbolide%2520inhibit%2520cell%2520proliferation%2520and%2520induce%2520apoptosis%2520in%2520an%2520animal%2520model%2520of%2520oral%2520oncogenesis%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2010%26volume%3D28%26spage%3D392%26epage%3D401%26doi%3D10.1007%2Fs10637-009-9263-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sophia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiran Kishore, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowshik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide, a neem limonoid inhibits phosphatidyl inositol-3 kinase to activate glycogen synthase kinase-3Î² in a hamster model of oral oncogenesis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">22192</span>, <span class="refDoi">Â DOI: 10.1038/srep22192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fsrep22192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=26902162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1egtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=22192&author=J.+Sophiaauthor=T.+K.+Kiran+Kishoreauthor=J.+Kowshikauthor=R.+Mishraauthor=S.+Nagini&title=Nimbolide%2C+a+neem+limonoid+inhibits+phosphatidyl+inositol-3+kinase+to+activate+glycogen+synthase+kinase-3%CE%B2+in+a+hamster+model+of+oral+oncogenesis&doi=10.1038%2Fsrep22192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3Î² in a hamster model of oral oncogenesis</span></div><div class="casAuthors">Sophia, Josephraj; Kiran Kishore T., Kranthi; Kowshik, Jaganathan; Mishra, Rajakishore; Nagini, Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22192</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3Î² (GSK-3Î²), a serine/threonine kinase is frequently inactivated by the oncogenic signalling kinases PI3K/Akt and MAPK/ERK in diverse malignancies.  The present study was designed to investigate GSK-3Î² signalling circuits in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis model and the therapeutic potential of the neem limonoid nimbolide.  Inactivation of GSK-3Î² by phosphorylation at serine 9 and activation of PI3K/Akt, MAPK/ERK and Î²-catenin was assocd. with increased cell proliferation and apoptosis evasion during stepwise evolution of HBP carcinomas.  Administration of nimbolide inhibited PI3K/Akt signalling with consequent activation of GSK-3Î² thereby inducing trafficking of Î²-catenin away from the nucleus and enhancing the expression of miR-126 and let-7.  Mol. docking studies confirmed interaction of nimbolide with PI3K, Akt, ERK and GSK-3Î².  Furthermore, nimbolide attenuated cell proliferation and induced apoptosis as evidenced by increased p-cyclin D1Thr286 and pro-apoptotic proteins.  The present study has unravelled aberrant phosphorylation as a key determinant for oncogenic signalling and acquisition of cancer hallmarks in the HBP model.  The study has also provided mechanistic insights into the chemotherapeutic potential of nimbolide that may be a useful addn. to the armamentarium of natural compds. targeting PI3K for oral cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3DgWhliy6OrVg90H21EOLACvtfcHk0ljrtptjnud1FA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1egtbY%253D&md5=fc4ef6c29a137abfecad42af5d948e0b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fsrep22192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep22192%26sid%3Dliteratum%253Aachs%26aulast%3DSophia%26aufirst%3DJ.%26aulast%3DKiran%2BKishore%26aufirst%3DT.%2BK.%26aulast%3DKowshik%26aufirst%3DJ.%26aulast%3DMishra%26aufirst%3DR.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DNimbolide%252C%2520a%2520neem%2520limonoid%2520inhibits%2520phosphatidyl%2520inositol-3%2520kinase%2520to%2520activate%2520glycogen%2520synthase%2520kinase-3%25CE%25B2%2520in%2520a%2520hamster%2520model%2520of%2520oral%2520oncogenesis%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D22192%26doi%3D10.1038%2Fsrep22192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of cancer: The next generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">646</span>â <span class="NLM_lpage">674</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+The+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0ljrtptjnud1FA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520The%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shahar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larisch, S.</span></span> <span> </span><span class="NLM_article-title">Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">100712</span>, <span class="refDoi">Â DOI: 10.1016/j.drup.2020.100712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.drup.2020.100712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32599435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB38nlvFyhtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2020&pages=100712&author=N.+Shaharauthor=S.+Larisch&title=Inhibiting+the+inhibitors%3A+Targeting+anti-apoptotic+proteins+in+cancer+and+therapy+resistance&doi=10.1016%2Fj.drup.2020.100712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance</span></div><div class="casAuthors">Shahar Nir; Larisch Sarit</div><div class="citationInfo"><span class="NLM_cas:title">Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">100712</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The cytotoxic effect of anti-cancer drugs relies on their ability to induce programmed cell death known as apoptosis.  Evading apoptosis is a common characteristic of cancer cells and it is linked to both carcinogenesis and anticancer drug resistance.  To escape apoptosis, cancer cells often express high levels of anti-apoptotic proteins and become "addicted "to them for their survival.  Consequently, anti-apoptotic proteins have emerged as attractive druggable targets for the development of cancer therapeutics.  In this review we focus on two major anti-apoptotic protein families: IAPs (Inhibitor of Apoptosis) proteins and Bcl-2 (B-cell lymphoma-2) family members.  We also discuss insights into the regulation of these proteins by natural antagonists, which has provided the conceptual basis for developing novel anti-cancer drugs.  Significantly, the pro-apoptotic protein ARTS (apoptosis-related protein in the TGF-Î² signaling pathway; Sept4_i2) acts as a dual antagonist of both X-linked inhibitor of apoptosis protein (XIAP) and Bcl-2.  Because upregulation of anti-apoptotic proteins in response to cancer therapy contributes to drug resistance, targeted inhibition of these proteins is expected to enhance the efficacy of chemotherapy.  Finally, we discuss the role of proteasome-mediated degradation in the regulation of apoptosis, and how this mechanism can be harnessed to develop small molecules that stimulate degradation of anti-apoptotic proteins for cancer therapy.  This strategy has the potential to overcome drug resistance more effectively than mere inhibition.  Therefore, this approach may allow use of lower drug concentrations and thereby reduce cytotoxicity and untoward side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYsIJWD7spUsyail4HZd-ifW6udTcc2eb8dCyZ-RCk_7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38nlvFyhtQ%253D%253D&md5=31920b881f86727c398222d4220d0607</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2020.100712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2020.100712%26sid%3Dliteratum%253Aachs%26aulast%3DShahar%26aufirst%3DN.%26aulast%3DLarisch%26aufirst%3DS.%26atitle%3DInhibiting%2520the%2520inhibitors%253A%2520Targeting%2520anti-apoptotic%2520proteins%2520in%2520cancer%2520and%2520therapy%2520resistance%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2020%26volume%3D52%26spage%3D100712%26doi%3D10.1016%2Fj.drup.2020.100712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span>; <span class="NLM_string-name">Vidya Priyadarsini, R.</span></span> <span> </span><span class="NLM_article-title">Apoptosis induction by nimbolide, a limonoid from Azadirachta indica: Molecular targets and signaling networks</span>. In  <i>Novel apoptotic regulators in carcinogenesis</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. C.</span>, <span class="NLM_string-name">Lai, P. B. S.</span></span>, Eds.; <span class="NLM_publisher-name">Springer Verlag</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">27</span>â <span class="NLM_lpage">44</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=27-44&author=S.+Nagini&author=R.+Vidya+Priyadarsiniauthor=G.+C.+Chen&author=P.+B.+S.+Lai&title=Novel+apoptotic+regulators+in+carcinogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DApoptosis%2520induction%2520by%2520nimbolide%252C%2520a%2520limonoid%2520from%2520Azadirachta%2520indica%253A%2520Molecular%2520targets%2520and%2520signaling%2520networks%26btitle%3DNovel%2520apoptotic%2520regulators%2520in%2520carcinogenesis%26aulast%3DChen%26aufirst%3DG.%2BC.%26pub%3DSpringer%2520Verlag%26date%3D2012%26spage%3D27%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, D.</span></span> <span> </span><span class="NLM_article-title">Neem components as potential agents for cancer prevention and treatment</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1846</i></span>,  <span class="NLM_fpage">247</span>â <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.bbcan.2014.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=25016141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1OqsbjJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1846&publication_year=2014&pages=247-257&author=F.+Haoauthor=S.+Kumarauthor=N.+Yadavauthor=D.+Chandra&title=Neem+components+as+potential+agents+for+cancer+prevention+and+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Neem components as potential agents for cancer prevention and treatment</span></div><div class="casAuthors">Hao, Fang; Kumar, Sandeep; Yadav, Neelu; Chandra, Dhyan</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1846</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">247-257</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Azadirachta indica, also known as neem, is commonly found in many semi-tropical and tropical countries including India, Pakistan, and Bangladesh.  The components extd. from neem plant have been used in traditional medicine for the cure of multiple diseases including cancer for centuries.  The exts. of seeds, leaves, flowers, and fruits of neem have consistently shown chemopreventive and antitumor effects in different types of cancer.  Azadirachtin and nimbolide are among the few bioactive components in neem that have been studied extensively, but research on a great no. of addnl. bioactive components is warranted.  The key anticancer effects of neem components on malignant cells include inhibition of cell proliferation, induction of cell death, suppression of cancer angiogenesis, restoration of cellular redn./oxidn. (redox) balance, and enhancement of the host immune responses against tumor cells.  While the underlying mechanisms of these effects are mostly unclear, the suppression of NF-ÎºB signaling pathway is, at least partially, involved in the anticancer functions of neem components.  Importantly, the anti-proliferative and apoptosis-inducing effects of neem components are tumor selective as the effects on normal cells are significantly weaker.  In addn., neem exts. sensitize cancer cells to immunotherapy and radiotherapy, and enhance the efficacy of certain cancer chemotherapeutic agents.  This review summarizes the current updates on the anticancer effects of neem components and their possible impact on managing cancer incidence and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPwcs3R1OE5rVg90H21EOLACvtfcHk0lijXamTVOGWOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1OqsbjJ&md5=b8339f4d4a1fd08fe6db180ed981090a</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2014.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2014.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DF.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DN.%26aulast%3DChandra%26aufirst%3DD.%26atitle%3DNeem%2520components%2520as%2520potential%2520agents%2520for%2520cancer%2520prevention%2520and%2520treatment%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2014%26volume%3D1846%26spage%3D247%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuya, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, B. C.</span></span> <span> </span><span class="NLM_article-title">Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">44790</span>â <span class="NLM_lpage">44802</span>, <span class="refDoi">Â DOI: 10.18632/oncotarget.8316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.18632%2Foncotarget.8316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=27027349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC28fkvVGrsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=44790-44802&author=L.+Wangauthor=D.+D.+Phanauthor=J.+Zhangauthor=P.+S.+Ongauthor=W.+L.+Thuyaauthor=R.+Sooauthor=A.+L.+Wongauthor=W.+P.+Yongauthor=S.+C.+Leeauthor=P.+C.+Hoauthor=G.+Sethiauthor=B.+C.+Goh&title=Anticancer+properties+of+nimbolide+and+pharmacokinetic+considerations+to+accelerate+its+development&doi=10.18632%2Foncotarget.8316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development</span></div><div class="casAuthors">Wang Lingzhi; Phan Do Dang Khoa; Thuya Win Lwin; Soo Ross; Wong Andrea Li-Ann; Yong Wei Peng; Lee Soo Chin; Goh Boon Cher; Wang Lingzhi; Zhang Jingwen; Sethi Gautam; Goh Boon Cher; Phan Do Dang Khoa; Ong Pei-Shi; Thuya Win Lwin; Ho Paul Chi-Lui; Soo Ross; Wong Andrea Li-Ann; Yong Wei Peng; Lee Soo Chin; Goh Boon Cher</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">44790-44802</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nimbolide is one of the main components in the leaf extract of Azadirachta indica (A. indica).  Accumulating evidence from various in vitro and in vivo studies indicates that nimbolide possesses potent anticancer activity against several types of cancer and also shows potential chemopreventive activity in animal models.  The main mechanisms of action of nimbolide include anti-proliferation, induction of apoptosis, inhibition of metastasis and angiogenesis, and modulation of carcinogen-metabolizing enzymes.  Although multiple pharmacodynamic (PD) studies have been carried out, nimbolide is still at the infant stage in the drug development pipeline due to the lack of systematic pharmacokinetic (PK) studies and long-term toxicological studies.  Preclinical PK and toxicological studies are vital in determining the dosage range to support the safety of nimbolide for first-in-human clinical trials.  In this review, we will provide a comprehensive summary for the current status of nimbolide as an anticancer and chemopreventive lead compound, and highlight the importance of systematic preclinical PK and toxicological studies in accelerating the process of application of nimbolide as a therapeutic agent against various malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRi_DV2txfJVny-c-E1v-fmfW6udTcc2eb8dCyZ-RCk_7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fkvVGrsg%253D%253D&md5=67bb5ca109816b6a367c1ed03239fe76</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8316%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPhan%26aufirst%3DD.%2BD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DOng%26aufirst%3DP.%2BS.%26aulast%3DThuya%26aufirst%3DW.%2BL.%26aulast%3DSoo%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DA.%2BL.%26aulast%3DYong%26aufirst%3DW.%2BP.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DHo%26aufirst%3DP.%2BC.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DGoh%26aufirst%3DB.%2BC.%26atitle%3DAnticancer%2520properties%2520of%2520nimbolide%2520and%2520pharmacokinetic%2520considerations%2520to%2520accelerate%2520its%2520development%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D44790%26epage%3D44802%26doi%3D10.18632%2Foncotarget.8316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaiswara, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawat, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span> <span> </span><span class="NLM_article-title">Nimbolide induces cell death in T lymphoma cells: Implication of altered apoptosis and glucose metabolism</span>. <i>Environ. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, in press</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=33274819" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=P.+K.+Jaiswaraauthor=V.+K.+Guptaauthor=P.+Sonkerauthor=S.+G.+Rawatauthor=R.+K.+Tiwariauthor=C.+Pathakauthor=S.+Kumarauthor=A.+Kumar&title=Nimbolide+induces+cell+death+in+T+lymphoma+cells%3A+Implication+of+altered+apoptosis+and+glucose+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaiswara%26aufirst%3DP.%2BK.%26aulast%3DGupta%26aufirst%3DV.%2BK.%26aulast%3DSonker%26aufirst%3DP.%26aulast%3DRawat%26aufirst%3DS.%2BG.%26aulast%3DTiwari%26aufirst%3DR.%2BK.%26aulast%3DPathak%26aufirst%3DC.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DA.%26atitle%3DNimbolide%2520induces%2520cell%2520death%2520in%2520T%2520lymphoma%2520cells%253A%2520Implication%2520of%2520altered%2520apoptosis%2520and%2520glucose%2520metabolism%26jtitle%3DEnviron.%2520Toxicol.%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulcahy
Levy, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorburn, A.</span></span> <span> </span><span class="NLM_article-title">Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">843</span>â <span class="NLM_lpage">857</span>, <span class="refDoi">Â DOI: 10.1038/s41418-019-0474-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fs41418-019-0474-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31836831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3MbgtV2itQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2020&pages=843-857&author=J.+M.+Mulcahy%0ALevyauthor=A.+Thorburn&title=Autophagy+in+cancer%3A+moving+from+understanding+mechanism+to+improving+therapy+responses+in+patients&doi=10.1038%2Fs41418-019-0474-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients</span></div><div class="casAuthors">Mulcahy Levy Jean M; Mulcahy Levy Jean M; Mulcahy Levy Jean M; Thorburn Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Cell death and differentiation</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">843-857</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autophagy allows for cellular material to be delivered to lysosomes for degradation resulting in basal or stress-induced turnover of cell components that provide energy and macromolecular precursors.  These activities are thought to be particularly important in cancer where both tumor-promoting and tumor-inhibiting functions of autophagy have been described.  Autophagy has also been intricately linked to apoptosis and programmed cell death, and understanding these interactions is becoming increasingly important in improving cancer therapy and patient outcomes.  In this review, we consider how recent discoveries about how autophagy manipulation elicits its effects on cancer cell behavior can be leveraged to improve therapeutic responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMGtKuqQuoSe2qxNLjzXe8fW6udTcc2ebC0W40Td1QPbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MbgtV2itQ%253D%253D&md5=2c94adad3884746f0fecd7a2ad270d8f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fs41418-019-0474-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-019-0474-7%26sid%3Dliteratum%253Aachs%26aulast%3DMulcahy%2BLevy%26aufirst%3DJ.%2BM.%26aulast%3DThorburn%26aufirst%3DA.%26atitle%3DAutophagy%2520in%2520cancer%253A%2520moving%2520from%2520understanding%2520mechanism%2520to%2520improving%2520therapy%2520responses%2520in%2520patients%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2020%26volume%3D27%26spage%3D843%26epage%3D857%26doi%3D10.1038%2Fs41418-019-0474-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikoletopoulou, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palikaras, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavernarakis, N.</span></span> <span> </span><span class="NLM_article-title">Crosstalk between apoptosis, necrosis and autophagy</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1833</i></span>,  <span class="NLM_fpage">3448</span>â <span class="NLM_lpage">3459</span>, <span class="refDoi">Â DOI: 10.1016/j.bbamcr.2013.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.bbamcr.2013.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=23770045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVCgsLfK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1833&publication_year=2013&pages=3448-3459&author=V.+Nikoletopoulouauthor=M.+Markakiauthor=K.+Palikarasauthor=N.+Tavernarakis&title=Crosstalk+between+apoptosis%2C+necrosis+and+autophagy&doi=10.1016%2Fj.bbamcr.2013.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Crosstalk between apoptosis, necrosis and autophagy</span></div><div class="casAuthors">Nikoletopoulou, Vassiliki; Markaki, Maria; Palikaras, Konstantinos; Tavernarakis, Nektarios</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1833</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3448-3459</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Apoptosis and necrosis are the two major modes of cell death, the mol. mechanisms of which have been extensively studied.  Although initially thought to constitute mutually exclusive cellular states, recent findings reveal cellular contexts that require a balanced interplay between these two modes of cellular demise.  Several death initiator and effector mols., signaling pathways and subcellular sites have been identified as key mediators in both processes, either by constituting common modules or alternatively by functioning as a switch allowing cells to decide which route to take, depending on the specific situation.  Importantly, autophagy, which is a predominantly cytoprotective process, has been linked to both types of cell death, serving either a pro-survival or pro-death function.  Here we review the recent literature that highlights the intricate interplay between apoptosis, necrosis and autophagy, focusing on the relevance and impact of this crosstalk in normal development and in pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNvA37bCDG17Vg90H21EOLACvtfcHk0lgaX7096gqJWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVCgsLfK&md5=c4efdd529cb9724fb03dca0f6800d244</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2013.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2013.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DNikoletopoulou%26aufirst%3DV.%26aulast%3DMarkaki%26aufirst%3DM.%26aulast%3DPalikaras%26aufirst%3DK.%26aulast%3DTavernarakis%26aufirst%3DN.%26atitle%3DCrosstalk%2520between%2520apoptosis%252C%2520necrosis%2520and%2520autophagy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2013%26volume%3D1833%26spage%3D3448%26epage%3D3459%26doi%3D10.1016%2Fj.bbamcr.2013.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vijayarathna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jothy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanwar, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasidharan, S.</span></span> <span> </span><span class="NLM_article-title">Anti-cancer natural products inducing cross-talk between apoptosis and autophagy mutual proteins to regulate cancer cell death: Design of future green anticancer therapies</span>. <i>Asian Pac. J. Cancer Prev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">6175</span>â <span class="NLM_lpage">6176</span>, <span class="refDoi">Â DOI: 10.7314/APJCP.2015.16.14.6175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.7314%2FAPJCP.2015.16.14.6175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=26320517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC287ns1Kkug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=6175-6176&author=S.+Vijayarathnaauthor=S.+L.+Jothyauthor=Y.+Chenauthor=J.+R.+Kanwarauthor=S.+Sasidharan&title=Anti-cancer+natural+products+inducing+cross-talk+between+apoptosis+and+autophagy+mutual+proteins+to+regulate+cancer+cell+death%3A+Design+of+future+green+anticancer+therapies&doi=10.7314%2FAPJCP.2015.16.14.6175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Cancer Natural Products Inducing Cross-talk between Apoptosis and Autophagy Mutual Proteins to Regulate Cancer Cell Death: Design of Future Green Anticancer Therapies</span></div><div class="casAuthors">Vijayarathna Soundararajan; Jothy Subramanion L; Chen Yeng; Kanwar Jagat R; Sasidharan Sreenivasan</div><div class="citationInfo"><span class="NLM_cas:title">Asian Pacific journal of cancer prevention : APJCP</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6175-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRhCZiIeyQYMkwlCcfExbvbfW6udTcc2ebC0W40Td1QPbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287ns1Kkug%253D%253D&md5=99dce9c3c5dd0ecf7b088c2609507ee4</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.7314%2FAPJCP.2015.16.14.6175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7314%252FAPJCP.2015.16.14.6175%26sid%3Dliteratum%253Aachs%26aulast%3DVijayarathna%26aufirst%3DS.%26aulast%3DJothy%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKanwar%26aufirst%3DJ.%2BR.%26aulast%3DSasidharan%26aufirst%3DS.%26atitle%3DAnti-cancer%2520natural%2520products%2520inducing%2520cross-talk%2520between%2520apoptosis%2520and%2520autophagy%2520mutual%2520proteins%2520to%2520regulate%2520cancer%2520cell%2520death%253A%2520Design%2520of%2520future%2520green%2520anticancer%2520therapies%26jtitle%3DAsian%2520Pac.%2520J.%2520Cancer%2520Prev.%26date%3D2015%26volume%3D16%26spage%3D6175%26epage%3D6176%26doi%3D10.7314%2FAPJCP.2015.16.14.6175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. C.</span></span> <span> </span><span class="NLM_article-title">Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">6139</span>â <span class="NLM_lpage">6156</span>, <span class="refDoi">Â DOI: 10.1038/s41388-020-01432-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fs41388-020-01432-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32839493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1KjsrzE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2020&pages=6139-6156&author=Q.+Weiauthor=Y.+Qianauthor=J.+Yuauthor=C.+C.+Wong&title=Metabolic+rewiring+in+the+promotion+of+cancer+metastasis%3A+mechanisms+and+therapeutic+implications&doi=10.1038%2Fs41388-020-01432-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications</span></div><div class="casAuthors">Wei, Qinyao; Qian, Yun; Yu, Jun; Wong, Chi Chun</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">6139-6156</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Abstr.: Tumor metastasis is the major cause of mortality from cancer.  Metabolic rewiring and the metastatic cascade are highly intertwined, co-operating to promote multiple steps of cancer metastasis.  Metabolites generated by cancer cells influence the metastatic cascade, encompassing epithelial-mesenchymal transition (EMT), survival of cancer cells in circulation, and metastatic colonization at distant sites.  A variety of mol. mechanisms underlie the prometastatic effect of tumor-derived metabolites, such as epigenetic deregulation, induction of matrix metalloproteinases (MMPs), promotion of cancer stemness, and alleviation of oxidative stress.  Conversely, metastatic signaling regulates expression and activity of rate-limiting metabolic enzymes to generate prometastatic metabolites thereby reinforcing the metastasis cascade.  Understanding the complex interplay between metab. and metastasis could unravel novel mol. targets, whose intervention could lead to improvements in the treatment of cancer.  In this review, we summarized the recent discoveries involving metab. and tumor metastasis, and emphasized the promising mol. targets, with an update on the development of small mol. or biol. inhibitors against these aberrant situations in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_PxF6z7qzr7Vg90H21EOLACvtfcHk0lhgyO4ge5PHmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1KjsrzE&md5=b98a641dac58116929105caf0811b628</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fs41388-020-01432-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41388-020-01432-7%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DQ.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DC.%2BC.%26atitle%3DMetabolic%2520rewiring%2520in%2520the%2520promotion%2520of%2520cancer%2520metastasis%253A%2520mechanisms%2520and%2520therapeutic%2520implications%26jtitle%3DOncogene%26date%3D2020%26volume%3D39%26spage%3D6139%26epage%3D6156%26doi%3D10.1038%2Fs41388-020-01432-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">RECKing MMP: relevance of reversion-inducing cysteine-rich protein with Kazal motifs as a prognostic marker and therapeutic target for cancer (a review)</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">718</span>â <span class="NLM_lpage">725</span>, <span class="refDoi">Â DOI: 10.2174/187152012802650237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.2174%2F187152012802650237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=22292753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsF2nsrnO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=718-725&author=S.+Nagini&title=RECKing+MMP%3A+relevance+of+reversion-inducing+cysteine-rich+protein+with+Kazal+motifs+as+a+prognostic+marker+and+therapeutic+target+for+cancer+%28a+review%29&doi=10.2174%2F187152012802650237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">RECKing MMP: relevance of reversion-inducing cysteine-rich protein with Kazal motifs as a prognostic marker and therapeutic target for cancer (a review)</span></div><div class="casAuthors">Nagini, Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">718-725</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is a membrane-anchored glycoprotein that neg. regulates the activities of matrix metalloproteinases (MMPs) and inhibits tumor invasion, metastasis, and angiogenesis.  RECK is essential for normal development and is a key mediator of tissue remodeling and stabilization of tissue architechture.  Downregulation of RECK documented in a wide range of malignant neoplasms correlates with poor prognosis, and tumor metastasis.  The RECK gene is a common neg. target for oncogenic signals that act on the Sp1-binding site of the RECK promoter.  Both natural and synthetic agents have been identified as upregulators of RECK.  Several strategies have been proposed to enhance RECK expression including forced expression of RECK, use of mimetics, recombinant peptides, microRNA antagonists, and gene therapy.  Upregulation of RECK could be a valuable therapeutic option to improve prognosis and block tumor progression.  This review addresses the potential value of RECK as a prognostic marker and as a mol. target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmxG-fnlsN67Vg90H21EOLACvtfcHk0lhgyO4ge5PHmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsF2nsrnO&md5=24516f2e5d210d055f3d57ea9350782e</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.2174%2F187152012802650237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152012802650237%26sid%3Dliteratum%253Aachs%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DRECKing%2520MMP%253A%2520relevance%2520of%2520reversion-inducing%2520cysteine-rich%2520protein%2520with%2520Kazal%2520motifs%2520as%2520a%2520prognostic%2520marker%2520and%2520therapeutic%2520target%2520for%2520cancer%2520%2528a%2520review%2529%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D718%26epage%3D725%26doi%3D10.2174%2F187152012802650237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teleanu, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chircov, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grumezescu, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teleanu, D. M.</span></span> <span> </span><span class="NLM_article-title">Tumor angiogenesis and anti-angiogenic strategies for cancer treatment</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">84</span>, <span class="refDoi">Â DOI: 10.3390/jcm9010084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3390%2Fjcm9010084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsVCks7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=84&author=R.+I.+Teleanuauthor=C.+Chircovauthor=A.+M.+Grumezescuauthor=D.+M.+Teleanu&title=Tumor+angiogenesis+and+anti-angiogenic+strategies+for+cancer+treatment&doi=10.3390%2Fjcm9010084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor angiogenesis and anti-angiogenic strategies for cancer treatment</span></div><div class="casAuthors">Teleanu, Raluca Ioana; Chircov, Cristina; Grumezescu, Alexandru Mihai; Teleanu, Daniel Mihai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Angiogenesis is the process through which novel blood vessels are formed from pre-existing ones and it is involved in both physiol. and pathol. processes of the body.  Furthermore, tumor angiogenesis is a crucial factor assocd. with tumor growth, progression, and metastasis.  In this manner, there has been a great interest in the development of anti-angiogenesis strategies that could inhibit tumor vascularization.  Conventional approaches comprise the administration of anti-angiogenic drugs that target and block the activity of proangiogenic factors.  However, as their efficacy is still a matter of debate, novel strategies have been focusing on combining anti-angiogenic agents with chemotherapy or immunotherapy.  Moreover, nanotechnol. has also been investigated for the potential of nanomaterials to target and release anti-angiogenic drugs at specific sites.  The aim of this paper is to review the mechanisms involved in angiogenesis and tumor vascularization and provide an overview of the recent trends in anti-angiogenic strategies for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvl88ZQmHgabVg90H21EOLACvtfcHk0ljEY_cbgfDgXw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsVCks7w%253D&md5=d68a26796decf8f1cfb66cfabf8eee51</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.3390%2Fjcm9010084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm9010084%26sid%3Dliteratum%253Aachs%26aulast%3DTeleanu%26aufirst%3DR.%2BI.%26aulast%3DChircov%26aufirst%3DC.%26aulast%3DGrumezescu%26aufirst%3DA.%2BM.%26aulast%3DTeleanu%26aufirst%3DD.%2BM.%26atitle%3DTumor%2520angiogenesis%2520and%2520anti-angiogenic%2520strategies%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2020%26volume%3D9%26spage%3D84%26doi%3D10.3390%2Fjcm9010084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kowshik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sophia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rautray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anbarasu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahalingam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide upregulates RECK by targeting miR-21 and HIF-1Î± in cell lines and in a hamster oral carcinogenesis model</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2045</span>, <span class="refDoi">Â DOI: 10.1038/s41598-017-01960-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fs41598-017-01960-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=28515436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC1crotl2ltA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=2045&author=J.+Kowshikauthor=R.+Mishraauthor=J.+Sophiaauthor=S.+Rautrayauthor=K.+Anbarasuauthor=G.+D.+Reddyauthor=M.+Dixitauthor=S.+Mahalingamauthor=S.+Nagini&title=Nimbolide+upregulates+RECK+by+targeting+miR-21+and+HIF-1%CE%B1+in+cell+lines+and+in+a+hamster+oral+carcinogenesis+model&doi=10.1038%2Fs41598-017-01960-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide upregulates RECK by targeting miR-21 and HIF-1Î± in cell lines and in a hamster oral carcinogenesis model</span></div><div class="casAuthors">Kowshik Jaganathan; Sophia Josephraj; Rautray Satabdi; Nagini Siddavaram; Mishra Rajakishore; Anbarasu Kumaraswamy; Dixit Madhulika; Mahalingam Sundarasamy; Reddy G Deepak</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2045</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Reversion-inducing cysteine-rich protein with Kazal motifs (RECK), a potent inhibitor of matrix metalloproteinases (MMPs) is a common negative target of oncogenic signals and a potential therapeutic target for novel drug development.  Here, we show that sequential RECKlessness stimulates angiogenesis and Notch signalling in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis model, a paradigm for oral oncogenesis and chemointervention.  We also report the chemotherapeutic effect of nimbolide, a limonoid from the neem tree (Azadirachta indica) based on the upregulation of RECK as well as modulation of the expression of key molecules involved in invasion and angiogenesis.  We demonstrate that nimbolide upregulates RECK by targeting miR-21, and HIF-1Î± resulting in reduced MMP activity and blockade of VEGF and Notch signalling.  Nimbolide reduced microvascular density, confirming its anti-angiogenic potential.  Molecular docking analysis revealed interaction of nimbolide with HIF-1Î±.  Additionally, we demonstrate that nimbolide upregulates RECK expression via downregulation of HIF-1Î± and miR-21 by overexpression and knockdown experiments in SCC4 and EAhy926 cell lines.  Taken together, these findings provide compelling evidence that targeting RECK, a keystone protein that regulates mediators of invasion and angiogenesis with phytochemicals such as nimbolide may be a robust therapeutic approach to prevent oral cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxLKh8DGKPB3tlzo9xastyfW6udTcc2eYcaPv1DVQ-Wbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crotl2ltA%253D%253D&md5=322ad3581707fc54d6c74a2ea6e8ed16</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-01960-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-01960-5%26sid%3Dliteratum%253Aachs%26aulast%3DKowshik%26aufirst%3DJ.%26aulast%3DMishra%26aufirst%3DR.%26aulast%3DSophia%26aufirst%3DJ.%26aulast%3DRautray%26aufirst%3DS.%26aulast%3DAnbarasu%26aufirst%3DK.%26aulast%3DReddy%26aufirst%3DG.%2BD.%26aulast%3DDixit%26aufirst%3DM.%26aulast%3DMahalingam%26aufirst%3DS.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DNimbolide%2520upregulates%2520RECK%2520by%2520targeting%2520miR-21%2520and%2520HIF-1%25CE%25B1%2520in%2520cell%2520lines%2520and%2520in%2520a%2520hamster%2520oral%2520carcinogenesis%2520model%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D2045%26doi%3D10.1038%2Fs41598-017-01960-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baby, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajguru, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakkannavar, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujari, V. B.</span></span> <span> </span><span class="NLM_article-title">Inflammation and cancer</span>. <i>Ann. Afr. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">121</span>â <span class="NLM_lpage">126</span>, <span class="refDoi">Â DOI: 10.4103/aam.aam_56_18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.4103%2Faam.aam_56_18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31417011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3MvosVWmtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=121-126&author=N.+Singhauthor=D.+Babyauthor=J.+P.+Rajguruauthor=P.+B.+Patilauthor=S.+S.+Thakkannavarauthor=V.+B.+Pujari&title=Inflammation+and+cancer&doi=10.4103%2Faam.aam_56_18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and cancer</span></div><div class="casAuthors">Singh Nitin; Baby Deepak; Rajguru Jagadish Prasad; Patil Pankaj B; Thakkannavar Savita S; Pujari Veena Bhojaraj</div><div class="citationInfo"><span class="NLM_cas:title">Annals of African medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">121-126</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammation is often associated with the development and progression of cancer.  The cells responsible for cancer-associated inflammation are genetically stable and thus are not subjected to rapid emergence of drug resistance; therefore, the targeting of inflammation represents an attractive strategy both for cancer prevention and for cancer therapy.  Tumor-extrinsic inflammation is caused by many factors, including bacterial and viral infections, autoimmune diseases, obesity, tobacco smoking, asbestos exposure, and excessive alcohol consumption, all of which increase cancer risk and stimulate malignant progression.  In contrast, cancer-intrinsic or cancer-elicited inflammation can be triggered by cancer-initiating mutations and can contribute to malignant progression through the recruitment and activation of inflammatory cells.  Both extrinsic and intrinsic inflammations can result in immunosuppression, thereby providing a preferred background for tumor development.  The current review provides a link between inflammation and cancer development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpl6QIfQj1zGgRQsDqrjW_fW6udTcc2eYcaPv1DVQ-Wbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvosVWmtQ%253D%253D&md5=ca8897670da47b68187a3c98daed8d60</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.4103%2Faam.aam_56_18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252Faam.aam_56_18%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DBaby%26aufirst%3DD.%26aulast%3DRajguru%26aufirst%3DJ.%2BP.%26aulast%3DPatil%26aufirst%3DP.%2BB.%26aulast%3DThakkannavar%26aufirst%3DS.%2BS.%26aulast%3DPujari%26aufirst%3DV.%2BB.%26atitle%3DInflammation%2520and%2520cancer%26jtitle%3DAnn.%2520Afr.%2520Med.%26date%3D2019%26volume%3D18%26spage%3D121%26epage%3D126%26doi%3D10.4103%2Faam.aam_56_18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. X.</span></span> <span> </span><span class="NLM_article-title">Natural products and their derivatives: Promising modulators of tumor immunotherapy</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">493</span>â <span class="NLM_lpage">508</span>, <span class="refDoi">Â DOI: 10.1002/JLB.3MR0320-444R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2FJLB.3MR0320-444R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32678943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtl2qt7vF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2020&pages=493-508&author=L.+J.+Dengauthor=M.+Qiauthor=N.+Liauthor=Y.+H.+Leiauthor=D.+M.+Zhangauthor=J.+X.+Chen&title=Natural+products+and+their+derivatives%3A+Promising+modulators+of+tumor+immunotherapy&doi=10.1002%2FJLB.3MR0320-444R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Natural products and their derivatives: Promising modulators of tumor immunotherapy</span></div><div class="casAuthors">Deng, Li-Juan; Qi, Ming; Li, Nan; Lei, Yu-He; Zhang, Dong-Mei; Chen, Jia-Xu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">493-508</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">1938-3673</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  A wealth of evidence supports the role of tumor immunotherapy as a vital therapeutic option in cancer.  In recent decades, accumulated studies have revealed the anticancer activities of natural products and their derivs.  Increasing interest has been driven toward finding novel potential modulators of tumor immunotherapy from natural products, a hot research topic worldwide.  These works of research mainly focused on natural products, including polyphenols (e.g., curcumin, resveratrol), cardiotonic steroids (e.g., bufalin and digoxin), terpenoids (e.g., paclitaxel and artemisinins), and polysaccharide exts. (e.g., lentinan).  Compelling data highlight that natural products have a promising future in tumor immunotherapy.  Considering the importance and significance of this topic, we initially discussed the integrated research progress of natural products and their derivs., including target T cells, macrophages, B cells, NKs, regulatory T cells, myeloid-derived suppressor cells, inflammatory cytokines and chemokines, immunogenic cell death, and immune checkpoints.  Furthermore, these natural compds. inactivate several key pathways, including NF-ÎºB, PI3K/Akt, MAPK, and JAK/STAT pathways.  Here, we performed a deep generalization, anal., and summarization of the previous achievements, recent progress, and the bottlenecks in the development of natural products as tumor immunotherapy.  We expect this review to provide some insight for guiding future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4TwBZ7eFkj7Vg90H21EOLACvtfcHk0lgegSnoZPPCQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtl2qt7vF&md5=acce72428fb0da0e20de2eae6f8d3891</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2FJLB.3MR0320-444R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252FJLB.3MR0320-444R%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DL.%2BJ.%26aulast%3DQi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLei%26aufirst%3DY.%2BH.%26aulast%3DZhang%26aufirst%3DD.%2BM.%26aulast%3DChen%26aufirst%3DJ.%2BX.%26atitle%3DNatural%2520products%2520and%2520their%2520derivatives%253A%2520Promising%2520modulators%2520of%2520tumor%2520immunotherapy%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2020%26volume%3D108%26spage%3D493%26epage%3D508%26doi%3D10.1002%2FJLB.3MR0320-444R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rad, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tee, A. R.</span></span> <span> </span><span class="NLM_article-title">Oncogenic signalling through mechanistic target of rapamycin (mTOR): A driver of metabolic transformation and cancer progression</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">5</span>, <span class="refDoi">Â DOI: 10.3390/cancers10010005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3390%2Fcancers10010005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisV2ru7nF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=5&author=E.+Radauthor=J.+T.+Murrayauthor=A.+R.+Tee&title=Oncogenic+signalling+through+mechanistic+target+of+rapamycin+%28mTOR%29%3A+A+driver+of+metabolic+transformation+and+cancer+progression&doi=10.3390%2Fcancers10010005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic signalling through mechanistic target of rapamycin (mTOR): a driver of metabolic transformation and cancer progression</span></div><div class="casAuthors">Rad, Ellie; Murray, James T.; Tee, Andrew R.</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5/1-5/17</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Throughout the years, research into signalling pathways involved in cancer progression has led to many discoveries of which mechanistic target of rapamycin (mTOR) is a key player. mTOR is a master regulator of cell growth control. mTOR is historically known to promote cell growth by enhancing the efficiency of protein translation.  Research in the last decade has revealed that mTOR's role in promoting cell growth is much more multifaceted.  While mTOR is necessary for normal human physiol., cancer cells take advantage of mTOR signalling to drive their neoplastic growth and progression.  Oncogenic signal transduction through mTOR is a common occurrence in cancer, leading to metabolic transformation, enhanced proliferative drive and increased metastatic potential through neovascularisation.  This review focuses on the downstream mTOR-regulated processes that are implicated in the "hallmarks" of cancer with focus on mTOR's involvement in proliferative signalling, metabolic reprogramming, angiogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE9-Hny_J3ALVg90H21EOLACvtfcHk0lgegSnoZPPCQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisV2ru7nF&md5=b027b848a78dfdd624e10d75d20e10b8</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.3390%2Fcancers10010005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers10010005%26sid%3Dliteratum%253Aachs%26aulast%3DRad%26aufirst%3DE.%26aulast%3DMurray%26aufirst%3DJ.%2BT.%26aulast%3DTee%26aufirst%3DA.%2BR.%26atitle%3DOncogenic%2520signalling%2520through%2520mechanistic%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%253A%2520A%2520driver%2520of%2520metabolic%2520transformation%2520and%2520cancer%2520progression%26jtitle%3DCancers%26date%3D2018%26volume%3D10%26spage%3D5%26doi%3D10.3390%2Fcancers10010005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Vega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armenia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatila, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitriadoy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantheti, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghafinia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foltz, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shmulevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heins, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochoa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandoth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahceci, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dervishi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogrusoz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Way, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bivona, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazar, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammer, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McArthur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tward, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group">Cancer Genome Atlas Research Network</span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Allen, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherniack, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sander, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, N.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Oncogenic signaling pathways in the cancer genome atlas</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">321</span>â <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.cell.2018.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29625050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntFahsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2018&pages=321-337&author=F.+Sanchez-Vegaauthor=M.+Minaauthor=J.+Armeniaauthor=W.+K.+Chatilaauthor=A.+Lunaauthor=K.+C.+Laauthor=S.+Dimitriadoyauthor=D.+L.+Liuauthor=H.+S.+Kanthetiauthor=S.+Saghafiniaauthor=D.+Chakravartyauthor=F.+Daianauthor=Q.+Gaoauthor=M.+H.+Baileyauthor=W.+W.+Liangauthor=S.+M.+Foltzauthor=I.+Shmulevichauthor=L.+Dingauthor=Z.+Heinsauthor=A.+Ochoaauthor=B.+Grossauthor=J.+Gaoauthor=H.+Zhangauthor=R.+Kundraauthor=C.+Kandothauthor=I.+Bahceciauthor=L.+Dervishiauthor=U.+Dogrusozauthor=W.+Zhouauthor=H.+Shenauthor=P.+W.+Lairdauthor=G.+P.+Wayauthor=C.+S.+Greeneauthor=H.+Liangauthor=Y.+Xiaoauthor=C.+Wangauthor=A.+Iavaroneauthor=A.+H.+Bergerauthor=T.+G.+Bivonaauthor=A.+J.+Lazarauthor=G.+D.+Hammerauthor=T.+Giordanoauthor=L.+N.+Kwongauthor=G.+McArthurauthor=C.+Huangauthor=A.+D.+Twardauthor=M.+J.+Frederickauthor=F.+McCormickauthor=M.+Meyersonauthor=Cancer+Genome+Atlas+Research+Networkauthor=E.+M.+Van+Allenauthor=A.+D.+Cherniackauthor=G.+Cirielloauthor=C.+Sanderauthor=N.+Schultz&title=Oncogenic+signaling+pathways+in+the+cancer+genome+atlas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic signaling pathways in the cancer genome atlas</span></div><div class="casAuthors">Sanchez-Vega, Francisco; Mina, Marco; Armenia, Joshua; Chatila, Walid K.; Luna, Augustin; La, Konnor C.; Dimitriadoy, Sofia; Liu, David L.; Kantheti, Havish S.; Saghafinia, Sadegh; Chakravarty, Debyani; Daian, Foysal; Gao, Qingsong; Bailey, Matthew H.; Liang, Wen-Wei; Foltz, Steven M.; Shmulevich, Ilya; Ding, Li; Heins, Zachary; Ochoa, Angelica; Gross, Benjamin; Gao, Jianjiong; Zhang, Hongxin; Kundra, Ritika; Kandoth, Cyriac; Bahceci, Istemi; Dervishi, Leonard; Dogrusoz, Ugur; Zhou, Wanding; Shen, Hui; Laird, Peter W.; Way, Gregory P.; Greene, Casey S.; Liang, Han; Xiao, Yonghong; Wang, Chen; Iavarone, Antonio; Berger, Alice H.; Bivona, Trever G.; Lazar, Alexander J.; Hammer, Gary D.; Giordano, Thomas; Kwong, Lawrence N.; McArthur, Grant; Huang, Chenfei; Tward, Aaron D.; Frederick, Mitchell J.; McCormick, Frank; Meyerson, Matthew; Van Allen, Eliezer M.; Cherniack, Andrew D.; Ciriello, Giovanni; Sander, Chris; Schultz, Nikolaus</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-337.e10</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Genetic alterations in signaling pathways that control cell-cycle progression, apoptosis, and cell growth are common hallmarks of cancer, but the extent, mechanisms, and co-occurrence of alterations in these pathways differ between individual tumors and tumor types.  Using mutations, copy-no. changes, mRNA expression, gene fusions and DNA methylation in 9125 tumors profiled by The Cancer Genome Atlas (TCGA), we analyzed the mechanisms and patterns of somatic alterations in ten canonical pathways: cell cycle, Hippo, Myc, Notch, Nrf2, PI-3-Kinase/Akt, RTK-RAS, TGFÎ² signaling, p53 and Î²-catenin/Wnt.  We charted the detailed landscape of pathway alterations in 33 cancer types, stratified into 64 subtypes, and identified patterns of co-occurrence and mutual exclusivity.  Eighty-nine percent of tumors had at least one driver alteration in these pathways, and 57% percent of tumors had at least one alteration potentially targetable by currently available drugs.  Thirty percent of tumors had multiple targetable alterations, indicating opportunities for combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv_ggbxuypEbVg90H21EOLACvtfcHk0lgegSnoZPPCQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntFahsrs%253D&md5=3677d3a77b12767c828f48eb80d71141</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez-Vega%26aufirst%3DF.%26aulast%3DMina%26aufirst%3DM.%26aulast%3DArmenia%26aufirst%3DJ.%26aulast%3DChatila%26aufirst%3DW.%2BK.%26aulast%3DLuna%26aufirst%3DA.%26aulast%3DLa%26aufirst%3DK.%2BC.%26aulast%3DDimitriadoy%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DD.%2BL.%26aulast%3DKantheti%26aufirst%3DH.%2BS.%26aulast%3DSaghafinia%26aufirst%3DS.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DDaian%26aufirst%3DF.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DBailey%26aufirst%3DM.%2BH.%26aulast%3DLiang%26aufirst%3DW.%2BW.%26aulast%3DFoltz%26aufirst%3DS.%2BM.%26aulast%3DShmulevich%26aufirst%3DI.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DHeins%26aufirst%3DZ.%26aulast%3DOchoa%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DKundra%26aufirst%3DR.%26aulast%3DKandoth%26aufirst%3DC.%26aulast%3DBahceci%26aufirst%3DI.%26aulast%3DDervishi%26aufirst%3DL.%26aulast%3DDogrusoz%26aufirst%3DU.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DLaird%26aufirst%3DP.%2BW.%26aulast%3DWay%26aufirst%3DG.%2BP.%26aulast%3DGreene%26aufirst%3DC.%2BS.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DIavarone%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DA.%2BH.%26aulast%3DBivona%26aufirst%3DT.%2BG.%26aulast%3DLazar%26aufirst%3DA.%2BJ.%26aulast%3DHammer%26aufirst%3DG.%2BD.%26aulast%3DGiordano%26aufirst%3DT.%26aulast%3DKwong%26aufirst%3DL.%2BN.%26aulast%3DMcArthur%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DTward%26aufirst%3DA.%2BD.%26aulast%3DFrederick%26aufirst%3DM.%2BJ.%26aulast%3DMcCormick%26aufirst%3DF.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3D%26aulast%3DVan%2BAllen%26aufirst%3DE.%2BM.%26aulast%3DCherniack%26aufirst%3DA.%2BD.%26aulast%3DCiriello%26aufirst%3DG.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DSchultz%26aufirst%3DN.%26atitle%3DOncogenic%2520signaling%2520pathways%2520in%2520the%2520cancer%2520genome%2520atlas%26jtitle%3DCell%26date%3D2018%26volume%3D173%26spage%3D321%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sophia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, R.</span></span> <span> </span><span class="NLM_article-title">Glycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">25</span>â <span class="NLM_lpage">36</span>, <span class="refDoi">Â DOI: 10.1016/j.semcancer.2017.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.semcancer.2017.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29309927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVWrtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2019&pages=25-36&author=S.+Naginiauthor=J.+Sophiaauthor=R.+Mishra&title=Glycogen+synthase+kinases%3A+Moonlighting+proteins+with+theranostic+potential+in+cancer&doi=10.1016%2Fj.semcancer.2017.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer</span></div><div class="casAuthors">Nagini, Siddavaram; Sophia, Josephraj; Mishra, Rajakishore</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-36</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3 (GSK-3), a serine/threonine kinase is an archetypal multifunctional moonlighting protein involved in diverse cellular processes including metab., insulin signaling, proliferation, differentiation, apoptosis, neuronal function and embryonic development.  The two known isoforms, GSK-3Î± and GSK-3Î² that undergo activation/inactivation by post-translational, site-specific phosphorylation incorporate a vast no. of substrates in their repertoire.  Dysregulation of GSK-3 has been linked to diverse disease entities including cancer.  The role of GSK-3 in cancer is paradoxical and enigmatic.  The enzyme functions as a tumor promoter or suppressor based on the context, cell type and phosphorylation status.  GSK-3 is the central hub that orchestrates signals from the Wnt/Î²-catenin, PI3K/PTEN/Akt/mTOR, Ras/Raf/MEK/ERK, hedgehog, Notch and TP53 pathways to elicit regulatory influences on cancer initiation, epithelial-mesenchymal transition, and resistance to therapy.  As a direct target of several microRNAs, GSK-3 influences hallmark attributes of cancer, cancer stemness and treatment resistance.  There is overwhelming evidence to indicate that GSK-3 is aberrantly regulated in different cancer types.  Consequently, GSK-3 has emerged as a potential therapeutic target in cancer.  A plethora of natural and synthetic GSK-3 modulators have been discovered and the no. of patents published for GSK-3 inhibitors has also been steadily increasing in recent years.  This review focuses on the intricate interactions between GSK-3 and oncogenic signalling circuits as well as the feasibility of targeting GSK-3 for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVoZ1tqIrqErVg90H21EOLACvtfcHk0lgu-M__zaPsnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVWrtw%253D%253D&md5=b012c15396c852fd3777a651a1580f1f</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2017.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2017.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DNagini%26aufirst%3DS.%26aulast%3DSophia%26aufirst%3DJ.%26aulast%3DMishra%26aufirst%3DR.%26atitle%3DGlycogen%2520synthase%2520kinases%253A%2520Moonlighting%2520proteins%2520with%2520theranostic%2520potential%2520in%2520cancer%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2019%26volume%3D56%26spage%3D25%26epage%3D36%26doi%3D10.1016%2Fj.semcancer.2017.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alex, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bast, F.</span></span> <span> </span><span class="NLM_article-title">Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer</span>. <i>Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">805</span>, <span class="refDoi">Â DOI: 10.1007/s12032-013-0805-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs12032-013-0805-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=24338270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC2c3otVOmsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=805&author=P.+Singhauthor=J.+M.+Alexauthor=F.+Bast&title=Insulin+receptor+%28IR%29+and+insulin-like+growth+factor+receptor+1+%28IGF-1R%29+signaling+systems%3A+novel+treatment+strategies+for+cancer&doi=10.1007%2Fs12032-013-0805-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer</span></div><div class="casAuthors">Singh Pushpendra; Alex Jimi Marin; Bast Felix</div><div class="citationInfo"><span class="NLM_cas:title">Medical oncology (Northwood, London, England)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">805</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Insulin and insulin-like growth factor (IGF) signaling system, commonly known for fine-tuning numerous biological processes, has lately made its mark as a much sought-after therapeutic targets for diabetes and cancer.  These receptors make an attractive anticancer target owing to their overexpression in variety of cancer especially in prostate and breast cancer.  Inhibitors of IGF signaling were subjected to clinical cancer trials with the main objective to confirm the effectiveness of these receptors as a therapeutic target.  However, the results that these trials produced proved to be disappointing as the role played by the cross talk between IGF and insulin receptor (IR) signaling pathways at the receptor level or at downstream signaling level became more lucid.  Therapeutic strategy for IGF-1R and IR inhibition mainly encompasses three main approaches namely receptor blockade with monoclonal antibodies, tyrosine kinase inhibition (ATP antagonist and non-ATP antagonist), and ligand neutralization via monoclonal antibodies targeted to ligand or recombinant IGF-binding proteins.  Other drug-discovery approaches are employed to target IGF-1R, and IR includes antisense oligonucleotides and recombinant IGF-binding proteins.  However, therapies with monoclonal antibodies and tyrosine kinase inhibition targeting the IGF-1R are not evidenced to be satisfactory as expected.  Factors that are duly held responsible for the unsuccessfulness of these therapies include (a) the existence of the IR isoform A overexpressed on a variety of cancers, enhancing the mitogenic signals to the nucleus leading to the endorsement of cell growth, (b) IGF-1R and IR that form hybrid receptors sensitive to the stimulation of all three IGF axis ligands, and (c) IGF-1R and IR that also have the potential to form hybrid receptors with other tyrosine kinase to potentiate the cellular transformation, tumorigenesis, and tumor vascularization.  This mini review is a concerted effort to explore and fathom the well-recognized roles of the IRA signaling system in human cancer phenotype and the main strategies that have been so far evaluated to target the IR and IGF-1R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTj-XGoenfx9Wx8TEN9K18QfW6udTcc2eaXFQWPddqK-rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3otVOmsA%253D%253D&md5=1c2f19cb1f7810d57a80757afe5deee3</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1007%2Fs12032-013-0805-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12032-013-0805-3%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DAlex%26aufirst%3DJ.%2BM.%26aulast%3DBast%26aufirst%3DF.%26atitle%3DInsulin%2520receptor%2520%2528IR%2529%2520and%2520insulin-like%2520growth%2520factor%2520receptor%25201%2520%2528IGF-1R%2529%2520signaling%2520systems%253A%2520novel%2520treatment%2520strategies%2520for%2520cancer%26jtitle%3DMed.%2520Oncol.%26date%3D2014%26volume%3D31%26spage%3D805%26doi%3D10.1007%2Fs12032-013-0805-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raja
Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugantha Priya, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunkumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharmila, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajalakshmi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunakaran, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cell survival and proliferation by nimbolide in human androgen-independent prostate cancer (PC-3) cells: involvement of the PI3K/Akt pathway</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>427</i></span>,  <span class="NLM_fpage">69</span>â <span class="NLM_lpage">79</span>, <span class="refDoi">Â DOI: 10.1007/s11010-016-2898-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs11010-016-2898-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=28025797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGhs73F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2017&pages=69-79&author=P.+Raja%0ASinghauthor=E.+Sugantha+Priyaauthor=S.+Balakrishnanauthor=R.+Arunkumarauthor=G.+Sharmilaauthor=M.+Rajalakshmiauthor=J.+Arunakaran&title=Inhibition+of+cell+survival+and+proliferation+by+nimbolide+in+human+androgen-independent+prostate+cancer+%28PC-3%29+cells%3A+involvement+of+the+PI3K%2FAkt+pathway&doi=10.1007%2Fs11010-016-2898-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cell survival and proliferation by nimbolide in human androgen-independent prostate cancer (PC-3) cells: involvement of the PI3K/Akt pathway</span></div><div class="casAuthors">Raja Singh, Paulraj; Sugantha Priya, Elayapillai; Balakrishnan, Solaimuthu; Arunkumar, Ramachandran; Sharmila, Govindaraj; Rajalakshmi, Manikkam; Arunakaran, Jagadeesan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">427</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">69-79</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Prostate cancer is most common malignancy among men in the world.  PI3K-Akt signaling appears to be crit. to prostate cancer cell proliferation and survival.  Our earlier study reveals that nimbolide (2 Î¼M) prevents cell survival via IGF signaling pathway through PI3K/Akt and induces apoptosis in PC-3 cell line.  Akt mediates the phosphorylation and activation of mTOR that plays a crit. role in the regulation of protein translation and synthesis, angiogenesis, and cell cycle progression.  The present study was aimed to investigate the effect of nimbolide on tPI3K, tAkt, pAkt, tmTOR, GSK3Î², pGSK3Î², PCNA, c-Myc, Cyclin D1, and Survivin protein levels by western blot anal.  Apoptosis was visualized by Ao/EtBr dual staining (20Ã), and protein expression of PCNA by immunocytochem. was performed.  Mol. docking was performed to understand the possible interaction between nimbolide and Akt, PCNA, and Cyclin D1.  Nimbolide altered the PI3K-Akt-mediated cell survival and proliferative mols.  Thus, nimbolide exerted anticancer effects in vitro by representing the PI3K-Akt-mTOR pathway in PC-3 cells.  Thereby, it acts as a potent anticancer drug for prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX7e7SWuT9jbVg90H21EOLACvtfcHk0lgu-M__zaPsnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGhs73F&md5=ae77737c1488bc308bb147de6275bf80</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1007%2Fs11010-016-2898-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-016-2898-4%26sid%3Dliteratum%253Aachs%26aulast%3DRaja%2BSingh%26aufirst%3DP.%26aulast%3DSugantha%2BPriya%26aufirst%3DE.%26aulast%3DBalakrishnan%26aufirst%3DS.%26aulast%3DArunkumar%26aufirst%3DR.%26aulast%3DSharmila%26aufirst%3DG.%26aulast%3DRajalakshmi%26aufirst%3DM.%26aulast%3DArunakaran%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520cell%2520survival%2520and%2520proliferation%2520by%2520nimbolide%2520in%2520human%2520androgen-independent%2520prostate%2520cancer%2520%2528PC-3%2529%2520cells%253A%2520involvement%2520of%2520the%2520PI3K%252FAkt%2520pathway%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2017%26volume%3D427%26spage%3D69%26epage%3D79%26doi%3D10.1007%2Fs11010-016-2898-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fusella, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SeclÃ¬, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannata, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancaccio, M.</span></span> <span> </span><span class="NLM_article-title">The one thousand and one chaperones of the NF-ÎºB pathway</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">2275</span>â <span class="NLM_lpage">2288</span>, <span class="refDoi">Â DOI: 10.1007/s00018-019-03402-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs00018-019-03402-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31811308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlegsrvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2020&pages=2275-2288&author=F.+Fusellaauthor=L.+Secl%C3%ACauthor=C.+Cannataauthor=M.+Brancaccio&title=The+one+thousand+and+one+chaperones+of+the+NF-%CE%BAB+pathway&doi=10.1007%2Fs00018-019-03402-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">The one thousand and one chaperones of the NF-ÎºB pathway</span></div><div class="casAuthors">Fusella, Federica; Secli, Laura; Cannata, Cristiana; Brancaccio, Mara</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2275-2288</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">The NF-ÎºB pathway represents a crucial signaling mechanism in sensing and integrating a multitude of environmental and intracellular stimuli and directing a coordinated response that from the cellular level may impact on the entire organism.  A plethora of chaperone proteins work at multiple steps of the pathway, from membrane receptor activation to transcription factor binding to DNA.  Indeed, chaperones are required to assist protein conformational changes, to assemble supramol. complexes and to regulate protein ubiquitination, required for pathway activation.  Some chaperones acquired a role as integral components of the signaling complexes, needed for signal progression.  Here we describe the chaperones involved in the NF-ÎºB pathway and their specific roles in the different contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCYrhGUiKN9bVg90H21EOLACvtfcHk0lgARBgjmJ08-Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlegsrvP&md5=77e910fb28d765cf155e8b91dcf24be1</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs00018-019-03402-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-019-03402-z%26sid%3Dliteratum%253Aachs%26aulast%3DFusella%26aufirst%3DF.%26aulast%3DSecl%25C3%25AC%26aufirst%3DL.%26aulast%3DCannata%26aufirst%3DC.%26aulast%3DBrancaccio%26aufirst%3DM.%26atitle%3DThe%2520one%2520thousand%2520and%2520one%2520chaperones%2520of%2520the%2520NF-%25CE%25BAB%2520pathway%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2020%26volume%3D77%26spage%3D2275%26epage%3D2288%26doi%3D10.1007%2Fs00018-019-03402-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bose, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pumarol, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croley, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishayee, A.</span></span> <span> </span><span class="NLM_article-title">Targeting the JAK/STAT signaling pathway using phytocompounds for cancer prevention and therapy</span>. <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1451</span>, <span class="refDoi">Â DOI: 10.3390/cells9061451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3390%2Fcells9061451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXis1Chs77N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=1451&author=S.+Boseauthor=S.+Banerjeeauthor=A.+Mondalauthor=U.+Chakrabortyauthor=J.+Pumarolauthor=C.+R.+Croleyauthor=A.+Bishayee&title=Targeting+the+JAK%2FSTAT+signaling+pathway+using+phytocompounds+for+cancer+prevention+and+therapy&doi=10.3390%2Fcells9061451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the JAK/STAT signaling pathway using phytocompounds for cancer prevention and therapy</span></div><div class="casAuthors">Bose, Sankhadip; Banerjee, Sabyasachi; Mondal, Arijit; Chakraborty, Utsab; Pumarol, Joshua; Croley, Courtney R.; Bishayee, Anupam</div><div class="citationInfo"><span class="NLM_cas:title">Cells</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1451</span>CODEN:
                <span class="NLM_cas:coden">CELLC6</span>;
        ISSN:<span class="NLM_cas:issn">2073-4409</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Cancer is a prevalent cause of mortality around the world.  Aberrated activation of Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway promotes tumorigenesis.  Natural agents, including phytochems., exhibit potent anticancer activities via various mechanisms.  However, the therapeutic potency of phytoconstituents as inhibitors of JAK/STAT signaling against cancer has only come into focus in recent days.  The current review highlights phytochems. that can suppress the JAK/STAT pathway in order to impede cancer cell growth.  Various databases, such as PubMed, ScienceDirect, Web of Science, SpringerLink, Scopus, and Google Scholar, were searched using relevant keywords.  Once the authors were in agreement regarding the suitability of a study, a full-length form of the relevant article was obtained, and the information was gathered and cited.  All the complete articles that were incorporated after the literature collection rejection criteria were applied were perused in-depth and material was extd. based on the importance, relevance, and advancement of the apprehending of the JAK/STAT pathway and their relation to phytochems.  Based on the crit. and comprehensive anal. of literature presented in this review, phytochems. from diverse plant origins exert therapeutic and cancer preventive effects, at least in part, through regulation of the JAK/STAT pathway.  Nevertheless, more preclin. and clin. research is necessary to completely comprehend the capability of modulating JAK/STAT signaling to achieve efficient cancer control and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaw1BBM7EFLLVg90H21EOLACvtfcHk0lgARBgjmJ08-Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXis1Chs77N&md5=842acf23595c94c42d58f791fd100f74</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.3390%2Fcells9061451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells9061451%26sid%3Dliteratum%253Aachs%26aulast%3DBose%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DMondal%26aufirst%3DA.%26aulast%3DChakraborty%26aufirst%3DU.%26aulast%3DPumarol%26aufirst%3DJ.%26aulast%3DCroley%26aufirst%3DC.%2BR.%26aulast%3DBishayee%26aufirst%3DA.%26atitle%3DTargeting%2520the%2520JAK%252FSTAT%2520signaling%2520pathway%2520using%2520phytocompounds%2520for%2520cancer%2520prevention%2520and%2520therapy%26jtitle%3DCells%26date%3D2020%26volume%3D9%26spage%3D1451%26doi%3D10.3390%2Fcells9061451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">da
Costa, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galucio, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jesus, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima e Lima, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taube, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">dos Santos, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lameira, J.</span></span> <span> </span><span class="NLM_article-title">Targeting peptidyl-prolyl cis-trans isomerase NIMA-interacting 1: A Structure-based virtual screening approach to find novel inhibitors</span>. <i>Curr. Comput.-Aided Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">605</span>â <span class="NLM_lpage">617</span>, <span class="refDoi">Â DOI: 10.2174/1573409915666191025114009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.2174%2F1573409915666191025114009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31654518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlKhsL7K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2020&pages=605-617&author=K.+S.+da%0ACostaauthor=J.+M.+Galucioauthor=D.+A.+de+Jesusauthor=G.+C.+Gomesauthor=A.+H.+Lima+e+Limaauthor=P.+S.+Taubeauthor=A.+M.+dos+Santosauthor=J.+Lameira&title=Targeting+peptidyl-prolyl+cis-trans+isomerase+NIMA-interacting+1%3A+A+Structure-based+virtual+screening+approach+to+find+novel+inhibitors&doi=10.2174%2F1573409915666191025114009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Peptidyl-prolyl Cis-trans Isomerase NIMA-interacting 1: A Structure-based Virtual Screening Approach to Find Novel Inhibitors</span></div><div class="casAuthors">da Costa, Kaue Santana; Galucio, Joao M.; de Jesus, Deivid Almeida; Gomes, Guelber Cardoso; Lima e Lima, Anderson Henrique; Taube, Paulo S.; dos Santos, Alberto M.; Lameira, Jeronimo</div><div class="citationInfo"><span class="NLM_cas:title">Current Computer-Aided Drug Design</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">605-617</span>CODEN:
                <span class="NLM_cas:coden">CCDDAS</span>;
        ISSN:<span class="NLM_cas:issn">1573-4099</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) is an enzyme that isomerizes phosphorylated serine or threonine motifs adjacent to proline residues.  Pin1 has important roles in several cellular signaling pathways, consequently impacting the development of multiple types of cancers.  Methods: Based on the previously reported inhibitory activity of pentacyclic triterpenoids isolated from the gum resin of Boswellia genus against Pin1, we designed a computational expt. using mol. docking, pharmacophore filtering, and structural clustering allied to mol. dynamics (MD) simulations and binding free energy calcns. to explore the inhibitory activity of new triterpenoids against Pin1 structure.  Results: Here, we report different computational evidence that triterpenoids from neem (Azadirachta indica A. Juss), such as 6-deacetylnimbinene, 6-Oacetylnimbandiol, and nimbolide, replicate the binding mode of the Pin1 substrate peptide, interacting with high affinity with the binding site and thus destabilizing the Pin1 structure.  Conclusions: Our results are supported by exptl. data, and provide interesting structural insights into their mol. mechanism of action, indicating that their structural scaffolds could be used as a start point to develop new inhibitors against Pin1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ9LPnqq5HrLVg90H21EOLACvtfcHk0lgARBgjmJ08-Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlKhsL7K&md5=6876bde8bc377e85dce07a78b8632c20</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.2174%2F1573409915666191025114009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1573409915666191025114009%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BCosta%26aufirst%3DK.%2BS.%26aulast%3DGalucio%26aufirst%3DJ.%2BM.%26aulast%3Dde%2BJesus%26aufirst%3DD.%2BA.%26aulast%3DGomes%26aufirst%3DG.%2BC.%26aulast%3DLima%2Be%2BLima%26aufirst%3DA.%2BH.%26aulast%3DTaube%26aufirst%3DP.%2BS.%26aulast%3Ddos%2BSantos%26aufirst%3DA.%2BM.%26aulast%3DLameira%26aufirst%3DJ.%26atitle%3DTargeting%2520peptidyl-prolyl%2520cis-trans%2520isomerase%2520NIMA-interacting%25201%253A%2520A%2520Structure-based%2520virtual%2520screening%2520approach%2520to%2520find%2520novel%2520inhibitors%26jtitle%3DCurr.%2520Comput.-Aided%2520Drug%2520Des.%26date%3D2020%26volume%3D16%26spage%3D605%26epage%3D617%26doi%3D10.2174%2F1573409915666191025114009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campitelli, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taipale, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weirauch, M. T.</span></span> <span> </span><span class="NLM_article-title">The human transcription factors</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>172</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">650</span>â <span class="NLM_lpage">665</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2018.01.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.cell.2018.01.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29425488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis1amsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2018&pages=650-665&issue=4&author=S.+A.+Lambertauthor=A.+Jolmaauthor=L.+F.+Campitelliauthor=P.+K.+Dasauthor=Y.+Yinauthor=M.+Albuauthor=X.+Chenauthor=J.+Taipaleauthor=T.+R.+Hughesauthor=M.+T.+Weirauch&title=The+human+transcription+factors&doi=10.1016%2Fj.cell.2018.01.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Transcription Factors</span></div><div class="casAuthors">Lambert, Samuel A.; Jolma, Arttu; Campitelli, Laura F.; Das, Pratyush K.; Yin, Yimeng; Albu, Mihai; Chen, Xiaoting; Taipale, Jussi; Hughes, Timothy R.; Weirauch, Matthew T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">650-665</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Transcription factors (TFs) recognize specific DNA sequences to control chromatin and transcription, forming a complex system that guides expression of the genome.  Despite keen interest in understanding how TFs control gene expression, it remains challenging to det. how the precise genomic binding sites of TFs are specified and how TF binding ultimately relates to regulation of transcription.  This review considers how TFs are identified and functionally characterized, principally through the lens of a catalog of over 1600 likely human TFs and binding motifs for two-thirds of them.  Major classes of human TFs differ markedly in their evolutionary trajectories and expression patterns, underscoring distinct functions.  TFs likewise underlie many different aspects of human physiol., disease, and variation, highlighting the importance of continued effort to understand TF-mediated gene regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGN_jQqNzpvrVg90H21EOLACvtfcHk0lguA9BLWA2tlw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1amsbs%253D&md5=a53a2bf38c15419c7589893428efd738</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.01.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.01.029%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DS.%2BA.%26aulast%3DJolma%26aufirst%3DA.%26aulast%3DCampitelli%26aufirst%3DL.%2BF.%26aulast%3DDas%26aufirst%3DP.%2BK.%26aulast%3DYin%26aufirst%3DY.%26aulast%3DAlbu%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DTaipale%26aufirst%3DJ.%26aulast%3DHughes%26aufirst%3DT.%2BR.%26aulast%3DWeirauch%26aufirst%3DM.%2BT.%26atitle%3DThe%2520human%2520transcription%2520factors%26jtitle%3DCell%26date%3D2018%26volume%3D172%26issue%3D4%26spage%3D650%26epage%3D665%26doi%3D10.1016%2Fj.cell.2018.01.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darwiche, N.</span></span> <span> </span><span class="NLM_article-title">Epigenetic mechanisms and the hallmarks of cancer: An intimate affair</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1954</span>â <span class="NLM_lpage">1978</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32774995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisVeisbvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=1954-1978&author=N.+Darwiche&title=Epigenetic+mechanisms+and+the+hallmarks+of+cancer%3A+An+intimate+affair"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic mechanisms and the hallmarks of cancer: an intimate affair</span></div><div class="casAuthors">Darwiche, Nadine</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1954-1978</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Epigenetic mechanisms comprising DNA methylation, histone modifications, and noncoding RNAs affect chromatin structure and regulate gene expression.  These mechanisms control normal embryonic development and adult life and their deregulation contributes to several diseases including cancer.  The process of tumorigenesis is complex and results from the evolution of different "hallmarks of cancer".  Hanahan and Weinberg presented in 2000 and 2011 seminal contributions in the cancer field, first the six hallmarks of cancer and a decade later two addnl. hallmarks and two enabling characteristics were added.  Here, we surmise that epigenetic mechanisms regulate and contribute to every single hallmark in cancer, and thus represent the hallmark of hallmarks in tumorigenesis.  Focusing on epigenetics as a major hallmark in cancer formation has profound preventive, therapeutic, and clin. implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrITfYPjS6-ZbVg90H21EOLACvtfcHk0lguA9BLWA2tlw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisVeisbvN&md5=27e405faed70ee5ccdd640bbb90c73c9</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDarwiche%26aufirst%3DN.%26atitle%3DEpigenetic%2520mechanisms%2520and%2520the%2520hallmarks%2520of%2520cancer%253A%2520An%2520intimate%2520affair%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2020%26volume%3D10%26spage%3D1954%26epage%3D1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaitak, V.</span></span> <span> </span><span class="NLM_article-title">Natural products as multidrug resistance modulators in cancer</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">268</span>â <span class="NLM_lpage">291</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2019.05.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.ejmech.2019.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31103904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvFaqt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=268-291&author=A.+Kumarauthor=V.+Jaitak&title=Natural+products+as+multidrug+resistance+modulators+in+cancer&doi=10.1016%2Fj.ejmech.2019.05.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Natural products as multidrug resistance modulators in cancer</span></div><div class="casAuthors">Kumar, Amit; Jaitak, Vikas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">268-291</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Cancer is a prominent cause of death globally.  Currently, many drugs that are in clin. practice are having a high prevalence of side effect and multidrug resistance.  Risk of tumors acquiring resistance to chemotherapy (multidrug resistance) remains a significant hurdle to the successful treatment of various types of cancer.  Membrane-embedded drug transporters, generally overexpressed in cancer, are the leading cause among multiple mechanisms of multidrug resistance (MDR).  P-glycoprotein (P-gp) also MDR1/ABCB1, multidrug resistance assocd. protein 1 (MRP1/ABCC1), MRP2 and breast cancer resistance protein (BCRP/ABCG2) are considered to be a prime factor for induction of MDR.  To date, several chem. substances have been tested in a no. of clin. trials for their MDR modulatory activity which are not having devoid of any side effects that necessitates to find newer and safer way to tackle the current problem of multidrug resistance in cancer.  The present study systematically discusses the various classes of natural products i.e flavonoids, alkaloids, terpenoids, coumarins (from plants, marine, and microorganisms) as potential MDR modulators and/or as a source of promising lead compds.  Recently a bisbenzyl isoquinoline alkaloid namely tetrandrine, isolated from Chinese herb Stephania tetrandra (Han-Fang-Chi) is in clin. trials for its MDR reversal activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlwWahGUuxErVg90H21EOLACvtfcHk0lguA9BLWA2tlw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvFaqt78%253D&md5=9c78294e42891916b342ab92529f0e1a</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DJaitak%26aufirst%3DV.%26atitle%3DNatural%2520products%2520as%2520multidrug%2520resistance%2520modulators%2520in%2520cancer%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D176%26spage%3D268%26epage%3D291%26doi%3D10.1016%2Fj.ejmech.2019.05.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashyap, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, R.</span></span> <span> </span><span class="NLM_article-title">Role and regulation of proapoptotic Bax in oral squamous cell carcinoma and drug resistance</span>. <i>Head Neck</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">185</span>â <span class="NLM_lpage">197</span>, <span class="refDoi">Â DOI: 10.1002/hed.25471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fhed.25471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=30549344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3cnhvFymtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2019&pages=185-197&author=M.+Alamauthor=T.+Kashyapauthor=P.+Mishraauthor=A.+K.+Pandaauthor=S.+Naginiauthor=R.+Mishra&title=Role+and+regulation+of+proapoptotic+Bax+in+oral+squamous+cell+carcinoma+and+drug+resistance&doi=10.1002%2Fhed.25471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Role and regulation of proapoptotic Bax in oral squamous cell carcinoma and drug resistance</span></div><div class="casAuthors">Alam Manzar; Kashyap Tanushree; Panda Aditya K; Mishra Rajakishore; Mishra Prajna; Nagini Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">Head & neck</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">185-197</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Bax, a proapoptotic protein but its regulation during oral cancer progression and resistance remains elusive.  METHODS:  A total of 127 samples including adjacent normal, primary tumor, and resistance to chemoradiation therapy (RCRT) samples from oral squamous cell carcinoma (OSCC) patients were used.  The status of Bax was analyzed at DNA/mRNA/protein levels and the results were correlated with p53 and Akt expression in tissue samples/cisplatin-resistant oral tongue SCC (SCC9/SCC4-CisR) cell line.  RESULTS:  Frequent progressive decrease of Bax expression with infrequent promoter methylation, polymorphisms G(-248)A, and mutations was observed in OSCC progression/resistance.  Furthermore, by targeting Akt pathway, induction of Bax-dependent cell death was observed and this was further enhanced with nimbolide treatment in SCC9/SCC4-CisR cells.  CONCLUSION:  Hence, the Bax gene alteration and its deregulation through p53/Akt pathway are important for OSCC progression and drug resistance.  Akt Inhibitor VIII and nimbolide synergistically induce Bax, and it is therefore beneficial for chemosensitizing cisplatin-resistant human OSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQz9C6iDAEbA75oR8RchjrrfW6udTcc2eaL789_APH3Wbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cnhvFymtA%253D%253D&md5=e59b03b88f88991c28a6d896a790a682</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1002%2Fhed.25471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhed.25471%26sid%3Dliteratum%253Aachs%26aulast%3DAlam%26aufirst%3DM.%26aulast%3DKashyap%26aufirst%3DT.%26aulast%3DMishra%26aufirst%3DP.%26aulast%3DPanda%26aufirst%3DA.%2BK.%26aulast%3DNagini%26aufirst%3DS.%26aulast%3DMishra%26aufirst%3DR.%26atitle%3DRole%2520and%2520regulation%2520of%2520proapoptotic%2520Bax%2520in%2520oral%2520squamous%2520cell%2520carcinoma%2520and%2520drug%2520resistance%26jtitle%3DHead%2520Neck%26date%3D2019%26volume%3D41%26spage%3D185%26epage%3D197%26doi%3D10.1002%2Fhed.25471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phi, L. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sari, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, H. Y.</span></span> <span> </span><span class="NLM_article-title">Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment</span>. <i>Stem Cells Int.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">5416923</span>, <span class="refDoi">Â DOI: 10.1155/2018/5416923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1155%2F2018%2F5416923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29681949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC1MjltlGgsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=5416923&author=L.+T.+H.+Phiauthor=I.+N.+Sariauthor=Y.+G.+Yangauthor=S.+H.+Leeauthor=N.+Junauthor=K.+S.+Kimauthor=Y.+K.+Leeauthor=H.+Y.+Kwon&title=Cancer+stem+cells+%28CSCs%29+in+drug+resistance+and+their+therapeutic+implications+in+cancer+treatment&doi=10.1155%2F2018%2F5416923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment</span></div><div class="casAuthors">Phi Lan Thi Hanh; Sari Ita Novita; Yang Ying-Gui; Lee Sang-Hyun; Jun Nayoung; Kim Kwang Seock; Lee Yun Kyung; Kwon Hyog Young</div><div class="citationInfo"><span class="NLM_cas:title">Stem cells international</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2018</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5416923</span>
        ISSN:<span class="NLM_cas:issn">1687-966X</span>.
    </div><div class="casAbstract">Cancer stem cells (CSCs), also known as tumor-initiating cells (TICs), are suggested to be responsible for drug resistance and cancer relapse due in part to their ability to self-renew themselves and differentiate into heterogeneous lineages of cancer cells.  Thus, it is important to understand the characteristics and mechanisms by which CSCs display resistance to therapeutic agents.  In this review, we highlight the key features and mechanisms that regulate CSC function in drug resistance as well as recent breakthroughs of therapeutic approaches for targeting CSCs.  This promises new insights of CSCs in drug resistance and provides better therapeutic rationales to accompany novel anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ832gT2olHIa91pGlMMoT5fW6udTcc2eawiL0LrPdeGbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MjltlGgsQ%253D%253D&md5=e90fa5e53fbb5ccf47d267ce645daf2a</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1155%2F2018%2F5416923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2018%252F5416923%26sid%3Dliteratum%253Aachs%26aulast%3DPhi%26aufirst%3DL.%2BT.%2BH.%26aulast%3DSari%26aufirst%3DI.%2BN.%26aulast%3DYang%26aufirst%3DY.%2BG.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DJun%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DLee%26aufirst%3DY.%2BK.%26aulast%3DKwon%26aufirst%3DH.%2BY.%26atitle%3DCancer%2520stem%2520cells%2520%2528CSCs%2529%2520in%2520drug%2520resistance%2520and%2520their%2520therapeutic%2520implications%2520in%2520cancer%2520treatment%26jtitle%3DStem%2520Cells%2520Int.%26date%3D2018%26volume%3D2018%26spage%3D5416923%26doi%3D10.1155%2F2018%2F5416923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baira, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khurana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somagoni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talluri, M. V. N. K.</span></span> <span> </span><span class="NLM_article-title">First report on the pharmacokinetic profile of nimbolide, a novel anticancer agent in oral and intravenous administrated rats by LC/MS method</span>. <i>J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1092</i></span>,  <span class="NLM_fpage">191</span>â <span class="NLM_lpage">198</span>, <span class="refDoi">Â DOI: 10.1016/j.jchromb.2018.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.jchromb.2018.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29908468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFCqsb7E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1092&publication_year=2018&pages=191-198&author=S.+M.+Bairaauthor=A.+Khuranaauthor=J.+Somagoniauthor=R.+Srinivasauthor=C.+Goduguauthor=M.+V.+N.+K.+Talluri&title=First+report+on+the+pharmacokinetic+profile+of+nimbolide%2C+a+novel+anticancer+agent+in+oral+and+intravenous+administrated+rats+by+LC%2FMS+method&doi=10.1016%2Fj.jchromb.2018.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">First report on the pharmacokinetic profile of nimbolide, a novel anticancer agent in oral and intravenous administrated rats by LC/MS method</span></div><div class="casAuthors">Baira, Shandilya Mahamuni; Khurana, Amit; Somagoni, Jaganmohan; Srinivas, R.; Godugu, Chandraiah; Talluri, M. V. N. Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1092</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">191-198</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nimbolide is a novel, natural compd. with promising potential as a drug candidate for anticancer activity.  It is isolated from the Indian traditional medicinal plant Azadirachta indica popularly known as neem.  The present study was undertaken to explore the oral bioavailability and pharmacokinetic characteristics of nimbolide in rats using the LC/QTOF/MS method.  A simple protein pptn. method using acetonitrile was employed for extg. nimbolide from rat plasma.  The chromatog. sepn. of nimbolide and the internal std. (regorafenib) was attained on an Aquity BEH C18 column (100Ã2.1mm, 2.7Î¼m), using ACN and 0.1% of formic acid in water as mobile phase components in a gradient elution mode at a flow rate of 0.45mL/min over a short run time of 4min.  A mass detection was carried out using target ions of [M+H]+ at m/z 467.2074 for nimbolide and m/z 483.0847 for the internal std.  The LC/MS method was validated and all the parameters were found well within the specified limits.  The calibration curve was constructed in the range of 1-1000ng/mL.  The method shows good accuracy (91.66-97.12%) and precision (intra 2.21-6.92% CV and inter-day 2.56-4.62% CV).  This developed LC/MS method was effectively applied to the pharmacokinetic study of nimbolide upon oral and i.v. administration in rats.  In concordance with its physicochem. properties and high lipophilicity, we found that it shows poor oral absorption at different doses (10, 30 and 50mg/kg).  As expected, higher plasma levels were obsd. upon i.v. (10mg/kg) administration.  This method can be extended for evaluation of drug interaction and drug metab. in rats as well as in humans.  Moreover, our rapid and sensitive method may cater the need to accelerate the preclin. formulation development and lead optimization for future drug development of this potent anticancer agent.  Further, our oral bioavailability studies demonstrated that nimbolide possesses poor oral absorption, which could be the probable reason for the delay in therapeutic translation of this promising agent for clin. use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoozrI6BEnwjbVg90H21EOLACvtfcHk0liI6WR67Q54Tw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFCqsb7E&md5=a59323ce4452b99ecc9e7b5bbbd102db</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2018.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2018.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DBaira%26aufirst%3DS.%2BM.%26aulast%3DKhurana%26aufirst%3DA.%26aulast%3DSomagoni%26aufirst%3DJ.%26aulast%3DSrinivas%26aufirst%3DR.%26aulast%3DGodugu%26aufirst%3DC.%26aulast%3DTalluri%26aufirst%3DM.%2BV.%2BN.%2BK.%26atitle%3DFirst%2520report%2520on%2520the%2520pharmacokinetic%2520profile%2520of%2520nimbolide%252C%2520a%2520novel%2520anticancer%2520agent%2520in%2520oral%2520and%2520intravenous%2520administrated%2520rats%2520by%2520LC%252FMS%2520method%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2018%26volume%3D1092%26spage%3D191%26epage%3D198%26doi%3D10.1016%2Fj.jchromb.2018.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuya, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, B. C.</span></span> <span> </span><span class="NLM_article-title">A sensitive liquid chromatography-tandem mass spectrometry method for the determination of nimbolide in mouse serum: Application to a preclinical pharmacokinetics study</span>. <i>Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">123</span>, <span class="refDoi">Â DOI: 10.3390/pharmaceutics10030123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3390%2Fpharmaceutics10030123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVOjt7zL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=123&author=L.+Wangauthor=D.+K.+Phanauthor=N.+Synauthor=X.+Xiangauthor=H.+Songauthor=W.+L.+Thuyaauthor=S.+Yangauthor=A.+L.+Wongauthor=A.+P.+Kumarauthor=W.+P.+Yongauthor=G.+Sethiauthor=P.+C.+Hoauthor=B.+C.+Goh&title=A+sensitive+liquid+chromatography-tandem+mass+spectrometry+method+for+the+determination+of+nimbolide+in+mouse+serum%3A+Application+to+a+preclinical+pharmacokinetics+study&doi=10.3390%2Fpharmaceutics10030123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">A sensitive liquid chromatography-tandem mass spectrometry method for the determination of nimbolide in mouse serum: application to a preclinical pharmacokinetics study</span></div><div class="casAuthors">Wang, Lingzhi; Phan, Do-Dang Khoa; Syn, Nicholas; Xiang, Xiaoqiang; Song, Hongyan; Thuya, Win Lwin; Yang, Shili; Wong, Andrea Li-Ann; Id, Alan Prem Kumar; Yong, Wei Peng; Sethi, Gautam; Ho, Paul Chi-Lui; Goh, Boon Cher</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">123</span>CODEN:
                <span class="NLM_cas:coden">PHARK5</span>;
        ISSN:<span class="NLM_cas:issn">1999-4923</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A sensitive and robust liq. chromatog.-tandem mass spectrometric (LC-MS/MS) method was developed and validated for the detn. of nimbolide in mouse serum.  Exemestane was used as the internal std. (IS).  Here, we employed acetonitrile-based protein pptn. (PPT) for serum sample prepn., and performed chromatog. sepn. using an ODS Hypersil C18 column (100 mm Ã 2.1 mm, 5 Î¼m) with gradient elution (0.1% formic acid in water vs 100% acetonitrile).  The run time was 6 min.  Instrumental anal. was performed by electrospray ionization tandem mass spectrometry (ESI-MS/MS) in the multiple-reaction monitoring (MRM) under pos. mode.  A good linear calibration was achieved in the 5-1000 ng/mL range.  The intra- and inter-day precisions for nimbolide were â¤12.6% and â¤13.9% resp.  Intra-day accuracy ranged from 96.9-109.3%, while inter-day accuracy ranged from 94.3-110.2%.  The matrix effect of nimbolide, detected but consistent at low and high concns., do not affect linearity of std. curve.  In conclusion, we have developed and validated a sensitive anal. method for detn. of a novel natural compd. nimbolide in mouse serum, and it has been successfully applied to our preclin. study in investigating the pharmacokinetic properties of nimbolide, which could greatly facilitate the preclin. development of the promising lead compd. for anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocQj2IA-6qkrVg90H21EOLACvtfcHk0liI6WR67Q54Tw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVOjt7zL&md5=bbaa3fd070b78ea57bc6dd46ea8c84ef</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.3390%2Fpharmaceutics10030123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpharmaceutics10030123%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPhan%26aufirst%3DD.%2BK.%26aulast%3DSyn%26aufirst%3DN.%26aulast%3DXiang%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DThuya%26aufirst%3DW.%2BL.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DA.%2BL.%26aulast%3DKumar%26aufirst%3DA.%2BP.%26aulast%3DYong%26aufirst%3DW.%2BP.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DHo%26aufirst%3DP.%2BC.%26aulast%3DGoh%26aufirst%3DB.%2BC.%26atitle%3DA%2520sensitive%2520liquid%2520chromatography-tandem%2520mass%2520spectrometry%2520method%2520for%2520the%2520determination%2520of%2520nimbolide%2520in%2520mouse%2520serum%253A%2520Application%2520to%2520a%2520preclinical%2520pharmacokinetics%2520study%26jtitle%3DPharmaceutics%26date%3D2018%26volume%3D10%26spage%3D123%26doi%3D10.3390%2Fpharmaceutics10030123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Umar, H. I.</span>; <span class="NLM_string-name">Josiah, S. S.</span>; <span class="NLM_string-name">Saliu, T. P.</span>; <span class="NLM_string-name">Jimoh, T. O.</span>; <span class="NLM_string-name">Ajayi, A.</span>; <span class="NLM_string-name">Danjuma, J. B.</span></span> <span> </span><span class="NLM_article-title">In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants</span>.  <i>J. Taibah Univ Med. Sci.</i> (in press).<span class="NLM_year" style="font-weight: bold;">2021</span><span class="refDoi">Â DOI: 10.1016/j.jtumed.2020.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.jtumed.2020.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=33437230" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&author=H.+I.+Umar&author=S.+S.+Josiah&author=T.+P.+Saliu&author=T.+O.+Jimoh&author=A.+Ajayi&author=J.+B.+Danjuma&title=In-silico+analysis+of+the+inhibition+of+the+SARS-CoV-2+main+protease+by+some+active+compounds+from+selected+African+plants&doi=10.1016%2Fj.jtumed.2020.12.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.jtumed.2020.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jtumed.2020.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DUmar%26aufirst%3DH.%2BI.%26atitle%3DIn-silico%2520analysis%2520of%2520the%2520inhibition%2520of%2520the%2520SARS-CoV-2%2520main%2520protease%2520by%2520some%2520active%2520compounds%2520from%2520selected%2520African%2520plants%26jtitle%3DJ.%2520Taibah%2520Univ%2520Med.%2520Sci.%26date%3D2021%26doi%3D10.1016%2Fj.jtumed.2020.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glinsukon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somjaree, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piyachaturawat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thebtaranonth, Y.</span></span> <span> </span><span class="NLM_article-title">Acute toxicity of nimbolide and nimbic acid in mice, rats and hamsters</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">159</span>â <span class="NLM_lpage">166</span>, <span class="refDoi">Â DOI: 10.1016/0378-4274(86)90098-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2F0378-4274%2886%2990098-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=3754662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADyaL28XksFCit7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1986&pages=159-166&author=T.+Glinsukonauthor=R.+Somjareeauthor=P.+Piyachaturawatauthor=Y.+Thebtaranonth&title=Acute+toxicity+of+nimbolide+and+nimbic+acid+in+mice%2C+rats+and+hamsters&doi=10.1016%2F0378-4274%2886%2990098-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Acute toxicity of nimbolide and nimbic acid in mice, rats and hamsters</span></div><div class="casAuthors">Glinsukon, Thirayudh; Somjaree, Rosenee; Piyachaturawat, Pawinee; Thebtaranonth, Yodhathai</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-66</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    </div><div class="casAbstract">Nimbolide (I)  [25990-37-8] and nimbic acid (II)  [11030-74-3] are toxic to mice only when given i.p. and i.v. but they are less toxic to rats and hamsters than to mice.  The LD50 values of a single i.p. administration of nimbolide in adult male and female and weanling mice were 225, 280, and 240 mg/kg, resp., and its i.v. LD50 value was only 24 mg/kg in adult male mice.  No fatality was obsd. when nimbolide was given orally, i.m. and s.c. to adult male mice.  Estd. LD50 values of nimbolide in rats and hamsters were somewhat greater than 600 and 500 mg/kg, resp.  Twelve-23 h after i.p. administration of an LD, most animals had died of possible dysfunctions in kidneys (tubular necrosis), small intestine hemorrhagic necrosis), pancreas (acinar cell necrosis), and liver (mild fatty infiltration and focal necrosis).  In contrast, mice and rats given an LD of nimbolide (i.v.) died of a marked and sudden drop in arterial blood pressure and respiratory paralysis within about 1-18 min.  Nimbic acid was less toxic than nimbolide to mice, with an i.v. LD50 value of 265 mg/kg and i.p. and oral LD50 values >600 mg/kg.  The possible cause of death induced by nimbic acid may be similar to that by nimbolide given i.v. and this is sudden hypotensive shock.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf3YWv7zwoO7Vg90H21EOLACvtfcHk0lihvsqAiM5OmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XksFCit7k%253D&md5=ebf0d38e1de96efa0218c5c8e88d920f</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2F0378-4274%2886%2990098-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4274%252886%252990098-6%26sid%3Dliteratum%253Aachs%26aulast%3DGlinsukon%26aufirst%3DT.%26aulast%3DSomjaree%26aufirst%3DR.%26aulast%3DPiyachaturawat%26aufirst%3DP.%26aulast%3DThebtaranonth%26aufirst%3DY.%26atitle%3DAcute%2520toxicity%2520of%2520nimbolide%2520and%2520nimbic%2520acid%2520in%2520mice%252C%2520rats%2520and%2520hamsters%26jtitle%3DToxicol.%2520Lett.%26date%3D1986%26volume%3D30%26spage%3D159%26epage%3D166%26doi%3D10.1016%2F0378-4274%2886%2990098-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uwaifo, A. O.</span></span> <span> </span><span class="NLM_article-title">The mutagenicities of seven coumarin derivatives and a furan derivative (nimbolide) isolated from three medicinal plants</span>. <i>J. Toxicol. Environ. Health</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">521</span>â <span class="NLM_lpage">530</span>, <span class="refDoi">Â DOI: 10.1080/15287398409530517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1080%2F15287398409530517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=6387161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADyaL2cXlvVels7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1984&pages=521-530&author=A.+O.+Uwaifo&title=The+mutagenicities+of+seven+coumarin+derivatives+and+a+furan+derivative+%28nimbolide%29+isolated+from+three+medicinal+plants&doi=10.1080%2F15287398409530517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">The mutagenicities of seven coumarin derivatives and a furan derivative (nimbolide) isolated from three medicinal plants</span></div><div class="casAuthors">Uwaifo, Anthony O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Toxicology and Environmental Health</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4-6</span>),
    <span class="NLM_cas:pages">521-30</span>CODEN:
                <span class="NLM_cas:coden">JTEHD6</span>;
        ISSN:<span class="NLM_cas:issn">0098-4108</span>.
    </div><div class="casAbstract">Seven coumarin derivs. imperatorin (I, R=CH2C:CMe2)  [482-44-0], heraclenin (I, R= dimethyloxiranylmethyl)  [2880-49-1], xanthotoxin (I, R = Me)  [298-81-7], marmesin (II, R1 = CMe2OH; R2 = R3 = H)  [13849-08-6], chalepin (II, R1 = CMe2OH, R2=H, R3 = CMe2CH:CH2)  [13164-04-0], oxypeucedanin  [26091-73-6], and esculin (III)  [531-75-9] and a furan deriv. nimbolide (IV)  [25990-37-8] were screened with Ames tester strains (TA 92, 94, 97, 98, 100, and 102).  Marmesin and imperatorin were mutagenic in all tester strains except TA 94 and 102.  The mutagenicity potencies of marmesin and imperatorin were 20 and 0.2, resp.  Mutagenicity was highest in TA98 and 100 in both compds.  Marmesin was optimally mutagenic at 1.04 Î¼g, and imperatorin at 30.0 Î¼g.  Microsomal activation was not required for mutagenicity in both compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjS5qbM6SVu7Vg90H21EOLACvtfcHk0lihvsqAiM5OmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXlvVels7c%253D&md5=3ff86bfebc760cfd18dfb5dcfa55ebbc</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1080%2F15287398409530517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15287398409530517%26sid%3Dliteratum%253Aachs%26aulast%3DUwaifo%26aufirst%3DA.%2BO.%26atitle%3DThe%2520mutagenicities%2520of%2520seven%2520coumarin%2520derivatives%2520and%2520a%2520furan%2520derivative%2520%2528nimbolide%2529%2520isolated%2520from%2520three%2520medicinal%2520plants%26jtitle%3DJ.%2520Toxicol.%2520Environ.%2520Health%26date%3D1984%26volume%3D13%26spage%3D521%26epage%3D530%26doi%3D10.1080%2F15287398409530517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumbar, S. B.</span>; <span class="NLM_string-name">Jadaramkunti, U. C.</span>; <span class="NLM_string-name">Aladakatti, R. H.</span></span> <span> </span><span class="NLM_article-title">In-vitro effect of nimbolide, an isoprenoid of neem leaf, on antioxidant system of rat cauda epididymal spermatozoa: A dose dependent study</span>.  <i>J. Appl. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume">2</span>.<span class="refDoi">Â DOI: 10.7324/JAPS.2012.2514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.7324%2FJAPS.2012.2514" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&author=S.+B.+Kumbar&author=U.+C.+Jadaramkunti&author=R.+H.+Aladakatti&title=In-vitro+effect+of+nimbolide%2C+an+isoprenoid+of+neem+leaf%2C+on+antioxidant+system+of+rat+cauda+epididymal+spermatozoa%3A+A+dose+dependent+study&doi=10.7324%2FJAPS.2012.2514"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.7324%2FJAPS.2012.2514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7324%252FJAPS.2012.2514%26sid%3Dliteratum%253Aachs%26aulast%3DKumbar%26aufirst%3DS.%2BB.%26atitle%3DIn-vitro%2520effect%2520of%2520nimbolide%252C%2520an%2520isoprenoid%2520of%2520neem%2520leaf%252C%2520on%2520antioxidant%2520system%2520of%2520rat%2520cauda%2520epididymal%2520spermatozoa%253A%2520A%2520dose%2520dependent%2520study%26jtitle%3DJ.%2520Appl.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D2%26doi%3D10.7324%2FJAPS.2012.2514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aladakatti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukesh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadaramkunti, U. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiremath, M. B.</span></span> <span> </span><span class="NLM_article-title">Effect of graded doses of nimbolide (a major component of Azadirachta indica leaves) on biochemical and sperm functional parameters in male albino rats</span>. <i>J. Laborat. Anim. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">24</span>â <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=24-30&author=R.+Aladakattiauthor=B.+Sukeshauthor=U.+C.+Jadaramkuntiauthor=M.+B.+Hiremath&title=Effect+of+graded+doses+of+nimbolide+%28a+major+component+of+Azadirachta+indica+leaves%29+on+biochemical+and+sperm+functional+parameters+in+male+albino+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAladakatti%26aufirst%3DR.%26aulast%3DSukesh%26aufirst%3DB.%26aulast%3DJadaramkunti%26aufirst%3DU.%2BC.%26aulast%3DHiremath%26aufirst%3DM.%2BB.%26atitle%3DEffect%2520of%2520graded%2520doses%2520of%2520nimbolide%2520%2528a%2520major%2520component%2520of%2520Azadirachta%2520indica%2520leaves%2529%2520on%2520biochemical%2520and%2520sperm%2520functional%2520parameters%2520in%2520male%2520albino%2520rats%26jtitle%3DJ.%2520Laborat.%2520Anim.%2520Sci.%26date%3D2011%26volume%3D1%26spage%3D24%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suttiarporn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choommongkol, V.</span></span> <span> </span><span class="NLM_article-title">Microwave-assisted improved extraction and purification of anticancer nimbolide from Azadirachta indica (Neem) leaves</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2913</span>, <span class="refDoi">Â DOI: 10.3390/molecules25122913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3390%2Fmolecules25122913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVOhsLvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=2913&author=P.+Suttiarpornauthor=V.+Choommongkol&title=Microwave-assisted+improved+extraction+and+purification+of+anticancer+nimbolide+from+Azadirachta+indica+%28Neem%29+leaves&doi=10.3390%2Fmolecules25122913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Microwave-assisted improved extraction and purification of anticancer nimbolide from Azadirachta indica (Neem) leaves</span></div><div class="casAuthors">Suttiarporn, Panawan; Choommongkol, Vachira</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2913</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Nimbolide, a limonoid present in leaves of the neem tree (Azadirachta indica), is an anticancer compd. against a panel of human cancer cell lines.  The rapid process of extn. and purifn. of the nimbolide from the leaves of neem tree through microwave-assisted extn. (MAE) coupled with a chromatog. technique was accomplished.  The crude with a max. content of nimbolide could be recovered from neem leaves through MAE.  By using three-factors, three-level Box-Behnken design of response surface methodol. (RSM), the optimal conditions for nimbolide extn. (R2 = 0.9019) were solid/liq. ratio 1:16 g/mL, microwave power 280 W, and extn. time 22 min.  The enriched ext. was further purified by a preparative thin-layer chromatog. (PTLC), where nimbolide was obtained as 0.0336 g (0.67% yield, purity over 98%) with Et acetate/hexane = 4:6 in 3.0 h.  Structural elucidation was performed through spectroscopic techniques, including FT-IR, 1H, and 13C-NMR.  This method was simple and had a good potential for the purifn. of bioactive compds. from a natural product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVl84kTczeYrVg90H21EOLACvtfcHk0lhJQCeWX7eMtg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVOhsLvM&md5=1fa94ebd3ba490a1846ccb570f1bee94</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.3390%2Fmolecules25122913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules25122913%26sid%3Dliteratum%253Aachs%26aulast%3DSuttiarporn%26aufirst%3DP.%26aulast%3DChoommongkol%26aufirst%3DV.%26atitle%3DMicrowave-assisted%2520improved%2520extraction%2520and%2520purification%2520of%2520anticancer%2520nimbolide%2520from%2520Azadirachta%2520indica%2520%2528Neem%2529%2520leaves%26jtitle%3DMolecules%26date%3D2020%26volume%3D25%26spage%3D2913%26doi%3D10.3390%2Fmolecules25122913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satpathy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, M. D.</span></span> <span> </span><span class="NLM_article-title">Nanodelivery and anticancer effect of a limonoid, nimbolide, in breast and pancreatic cancer cells</span>. <i>Int. J. Nanomed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">8095</span>â <span class="NLM_lpage">8104</span>, <span class="refDoi">Â DOI: 10.2147/IJN.S208540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.2147%2FIJN.S208540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31632020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslamt7%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=8095-8104&author=A.+Patraauthor=S.+Satpathyauthor=M.+D.+Hussain&title=Nanodelivery+and+anticancer+effect+of+a+limonoid%2C+nimbolide%2C+in+breast+and+pancreatic+cancer+cells&doi=10.2147%2FIJN.S208540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Nanodelivery and anticancer effect of a limonoid, nimbolide, in breast and pancreatic cancer cells</span></div><div class="casAuthors">Patra, Arjun; Satpathy, Swaha; Hussain, Muhammad Delwar</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8095-8104</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2013</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Introduction: Nimbolide (Nim), a limonoid obtained from the neem tree, Azadirachta indica, has several pharmacol. properties, including anticancer effects in different type of cancers.  No drug-delivery system has been reported for enhancing the therapeutic application of this novel hydrophobic mol.  Methods: In the present research, poly(lactic-co-glycolic acid) (PLGA) nanoparticles of Nim (Nim-nano) were formulated by nanopptn., characterized for physicochem. properties, and screened for anticancer potential in breast (MCF-7 and MDA-MB-231) and pancreatic (AsPC-1) cancer cell lines.  Results: The Nim-nano had a particle size of 183.73 Â± 2.22 nm and 221.20 Â± 11.03 nm before and after lyophilization, resp.  Cryoprotectants (mannitol and sucrose) significantly inhibited growth in particle size due to lyophilization.  The Î¶-potential of the Nim-nano was -22.40 Â± 4.40 mV.  Drug loading and encapsulation efficiency of Nim-nano were 5.25% Â± 1.12% and 55.67% Â± 12.42%, resp.  The Nim-nano exhibited sustained release of Nim for more than 6 days in PBS (pH 7.4) and showed two- to three-fold enhanced cytotoxicity in breast and pancreatic cancer cell lines compared with free Nim.  Conclusion: The Nim-nano formulation has great potential for treatment of cancers, such as pancreatic and breast cancer.  Further, the PLGA-polymer surface can be modified by conjugation with polyethylene glycol, receptor-binding ligands (eg, folic acid), and other that which may lead to targeted delivery of Nim in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1llOTZT6GyLVg90H21EOLACvtfcHk0lhJQCeWX7eMtg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslamt7%252FI&md5=c47eceb5e9a2bffd0d4cbf35e769c8c3</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.2147%2FIJN.S208540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S208540%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DA.%26aulast%3DSatpathy%26aufirst%3DS.%26aulast%3DHussain%26aufirst%3DM.%2BD.%26atitle%3DNanodelivery%2520and%2520anticancer%2520effect%2520of%2520a%2520limonoid%252C%2520nimbolide%252C%2520in%2520breast%2520and%2520pancreatic%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2019%26volume%3D14%26spage%3D8095%26epage%3D8104%26doi%3D10.2147%2FIJN.S208540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pooladanda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatikonda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunnapu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwary, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemula, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talluri, M. V. N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">iRGD conjugated nimbolide liposomes protect against endotoxin induced acute respiratory distress syndrome</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">102351</span>, <span class="refDoi">Â DOI: 10.1016/j.nano.2020.102351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.nano.2020.102351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=33418136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3MXht1Smt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2021&pages=102351&author=V.+Pooladandaauthor=S.+Thatikondaauthor=O.+Sunnapuauthor=S.+Tiwaryauthor=P.+K.+Vemulaauthor=M.+V.+N.+K.+Talluriauthor=C.+Godugu&title=iRGD+conjugated+nimbolide+liposomes+protect+against+endotoxin+induced+acute+respiratory+distress+syndrome&doi=10.1016%2Fj.nano.2020.102351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">iRGD conjugated nimbolide liposomes protect against endotoxin induced acute respiratory distress syndrome</span></div><div class="casAuthors">Pooladanda, Venkatesh; Thatikonda, Sowjanya; Sunnapu, Omprakash; Tiwary, Shristy; Vemula, Praveen Kumar; Talluri, M. V. N. Kumar; Godugu, Chandraiah</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">102351</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Acute respiratory distress syndrome (ARDS) is a deadly respiratory illness assocd. with refractory hypoxemia and pulmonary edema.  The recent pandemic outbreak of COVID-19 is assocd. with severe pneumonia and inflammatory cytokine storm in the lungs.  The anti-inflammatory phytomedicine nimbolide (NIM) may not be feasible for clin. translation due to poor pharmacokinetic properties and lack of suitable delivery systems.  To overcome these barriers, we have developed nimbolide liposomes conjugated with iRGD peptide (iRGD-NIMLip) for targeting lung inflammation.  It was obsd. that iRGD-NIMLip treatment significantly inhibited oxidative stress and cytokine storm compared to nimbolide free-drug (f-NIM), nimbolide liposomes (NIMLip), and exhibited superior activity compared to dexamethasone (DEX).  IRGD-NIMLip abrogated the LPS induced p65 NF-ÎºB, Akt, MAPK, Integrin Î²3 and Î²5, STAT3, and DNMT1 expression.  Collectively, our results demonstrate that iRGD-NIMLip could be a promising novel drug delivery system to target severe pathol. consequences obsd. in ARDS and COVID-19 assocd. cytokine storm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkGZnoZMzzVrVg90H21EOLACvtfcHk0lhJQCeWX7eMtg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXht1Smt7c%253D&md5=e0511d096e4d9542bfa824d8da23f562</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2020.102351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2020.102351%26sid%3Dliteratum%253Aachs%26aulast%3DPooladanda%26aufirst%3DV.%26aulast%3DThatikonda%26aufirst%3DS.%26aulast%3DSunnapu%26aufirst%3DO.%26aulast%3DTiwary%26aufirst%3DS.%26aulast%3DVemula%26aufirst%3DP.%2BK.%26aulast%3DTalluri%26aufirst%3DM.%2BV.%2BN.%2BK.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DiRGD%2520conjugated%2520nimbolide%2520liposomes%2520protect%2520against%2520endotoxin%2520induced%2520acute%2520respiratory%2520distress%2520syndrome%26jtitle%3DNanomedicine%26date%3D2021%26volume%3D33%26spage%3D102351%26doi%3D10.1016%2Fj.nano.2020.102351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spradlin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novaes, L. F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brittain, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGregor, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maimone, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span> <span> </span><span class="NLM_article-title">A nimbolide-based kinase degrader preferentially degrades oncogenic BCR-ABL</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1788</span>â <span class="NLM_lpage">1794</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.0c00348</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.0c00348" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1WmsrrF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=1788-1794&author=B.+Tongauthor=J.+N.+Spradlinauthor=L.+F.+T.+Novaesauthor=E.+Zhangauthor=X.+Huauthor=M.+Moellerauthor=S.+M.+Brittainauthor=L.+M.+McGregorauthor=J.+M.+McKennaauthor=J.+A.+Tallaricoauthor=M.+Schirleauthor=T.+J.+Maimoneauthor=D.+K.+Nomura&title=A+nimbolide-based+kinase+degrader+preferentially+degrades+oncogenic+BCR-ABL&doi=10.1021%2Facschembio.0c00348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">A Nimbolide-Based Kinase Degrader Preferentially Degrades Oncogenic BCR-ABL</span></div><div class="casAuthors">Tong, Bingqi; Spradlin, Jessica N.; Novaes, Luiz F. T.; Zhang, Erika; Hu, Xirui; Moeller, Malte; Brittain, Scott M.; McGregor, Lynn M.; McKenna, Jeffrey M.; Tallarico, John A.; Schirle, Markus; Maimone, Thomas J.; Nomura, Daniel K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1788-1794</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeted protein degrdn. (TPD) and proteolysis-targeting chimeras (PROTACs) have arisen as powerful therapeutic modalities for degrading specific proteins in a proteasome-dependent manner.  However, a major limitation of TPD is the lack of E3 ligase recruiters.  Recently, we discovered the natural product nimbolide as a covalent recruiter for the E3 ligase RNF114.  Here, we show the broader utility of nimbolide as an E3 ligase recruiter for TPD applications.  We demonstrate that a PROTAC linking nimbolide to the kinase and BCR-ABL fusion oncogene inhibitor dasatinib, BT1, selectively degrades BCR-ABL over c-ABL in leukemia cancer cells, compared to previously reported cereblon or VHL-recruiting BCR-ABL degraders that show opposite selectivity or, in some cases, inactivity.  Thus, we further establish nimbolide as an addnl. general E3 ligase recruiter for PROTACs, and we demonstrate the importance of expanding upon the arsenal of E3 ligase recruiters, as such mols. confer differing selectivity for the degrdn. of neo-substrate proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAnHS_P6TP_rVg90H21EOLACvtfcHk0livwanfusa0NQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1WmsrrF&md5=a0f21565aacf07be7d68f7469708937c</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Facschembio.0c00348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.0c00348%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DB.%26aulast%3DSpradlin%26aufirst%3DJ.%2BN.%26aulast%3DNovaes%26aufirst%3DL.%2BF.%2BT.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DMoeller%26aufirst%3DM.%26aulast%3DBrittain%26aufirst%3DS.%2BM.%26aulast%3DMcGregor%26aufirst%3DL.%2BM.%26aulast%3DMcKenna%26aufirst%3DJ.%2BM.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DMaimone%26aufirst%3DT.%2BJ.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26atitle%3DA%2520nimbolide-based%2520kinase%2520degrader%2520preferentially%2520degrades%2520oncogenic%2520BCR-ABL%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2020%26volume%3D15%26spage%3D1788%26epage%3D1794%26doi%3D10.1021%2Facschembio.0c00348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spradlin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boike, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brittain, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maimone, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span> <span> </span><span class="NLM_article-title">Chemoproteomics-enabled discovery of covalent RNF114-based degraders that mimic natural product function</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2021.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.chembiol.2021.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=33513350" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&author=M.+Luoauthor=J.+N.+Spradlinauthor=L.+Boikeauthor=B.+Tongauthor=S.+M.+Brittainauthor=J.+M.+McKennaauthor=J.+A.+Tallaricoauthor=M.+Schirleauthor=T.+J.+Maimoneauthor=D.+K.+Nomura&title=Chemoproteomics-enabled+discovery+of+covalent+RNF114-based+degraders+that+mimic+natural+product+function&doi=10.1016%2Fj.chembiol.2021.01.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2021.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2021.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DM.%26aulast%3DSpradlin%26aufirst%3DJ.%2BN.%26aulast%3DBoike%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DB.%26aulast%3DBrittain%26aufirst%3DS.%2BM.%26aulast%3DMcKenna%26aufirst%3DJ.%2BM.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DMaimone%26aufirst%3DT.%2BJ.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26atitle%3DChemoproteomics-enabled%2520discovery%2520of%2520covalent%2520RNF114-based%2520degraders%2520that%2520mimic%2520natural%2520product%2520function%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2021%26doi%3D10.1016%2Fj.chembiol.2021.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bundela, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisen, P. S.</span></span> <span> </span><span class="NLM_article-title">Potential compounds for oral cancer treatment: Resveratrol, nimbolide, lovastatin, bortezomib, vorinostat, berberine, pterostilbene, deguelin, andrographolide, and colchicine</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0141719</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0141719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1371%2Fjournal.pone.0141719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=26536350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvV2iu7rE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0141719&author=S.+Bundelaauthor=A.+Sharmaauthor=P.+S.+Bisen&title=Potential+compounds+for+oral+cancer+treatment%3A+Resveratrol%2C+nimbolide%2C+lovastatin%2C+bortezomib%2C+vorinostat%2C+berberine%2C+pterostilbene%2C+deguelin%2C+andrographolide%2C+and+colchicine&doi=10.1371%2Fjournal.pone.0141719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Potential compounds for oral cancer treatment: resveratrol, nimbolide, lovastatin, bortezomib, vorinostat, berberine, pterostilbene, deguelin, andrographolide, and colchicines</span></div><div class="casAuthors">Bundela, Saurabh; Sharma, Anjana; Bisen, Prakash S.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e0141719/1-e0141719/31</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Oral cancer is one of the main causes of cancer-related deaths in South-Asian countries.  There are very limited treatment options available for oral cancer.  Research endeavors focused on discovery and development of novel therapies for oral cancer, is necessary to control the ever rising oral cancer related mortalities.  We mined the large pool of compds. from the publicly available compd. databases, to identify potential therapeutic compds. for oral cancer.  Over 84 million compds. were screened for the possible anti-cancer activity by custom build SVM classifier.  The mol. targets of the predicted anti-cancer compds. were mined from reliable sources like exptl. bioassays studies assocd. with the compd., and from protein-compd. interaction databases.  Therapeutic compds. from DrugBank, and a list of natural anti-cancer compds. derived from literature mining of published studies, were used for building partial least squares regression model.  The regression model thus built, was used for the estn. of oral cancer sp. wt.s based on the mol. targets.  These wts. were used to compute scores for screening the predicted anti-cancer compds. for their potential to treat oral cancer.  The list of potential compds. was annotated with corresponding physicochem. properties, cancer specific bioactivity evidences, and literature evidences.  In all, 288 compds. with the potential to treat oral cancer were identified in the current study.  The majority of the compds. in this list are natural products, which are well-tolerated and have minimal side-effects compared to the synthetic counterparts.  Some of the potential therapeutic compds. identified in the current study are resveratrol, nimbolide, lovastatin, bortezomib, vorinostat, berberine, pterostilbene, deguelin, andrographolide, and colchicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFC60xDH826LVg90H21EOLACvtfcHk0livwanfusa0NQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvV2iu7rE&md5=f085b521e37cfd4fa5c5e04fd4b54f6d</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0141719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0141719%26sid%3Dliteratum%253Aachs%26aulast%3DBundela%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DBisen%26aufirst%3DP.%2BS.%26atitle%3DPotential%2520compounds%2520for%2520oral%2520cancer%2520treatment%253A%2520Resveratrol%252C%2520nimbolide%252C%2520lovastatin%252C%2520bortezomib%252C%2520vorinostat%252C%2520berberine%252C%2520pterostilbene%252C%2520deguelin%252C%2520andrographolide%252C%2520and%2520colchicine%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0141719%26doi%3D10.1371%2Fjournal.pone.0141719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popli, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sircar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhry, A.</span></span> <span> </span><span class="NLM_article-title">A review of the anticancer activity of Azadirachta indica (Neem) in oral cancer</span>. <i>J. Oral Biol. Craniofac. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">206</span>â <span class="NLM_lpage">209</span>, <span class="refDoi">Â DOI: 10.1016/j.jobcr.2020.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.jobcr.2020.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32489822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB38rltV2ruw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=206-209&author=S.+Agrawalauthor=D.+B.+Popliauthor=K.+Sircarauthor=A.+Chowdhry&title=A+review+of+the+anticancer+activity+of+Azadirachta+indica+%28Neem%29+in+oral+cancer&doi=10.1016%2Fj.jobcr.2020.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the anticancer activity of Azadirachta indica (Neem) in oral cancer</span></div><div class="casAuthors">Agrawal Shikha; Bablani Popli Deepika; Sircar Keya; Chowdhry Aman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of oral biology and craniofacial research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">206-209</span>
        ISSN:<span class="NLM_cas:issn">2212-4268</span>.
    </div><div class="casAbstract">Background:  Azadirachta indica (neem), belongs to the family of Meliaceae plants, is found in the Indian subcontinent.  The neem tree is colloquially referred to as the village pharmacy due to its array of biological properties.  Every part of the neem tree like its bark, leaves, sap, fruit, seeds, and twigs find a multitude of uses.  It is customary to use them for management of skin diseases and various other infections.The anticancer properties of neem have been studied in the past and these include its ability to modulate the tumour environment, increase the cytotoxic ability of host monocytes and suppress the proliferation of tumour cells.  The present review was conducted with the objective of scrutinizing and assimilating data about the usefulness Azadirachta indica in oral cancer from all the previously done work.  Material and methods:  A planned review was conducted of all the studies that investigated the role of Azadirachta indica in oral cancer.  Literature search was carried out using PubMed, Scopus and Google scholar databases.  In addition to electronic searching, hand searching, cross referencing and various internet engines were also used to collect data.  The articles were perused and articles not pertinent to our search were omitted.  Results and conclusion:  The anticancer properties of neem were evaluated and the active constituents of neem have been demonstrated to unequivocally have preventive and therapeutic potential against oral cancer.  Although, greater exploration of the anticancer properties of neem are required in order to effectively integrate it into the routine management of oral cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqAADqqazzAxJ5E29YNGvQfW6udTcc2ebZ27aqpvNWKbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38rltV2ruw%253D%253D&md5=a84da9f9f07de63ce5f4edc81cc265c4</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.jobcr.2020.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jobcr.2020.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DPopli%26aufirst%3DD.%2BB.%26aulast%3DSircar%26aufirst%3DK.%26aulast%3DChowdhry%26aufirst%3DA.%26atitle%3DA%2520review%2520of%2520the%2520anticancer%2520activity%2520of%2520Azadirachta%2520indica%2520%2528Neem%2529%2520in%2520oral%2520cancer%26jtitle%3DJ.%2520Oral%2520Biol.%2520Craniofac.%2520Res.%26date%3D2020%26volume%3D10%26spage%3D206%26epage%3D209%26doi%3D10.1016%2Fj.jobcr.2020.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovic-Nikolic, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolic, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uliassi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">A perspective on multi-target drug discovery and design for complex diseases</span>. <i>Clin. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3</span>, <span class="refDoi">Â DOI: 10.1186/s40169-017-0181-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1186%2Fs40169-017-0181-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29340951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC1MvhsVaiug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&pages=3&author=R.+R.+Ramsayauthor=M.+R.+Popovic-Nikolicauthor=K.+Nikolicauthor=E.+Uliassiauthor=M.+L.+Bolognesi&title=A+perspective+on+multi-target+drug+discovery+and+design+for+complex+diseases&doi=10.1186%2Fs40169-017-0181-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">A perspective on multi-target drug discovery and design for complex diseases</span></div><div class="casAuthors">Ramsay Rona R; Popovic-Nikolic Marija R; Nikolic Katarina; Uliassi Elisa; Bolognesi Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and translational medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn">2001-1326</span>.
    </div><div class="casAbstract">Diseases of infection, of neurodegeneration (such as Alzheimer's and Parkinson's diseases), and of malignancy (cancers) have complex and varied causative factors.  Modern drug discovery has the power to identify potential modulators for multiple targets from millions of compounds.  Computational approaches allow the determination of the association of each compound with its target before chemical synthesis and biological testing is done.  These approaches depend on the prior identification of clinically and biologically validated targets.  This Perspective will focus on the molecular and computational approaches that underpin drug design by medicinal chemists to promote understanding and collaboration with clinical scientists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJhSGsWpifCZcXNb62YGmbfW6udTcc2eYjqWN6a7D9RLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvhsVaiug%253D%253D&md5=5b05a73a3bbc955c77b9b2df93deb946</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1186%2Fs40169-017-0181-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40169-017-0181-2%26sid%3Dliteratum%253Aachs%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26aulast%3DPopovic-Nikolic%26aufirst%3DM.%2BR.%26aulast%3DNikolic%26aufirst%3DK.%26aulast%3DUliassi%26aufirst%3DE.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DA%2520perspective%2520on%2520multi-target%2520drug%2520discovery%2520and%2520design%2520for%2520complex%2520diseases%26jtitle%3DClin.%2520Transl.%2520Med.%26date%3D2018%26volume%3D7%26spage%3D3%26doi%3D10.1186%2Fs40169-017-0181-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/medium/jm0c02239_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/large/jm0c02239_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02239&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/medium/jm0c02239_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/large/jm0c02239_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Two-dimensional (A) and three-dimensional structure of nimbolide (IUPAC name: methyl 2-[(1<i>R</i>,2<i>S</i>,4<i>R</i>,9<i>R</i>,11<i>R</i>,15<i>R</i>,18<i>R</i>)-6-(furan-3-yl)-7,9,11,15-tetramethyl-12,16-dioxo 3,17dioxapentacyclo [9.6.1.0<sup>2,9</sup>.0<sup>4,8</sup>.0<sup>15,18</sup>] octadeca-7,13-dien-10-yl]acetate). (PubChem CID: 138115244. Molecular Formula: C<sub>27</sub>H<sub>30</sub>O<sub>7</sub>. Molecular Weight: 466.5 g/mol.)</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/large/jm0c02239_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02239&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/medium/jm0c02239_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/large/jm0c02239_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Nimbolide prevents the acquisition of hallmark capabilities of cancer. Nimbolide inhibits cell proliferation, inflammation, EMT, invasion, migration, angiogenesis, and metastasis and induces apoptosis in cancer cells <i>in vitro</i> and <i>in vivo</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/large/jm0c02239_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02239&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/medium/jm0c02239_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/large/jm0c02239_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Nimbolide abrogates key oncogenic signaling pathways. Nimbolide inhibits PI3K/Akt/MAPK signaling to activate GSK-3Î² with consequent trafficking of Î²-catenin away from the nucleus. Nimbolide inhibits multiple steps in the NF-ÎºB signaling cascade including IKKÎ² activation, IÎºB degradation, phosphorylation of IKKÎ±/Î², IÎºBÎ± and NF-ÎºB subunits, nuclear translocation, and DNA binding activity of NF-ÎºB. Nimbolide impedes aberrant activation of the JAK/STAT3 pathway by preventing phosphorylation of STAT3, a prerequisite for its nuclear translocation. Likewise, by activating RECK, nimbolide represses HIF-1Î±, preventing its nuclear translocation. Thus, nimbolide blocks DNA binding activity of oncogenic transcription factors such as Î²-catenin, NF-ÎºB, STAT3, and HIF1-Î± and transactivation of genes implicated in the acquisition of hallmark capabilities of cancer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02239/20210331/images/large/jm0c02239_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02239&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83827" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83827" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 106 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferlay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soerjomataram, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PiÃ±eros, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Znaor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, F.</span></span> <span> </span><span class="NLM_article-title">Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">1941</span>â <span class="NLM_lpage">1953</span>, <span class="refDoi">Â DOI: 10.1002/ijc.31937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fijc.31937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=30350310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVaku77O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2019&pages=1941-1953&author=J.+Ferlayauthor=M.+Colombetauthor=I.+Soerjomataramauthor=C.+Mathersauthor=D.+M.+Parkinauthor=M.+Pi%C3%B1erosauthor=A.+Znaorauthor=F.+Bray&title=Estimating+the+global+cancer+incidence+and+mortality+in+2018%3A+GLOBOCAN+sources+and+methods&doi=10.1002%2Fijc.31937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods</span></div><div class="casAuthors">Ferlay, J.; Colombet, M.; Soerjomataram, I.; Mathers, C.; Parkin, D. M.; Pineros, M.; Znaor, A.; Bray, F.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1941-1953</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Ests. of the worldwide incidence and mortality from 36 cancers and for all cancers combined for the year 2018 are now available in the GLOBOCAN 2018 database, compiled and disseminated by the International Agency for Research on Cancer (IARC).  This paper reviews the sources and methods used in compiling the cancer statistics in 185 countries.  The validity of the national ests. depends upon the representativeness of the source information, and to take into account possible sources of bias, uncertainty intervals are now provided for the estd. sex- and site-specific all-ages no. of new cancer cases and cancer deaths.  We briefly describe the key results globally and by world region.  There were an estd. 18.1 million (95% UI: 17.5-18.7 million) new cases of cancer (17 million excluding non-melanoma skin cancer) and 9.6 million (95% UI: 9.3-9.8 million) deaths from cancer (9.5 million excluding non-melanoma skin cancer) worldwide in 2018.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFkXwTr-9_ibVg90H21EOLACvtfcHk0lgQCHkWkL4TPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVaku77O&md5=db8d895060c7770078fec16e2d9eb816</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fijc.31937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.31937%26sid%3Dliteratum%253Aachs%26aulast%3DFerlay%26aufirst%3DJ.%26aulast%3DColombet%26aufirst%3DM.%26aulast%3DSoerjomataram%26aufirst%3DI.%26aulast%3DMathers%26aufirst%3DC.%26aulast%3DParkin%26aufirst%3DD.%2BM.%26aulast%3DPi%25C3%25B1eros%26aufirst%3DM.%26aulast%3DZnaor%26aufirst%3DA.%26aulast%3DBray%26aufirst%3DF.%26atitle%3DEstimating%2520the%2520global%2520cancer%2520incidence%2520and%2520mortality%2520in%25202018%253A%2520GLOBOCAN%2520sources%2520and%2520methods%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2019%26volume%3D144%26spage%3D1941%26epage%3D1953%26doi%3D10.1002%2Fijc.31937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choudhari, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandave, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshpande, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranjekar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, O.</span></span> <span> </span><span class="NLM_article-title">Phytochemicals in cancer treatment: From preclinical studies to clinical practice</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1614</span>, <span class="refDoi">Â DOI: 10.3389/fphar.2019.01614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3389%2Ffphar.2019.01614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32116665" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=1614&author=A.+S.+Choudhariauthor=P.+C.+Mandaveauthor=M.+Deshpandeauthor=P.+Ranjekarauthor=O.+Prakash&title=Phytochemicals+in+cancer+treatment%3A+From+preclinical+studies+to+clinical+practice&doi=10.3389%2Ffphar.2019.01614"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.01614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.01614%26sid%3Dliteratum%253Aachs%26aulast%3DChoudhari%26aufirst%3DA.%2BS.%26aulast%3DMandave%26aufirst%3DP.%2BC.%26aulast%3DDeshpande%26aufirst%3DM.%26aulast%3DRanjekar%26aufirst%3DP.%26aulast%3DPrakash%26aufirst%3DO.%26atitle%3DPhytochemicals%2520in%2520cancer%2520treatment%253A%2520From%2520preclinical%2520studies%2520to%2520clinical%2520practice%26jtitle%3DFront.%2520Pharmacol.%26date%3D2020%26volume%3D10%26spage%3D1614%26doi%3D10.3389%2Ffphar.2019.01614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagulapalli Venkata, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharyya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishayee, A.</span></span> <span> </span><span class="NLM_article-title">Potential of neem (Azadirachta indica L.) for prevention and treatment of oncologic diseases</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>40â41</i></span>,  <span class="NLM_fpage">100</span>â <span class="NLM_lpage">115</span>, <span class="refDoi">Â DOI: 10.1016/j.semcancer.2016.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.semcancer.2016.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=27019417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28Xms1WktLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40%E2%80%9341&publication_year=2016&pages=100-115&author=S.+M.+Patelauthor=K.+C.+Nagulapalli+Venkataauthor=P.+Bhattacharyyaauthor=G.+Sethiauthor=A.+Bishayee&title=Potential+of+neem+%28Azadirachta+indica+L.%29+for+prevention+and+treatment+of+oncologic+diseases&doi=10.1016%2Fj.semcancer.2016.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Potential of neem (Azadirachta indica L.) for prevention and treatment of oncologic diseases</span></div><div class="casAuthors">Patel, Shradha M.; Nagulapalli Venkata, Kalyan C.; Bhattacharyya, Piyali; Sethi, Gautam; Bishayee, Anupam</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">40-41</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">100-115</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Throughout time, plants have often displayed medicinal properties that have been underscored.  We often derive medicines involved in treating cancer from components in plants.  Azadirachta indica, commonly known as "neem", has been used to treat different ailments in many Asian countries.  Due to its widespread beneficial uses, A. indica has often been referred to as "the wonder tree" or "nature's drug store".  Various parts of this plant, including, leaves, flowers, fruits, seeds, roots, bark and oil, produce a large no. of phytochems. with various biol. and pharmacol. activities.  The numerous biol. activities of the phytoconstituents of A. indica explain its beneficial uses for the prevention and therapy of cancer.  The chemopreventive and anticancer therapeutic efficacy of A. indica fractions and compds. could be explained by multiple cellular and mol. mechanisms, including free radical scavenging, carcinogen-detoxification, DNA repair, cell cycle alteration, programmed cell death (apoptosis) and autophagy, immune surveillance, anti-inflammatory, anti-angiogenic, anti-invasive and anti-metastatic activities as well as their ability to modulate several dysregulated oncogenic signaling pathways.  This article aims to present the collective and crit. anal. of multiple phytoconstituents of A. indica and their mol. mechanisms implicated in cancer chemopreventive and therapeutic effects based on published preclin. and clin. results.  Current limitations and future directions of research on this medicinal plant are also critically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9KcC7SJ3-YrVg90H21EOLACvtfcHk0lgQCHkWkL4TPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xms1WktLo%253D&md5=8d3c9362632987d6aeef9029498f942d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2016.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2016.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%2BM.%26aulast%3DNagulapalli%2BVenkata%26aufirst%3DK.%2BC.%26aulast%3DBhattacharyya%26aufirst%3DP.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DBishayee%26aufirst%3DA.%26atitle%3DPotential%2520of%2520neem%2520%2528Azadirachta%2520indica%2520L.%2529%2520for%2520prevention%2520and%2520treatment%2520of%2520oncologic%2520diseases%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2016%26volume%3D40%25E2%2580%259341%26spage%3D100%26epage%3D115%26doi%3D10.1016%2Fj.semcancer.2016.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Islas, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acosta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">G-Buentello, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado-Gallegos, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-TreviÃ±o, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escalante, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Cuevas, J. E.</span></span> <span> </span><span class="NLM_article-title">An overview of neem (Azadirachta indica) and its potential impact on health</span>. <i>J. Funct. Foods</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">104171</span>, <span class="refDoi">Â DOI: 10.1016/j.jff.2020.104171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.jff.2020.104171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVSmtLvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2020&pages=104171&author=J.+F.+Islasauthor=E.+Acostaauthor=Z.+G-Buentelloauthor=J.+L.+Delgado-Gallegosauthor=M.+G.+Moreno-Trevi%C3%B1oauthor=B.+Escalanteauthor=J.+E.+Moreno-Cuevas&title=An+overview+of+neem+%28Azadirachta+indica%29+and+its+potential+impact+on+health&doi=10.1016%2Fj.jff.2020.104171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of Neem (Azadirachta indica) and its potential impact on health</span></div><div class="casAuthors">Islas, Jose Francisco; Acosta, Ezeiza; G-Buentello, Zuca; Delgado-Gallegos, Juan Luis; Moreno-Trevino, Maria Guadalupe; Escalante, Bruno; Moreno-Cuevas, Jorge E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Functional Foods</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104171</span>CODEN:
                <span class="NLM_cas:coden">JFFOAX</span>;
        ISSN:<span class="NLM_cas:issn">1756-4646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Global health and medical practice seek to merge alternative medicine with evidence-based medicine for a better understanding of the metabolic process and its effects in the human body.  An example is the use of complementary medicine like phytotherapy.  Azadirachta indica (Neem), a tree originally from India and Myanmar, called by many "The village pharmacy" or "Divine tree" because of its many health properties.  In recent times, Neem-derived exts. have been shown to work from anywhere from insect repellent, to supplements to lower inflammation, diabetic control, and even to combat cancer.  Herein, we state the health benefits found in diverse compds. and exts. derived from Neem, highlighting the mechanisms and pathways in which Neem compds. produce their effects, while warning that the improper and unstandardized conditions to produce exts. can lead to health issues, particularly certain compds. might have damaging effects on the liver and kidneys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiw1_OFgHZcLVg90H21EOLACvtfcHk0lhf8_a2_kVHVw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVSmtLvP&md5=78401485d482c2e1408f9f95af4fb3be</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jff.2020.104171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jff.2020.104171%26sid%3Dliteratum%253Aachs%26aulast%3DIslas%26aufirst%3DJ.%2BF.%26aulast%3DAcosta%26aufirst%3DE.%26aulast%3DG-Buentello%26aufirst%3DZ.%26aulast%3DDelgado-Gallegos%26aufirst%3DJ.%2BL.%26aulast%3DMoreno-Trevi%25C3%25B1o%26aufirst%3DM.%2BG.%26aulast%3DEscalante%26aufirst%3DB.%26aulast%3DMoreno-Cuevas%26aufirst%3DJ.%2BE.%26atitle%3DAn%2520overview%2520of%2520neem%2520%2528Azadirachta%2520indica%2529%2520and%2520its%2520potential%2520impact%2520on%2520health%26jtitle%3DJ.%2520Funct.%2520Foods%26date%3D2020%26volume%3D74%26spage%3D104171%26doi%3D10.1016%2Fj.jff.2020.104171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subapriya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Medicinal properties of neem leaves: A review</span>. <i>Curr. Med. Chem.: Anti-Cancer Agents</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">149</span>â <span class="NLM_lpage">156</span>, <span class="refDoi">Â DOI: 10.2174/1568011053174828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.2174%2F1568011053174828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=15777222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVCjurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=149-156&author=R.+Subapriyaauthor=S.+Nagini&title=Medicinal+properties+of+neem+leaves%3A+A+review&doi=10.2174%2F1568011053174828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal properties of neem leaves: a review</span></div><div class="casAuthors">Subapriya, R.; Nagini, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Cancer Agents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-156</span>CODEN:
                <span class="NLM_cas:coden">CMCACI</span>;
        ISSN:<span class="NLM_cas:issn">1568-0118</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Azadirachta indica, commonly known as neem, has attracted worldwide prominence in recent years, owing to its wide range of medicinal properties.  Neem was extensively used in Ayurveda, Unani and Homeopathic medicine and has become a cynosure of modern medicine.  Neem elaborates a vast array of biol. active compds. that are chem. diverse and structurally complex.  More than 140 compds. were isolated from different parts of neem.  All parts of the neem tree- leaves, flowers, seeds, fruits, roots and bark were used traditionally for the treatment of inflammation, infections, fever, skin diseases and dental disorders.  The medicinal utilities were described esp. for neem leaf.  Neem leaf and its constituents were demonstrated to exhibit immunomodulatory, anti-inflammatory, antihyperglycemic, antiulcer, antimalarial, antifungal, antibacterial, antiviral, antioxidant, antimutagenic and anticarcinogenic properties.  This review summarizes the wide range of pharmacol. activities of neem leaf.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU21nKb01Ku7Vg90H21EOLACvtfcHk0lhf8_a2_kVHVw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVCjurY%253D&md5=25f2e5faf32afd520f605dc590c846c7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568011053174828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568011053174828%26sid%3Dliteratum%253Aachs%26aulast%3DSubapriya%26aufirst%3DR.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DMedicinal%2520properties%2520of%2520neem%2520leaves%253A%2520A%2520review%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Cancer%2520Agents%26date%3D2005%26volume%3D5%26spage%3D149%26epage%3D156%26doi%3D10.2174%2F1568011053174828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hummel, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langner, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leithold, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmutterer, H.</span></span> <span> </span><span class="NLM_article-title">Neem: Unusually versatile plant genus Azadirachta with many useful and so far insufficiently exploited properties for agriculture, medicine, and industry</span>. <i>Commun. Agric. Appl. Biol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">211</span>â <span class="NLM_lpage">228</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=26084100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC2Mbks1CrsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=211-228&author=H.+E.+Hummelauthor=S.+S.+Langnerauthor=G.+Leitholdauthor=H.+Schmutterer&title=Neem%3A+Unusually+versatile+plant+genus+Azadirachta+with+many+useful+and+so+far+insufficiently+exploited+properties+for+agriculture%2C+medicine%2C+and+industry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">NEEM: UNUSUALLY VERSATILE PLANT GENUS AZADIRACHTA WITH MANY USEFUL AND SO FAR INSUFFICIENTLY EXPLOITED PROPERTIES FOR AGRICULTURE, MEDICINE, AND INDUSTRY</span></div><div class="casAuthors">Hummel H E; Langner S S; Leithold G; Schmutterer H</div><div class="citationInfo"><span class="NLM_cas:title">Communications in agricultural and applied biological sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-28</span>
        ISSN:<span class="NLM_cas:issn">1379-1176</span>.
    </div><div class="casAbstract">Neem plants (Rutales: Meliaceae) are well known for their multitude of human benefits in various fields.  Specifically well investigated are the Indian neem tree Azadirachta indica A.  Juss., the Thai neem A. siamensis Val., the originally Malaysian/Philippinean neem A. excelsa (Jack) and, as a close relative, the Persian lilac, Melia azedarach.  The major and most active natural products are azadirachtin, salannin, nimbin and marrangin from Azadirachta species, and azadirachtin analogues like meliantriol from Melia species.  Neem fruits, leaves, bark, and roots have specific virtues.  They have been traditionally exploited for a considerable part of human history and are documented in Sanskrit texts.  Due to human activity in trade and travel both at land and sea, the plant species has been distributed around the globe and is cultivated in many tropical, and subtropical regions.  A multitude of natural products of neem have been isolated, chemically characterized or identified, and investigated for their properties in the management of insects, Acarina, Crustacea, nematodes, bacteria, fungi, viruses and soil fertility (for reviews see Kraus, 2002; Schmutterer, 2002A; Rembold, 2002; Koul, 2004; Schmutterer and Huber, 2005; Kleeberg and Strang, 2009; Hummel et al., 2008, 2011, 2012).  Neem products are virtually nontoxic, compatible with beneficial insects, pollinators and bees.  They are environmentally benign, sustainable, renewable, and of a price affordable for developed countries.  In conclusion, neem is a prime example of a natural resource with many beneficial applications in agriculture, human and veterinary medicine.  So far, its use is practically free of resistance problems which are frustratingly prevalent in many areas of synthetic insecticide and drug development.  Investigating more neem applications will increase future human welfare and health while being of general ecological benefit to the planet.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwQb8DoRSnI8yail4HZd-ifW6udTcc2eY7kWnZPw8n-rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mbks1CrsQ%253D%253D&md5=6b0a8185f092ca4c11299c8dd0e6907f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHummel%26aufirst%3DH.%2BE.%26aulast%3DLangner%26aufirst%3DS.%2BS.%26aulast%3DLeithold%26aufirst%3DG.%26aulast%3DSchmutterer%26aufirst%3DH.%26atitle%3DNeem%253A%2520Unusually%2520versatile%2520plant%2520genus%2520Azadirachta%2520with%2520many%2520useful%2520and%2520so%2520far%2520insufficiently%2520exploited%2520properties%2520for%2520agriculture%252C%2520medicine%252C%2520and%2520industry%26jtitle%3DCommun.%2520Agric.%2520Appl.%2520Biol.%2520Sci.%26date%3D2014%26volume%3D79%26spage%3D211%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kharwar, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gond, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaushik, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revuru, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusari, S.</span></span> <span> </span><span class="NLM_article-title">Harnessing the phytotherapeutic treasure troves of the ancient medicinal plant Azadirachta indica (neem) and associated endophytic microorganisms</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">906</span>â <span class="NLM_lpage">940</span>, <span class="refDoi">Â DOI: 10.1055/a-1107-9370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1055%2Fa-1107-9370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32126583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVynsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2020&pages=906-940&author=R.+N.+Kharwarauthor=V.+K.+Sharmaauthor=A.+Mishraauthor=J.+Kumarauthor=D.+K.+Singhauthor=S.+K.+Vermaauthor=S.+K.+Gondauthor=A.+Kumarauthor=N.+Kaushikauthor=B.+Revuruauthor=S.+Kusari&title=Harnessing+the+phytotherapeutic+treasure+troves+of+the+ancient+medicinal+plant+Azadirachta+indica+%28neem%29+and+associated+endophytic+microorganisms&doi=10.1055%2Fa-1107-9370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing the Phytotherapeutic Treasure Troves of the Ancient Medicinal Plant Azadirachta indica (Neem) and Associated Endophytic Microorganisms</span></div><div class="casAuthors">Kharwar, Ravindra N.; Sharma, Vijay K.; Mishra, Ashish; Kumar, Jitendra; Singh, Dheeraj K.; Verma, Satish K.; Gond, Surendra K.; Kumar, Anuj; Kaushik, Nutan; Revuru, Bharadwaj; Kusari, Souvik</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">13/14</span>),
    <span class="NLM_cas:pages">906-940</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Azadirachta indica, commonly known as neem, is an evergreen tree of the tropics and sub-tropics native to the Indian subcontinent with demonstrated ethnomedicinal value and importance in agriculture as well as in the pharmaceutical industry.  This ancient medicinal tree, often called the "wonder tree", is regarded as a chem. factory of diverse and complex compds. with a plethora of structural scaffolds that is very difficult to mimic by chem. synthesis.  Such multifaceted chem. diversity leads to a fantastic repertoire of functional traits, encompassing a wide variety of biol. activity and unique modes of action against specific and generalist pathogens and pests.  Until now, more than 400 compds. have been isolated from different parts of neem including important bioactive secondary metabolites such as azadirachtin, nimbidin, nimbin, nimbolide, gedunin, and many more.  In addn. to its insecticidal property, the plant is also known for antimicrobial, antimalarial, antiviral, anti-inflammatory, analgesic, antipyretic, hypoglycemic, antiulcer, antifertility, anticarcinogenic, hepatoprotective, antioxidant, anxiolytic, molluscicidal, acaricidal, and antifilarial properties.  Notwithstanding the chem. and biol. virtuosity of neem, it has also been extensively explored for assocd. microorganisms, esp. a class of mutualists called endophytic microorganisms (or endophytes).  More than 30 compds., including neem "mimetic" compds., have been reported from endophytes harbored in the neem trees in different ecol. niches.  In this review, we provide an informative and in-depth overview of the topic that can serve as a point of ref. for an understanding of the functions and applications of a medicinal plant such as neem, including assocd. endophytes, within the overall theme of phytopathol.  Our review further exemplifies the already-noted current surge of interest in plant and microbial natural products for implications both within the ecol. and clin. settings, for a more secure and sustainable future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAZ7LPziK8ObVg90H21EOLACvtfcHk0lhf8_a2_kVHVw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVynsb0%253D&md5=ae3f5614213b0569872de57e94e7d70f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1055%2Fa-1107-9370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fa-1107-9370%26sid%3Dliteratum%253Aachs%26aulast%3DKharwar%26aufirst%3DR.%2BN.%26aulast%3DSharma%26aufirst%3DV.%2BK.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DD.%2BK.%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DGond%26aufirst%3DS.%2BK.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DKaushik%26aufirst%3DN.%26aulast%3DRevuru%26aufirst%3DB.%26aulast%3DKusari%26aufirst%3DS.%26atitle%3DHarnessing%2520the%2520phytotherapeutic%2520treasure%2520troves%2520of%2520the%2520ancient%2520medicinal%2520plant%2520Azadirachta%2520indica%2520%2528neem%2529%2520and%2520associated%2520endophytic%2520microorganisms%26jtitle%3DPlanta%2520Med.%26date%3D2020%26volume%3D86%26spage%3D906%26epage%3D940%26doi%3D10.1055%2Fa-1107-9370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Neem limonoids as anticancer agents: Modulation of cancer hallmarks and oncogenic signaling</span>. <i>Enzymes</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">131</span>â <span class="NLM_lpage">147</span>, <span class="refDoi">Â DOI: 10.1016/B978-0-12-802215-3.00007-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2FB978-0-12-802215-3.00007-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=27102702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yru7rO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2014&pages=131-147&author=S.+Nagini&title=Neem+limonoids+as+anticancer+agents%3A+Modulation+of+cancer+hallmarks+and+oncogenic+signaling&doi=10.1016%2FB978-0-12-802215-3.00007-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Neem limonoids as anticancer agents: modulation of cancer hallmarks and oncogenic signaling</span></div><div class="casAuthors">Nagini, Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">Enzymes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">131-147</span>CODEN:
                <span class="NLM_cas:coden">25GLAS</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Neem (Azadirachta indica A. Juss) is one of the most versatile medicinal plants, widely distributed in the Indian subcontinent.  Neem is a rich source of limonoids that are endowed with potent medicinal properties predominantly antioxidant, anti-inflammatory, and anticancer activities.  Azadirachtin, gedunin, and nimbolide are more extensively investigated relative to other neem limonoids.  Accumulating evidence indicates that the anticancer effects of neem limonoids are mediated through the inhibition of hallmark capabilities of cancer such as cell proliferation, apoptosis evasion, inflammation, invasion, and angiogenesis.  The neem limonoids have been demonstrated to target oncogenic signaling kinases and transcription factors chiefly, NF-ÎºB, Wnt/Î²-catenin, PI3K/Akt, MAPK, and JAK/STAT signaling pathways.  Neem limonoids that target multiple pathways that are aberrant in cancer are ideal candidates for cancer chemoprevention and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpBKNV6Gh4K7Vg90H21EOLACvtfcHk0lgOXhPXo0z0NA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yru7rO&md5=6596df3ba46c91471d4eea739e3e0292</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-802215-3.00007-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-802215-3.00007-0%26sid%3Dliteratum%253Aachs%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DNeem%2520limonoids%2520as%2520anticancer%2520agents%253A%2520Modulation%2520of%2520cancer%2520hallmarks%2520and%2520oncogenic%2520signaling%26jtitle%3DEnzymes%26date%3D2014%26volume%3D36%26spage%3D131%26epage%3D147%26doi%3D10.1016%2FB978-0-12-802215-3.00007-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quistad, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casida, J. E.</span></span> <span> </span><span class="NLM_article-title">Cytotoxicity of nimbolide, epoxyazadiradione and other limonoids from neem insecticide</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1075</span>â <span class="NLM_lpage">1081</span>, <span class="refDoi">Â DOI: 10.1016/0024-3205(96)00061-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2F0024-3205%2896%2900061-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=8622560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADyaK28XhsVWrsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1996&pages=1075-1081&author=E.+Cohenauthor=G.+B.+Quistadauthor=J.+E.+Casida&title=Cytotoxicity+of+nimbolide%2C+epoxyazadiradione+and+other+limonoids+from+neem+insecticide&doi=10.1016%2F0024-3205%2896%2900061-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxicity of nimbolide, epoxyazadiradione and other limonoids from neem insecticide</span></div><div class="casAuthors">Cohen, Ephraim; Quistad, Gary B.; Casida, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1075-81</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Neem seed prepns. contain not only azadirachtin as the active insect antifeedant or growth regulator but also a variety of other limonoids, some of which are cytotoxic to N1E-115 neuroblastoma (mouse), 143B.TK- osteosarcoma (human) and Sf9 (insect) cultured cell lines.  The most potent of these limonoids is nimbolide with an IC50 ranging from 4 to 10 Î¼M and averaging 6 Î¼M for the three cell lines.  Other limonoids of decreasing potency and their av. IC50 values (Î¼M) are epoxyazadiradione 27 Î¼M, salannin 112 Î¼M, and nimbin, deacetylnimbin and azadirachtin each >200 Î¼M (practically nontoxic).  Nimbolide at 10 Î¼M acts rapidly in the neuroblastoma cells to induce blebbing assocd. with disruption of plasma membranes almost instantaneously and 50% loss of cell viability within 30 min.  At 5 Î¼M nimbolide, the cells become elongated and assume a neuronal shape accompanied by spikes and lamellipodia within 1-2 h followed shortly thereafter by extensive cytol. changes and vacuolization assocd. with irreversible processes leading to cell death.  Calcium is apparently not involved in the cytotoxic effect since a calcium-free medium, leading to profound morphol. changes, does not alter the sensitivity to nimbolide.  In contrast, epoxyazadiradione requires higher concns. and a few hours for 50% viability loss without major morphol. changes, indicating a difference in mode of action for nimbolide and epoxyazadiradione.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBbj736fCtirVg90H21EOLACvtfcHk0lgOXhPXo0z0NA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsVWrsLk%253D&md5=09405fc8e2475a4f25c71f0dd7de581e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2896%2900061-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252896%252900061-6%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DE.%26aulast%3DQuistad%26aufirst%3DG.%2BB.%26aulast%3DCasida%26aufirst%3DJ.%2BE.%26atitle%3DCytotoxicity%2520of%2520nimbolide%252C%2520epoxyazadiradione%2520and%2520other%2520limonoids%2520from%2520neem%2520insecticide%26jtitle%3DLife%2520Sci.%26date%3D1996%26volume%3D58%26spage%3D1075%26epage%3D1081%26doi%3D10.1016%2F0024-3205%2896%2900061-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anitha, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josepha Lourdu Raj, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand Solomon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajan, S. S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide and isonimbolide</span>. <i>J. Asian Nat. Prod. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">445</span>â <span class="NLM_lpage">449</span>, <span class="refDoi">Â DOI: 10.1080/10286020500173267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1080%2F10286020500173267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=16864461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVequr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=445-449&author=G.+Anithaauthor=J.+Josepha+Lourdu+Rajauthor=S.+Narasimhanauthor=K.+Anand+Solomonauthor=S.+S.+Rajan&title=Nimbolide+and+isonimbolide&doi=10.1080%2F10286020500173267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide and isonimbolide</span></div><div class="casAuthors">Anitha, G.; Raj, J. Josepha Lourdu; Narasimhan, S.; Solomon, K. Anand; Rajan, S. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Asian Natural Products Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">445-449</span>CODEN:
                <span class="NLM_cas:coden">JANRFI</span>;
        ISSN:<span class="NLM_cas:issn">1028-6020</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Nimbolide 1, a potent mol. of biol. significance, was isolated.  Attempts were made to cleave the ether linkage in nimbolide using boron trifluoride etherate in the presence of tetra-Bu ammonium bromide so as to generate a ring-opened structure akin to azadirachtins, which are known to possess excellent antifeedant properties.  However, a novel rearranged product was envisaged during the course of the reaction, which was detd. as isonimbolide 2-a structural isomer of nimbolide through spectroscopic methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvWPGkWUK3wbVg90H21EOLACvtfcHk0lgOXhPXo0z0NA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVequr8%253D&md5=2fe43e1f62456c98761f125b2c468b36</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1080%2F10286020500173267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10286020500173267%26sid%3Dliteratum%253Aachs%26aulast%3DAnitha%26aufirst%3DG.%26aulast%3DJosepha%2BLourdu%2BRaj%26aufirst%3DJ.%26aulast%3DNarasimhan%26aufirst%3DS.%26aulast%3DAnand%2BSolomon%26aufirst%3DK.%26aulast%3DRajan%26aufirst%3DS.%2BS.%26atitle%3DNimbolide%2520and%2520isonimbolide%26jtitle%3DJ.%2520Asian%2520Nat.%2520Prod.%2520Res.%26date%3D2006%26volume%3D8%26spage%3D445%26epage%3D449%26doi%3D10.1080%2F10286020500173267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sastry, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh Babu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hari Babu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhusudana Rao, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of amide derivatives of nimbolide</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">4391</span>â <span class="NLM_lpage">4394</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2006.05.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.bmcl.2006.05.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=16793266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFertb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4391-4394&author=B.+S.+Sastryauthor=K.+Suresh+Babuauthor=T.+Hari+Babuauthor=S.+Chandrasekharauthor=P.+V.+Srinivasauthor=A.+K.+Saxenaauthor=J.+Madhusudana+Rao&title=Synthesis+and+biological+activity+of+amide+derivatives+of+nimbolide&doi=10.1016%2Fj.bmcl.2006.05.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activity of amide derivatives of nimbolide</span></div><div class="casAuthors">Sastry, B. S.; Babu, K. Suresh; Babu, T. Hari; Chandrasekhar, S.; Srinivas, P. V.; Saxena, A. K.; Rao, J. Madhusudana</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4391-4394</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nimbolide (I), a limonoid isolated from Azadirachta indica, is the chief cytotoxic principle in Neem leaves ext.  Using nimbolide as a lead compd. for anti-cancer analog design, a series of nimbolide derivs., e.g., II, have been synthesized by ring-opening of the lactone ring with amines, and evaluated for in vitro cytotoxic activity against a panel of human cancer cell lines.  Out of the 10 compds. screened, three of them, including II, showed potent activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpk1kkyld14rVg90H21EOLACvtfcHk0li8MzruBKwWCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFertb8%253D&md5=b391fbc6ba29c2d512226cf34259e605</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.05.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.05.105%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DB.%2BS.%26aulast%3DSuresh%2BBabu%26aufirst%3DK.%26aulast%3DHari%2BBabu%26aufirst%3DT.%26aulast%3DChandrasekhar%26aufirst%3DS.%26aulast%3DSrinivas%26aufirst%3DP.%2BV.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DMadhusudana%2BRao%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520amide%2520derivatives%2520of%2520nimbolide%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4391%26epage%3D4394%26doi%3D10.1016%2Fj.bmcl.2006.05.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rochanakij, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thebtaranonth, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yenjai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuthavong, Y.</span></span> <span> </span><span class="NLM_article-title">Nimbolide, a constituent of Azadirachta indica, inhibits Plasmodium falciparum in culture</span>. <i>Southeast Asian J. Trop. Med. Public Health</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">66</span>â <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=3895455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADyaL28Xis1U%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1985&pages=66-67&author=S.+Rochanakijauthor=Y.+Thebtaranonthauthor=C.+Yenjaiauthor=Y.+Yuthavong&title=Nimbolide%2C+a+constituent+of+Azadirachta+indica%2C+inhibits+Plasmodium+falciparum+in+culture"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide, a constituent of Azadirachta indica, inhibits Plasmodium falciparum in culture</span></div><div class="casAuthors">Rochanakij, Sudaratana; Thebtaranonth, Yodhathai; Yenjai, Chavi; Yuthavong, Yongyuth</div><div class="citationInfo"><span class="NLM_cas:title">Southeast Asian Journal of Tropical Medicine and Public Health</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-72</span>CODEN:
                <span class="NLM_cas:coden">SJTMAK</span>;
        ISSN:<span class="NLM_cas:issn">0125-1562</span>.
    </div><div class="casAbstract">The terpenoid lactone nimbolide (I)  [25990-37-8] inhibited P. falciparum in culture with a moderate potency.  The EC50 against the parasite line K1 from Thailand was approx. 2.0 Î¼M (0.95 Î¼g/m).  The EC50 of crude aq. ext. of Azadirachta indica siamensis (Sadao tree), was 115 Î¼g/mL, and of crude EtOH ext. was 5.0 Î¼g/mL.  Since I is a major constituent in these exts., it could account substantially for their inhibitory activity.  However, neither the crude exts. nor I showed any activity in vivo against P. berghei in the mouse either through ingestion (746 mg aq. ext., 62.5 mg EtOH ext. or 12.5 mg nimbolide/kg/day), or s.c. injection (93 mg aq. ext., 31 mg EtOH ext. or 12.5 mg I/kg/day).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodIQyjZzeCbrVg90H21EOLACvtfcHk0li8MzruBKwWCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xis1U%253D&md5=83b8daf0560b6de9ed42e589774d190e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRochanakij%26aufirst%3DS.%26aulast%3DThebtaranonth%26aufirst%3DY.%26aulast%3DYenjai%26aufirst%3DC.%26aulast%3DYuthavong%26aufirst%3DY.%26atitle%3DNimbolide%252C%2520a%2520constituent%2520of%2520Azadirachta%2520indica%252C%2520inhibits%2520Plasmodium%2520falciparum%2520in%2520culture%26jtitle%3DSoutheast%2520Asian%2520J.%2520Trop.%2520Med.%2520Public%2520Health%26date%3D1985%26volume%3D16%26spage%3D66%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Githua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassanali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keriko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murilla, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndungu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyagah, G.</span></span> <span> </span><span class="NLM_article-title">New antitrypanosomal tetranotriterpenoids from Azadirachta indica</span>. <i>Afr. J. Tradit. Complement Altern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">207</span>â <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.4314%2Fajtcam.v7i3.54776" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=21461147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlWnsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=207-213&author=M.+Githuaauthor=A.+Hassanaliauthor=J.+Kerikoauthor=G.+Murillaauthor=M.+Ndunguauthor=G.+Nyagah&title=New+antitrypanosomal+tetranotriterpenoids+from+Azadirachta+indica"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">New antitrypanosomal tetranotriterpenoids from Azadirachta indica</span></div><div class="casAuthors">Githua, Mercy; Hassanali, Ahmed; Keriko, Joseph; Murilla, Grace; Ndungu, Mary; Nyagah, Gathu</div><div class="citationInfo"><span class="NLM_cas:title">African Journal of Traditional, Complementary and Alternative Medicines</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-213</span>CODEN:
                <span class="NLM_cas:coden">AJTCAU</span>;
        ISSN:<span class="NLM_cas:issn">0189-6016</span>.
    
            (<span class="NLM_cas:orgname">African Networks on Ethnomedicines</span>)
        </div><div class="casAbstract">Org. exts. of the leaves of Azadirachta indica A. Juss. yielded ten antitrypanosomal terpenoids.  Three of these (1 - 3), are novel and are derivs. of nimbolide and nimbin.  They were extd. from chloroform fraction of methanol ext.  These compds. were found to exhibit strong antitrypanosomal activities against Trypanosoma brucei rhodesiense with MIC values ranging of 6.9, 15.6 and 7.8 Î¼g/mL resp. and were more active than Cymerlarsan (a std. drug), which had an MIC value of 187.5 Î¼g/mL when tested against T. b. rhodesiense.  The structures were elucidated by spectroscopic methods including; NMR, MS, UV and IR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok10RFUmB_ebVg90H21EOLACvtfcHk0li8MzruBKwWCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlWnsbc%253D&md5=c8f739a201ff53127dca4fbedfe42589</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4314%2Fajtcam.v7i3.54776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4314%252Fajtcam.v7i3.54776%26sid%3Dliteratum%253Aachs%26aulast%3DGithua%26aufirst%3DM.%26aulast%3DHassanali%26aufirst%3DA.%26aulast%3DKeriko%26aufirst%3DJ.%26aulast%3DMurilla%26aufirst%3DG.%26aulast%3DNdungu%26aufirst%3DM.%26aulast%3DNyagah%26aufirst%3DG.%26atitle%3DNew%2520antitrypanosomal%2520tetranotriterpenoids%2520from%2520Azadirachta%2520indica%26jtitle%3DAfr.%2520J.%2520Tradit.%2520Complement%2520Altern.%2520Med.%26date%3D2010%26volume%3D7%26spage%3D207%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharyya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thankamani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koley, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bag, P. K.</span></span> <span> </span><span class="NLM_article-title">Intracellular, biofilm-inhibitory and membrane-damaging activities of nimbolide isolated from Azadirachta indica A. Juss (Meliaceae) against meticillin-resistant Staphylococcus aureus</span>. <i>J. Med. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1205</span>â <span class="NLM_lpage">1214</span>, <span class="refDoi">Â DOI: 10.1099/jmm.0.000343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1099%2Fjmm.0.000343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=27553840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlSntb7K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1205-1214&author=P.+Sarkarauthor=S.+Acharyyaauthor=A.+Banerjeeauthor=A.+Patraauthor=K.+Thankamaniauthor=H.+Koleyauthor=P.+K.+Bag&title=Intracellular%2C+biofilm-inhibitory+and+membrane-damaging+activities+of+nimbolide+isolated+from+Azadirachta+indica+A.+Juss+%28Meliaceae%29+against+meticillin-resistant+Staphylococcus+aureus&doi=10.1099%2Fjmm.0.000343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular, biofilm-inhibitory and membrane-damaging activities of nimbolide isolated from Azadirachta indica A. Juss (Meliaceae) against meticillin-resistant Staphylococcus aureus</span></div><div class="casAuthors">Sarkar, Prodipta; Acharyya, Saurabh; Banerjee, Anirban; Patra, Amarendra; Thankamani, Karthika; Koley, Hemanta; Bag, Prasanta K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Microbiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1205-1214</span>CODEN:
                <span class="NLM_cas:coden">JMMIAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-2615</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Staphylococcus aureus is a leading etiol. agent of nosocomial- and community-acquired infectious diseases worldwide.  The public health concern regarding staphylococcal infections is inflated by the increasing occurrence of multidrug-resistant strains, e.g. multidrug- and meticillin-resistant S. aureus (MDR MRSA).  This study was designed to evaluate the intracellular killing, membrane-damaging and biofilm-inhibitory activities of nimbolide isolated from Azadirachta indica against MDR MRSA.  In vitro antibacterial activity of nimbolide was detd. by performing MIC, minimal bactericidal concn. (MBC) and time-kill kinetic studies.  Bacterial membrane-damaging activity was detd. by membrane perturbation and SEM (SEM) examn.  Biofilm-inhibitory activities were detd. by SEM.  Cellular drug accumulation and assessments of intracellular activities were performed using Vero cell culture.  SEM revealed that nimbolide caused significant membrane damage and lysis of the S. aureus cells.  The biofilm structure was disrupted, and the biofilm formation was greatly reduced in the presence of nimbolide as examd. by SEM.  The level of accumulation of nimbolide in Vero cells incubated for 24 h is relatively higher than that of ciprofloxacin and nalidixic acid (Cc/Ce for nimbolide > ciprofloxacin and nalidixic acid).  The viable no. of intracellular S. aureus was decreased [redn. of â¼2 log10 c.f.u. (mg Vero cell protein)-1] in a time-dependent manner in the presence of nimbolide (4Ã MBC) that was comparable to that of tetracycline and nalidixic acid.  The significant intracellular, biofilm-inhibitory and bacterial membrane-damaging activities of nimbolide demonstrated here suggested that it has potential as an effective antibacterial agent for the treatment of severe infections caused by MDR MRSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxtWG5beE2hrVg90H21EOLACvtfcHk0lifDPMlIDHP1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlSntb7K&md5=3d371999538ec7bacf09dd663c45d844</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1099%2Fjmm.0.000343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fjmm.0.000343%26sid%3Dliteratum%253Aachs%26aulast%3DSarkar%26aufirst%3DP.%26aulast%3DAcharyya%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DPatra%26aufirst%3DA.%26aulast%3DThankamani%26aufirst%3DK.%26aulast%3DKoley%26aufirst%3DH.%26aulast%3DBag%26aufirst%3DP.%2BK.%26atitle%3DIntracellular%252C%2520biofilm-inhibitory%2520and%2520membrane-damaging%2520activities%2520of%2520nimbolide%2520isolated%2520from%2520Azadirachta%2520indica%2520A.%2520Juss%2520%2528Meliaceae%2529%2520against%2520meticillin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DJ.%2520Med.%2520Microbiol.%26date%3D2016%26volume%3D65%26spage%3D1205%26epage%3D1214%26doi%3D10.1099%2Fjmm.0.000343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anjum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassan, I. Md.</span></span> <span> </span><span class="NLM_article-title">Search of potential inhibitor against New Delhi metallo-beta-lactamase 1 from a series of antibacterial natural compounds</span>. <i>J. Nat. Sci. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">51</span>â <span class="NLM_lpage">56</span>, <span class="refDoi">Â DOI: 10.4103/0976-9668.107260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.4103%2F0976-9668.107260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=23633835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvV2iu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=51-56&author=P.+K.+Thakurauthor=J.+Kumarauthor=D.+Rayauthor=F.+Anjumauthor=I.+Md.+Hassan&title=Search+of+potential+inhibitor+against+New+Delhi+metallo-beta-lactamase+1+from+a+series+of+antibacterial+natural+compounds&doi=10.4103%2F0976-9668.107260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Search of potential inhibitor against New Delhi metallo-beta-lactamase 1 from a series of antibacterial natural compounds</span></div><div class="casAuthors">Thakur, Prasoon Kumar; Kumar, Jitender; Ray, Divya; Anjum, Farah; Hassan, Md. Imtaiyaz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Science, Biology and Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-56</span>CODEN:
                <span class="NLM_cas:coden">JNSBAD</span>;
        ISSN:<span class="NLM_cas:issn">2229-7707</span>.
    
            (<span class="NLM_cas:orgname">Medknow Publications and Media Pvt. Ltd.</span>)
        </div><div class="casAbstract">New Delhi metallo-Î²-lactamase-1 (NDM-1)-producing Gram-neg. bacteria are today's major worldwide health concern.  The enzyme NDM-1 provides bacterial resistance by its hydrolytic activity against the Î²-lactam ring of antibiotics.  Inhibition of NDM-1 may prevent the hydrolysis of Î²-lactam ring of the antibiotics, and therefore, plays an important role against antibacterial resistance.  Materials and Methods: Here we made an attempt to design suitable inhibitors against NDM-1 from different natural antibacterial compds. using mol. docking approach.  Results: We obsd. that natural compds. such as Nimbolide and Isomargololone are showing an appreciable IC50 value as well as significant binding energy value for NDM-1.  We further obsd. these compds. showing better affinity to NDM-1 on comparison with 14 Î²-lactam antibiotics.  Conclusion: Finally, our study provides a platform for the development of a potent inhibitor of NDM-1, which may be considered as a potential drug candidate against bacterial resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg1iu7-fKfhbVg90H21EOLACvtfcHk0lifDPMlIDHP1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvV2iu7Y%253D&md5=c8f4650d012ed88b86d833fa1942a0a6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4103%2F0976-9668.107260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0976-9668.107260%26sid%3Dliteratum%253Aachs%26aulast%3DThakur%26aufirst%3DP.%2BK.%26aulast%3DKumar%26aufirst%3DJ.%26aulast%3DRay%26aufirst%3DD.%26aulast%3DAnjum%26aufirst%3DF.%26aulast%3DHassan%26aufirst%3DI.%2BMd.%26atitle%3DSearch%2520of%2520potential%2520inhibitor%2520against%2520New%2520Delhi%2520metallo-beta-lactamase%25201%2520from%2520a%2520series%2520of%2520antibacterial%2520natural%2520compounds%26jtitle%3DJ.%2520Nat.%2520Sci.%2520Biol.%2520Med.%26date%3D2013%26volume%3D4%26spage%3D51%26epage%3D56%26doi%3D10.4103%2F0976-9668.107260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vora, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chhabria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrivastava, N.</span></span> <span> </span><span class="NLM_article-title">Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV</span>. <i>J. Biomol. Struct. Dyn.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">131</span>â <span class="NLM_lpage">146</span>, <span class="refDoi">Â DOI: 10.1080/07391102.2017.1420489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1080%2F07391102.2017.1420489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29268664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWqt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=131-146&author=J.+Voraauthor=S.+Patelauthor=S.+Sinhaauthor=S.+Sharmaauthor=A.+Srivastavaauthor=M.+Chhabriaauthor=N.+Shrivastava&title=Molecular+docking%2C+QSAR+and+ADMET+based+mining+of+natural+compounds+against+prime+targets+of+HIV&doi=10.1080%2F07391102.2017.1420489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV</span></div><div class="casAuthors">Vora, Jaykant; Patel, Shivani; Sinha, Sonam; Sharma, Sonal; Srivastava, Anshu; Chhabria, Mahesh; Shrivastava, Neeta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Structure and Dynamics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-146</span>CODEN:
                <span class="NLM_cas:coden">JBSDD6</span>;
        ISSN:<span class="NLM_cas:issn">0739-1102</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">AIDS is one of the multifaceted diseases and this underlying complexity hampers its complete cure.  The toxicity of existing drugs and emergence of multidrug-resistant virus makes the treatment worse.  Development of effective, safe and low-cost anti-HIV drugs is among the top global priority.  Exploration of natural resources may give ray of hope to develop new anti-HIV leads.  Among the various therapeutic targets for HIV treatment, reverse transcriptase, protease, integrase, GP120, and RNase are the prime focus.  In the present study, we predicted potential plant-derived natural mols. for HIV treatment using computational approach, i.e. mol. docking, quant. structure activity relationship (QSAR), and ADMET studies.  Receptor-ligand binding studies were performed using three different software for precise prediction - Discovery studio 4.0, Schrodinger and Molegrow virtual docker.  Docking scores revealed that Mulberrosides, Anolignans, Curcumin and Chebulic acid are promising candidates that bind with multi targets of HIV, while Neo-andrographolide, Nimbolide and Punigluconin were target-specific candidates.  Subsequently, QSAR was performed using biol. proved compds. which predicted the biol. activity of compds.  We identified Anolignans, Curcumin, Mulberrosides, Chebulic acid and Neo-andrographolide as potential natural mols. for HIV treatment from results of mol. docking and 3D-QSAR.  In silico ADMET studies showed drug-likeness of these lead mols.  Structure similarities of identified lead mols. were compared with identified marketed drugs by superimposing both the mols.  Using in silico studies, we have identified few best fit mols. of natural origin against identified targets which may give new drugs to combat HIV infection after wet lab validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFAr9GeHPXCbVg90H21EOLACvtfcHk0lifDPMlIDHP1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWqt7Y%253D&md5=f01b6e6fb4acd43fa1bd7759cc33234f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1080%2F07391102.2017.1420489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07391102.2017.1420489%26sid%3Dliteratum%253Aachs%26aulast%3DVora%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DChhabria%26aufirst%3DM.%26aulast%3DShrivastava%26aufirst%3DN.%26atitle%3DMolecular%2520docking%252C%2520QSAR%2520and%2520ADMET%2520based%2520mining%2520of%2520natural%2520compounds%2520against%2520prime%2520targets%2520of%2520HIV%26jtitle%3DJ.%2520Biomol.%2520Struct.%2520Dyn.%26date%3D2019%26volume%3D37%26spage%3D131%26epage%3D146%26doi%3D10.1080%2F07391102.2017.1420489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diddi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulivendala, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma</span>. <i>Inflammopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">139</span>â <span class="NLM_lpage">149</span>, <span class="refDoi">Â DOI: 10.1007/s10787-018-0527-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs10787-018-0527-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=30218238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslCjsLrP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=139-149&author=S.+Diddiauthor=S.+Baleauthor=G.+Pulivendalaauthor=C.+Godugu&title=Nimbolide+ameliorates+fibrosis+and+inflammation+in+experimental+murine+model+of+bleomycin-induced+scleroderma&doi=10.1007%2Fs10787-018-0527-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma</span></div><div class="casAuthors">Diddi, Snehalatha; Bale, Swarna; Pulivendala, Gauthami; Godugu, Chandraiah</div><div class="citationInfo"><span class="NLM_cas:title">Inflammopharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-149</span>CODEN:
                <span class="NLM_cas:coden">IAOAES</span>;
        ISSN:<span class="NLM_cas:issn">0925-4692</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Objective: Our current study is aimed at demonstrating the antifibrotic and anti-inflammatory potential of nimbolide, a triterpene derived from Indian traditional plant neem, in a murine model of Bleomycin-induced scleroderma.  Methods: Male C57BL/6 mice were administered with Bleomycin injections s.c., daily for 28 days, at a const. site on the dorsum of the mice.  Treatment with nimbolide lasted from day 1 to day 28.  At the time of study termination, the injected sites were collected and stored suitably to conduct further mol. expts. and protein expression studies.  Results and conclusion: The results of our study show that nimbolide can significantly intervene in the TGF-Î²/Smad signaling axis and the consequent EMT process, thus attenuating deposition of extracellular matrix.  Nimbolide also profoundly caused the regression of established inflammation-driven fibrosis, thus demonstrating both antifibrotic and anti-inflammatory activities.  Another commendable finding of this study is that nimbolide was able to decrease the levels of LOXL2, a collagen cross-linker, which is aberrantly expressed in scleroderma.  Although further mechanistic studies are required, our study displays nimbolide for the first time as a potent antifibrotic agent which can be used as a pharmacol. intervention for the treatment of scleroderma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgXhcAufdAl7Vg90H21EOLACvtfcHk0lhMd9JjCebatA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslCjsLrP&md5=811a1fa4594a44fa123465bb1d4d3d23</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs10787-018-0527-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10787-018-0527-4%26sid%3Dliteratum%253Aachs%26aulast%3DDiddi%26aufirst%3DS.%26aulast%3DBale%26aufirst%3DS.%26aulast%3DPulivendala%26aufirst%3DG.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DNimbolide%2520ameliorates%2520fibrosis%2520and%2520inflammation%2520in%2520experimental%2520murine%2520model%2520of%2520bleomycin-induced%2520scleroderma%26jtitle%3DInflammopharmacology%26date%3D2019%26volume%3D27%26spage%3D139%26epage%3D149%26doi%3D10.1007%2Fs10787-018-0527-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prashanth
Goud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulivendala, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">Therapeutic effects of nimbolide, an autophagy regulator, in ameliorating pulmonary fibrosis through attenuation of TGF-Î²1 driven epithelial-to-mesenchymal transition</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">105755</span>, <span class="refDoi">Â DOI: 10.1016/j.intimp.2019.105755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.intimp.2019.105755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31377591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFamsLrN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2019&pages=105755&author=M.+Prashanth%0AGoudauthor=S.+Baleauthor=G.+Pulivendalaauthor=C.+Godugu&title=Therapeutic+effects+of+nimbolide%2C+an+autophagy+regulator%2C+in+ameliorating+pulmonary+fibrosis+through+attenuation+of+TGF-%CE%B21+driven+epithelial-to-mesenchymal+transition&doi=10.1016%2Fj.intimp.2019.105755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic effects of Nimbolide, an autophagy regulator, in ameliorating pulmonary fibrosis through attenuation of TGF-gamma1 driven epithelial-to-mesenchymal transition</span></div><div class="casAuthors">Prashanth Goud, M.; Bale, Swarna; Pulivendala, Gauthami; Godugu, Chandraiah</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105755</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pulmonary fibrosis is an irreversible lung disorder with predictable decline in lung function leading to respiratory insufficiency.  Incidence of pulmonary fibrosis has been apparently increasing worldwide.  Though etiol. of this disease remains unclear, potential roles of infection, disordered cell biol., genetic influence etc. have been proposed.  Pirfenidone and nintedanib are the only two US FDA approved drugs to treat pulmonary fibrosis.  Autophagy is a catabolic intracellular pathway that plays a crucial role in maintaining cellular homeostasis, which is involved in many disorders including fibrotic diseases.  The present study investigated the role of Nimbolide, an important active constituent of Neem in TGF-gamma1 induced in vitro and bleomycin induced in vivo model of pulmonary fibrosis, with a slight emphasis on regulation of fibrosis related autophagy.  Protein expression studies showed significant redn. in mesenchymal, fibrotic markers and a substantial up regulation of epithelial markers upon treatment with Nimbolide.  Nimbolide regulated autophagy signaling by dampening LC-3 and p-62 expression and increasing Beclin 1 expression as evidenced by immunohistochem. and confocal microscopy.  Our study demonstrates Nimbolide as a potent anti-fibrotic agent and its ability to regulate fibrosis assocd. autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU1w29I2OkFrVg90H21EOLACvtfcHk0lhMd9JjCebatA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFamsLrN&md5=be71fe26c2afc0d4c07bb2c28ab12458</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2019.105755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2019.105755%26sid%3Dliteratum%253Aachs%26aulast%3DPrashanth%2BGoud%26aufirst%3DM.%26aulast%3DBale%26aufirst%3DS.%26aulast%3DPulivendala%26aufirst%3DG.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DTherapeutic%2520effects%2520of%2520nimbolide%252C%2520an%2520autophagy%2520regulator%252C%2520in%2520ameliorating%2520pulmonary%2520fibrosis%2520through%2520attenuation%2520of%2520TGF-%25CE%25B21%2520driven%2520epithelial-to-mesenchymal%2520transition%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2019%26volume%3D75%26spage%3D105755%26doi%3D10.1016%2Fj.intimp.2019.105755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Annaldas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saifi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khurana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">Nimbolide ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibition of TGF-beta and EMT/Slug signalling</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">247</span>â <span class="NLM_lpage">255</span>, <span class="refDoi">Â DOI: 10.1016/j.molimm.2019.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.molimm.2019.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31202101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFKjtLvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2019&pages=247-255&author=S.+Annaldasauthor=M.+A.+Saifiauthor=A.+Khuranaauthor=C.+Godugu&title=Nimbolide+ameliorates+unilateral+ureteral+obstruction-induced+renal+fibrosis+by+inhibition+of+TGF-beta+and+EMT%2FSlug+signalling&doi=10.1016%2Fj.molimm.2019.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibition of TGF-Î² and EMT/Slug signalling</span></div><div class="casAuthors">Annaldas, Shivaraju; Saifi, Mohd Aslam; Khurana, Amit; Godugu, Chandraiah</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247-255</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Chronic kidney disease (CKD) involves interstitial fibrosis as an underlying pathol. process assocd. with compromised renal function irresp. of etiol. cause of the injury.  The transforming growth factor-Î² (TGF-Î²) plays a pivotal role in progression of renal fibrosis.  TGF-Î² transduces its downstream signaling by phosphorylation of smad2/3 and also regulates epithelial-mesenchymal-transition (EMT), a program centrally involved in activation of fibroblasts.  Renal fibrosis was induced in Swiss albino mice by unilateral ureteral obstruction of animals.  Kidney tissues were evaluated for fibrotic protein expression by western blot and immunohistochem.  The administration of nimbolide (NB) to UUO animals reduced the oxidative stress, expression of ECM proteins, TGF-Î², p-smad and EMT program.  Further, NB administration also improved histoarchitecture of obstructed kidney and reduced the collagen deposition in kidney.  Our results provided compelling evidence to support antifibrotic activity of NB by redn. in oxidative stress, TGF-Î², and EMT program in fibrotic kidney.  The administration of NB in animals blunted the UUO-induced renal injury, inflammation and reduced fibrogenesis in obstructed kidney.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSsWMJ7mNpXrVg90H21EOLACvtfcHk0lhMd9JjCebatA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFKjtLvM&md5=8009e4ea6d7b30e07710fd036247447c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2019.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2019.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DAnnaldas%26aufirst%3DS.%26aulast%3DSaifi%26aufirst%3DM.%2BA.%26aulast%3DKhurana%26aufirst%3DA.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DNimbolide%2520ameliorates%2520unilateral%2520ureteral%2520obstruction-induced%2520renal%2520fibrosis%2520by%2520inhibition%2520of%2520TGF-beta%2520and%2520EMT%252FSlug%2520signalling%26jtitle%3DMol.%2520Immunol.%26date%3D2019%26volume%3D112%26spage%3D247%26epage%3D255%26doi%3D10.1016%2Fj.molimm.2019.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide inhibits nuclear factor-ÎºB pathway in intestinal epithelial cells and macrophages and alleviates experimental colitis in mice</span>. <i>Phytother. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1605</span>â <span class="NLM_lpage">1614</span>, <span class="refDoi">Â DOI: 10.1002/ptr.5657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fptr.5657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=27270592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1SjtLrF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=1605-1614&author=J.+Y.+Seoauthor=C.+Leeauthor=S.+W.+Hwangauthor=J.+Chunauthor=J.+P.+Imauthor=J.+S.+Kim&title=Nimbolide+inhibits+nuclear+factor-%CE%BAB+pathway+in+intestinal+epithelial+cells+and+macrophages+and+alleviates+experimental+colitis+in+mice&doi=10.1002%2Fptr.5657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide Inhibits Nuclear Factor-ÎºB Pathway in Intestinal Epithelial Cells and Macrophages and Alleviates Experimental Colitis in Mice</span></div><div class="casAuthors">Seo, Ji Yeon; Lee, Changhyun; Hwang, Sung Wook; Chun, Jaeyoung; Im, Jong Pil; Kim, Joo Sung</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1605-1614</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Nimbolide is a limonoid extd. from neem tree (Azadirachta indica) that has antiinflammatory properties.  The effect of nimbolide on the nuclear factor-kappa B (NF-ÎºB) pathway in intestinal epithelial cells (IECs), macrophages and in murine colitis models was investigated.  The IEC COLO 205, the murine macrophage cell line RAW 264.7, and peritoneal macrophages from interleukin-10-deficient (IL-10-/-) mice were preconditioned with nimbolide and then stimulated with tumor necrosis factor-Î± (TNF-Î±) or lipopolysaccharide.  Dextran sulfate sodium-induced acute colitis model and chronic colitis model in IL-10-/- mice were used for in vivo expts.  Nimbolide significantly suppressed the expression of inflammatory cytokines (IL-6, IL-8, IL-12, and TNF-Î±) and inhibited the phosphorylation of IÎºBÎ± and the DNA-binding affinity of NF-ÎºB in IECs and macrophages.  Nimbolide ameliorated wt. loss, colon shortening, disease activity index score, and histol. scores in dextran sulfate sodium colitis.  It also improved histopathol. scores in the chronic colitis of IL-10-/- mice.  Staining for phosphorylated IÎºBÎ± was significantly decreased in the colon tissue after treatment with nimbolide in both models.  Nimbolide inhibits NF-ÎºB signaling in IECs and macrophages and ameliorates exptl. colitis in mice.  These results suggest nimbolide could be a potentially new treatment for inflammatory bowel disease.  Copyright Â© 2016 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo_ZH2rI3Sd7Vg90H21EOLACvtfcHk0lhMd9JjCebatA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1SjtLrF&md5=0b41ee7dfc2978439e75b44a69d6012e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fptr.5657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.5657%26sid%3Dliteratum%253Aachs%26aulast%3DSeo%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DHwang%26aufirst%3DS.%2BW.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DIm%26aufirst%3DJ.%2BP.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DNimbolide%2520inhibits%2520nuclear%2520factor-%25CE%25BAB%2520pathway%2520in%2520intestinal%2520epithelial%2520cells%2520and%2520macrophages%2520and%2520alleviates%2520experimental%2520colitis%2520in%2520mice%26jtitle%3DPhytother.%2520Res.%26date%3D2016%26volume%3D30%26spage%3D1605%26epage%3D1614%26doi%3D10.1002%2Fptr.5657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bansod, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslam Saifi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khurana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">Nimbolide abrogates cerulein-induced chronic pancreatitis by modulating beta-catenin/Smad in a sirtuin-dependent way</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">104756</span>, <span class="refDoi">Â DOI: 10.1016/j.phrs.2020.104756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.phrs.2020.104756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32194177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlsFeqsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2020&pages=104756&author=S.+Bansodauthor=M.+Aslam+Saifiauthor=A.+Khuranaauthor=C.+Godugu&title=Nimbolide+abrogates+cerulein-induced+chronic+pancreatitis+by+modulating+beta-catenin%2FSmad+in+a+sirtuin-dependent+way&doi=10.1016%2Fj.phrs.2020.104756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide abrogates cerulein-induced chronic pancreatitis by modulating Î²-catenin/Smad in a sirtuin-dependent way</span></div><div class="casAuthors">Bansod, Sapana; Aslam Saifi, Mohd.; Khurana, Amit; Godugu, Chandraiah</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104756</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Chronic pancreatitis (CP) is one of the leading causes of mortality worldwide with no clin. approved therapeutic interventions.  The present study was designed to investigate the protective effect of nimbolide (NB), an active constituent of neem tree (Azadirachta indica), by targeting Î²-catenin/Smad/SIRT1 in caerulein-induced CP model.  The effects of NB was investigated on caerulein (50 Î¼g/kg/h*6 exposures /day, 3 days a week for 3 wk) induced CP in mice.  Amylase and lipase activity were measured and histopathol. evaluation was performed.  Collagen deposition in the pancreatic tissue was estd. by hydroxyproline assay, and collagen specific staining picrosirius red and Masson's trichrome.  Caerulein-induced CP was significantly controlled by NB treatment, as shown by the downregulation of Î²-catenin/Smad signaling in a SIRT1 dependent manner.  NB treatment significantly decreased Î±-SMA, MMP-2, collagen1a, fibronectin, TGF-Î²1, p-Smad-2/3 expression and extracellular matrix (ECM) deposition in pancreatic tissue.  However, the protective effects of NB on caerulein-induced CP were undermined by nicotinamide (NMD) or splitomicin, sirtuin 1 (SIRT1) inhibitors treatment.  NB treatment modulated protein expression by activating SIRT1 and decreasing the expression of Î²-catenin/Smad proteins in CP mice.  However, the expression of SIRT1 in pancreatic tissue was elevated by NB treatment and it was decreased by NMD or splitomicin treatment.  In summary, our results strongly suggest that NB exerted promising protective effects in caerulein-induced CP model by inhibiting Î²-catenin/Smad in a sirtuin-dependent manner, which could be attributed to its anti-inflammatory and antifibrotic effects.  Our study suggests that NB could be an effective therapeutic intervention for the treatment of CP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCWPzRrTvJu7Vg90H21EOLACvtfcHk0lg8gbGtgR6aWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlsFeqsb0%253D&md5=5a078f2269ce541fce8d409c3626c436</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2020.104756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2020.104756%26sid%3Dliteratum%253Aachs%26aulast%3DBansod%26aufirst%3DS.%26aulast%3DAslam%2BSaifi%26aufirst%3DM.%26aulast%3DKhurana%26aufirst%3DA.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DNimbolide%2520abrogates%2520cerulein-induced%2520chronic%2520pancreatitis%2520by%2520modulating%2520beta-catenin%252FSmad%2520in%2520a%2520sirtuin-dependent%2520way%26jtitle%3DPharmacol.%2520Res.%26date%3D2020%26volume%3D156%26spage%3D104756%26doi%3D10.1016%2Fj.phrs.2020.104756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seshadri, V. D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span> <span> </span><span class="NLM_article-title">Evaluation of antiarthritic activity of nimbolide against Freundâs adjuvant induced arthritis in rats</span>. <i>Artif. Cells, Nanomed., Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">3391</span>â <span class="NLM_lpage">3398</span>, <span class="refDoi">Â DOI: 10.1080/21691401.2019.1649269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1080%2F21691401.2019.1649269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31394949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFGgs7fK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=3391-3398&author=X.+Cuiauthor=R.+Wangauthor=P.+Bianauthor=Q.+Wuauthor=V.+D.+D.+Seshadriauthor=L.+Liu&title=Evaluation+of+antiarthritic+activity+of+nimbolide+against+Freund%E2%80%99s+adjuvant+induced+arthritis+in+rats&doi=10.1080%2F21691401.2019.1649269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of antiarthritic activity of nimbolide against Freund's adjuvant induced arthritis in rats</span></div><div class="casAuthors">Cui, Xin; Wang, Ruijing; Bian, Peimin; Wu, Qingke; Seshadri, Vidya Devanatha Desikan; Liu, Lun</div><div class="citationInfo"><span class="NLM_cas:title">Artificial Cells, Nanomedicine, and Biotechnology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3391-3398</span>CODEN:
                <span class="NLM_cas:coden">ACNBCI</span>;
        ISSN:<span class="NLM_cas:issn">2169-141X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Nimbolide, a triterpenoid isolated from flower of neem tree possess various therapeutic properties.  The objective of the study was to assess the anti-arthritic activity of nimbolide in arthritis induced rats.  Nimbolide (20 mg/kg per day) was given orally to arthritic rats induced with Complete Freund's Adjuvant and changes inpaw vol., body wt., organ indexes (thymus and spleen), arthritic score, biochem. parameters and proinflammatory cytokines levels were detd.  Histopathol. anal. was also performed.  Western blot anal. was also performed.  Rats treated with nimbolide displayed marked redn. in arthritic score, organ indexes, vol. of paw, edema formation, along with substantial enhancement in body wt.  Histopathol. findings showed significant redn. in destruction of joints and inflammation following nimbolide treatment.  The protective action of arthritic rats treated with nimbolide was also substantiated by mol. and biochem. studies.  The results of the study show that nimbolide treatment has markedly enhanced health and reduced inflammation via lessening the proinflammatory cytokines expression in arthritic rats.  Hence, nimbolide may be used as a potent therapeutic drug in treating rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTDYjQAyNNJLVg90H21EOLACvtfcHk0lg8gbGtgR6aWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFGgs7fK&md5=88dbf07b388ad7c5cb981c061fc73c67</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F21691401.2019.1649269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21691401.2019.1649269%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DBian%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DSeshadri%26aufirst%3DV.%2BD.%2BD.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DEvaluation%2520of%2520antiarthritic%2520activity%2520of%2520nimbolide%2520against%2520Freund%25E2%2580%2599s%2520adjuvant%2520induced%2520arthritis%2520in%2520rats%26jtitle%3DArtif.%2520Cells%252C%2520Nanomed.%252C%2520Biotechnol.%26date%3D2019%26volume%3D47%26spage%3D3391%26epage%3D3398%26doi%3D10.1080%2F21691401.2019.1649269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pooladanda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatikonda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattnaik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigalapalli, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathini, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-Î± mediated NF-ÎºB and HDAC-3 nuclear translocation</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">81</span>, <span class="refDoi">Â DOI: 10.1038/s41419-018-1247-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fs41419-018-1247-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=30692512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3cjmtleruw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=81&author=V.+Pooladandaauthor=S.+Thatikondaauthor=S.+Baleauthor=B.+Pattnaikauthor=D.+K.+Sigalapalliauthor=N.+B.+Bathiniauthor=S.+B.+Singhauthor=C.+Godugu&title=Nimbolide+protects+against+endotoxin-induced+acute+respiratory+distress+syndrome+by+inhibiting+TNF-%CE%B1+mediated+NF-%CE%BAB+and+HDAC-3+nuclear+translocation&doi=10.1038%2Fs41419-018-1247-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-Î± mediated NF-ÎºB and HDAC-3 nuclear translocation</span></div><div class="casAuthors">Pooladanda Venkatesh; Thatikonda Sowjanya; Bale Swarna; Singh Shashi Bala; Godugu Chandraiah; Pattnaik Bijay; Sigalapalli Dilep Kumar; Bathini Nagendra Babu</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acute respiratory distress syndrome (ARDS) is characterized by an excessive acute inflammatory response in lung parenchyma, which ultimately leads to refractory hypoxemia.  One of the earliest abnormalities seen in lung injury is the elevated levels of inflammatory cytokines, among them, the soluble tumor necrosis factor (TNF-Î±) has a key role, which exerts cytotoxicity in epithelial and endothelial cells thus exacerbates edema.  The bacterial lipopolysaccharide (LPS) was used both in vitro (RAW 264.7, THP-1, MLE-12, A549, and BEAS-2B) and in vivo (C57BL/6 mice), as it activates a plethora of overlapping inflammatory signaling pathways involved in ARDS.  Nimbolide is a chemical constituent of Azadirachta indica, which contains multiple biological properties, while its role in ARDS is elusive.  Herein, we have investigated the protective effects of nimbolide in abrogating the complications associated with ARDS.  We showed that nimbolide markedly suppressed the nitrosative-oxidative stress, inflammatory cytokines, and chemokines expression by suppressing iNOS, myeloperoxidase, and nitrotyrosine expression.  Moreover, nimbolide mitigated the migration of neutrophils and mast cells whilst normalizing the LPS-induced hypothermia.  Also, nimbolide modulated the expression of epigenetic regulators with multiple HDAC inhibitory activity by suppressing the nuclear translocation of NF-ÎºB and HDAC-3.  We extended our studies using molecular docking studies, which demonstrated a strong interaction between nimbolide and TNF-Î±.  Additionally, we showed that treatment with nimbolide increased GSH, Nrf-2, SOD-1, and HO-1 protein expression; concomitantly abrogated the LPS-triggered TNF-Î±, p38 MAPK, mTOR, and GSK-3Î² protein expression.  Collectively, these results indicate that TNF-Î±-regulated NF-ÎºB and HDAC-3 crosstalk was ameliorated by nimbolide with promising anti-nitrosative, antioxidant, and anti-inflammatory properties in LPS-induced ARDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkFD5PpqlwQz0SWnHPWbmmfW6udTcc2eZLygF3b6ukIbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjmtleruw%253D%253D&md5=fa7f58b4c6a6ad4f29307e170ffe25a5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fs41419-018-1247-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-018-1247-9%26sid%3Dliteratum%253Aachs%26aulast%3DPooladanda%26aufirst%3DV.%26aulast%3DThatikonda%26aufirst%3DS.%26aulast%3DBale%26aufirst%3DS.%26aulast%3DPattnaik%26aufirst%3DB.%26aulast%3DSigalapalli%26aufirst%3DD.%2BK.%26aulast%3DBathini%26aufirst%3DN.%2BB.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DNimbolide%2520protects%2520against%2520endotoxin-induced%2520acute%2520respiratory%2520distress%2520syndrome%2520by%2520inhibiting%2520TNF-%25CE%25B1%2520mediated%2520NF-%25CE%25BAB%2520and%2520HDAC-3%2520nuclear%2520translocation%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2019%26volume%3D10%26spage%3D81%26doi%3D10.1038%2Fs41419-018-1247-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinnathambi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alharbi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">Nimbolide prevents myocardial damage by regulating cardiac biomarkers, antioxidant level, and apoptosis signaling against doxorubicin-induced cardiotoxicity in rats</span>. <i>J. Biochem. Mol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e22543</span>, <span class="refDoi">Â DOI: 10.1002/jbt.22543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fjbt.22543" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=e22543&author=H.+Liauthor=B.+Xiaauthor=W.+Chenauthor=Y.+Zhangauthor=X.+Gaoauthor=A.+Chinnathambiauthor=S.+A.+Alharbiauthor=Y.+Zhao&title=Nimbolide+prevents+myocardial+damage+by+regulating+cardiac+biomarkers%2C+antioxidant+level%2C+and+apoptosis+signaling+against+doxorubicin-induced+cardiotoxicity+in+rats&doi=10.1002%2Fjbt.22543"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fjbt.22543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbt.22543%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DXia%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DChinnathambi%26aufirst%3DA.%26aulast%3DAlharbi%26aufirst%3DS.%2BA.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DNimbolide%2520prevents%2520myocardial%2520damage%2520by%2520regulating%2520cardiac%2520biomarkers%252C%2520antioxidant%2520level%252C%2520and%2520apoptosis%2520signaling%2520against%2520doxorubicin-induced%2520cardiotoxicity%2520in%2520rats%26jtitle%3DJ.%2520Biochem.%2520Mol.%2520Toxicol.%26date%3D2020%26volume%3D6%26spage%3De22543%26doi%3D10.1002%2Fjbt.22543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alshammari, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinnasamy, T.</span></span> <span> </span><span class="NLM_article-title">Nimbolide attenuate the lipid accumulation, oxidative stress and antioxidant in primary hepatocytes</span>. <i>Mol. Biol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">463</span>â <span class="NLM_lpage">474</span>, <span class="refDoi">Â DOI: 10.1007/s11033-017-4132-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs11033-017-4132-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29185131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2isbrP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2017&pages=463-474&author=G.+M.+Alshammariauthor=A.+Balakrishnanauthor=T.+Chinnasamy&title=Nimbolide+attenuate+the+lipid+accumulation%2C+oxidative+stress+and+antioxidant+in+primary+hepatocytes&doi=10.1007%2Fs11033-017-4132-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide attenuate the lipid accumulation, oxidative stress and antioxidant in primary hepatocytes</span></div><div class="casAuthors">Alshammari, Ghedeir M.; Balakrishnan, Aristatile; Chinnasamy, Thirunavukkarasu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">463-474</span>CODEN:
                <span class="NLM_cas:coden">MLBRBU</span>;
        ISSN:<span class="NLM_cas:issn">0301-4851</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Nimbolide is a bioactive compd. found in Azadirachta indica.  This work was devised to investigate the potential effects of nimbolide on intracellular lipid deposition and its assocd. redox modulation in primary hepatocytes (Heps).  Lipid accumulation was induced in Heps by supplementing 1 mM oleic acid for 24 h which was marked by significant accumulation of lipids.  The results demonstrated that nimbolide can decrease intracellular cholesterol, free fatty acids and triglycerides.  Nimbolide may also improve hepatocytes function through its antioxidant effects by inhibiting oxidative DNA damage and lipid peroxidn. by curtailing the reactive oxygen species levels.  Further it also restore the mitochondrial potential, improving the endogenous antioxidant levels such as GSH and antioxidant enzyme activities.  Nimbolide increased (P < 0.05) liver X receptor-Î± (LXRÎ±), peroxisome proliferator-activated receptor-Î³ (PPARÎ³) and sterol regulatory element-binding protein-1c (SREBP1c) gene expression in Heps.  The biol. significance of nimbolide may involve hypolipidemic effect, lipid peroxidn. inhibition, DNA damage inhibition, ROS inhibition, restoring mitochondrial function, increases in GSH and SOD & CAT activities, and direct regulation of LXRÎ±, PPARÎ³ and SREBP1c gene expression.  Nimbolide may be used as effective lipid lowering compd. and lipid deposition-induced Heps changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_7jsirgw6K7Vg90H21EOLACvtfcHk0ljjMvPrmanAUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2isbrP&md5=bf0a2fd3fcff5c5adc52551e42fd93c2</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs11033-017-4132-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11033-017-4132-1%26sid%3Dliteratum%253Aachs%26aulast%3DAlshammari%26aufirst%3DG.%2BM.%26aulast%3DBalakrishnan%26aufirst%3DA.%26aulast%3DChinnasamy%26aufirst%3DT.%26atitle%3DNimbolide%2520attenuate%2520the%2520lipid%2520accumulation%252C%2520oxidative%2520stress%2520and%2520antioxidant%2520in%2520primary%2520hepatocytes%26jtitle%3DMol.%2520Biol.%2520Rep.%26date%3D2017%26volume%3D44%26spage%3D463%26epage%3D474%26doi%3D10.1007%2Fs11033-017-4132-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Omiecinski, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Heuvel, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdew, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">S49</span>â <span class="NLM_lpage">S75</span>, <span class="refDoi">Â DOI: 10.1093/toxsci/kfq338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1093%2Ftoxsci%2Fkfq338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=21059794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1Cgs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2011&pages=S49-S75&author=C.+J.+Omiecinskiauthor=J.+P.+Vanden+Heuvelauthor=G.+H.+Perdewauthor=J.+M.+Peters&title=Xenobiotic+metabolism%2C+disposition%2C+and+regulation+by+receptors%3A+from+biochemical+phenomenon+to+predictors+of+major+toxicities&doi=10.1093%2Ftoxsci%2Fkfq338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities</span></div><div class="casAuthors">Omiecinski, Curtis J.; Vanden Heuvel, John P.; Perdew, Gary H.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">S1</span>),
    <span class="NLM_cas:pages">S49-S75</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  To commemorate the 50th anniversary of the Society of Toxicol., this special edition article reviews the history and current scope of xenobiotic metab. and transport, with special emphasis on the discoveries and impact of selected "xenobiotic receptors.  " This overall research realm has witnessed dynamic development in the past 50 years, and several of the key milestone events that mark the impressive progress in these areas of toxicol. sciences are highlighted.  From the initial observations regarding aspects of drug metab. dating from the mid- to late 1800's, the area of biotransformation research witnessed seminal discoveries in the mid-1900's and onward that are remarkable in retrospect, including the discovery and characterization of the phase I monooxygenases, the cytochrome P450s.  Further research uncovered many aspects of the biochem. of xenobiotic metab., expanding to phase II conjugation and phase III xenobiotic transport.  This led to hallmark developments involving integration of genomic technologies to elucidate the basis for interindividual differences in response to xenobiotic exposures and discovery of nuclear and sol. receptor families that selectively "sense" the chem. milieu of the mammalian cell and orchestrate compensatory changes in gene expression programming to accommodate complex xenobiotic exposures.  This review will briefly summarize these developments and investigate the expanding roles of xenobiotic receptor biol. in the underlying basis of toxicol. response to chem. agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqposuXaLetvbVg90H21EOLACvtfcHk0ljjMvPrmanAUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1Cgs7Y%253D&md5=6e530678dc2bb6c3754268bbecb1560e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfq338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfq338%26sid%3Dliteratum%253Aachs%26aulast%3DOmiecinski%26aufirst%3DC.%2BJ.%26aulast%3DVanden%2BHeuvel%26aufirst%3DJ.%2BP.%26aulast%3DPerdew%26aufirst%3DG.%2BH.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DXenobiotic%2520metabolism%252C%2520disposition%252C%2520and%2520regulation%2520by%2520receptors%253A%2520from%2520biochemical%2520phenomenon%2520to%2520predictors%2520of%2520major%2520toxicities%26jtitle%3DToxicol.%2520Sci.%26date%3D2011%26volume%3D120%26spage%3DS49%26epage%3DS75%26doi%3D10.1093%2Ftoxsci%2Fkfq338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Priyadarsini, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manikandan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">The neem limonoids azadirachtin and nimbolide inhibit hamster cheek pouch carcinogenesis by modulating xenobiotic-metabolizing enzymes, DNA damage, antioxidants, invasion and angiogenesis</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">492</span>â <span class="NLM_lpage">504</span>, <span class="refDoi">Â DOI: 10.1080/10715760902870637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1080%2F10715760902870637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=19391054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvFKhs7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2009&pages=492-504&author=R.+V.+Priyadarsiniauthor=P.+Manikandanauthor=G.+H.+Kumarauthor=S.+Nagini&title=The+neem+limonoids+azadirachtin+and+nimbolide+inhibit+hamster+cheek+pouch+carcinogenesis+by+modulating+xenobiotic-metabolizing+enzymes%2C+DNA+damage%2C+antioxidants%2C+invasion+and+angiogenesis&doi=10.1080%2F10715760902870637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The neem limonoids azadirachtin and nimbolide inhibit hamster cheek pouch carcinogenesis by modulating xenobiotic-metabolizing enzymes, DNA damage, antioxidants, invasion and angiogenesis</span></div><div class="casAuthors">Priyadarsini, Ramamurthi Vidya; Manikandan, Palrasu; Kumar, Gurram Harish; Nagini, Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">492-504</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The neem tree has attracted considerable research attention as a rich source of limonoids that have potent antioxidant and anti-cancer properties.  The present study was designed to evaluate the chemopreventive potential of the neem limonoids azadirachtin and nimbolide based on in vitro antioxidant assays and in vivo inhibitory effects on 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis.  Both azadirachtin and nimbolide exhibited concn.-dependent anti-radical scavenging activity and reductive potential in the order: nimbolide > azadirachtin > ascorbate.  Administration of both azadirachtin and nimbolide inhibited the development of DMBA-induced HBP carcinomas by influencing multiple mechanisms including prevention of procarcinogen activation and oxidative DNA damage, upregulation of antioxidant and carcinogen detoxification enzymes and inhibition of tumor invasion and angiogenesis.  On a comparative basis, nimbolide was found to be a more potent antioxidant and chemopreventive agent and offers promise as a candidate agent in multitargeted prevention and treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdF8lJIsGfYLVg90H21EOLACvtfcHk0ljjMvPrmanAUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvFKhs7g%253D&md5=ba185fa75f8732a90a05047c44116cdb</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F10715760902870637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715760902870637%26sid%3Dliteratum%253Aachs%26aulast%3DPriyadarsini%26aufirst%3DR.%2BV.%26aulast%3DManikandan%26aufirst%3DP.%26aulast%3DKumar%26aufirst%3DG.%2BH.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DThe%2520neem%2520limonoids%2520azadirachtin%2520and%2520nimbolide%2520inhibit%2520hamster%2520cheek%2520pouch%2520carcinogenesis%2520by%2520modulating%2520xenobiotic-metabolizing%2520enzymes%252C%2520DNA%2520damage%252C%2520antioxidants%252C%2520invasion%2520and%2520angiogenesis%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2009%26volume%3D43%26spage%3D492%26epage%3D504%26doi%3D10.1080%2F10715760902870637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sritanaudomchai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusamran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuakulkiat, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunyapraphatsara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiransalee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tepsuwan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusamran, W. R.</span></span> <span> </span><span class="NLM_article-title">Quinone reductase inducers in Azadirachta indica A. Juss flowers, and their mechanisms of action</span>. <i>Asian Pac. J. Cancer Prev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">263</span>â <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=16235984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BD2MrlvFGksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=263-269&author=H.+Sritanaudomchaiauthor=T.+Kusamranauthor=W.+Kuakulkiatauthor=N.+Bunyapraphatsaraauthor=A.+Hiransaleeauthor=A.+Tepsuwanauthor=W.+R.+Kusamran&title=Quinone+reductase+inducers+in+Azadirachta+indica+A.+Juss+flowers%2C+and+their+mechanisms+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Quinone reductase inducers in Azadirachta indica A. Juss flowers, and their mechanisms of action</span></div><div class="casAuthors">Sritanaudomchai Hathaitip; Kusamran Thanit; Kuakulkiat Worapun; Bunyapraphatsara Nuntavan; Hiransalee Ankana; Tepsuwan Anong; Kusamran Wannee R</div><div class="citationInfo"><span class="NLM_cas:title">Asian Pacific journal of cancer prevention : APJCP</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-9</span>
        ISSN:<span class="NLM_cas:issn">1513-7368</span>.
    </div><div class="casAbstract">We have previously shown that the flowers of neem tree (Azadirachta indica A.  Juss, family Meliaceae), Thai variety, strongly induced the activity of glutathione S-transferase (GST) while resulting in a significant reduction in the activities of some cytochrome P(450)-dependent monooxygenases in rat liver, and possess cancer chemopreventive potential against chemically-induced mammary gland and liver carcinogenesis in rats.  In the present study, 2 chemicals possessing strong QR inducing activity were fractionated from neem flowers using a bioassay based on the induction of QR activity in mouse hepatoma Hepa 1c1c7 cultured cells.  Spectroscopic characteristics revealed that these compounds were nimbolide and chlorophylls, having CD (concentration required to double QR specific activity) values of 0.16 and 3.8 mug/ml, respectively.  Nimbolide is a known constituent of neem leaves, but was found for the first time here in the flowers.  Both nimbolide and chlorophylls strongly enhanced the level of QR mRNA in Hepa 1c1c7 cells, as monitored by northern blot hybridization, indicating that the mechanism by which these constituents of neem flowers induced QR activity is the induction of QR gene expression.  These findings may have implication on cancer chemopreventive potential of neem flowers in experimental rats previously reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwLFuv8uoqC2Gmni0r9GoKfW6udTcc2ea3abz_UGIy77ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrlvFGksg%253D%253D&md5=af625dd87148d6c7fa312a260174dc29</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSritanaudomchai%26aufirst%3DH.%26aulast%3DKusamran%26aufirst%3DT.%26aulast%3DKuakulkiat%26aufirst%3DW.%26aulast%3DBunyapraphatsara%26aufirst%3DN.%26aulast%3DHiransalee%26aufirst%3DA.%26aulast%3DTepsuwan%26aufirst%3DA.%26aulast%3DKusamran%26aufirst%3DW.%2BR.%26atitle%3DQuinone%2520reductase%2520inducers%2520in%2520Azadirachta%2520indica%2520A.%2520Juss%2520flowers%252C%2520and%2520their%2520mechanisms%2520of%2520action%26jtitle%3DAsian%2520Pac.%2520J.%2520Cancer%2520Prev.%26date%3D2005%26volume%3D6%26spage%3D263%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manikandan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anandan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Azadirachta indica leaf fractions for in vitro antioxidant potential and protective effects against H2O2-induced oxidative damage to pBR322 DNA and red blood cells</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6990</span>â <span class="NLM_lpage">6996</span>, <span class="refDoi">Â DOI: 10.1021/jf901351n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf901351n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD1MXot1egsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2009&pages=6990-6996&author=P.+Manikandanauthor=R.+Anandanauthor=S.+Nagini&title=Evaluation+of+Azadirachta+indica+leaf+fractions+for+in+vitro+antioxidant+potential+and+protective+effects+against+H2O2-induced+oxidative+damage+to+pBR322+DNA+and+red+blood+cells&doi=10.1021%2Fjf901351n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Azadirachta indica Leaf Fractions for in Vitro Antioxidant Potential and Protective Effects against H2O2-Induced Oxidative Damage to pBR322 DNA and Red Blood Cells</span></div><div class="casAuthors">Manikandan, P.; Anandan, R.; Nagini, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6990-6996</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We evaluated the protective effects of subfractions of the Et acetate fraction (EAF) and the methanolic fraction (MF) from the crude ethanolic ext. (CEE) of Azadirachta indica A. Juss (neem) leaves against various free radicals and hydrogen peroxide (H2O2)-induced oxidative damage to red blood cells (RBCs) and pBR322 DNA.  Neem leaf fractions reduced DPPHÂ·, ABTSÂ·+, superoxide (OÂ·-), hydroxyl (OHÂ·), and nitric oxide radicals to nonradical forms in a concn.-dependent manner.  Treatment with the benzene insol. fraction from EAF (EBIF), the chloroform insol. fraction from EAF (ECIF), the chloroform insol. fraction from MF (MCIF), and the Et acetate insol. fraction from MF (MEIF) significantly mitigated H2O2-induced oxidative damage to RBCs and pBR322 DNA.  Although we found low in vitro free radical scavenging activity for the benzene insol. fraction from EAF (EBSF), the chloroform sol. fraction from EAF (ECSF), the chloroform sol. fraction from MF (MCSF), and the Et acetate sol. fraction from MF (MESF), these fractions showed no effect on H2O2-induced lipid peroxidn. and pBR322 DNA damage.  High-performance liq. chromatog. (HPLC) and TLC-Iatroscan anal. revealed that the greater efficacy of EBIF, ECIF, MCIF, and MEIF may be due to the presence of more polar compds. such as nimbolide and quercetin.  Our studies suggest that the antioxidant and protective effects of active neem leaf fractions against H2O2-induced lipid peroxidn. and pBR322 DNA damage can be attributed to their ability to inhibit various free radicals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdo7rLKD2dCbVg90H21EOLACvtfcHk0lg2U_1tGJQXgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXot1egsLw%253D&md5=03b0ba26aae2ee6ac5b23b4e3c2e9d33</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjf901351n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf901351n%26sid%3Dliteratum%253Aachs%26aulast%3DManikandan%26aufirst%3DP.%26aulast%3DAnandan%26aufirst%3DR.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DEvaluation%2520of%2520Azadirachta%2520indica%2520leaf%2520fractions%2520for%2520in%2520vitro%2520antioxidant%2520potential%2520and%2520protective%2520effects%2520against%2520H2O2-induced%2520oxidative%2520damage%2520to%2520pBR322%2520DNA%2520and%2520red%2520blood%2520cells%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2009%26volume%3D57%26spage%3D6990%26epage%3D6996%26doi%3D10.1021%2Fjf901351n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansari, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jameel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parveen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddique, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shadab, G. G. H. A.</span></span> <span> </span><span class="NLM_article-title">Protective role of nimbolide against chemotherapeutic drug hydroxyurea induced genetic and oxidative damage in an animal model</span>. <i>Environ. Toxicol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">91</span>â <span class="NLM_lpage">99</span>, <span class="refDoi">Â DOI: 10.1016/j.etap.2018.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.etap.2018.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29679812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVSms7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2018&pages=91-99&author=M.+F.+Ahmadauthor=M.+O.+Ansariauthor=S.+Jameelauthor=A.+L.+Waniauthor=N.+Parveenauthor=H.+R.+Siddiqueauthor=G.+G.+H.+A.+Shadab&title=Protective+role+of+nimbolide+against+chemotherapeutic+drug+hydroxyurea+induced+genetic+and+oxidative+damage+in+an+animal+model&doi=10.1016%2Fj.etap.2018.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Protective role of nimbolide against chemotherapeutic drug hydroxyurea induced genetic and oxidative damage in an animal model</span></div><div class="casAuthors">Ahmad, Md. Fahim; Ansari, Mohd. Owais; Jameel, Sana; Wani, Ab Latif; Parveen, Nuzhat; Siddique, Hifzur R.; Shadab, G. G. H. A.</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Toxicology and Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">91-99</span>CODEN:
                <span class="NLM_cas:coden">ETOPFR</span>;
        ISSN:<span class="NLM_cas:issn">1382-6689</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nimbolide is known to be an antioxidant found in neem plant.  Hydroxyurea is a medication frequently used in sickle-cell disease, different cancers and HIV infection.  The present study aimed to evaluate the adverse effect of HU and possible amelioration by nimbolide in Wistar rats.  To test the authors' hypothesis, the authors performed genotoxicity tests, biochem. assays, and histopathol. studies.  The authors obsd. that HU caused higher levels of genotoxicity in the treated animals.  The obsd. genetic and oxidative damage might be due to the presence of reactive species as HU increased the level of the malondialdehyde-a biomarker of oxidative damage.  Interestingly, co-treatment of animals with HU and nimbolide showed a lower level of damage.  The authors conclude that nimbolide significantly protects the cells from the adverse effect of HU and could be considered as a potential adjuvant for the patients under HU therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprHcUvw3gh77Vg90H21EOLACvtfcHk0lg2U_1tGJQXgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVSms7k%253D&md5=f523b8c2711e33fe58e0810e8eaf4a6e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.etap.2018.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.etap.2018.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DM.%2BF.%26aulast%3DAnsari%26aufirst%3DM.%2BO.%26aulast%3DJameel%26aufirst%3DS.%26aulast%3DWani%26aufirst%3DA.%2BL.%26aulast%3DParveen%26aufirst%3DN.%26aulast%3DSiddique%26aufirst%3DH.%2BR.%26aulast%3DShadab%26aufirst%3DG.%2BG.%2BH.%2BA.%26atitle%3DProtective%2520role%2520of%2520nimbolide%2520against%2520chemotherapeutic%2520drug%2520hydroxyurea%2520induced%2520genetic%2520and%2520oxidative%2520damage%2520in%2520an%2520animal%2520model%26jtitle%3DEnviron.%2520Toxicol.%2520Pharmacol.%26date%3D2018%26volume%3D60%26spage%3D91%26epage%3D99%26doi%3D10.1016%2Fj.etap.2018.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhammad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gho, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, S. K.</span></span> <span> </span><span class="NLM_article-title">Nimbolide represses the proliferation, migration, and invasion of bladder carcinoma cells via Chk2-mediated G2/M phase cell cycle arrest, altered signaling pathways, and reduced transcription factors-associated MMP-9 expression</span>. <i>Evid. Based Complement Alternat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2019</i></span>,  <span class="NLM_fpage">3753587</span>, <span class="refDoi">Â DOI: 10.1155/2019/3753587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1155%2F2019%2F3753587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31391858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3MvlvFSqtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&pages=3753587&author=S.+S.+Shinauthor=B.+Hwangauthor=K.+Muhammadauthor=Y.+Ghoauthor=J.+H.+Songauthor=W.+J.+Kimauthor=G.+Kimauthor=S.+K.+Moon&title=Nimbolide+represses+the+proliferation%2C+migration%2C+and+invasion+of+bladder+carcinoma+cells+via+Chk2-mediated+G2%2FM+phase+cell+cycle+arrest%2C+altered+signaling+pathways%2C+and+reduced+transcription+factors-associated+MMP-9+expression&doi=10.1155%2F2019%2F3753587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide Represses the Proliferation, Migration, and Invasion of Bladder Carcinoma Cells via Chk2-Mediated G2/M Phase Cell Cycle Arrest, Altered Signaling Pathways, and Reduced Transcription Factors-Associated MMP-9 Expression</span></div><div class="casAuthors">Shin Seung-Shick; Hwang Byungdoo; Gho Yujeong; Song Jun-Hui; Moon Sung-Kwon; Muhammad Kashif; Kim Gonhyung; Kim Wun-Jae</div><div class="citationInfo"><span class="NLM_cas:title">Evidence-based complementary and alternative medicine : eCAM</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2019</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3753587</span>
        ISSN:<span class="NLM_cas:issn">1741-427X</span>.
    </div><div class="casAbstract">Nimbolide, an active chemical constituent of Azadirachta indica, reportedly has several physiological effects.  Here, we assessed novel anticancer effects of nimbolide against bladder cancer EJ and 5637 cells.  Nimbolide treatment inhibited the proliferation of both bladder cancer cell lines with an IC50 value of 3 Î¼M.  Treatment of cells with nimbolide induced G2/M phase cell cycle arrest via both Chk2-Cdc25C-Cdc2/cyclin B1-Wee1 pathway and Chk2-p21WAF1-Cdc2/cyclin B1-Wee1 pathway.  Nimbolide increased JNK phosphorylation and decreased p38MAPK and AKT phosphorylation.  Additionally, nimbolide impeded both wound healing migration and invasion abilities by suppressing matrix metalloproteinase-9 (MMP-9) activity.  Finally, nimbolide repressed the binding activity of NF-ÎºB, Sp-1, and AP-1 motifs, which are key transcription factors for MMP-9 activity regulation.  Overall, our study indicates that nimbolide is a potential chemotherapeutic agent for bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSq3560K0J4HtNTrvPZP1IpfW6udTcc2ebsZioocIrTPLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvlvFSqtw%253D%253D&md5=a84a3a5ccf89bab120232869a4946745</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1155%2F2019%2F3753587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2019%252F3753587%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DS.%2BS.%26aulast%3DHwang%26aufirst%3DB.%26aulast%3DMuhammad%26aufirst%3DK.%26aulast%3DGho%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DW.%2BJ.%26aulast%3DKim%26aufirst%3DG.%26aulast%3DMoon%26aufirst%3DS.%2BK.%26atitle%3DNimbolide%2520represses%2520the%2520proliferation%252C%2520migration%252C%2520and%2520invasion%2520of%2520bladder%2520carcinoma%2520cells%2520via%2520Chk2-mediated%2520G2%252FM%2520phase%2520cell%2520cycle%2520arrest%252C%2520altered%2520signaling%2520pathways%252C%2520and%2520reduced%2520transcription%2520factors-associated%2520MMP-9%2520expression%26jtitle%3DEvid.%2520Based%2520Complement%2520Alternat.%2520Med.%26date%3D2019%26volume%3D2019%26spage%3D3753587%26doi%3D10.1155%2F2019%2F3753587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elumalai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunadharini, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senthilkumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banudevi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunkumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharmila, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunakaran, J.</span></span> <span> </span><span class="NLM_article-title">Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>215</i></span>,  <span class="NLM_fpage">131</span>â <span class="NLM_lpage">142</span>, <span class="refDoi">Â DOI: 10.1016/j.toxlet.2012.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.toxlet.2012.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=23089555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7nJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2012&pages=131-142&author=P.+Elumalaiauthor=D.+N.+Gunadhariniauthor=K.+Senthilkumarauthor=S.+Banudeviauthor=R.+Arunkumarauthor=C.+S.+Bensonauthor=G.+Sharmilaauthor=J.+Arunakaran&title=Induction+of+apoptosis+in+human+breast+cancer+cells+by+nimbolide+through+extrinsic+and+intrinsic+pathway&doi=10.1016%2Fj.toxlet.2012.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway</span></div><div class="casAuthors">Elumalai, P.; Gunadharini, D. N.; Senthilkumar, K.; Banudevi, S.; Arunkumar, R.; Benson, C. S.; Sharmila, G.; Arunakaran, J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-142</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">We aimed to investigate the cytotoxic effects of nimbolide, a limonoid present in leaves and flowers of the neem tree (Azadirachta indica) on human breast cancer cells.  The mol. mechanisms involved in the apoptotic activity exerted by nimbolide were studied on the estrogen dependent (MCF-7) and estrogen independent (MDA-MB-231) human breast cancer cell lines.  The growth inhibitory effect of nimbolide was assessed by MTT assay.  Apoptosis induction by nimbolide treatment was detd. by JC-1 mitochondrial membrane potential staining, cytochrome c release, caspase activation, cleavage of PARP and AO/EtBr dual staining.  The modulation of apoptotic proteins (intrinsic pathway: Bax, bad, Bcl-2, Bcl-xL, Mcl-1, XIAP-1 and caspase-3, 9; extrinsic pathway: TRAIL, FasL, FADDR and Caspase-8) were studied by western blot and real time PCR anal.  Treatment with nimbolide resulted in dose and time-dependent inhibition of growth of MCF-7 and MDA-MB-231 cells.  The occurrence of apoptosis in these cells was indicated by JC-1 staining, modulation of both intrinsic and extrinsic apoptotic signaling mols. expression and further apoptosis was confirmed by AO/EtBr dual staining.  These events were assocd. with: increased levels of proapoptotic proteins Bax, Bad, Fas-L, TRAIL, FADDR, cytochrome c and reduced levels of the anti-apoptotic proteins Bcl-2, Bcl-xL, Mcl-1 and XIAP-1.  Nimbolide induces the cleavage of pro-caspase-8, pro-caspase-3 and PARP.  The above data suggest that nimbolide induces apoptosis by both the intrinsic and extrinsic pathways.  With evidence of above data it is suggested that nimbolide exhibit anticancer effect through its apoptosis-inducing property.  Thus, nimbolide raises new hope for its use in anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbu-R8QusMprVg90H21EOLACvtfcHk0ljWs4E2vFXZFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7nJ&md5=39fb463162d9c9fb21e707b2af5b2b1a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2012.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2012.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DElumalai%26aufirst%3DP.%26aulast%3DGunadharini%26aufirst%3DD.%2BN.%26aulast%3DSenthilkumar%26aufirst%3DK.%26aulast%3DBanudevi%26aufirst%3DS.%26aulast%3DArunkumar%26aufirst%3DR.%26aulast%3DBenson%26aufirst%3DC.%2BS.%26aulast%3DSharmila%26aufirst%3DG.%26aulast%3DArunakaran%26aufirst%3DJ.%26atitle%3DInduction%2520of%2520apoptosis%2520in%2520human%2520breast%2520cancer%2520cells%2520by%2520nimbolide%2520through%2520extrinsic%2520and%2520intrinsic%2520pathway%26jtitle%3DToxicol.%2520Lett.%26date%3D2012%26volume%3D215%26spage%3D131%26epage%3D142%26doi%3D10.1016%2Fj.toxlet.2012.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elumalai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunkumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharmila, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunakaran, J.</span></span> <span> </span><span class="NLM_article-title">Nimbolide inhibits IGF-I-mediated PI3K/Akt and MAPK signalling in human breast cancer cell lines (MCF-7 and MDA-MB-231)</span>. <i>Cell Biochem.Funct.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">476</span>â <span class="NLM_lpage">484</span>, <span class="refDoi">Â DOI: 10.1002/cbf.3040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fcbf.3040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=24888707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOgtrfM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=476-484&author=P.+Elumalaiauthor=R.+Arunkumarauthor=C.+S.+Bensonauthor=G.+Sharmilaauthor=J.+Arunakaran&title=Nimbolide+inhibits+IGF-I-mediated+PI3K%2FAkt+and+MAPK+signalling+in+human+breast+cancer+cell+lines+%28MCF-7+and+MDA-MB-231%29&doi=10.1002%2Fcbf.3040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide inhibits IGF-I-mediated PI3K/Akt and MAPK signalling in human breast cancer cell lines (MCF-7 and MDA-MB-231)</span></div><div class="casAuthors">Elumalai, Perumal; Arunkumar, Ramachandran; Benson, Chellakkan Selvanesan; Sharmila, Govindaraj; Arunakaran, Jagadeesan</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Function</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">476-484</span>CODEN:
                <span class="NLM_cas:coden">CBFUDH</span>;
        ISSN:<span class="NLM_cas:issn">1099-0844</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The insulin-like growth factor I (IGF-I) signalling pathway contributes a major role on various cancer cell proliferation, survival and cell cycle.  The present study was aimed to investigate the effect of nimbolide on IGF signalling and cell cycle arrest in MCF-7 and MDA-MB-231 breast cancer cell lines.  The protein expression of IGF signalling mols. and cell cycle protein levels was assessed by western blot anal.  In order to study the interaction of nimbolide on IGF-1 signalling pathway, IGF-I and phosphoinositide 3-kinase (PI3K) inhibitor (LY294002) were used to treat MCF-7 and MDA-MB-231 cells.  Further, the cell cycle arrest was analyzed by flow cytometry.  The protein expression of IGF signalling mols. was significantly decreased in nimbolide-treated breast cancer cells.  PI3K inhibitor and IGF-I with nimbolide treatment notably inhibited phosphorylated Akt.  The cell cycle arrest was obsd. at the G0/G1 phase, and accumulation of apoptotic cells was obsd. in nimbolide-treated breast cancer cell lines.  Nimbolide also increased the protein expression of p21 and decreased the cyclins in both the cell lines.  Nimbolide decreases the proliferation of breast cancer cells by modulating the IGF signalling mols., which could be very useful for the breast cancer treatment.  Copyright 2014 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9883XOzRxSbVg90H21EOLACvtfcHk0ljWs4E2vFXZFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOgtrfM&md5=c3bb5fab0647b6d2fac5dce2f87218df</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fcbf.3040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbf.3040%26sid%3Dliteratum%253Aachs%26aulast%3DElumalai%26aufirst%3DP.%26aulast%3DArunkumar%26aufirst%3DR.%26aulast%3DBenson%26aufirst%3DC.%2BS.%26aulast%3DSharmila%26aufirst%3DG.%26aulast%3DArunakaran%26aufirst%3DJ.%26atitle%3DNimbolide%2520inhibits%2520IGF-I-mediated%2520PI3K%252FAkt%2520and%2520MAPK%2520signalling%2520in%2520human%2520breast%2520cancer%2520cell%2520lines%2520%2528MCF-7%2520and%2520MDA-MB-231%2529%26jtitle%3DCell%2520Biochem.Funct.%26date%3D2014%26volume%3D32%26spage%3D476%26epage%3D484%26doi%3D10.1002%2Fcbf.3040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elumalai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindha Mercy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunkamar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharmila, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunakaran, J.</span></span> <span> </span><span class="NLM_article-title">Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines</span>. <i>Cell Proliferation</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">540</span>â <span class="NLM_lpage">552</span>, <span class="refDoi">Â DOI: 10.1111/cpr.12148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1111%2Fcpr.12148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=25377085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2ht7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2014&pages=540-552&author=P.+Elumalaiauthor=A.+Brindha+Mercyauthor=R.+Arunkamarauthor=G.+Sharmilaauthor=F.+A.+Bhatauthor=S.+Balakrishnanauthor=P.+Raja+Singhauthor=J.+Arunakaran&title=Nimbolide+inhibits+invasion+and+migration%2C+and+down-regulates+uPAR+chemokine+gene+expression%2C+in+two+breast+cancer+cell+lines&doi=10.1111%2Fcpr.12148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines</span></div><div class="casAuthors">Elumalai, P.; Brindha Mercy, A.; Arunkamar, R.; Sharmila, G.; Bhat, F. A.; Balakrishnan, S.; Raja Singh, P.; Arunakaran, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Proliferation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">540-552</span>CODEN:
                <span class="NLM_cas:coden">CPROEM</span>;
        ISSN:<span class="NLM_cas:issn">0960-7722</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Objectives : Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women, worldwide.  Urokinase type plasminogen activator (uPA) is a serine protease that is involved in cancer progression, esp. invasion and metastasis of breast cancer.  Nimbolide is a potent cytotoxic limnoid isolated from Azadirachta indica.  Our previous studies have shown that nimbolide elicits pleiotropic effects on breast cancer cells; however, its roles in invasion and migration have not previously been fully elucidated.  Materials and methods : Protein expression of pEGFR, VEGFR, NFÎºB, IKKÎ±, IKKÎ², MMP-2, MMP-9 and TIMP-2 were analyzed by western blotting.  We also analyzed expressions of uPA, uPAR genes and chemokines by real-time PCR.  Breast cancer cell invasion was assessed by transwell invasion assay and cell migration analyzed by scratch wound healing assay.  Results : Our results showed that reduced protein expression of pEGFR, VEGFR, NFÎºB, IKKÎ±, Î², MMP-2, MMP-9 and TIMP-2 was higher in nimbolide-treated breast cancer cells. mRNA expression of uPA, uPAR, chemokines and their receptors were also significantly reduced in response to nimbolide treatment.  Nimbolide inhibited breast cancer cell migration and invasion as shown in transwell invasion and wound healing assays.  Conclusion : These results clearly proved inhibitory effects of nimbolide on tumor cell invasion and migration by down-regulating proteins critically involved in regulation of cell invasion and metastasis, suggesting a possible therapeutic role of nimbolide for breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy0lYpf5X9u7Vg90H21EOLACvtfcHk0lj85vx7FF_b3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2ht7nK&md5=3a3da381493a25678173aaaddbda9eae</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fcpr.12148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcpr.12148%26sid%3Dliteratum%253Aachs%26aulast%3DElumalai%26aufirst%3DP.%26aulast%3DBrindha%2BMercy%26aufirst%3DA.%26aulast%3DArunkamar%26aufirst%3DR.%26aulast%3DSharmila%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DF.%2BA.%26aulast%3DBalakrishnan%26aufirst%3DS.%26aulast%3DRaja%2BSingh%26aufirst%3DP.%26aulast%3DArunakaran%26aufirst%3DJ.%26atitle%3DNimbolide%2520inhibits%2520invasion%2520and%2520migration%252C%2520and%2520down-regulates%2520uPAR%2520chemokine%2520gene%2520expression%252C%2520in%2520two%2520breast%2520cancer%2520cell%2520lines%26jtitle%3DCell%2520Proliferation%26date%3D2014%26volume%3D47%26spage%3D540%26epage%3D552%26doi%3D10.1111%2Fcpr.12148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pooladanda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondi, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottumukkala, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">Nimbolide epigenetically regulates autophagy and apoptosis in breast cancer</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">114</span>â <span class="NLM_lpage">128</span>, <span class="refDoi">Â DOI: 10.1016/j.tiv.2018.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.tiv.2018.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29778718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVSgu7vM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2018&pages=114-128&author=V.+Pooladandaauthor=S.+Bandiauthor=S.+R.+Mondiauthor=K.+M.+Gottumukkalaauthor=C.+Godugu&title=Nimbolide+epigenetically+regulates+autophagy+and+apoptosis+in+breast+cancer&doi=10.1016%2Fj.tiv.2018.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide epigenetically regulates autophagy and apoptosis in breast cancer</span></div><div class="casAuthors">Pooladanda, Venkatesh; Bandi, Soumya; Mondi, Sandhya Rani; Gottumukkala, Krishna Mohan; Godugu, Chandraiah</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology In Vitro</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114-128</span>CODEN:
                <span class="NLM_cas:coden">TIVIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0887-2333</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Autophagy is a crit. regulator of cellular homeostasis and its dysregulation often results in various disease manifestations, including cancer.  Nimbolide, an active chem. constituent of neem (Azadirachta indica) exhibits potent anticancer effects.  Although, nimbolide mediated apoptosis activation in breast cancer cells is well known.  Nevertheless, its role in autophagy induction mechanism and epigenetic alteration is not explored previously.  The authors' current study intended to bridge the gaps in the existing research by exploring the potential of nimbolide in inducing autophagy, which could counter regulate the transformations in breast cancer.  In the authors' studies, nimbolide significantly inhibited the cell proliferation of MDA-MB-231 and MCF-7 cells with IC50 values of 1.97 and 5.04 Î¼M, resp.  Nimbolide markedly arrested the cell cycle progression and cell survival with loss of mitochondrial membrane potential by reducing Bcl-2 concomitantly inducing Bax and caspases protein expression with modulation of HDAC-2 and H3K27Ac expression.  Consequently, characteristic autophagolysosome accumulation was obsd. by acridine orange, monodansylcadaverine (MDC) and Lysotracker Red staining.  Moreover, nimbolide induced autophagy signaling by increasing Beclin 1 and LC3B along with decreased p62 and mTOR protein expression.  Thus, the authors' findings imply that nimbolide induces autophagy mediated apoptotic cell death in breast cancer with epigenetic modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEtzXopBYiOLVg90H21EOLACvtfcHk0lj85vx7FF_b3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVSgu7vM&md5=0585d8ebe91341dec1d41a27416e657b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2018.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2018.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DPooladanda%26aufirst%3DV.%26aulast%3DBandi%26aufirst%3DS.%26aulast%3DMondi%26aufirst%3DS.%2BR.%26aulast%3DGottumukkala%26aufirst%3DK.%2BM.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DNimbolide%2520epigenetically%2520regulates%2520autophagy%2520and%2520apoptosis%2520in%2520breast%2520cancer%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2018%26volume%3D51%26spage%3D114%26epage%3D128%26doi%3D10.1016%2Fj.tiv.2018.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spradlin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brittain, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proudfoot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornelas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woldegiorgis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olzmann, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bussiere, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maimone, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span> <span> </span><span class="NLM_article-title">Harnessing the anti-cancer natural product nimbolide for targeted protein degradation</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">747</span>â <span class="NLM_lpage">755</span>, <span class="refDoi">Â DOI: 10.1038/s41589-019-0304-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fs41589-019-0304-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31209351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFymtbjJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=747-755&author=J.+N.+Spradlinauthor=X.+Huauthor=C.+C.+Wardauthor=S.+M.+Brittainauthor=M.+D.+Jonesauthor=L.+Ouauthor=M.+Toauthor=A.+Proudfootauthor=E.+Ornelasauthor=M.+Woldegiorgisauthor=J.+A.+Olzmannauthor=D.+E.+Bussiereauthor=J.+Thomasauthor=J.+A.+Tallaricoauthor=J.+M.+McKennaauthor=M.+Schirleauthor=T.+J.+Maimoneauthor=D.+K.+Nomura&title=Harnessing+the+anti-cancer+natural+product+nimbolide+for+targeted+protein+degradation&doi=10.1038%2Fs41589-019-0304-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing the anti-cancer natural product nimbolide for targeted protein degradation</span></div><div class="casAuthors">Spradlin, Jessica N.; Hu, Xirui; Ward, Carl C.; Brittain, Scott M.; Jones, Michael D.; Ou, Lisha; To, Milton; Proudfoot, Andrew; Ornelas, Elizabeth; Woldegiorgis, Mikias; Olzmann, James A.; Bussiere, Dirksen E.; Thomas, Jason R.; Tallarico, John A.; McKenna, Jeffrey M.; Schirle, Markus; Maimone, Thomas J.; Nomura, Daniel K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">747-755</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Nimbolide, a terpenoid natural product derived from the Neem tree, impairs cancer pathogenicity; however, the direct targets and mechanisms by which nimbolide exerts its effects are poorly understood.  Here, we used activity-based protein profiling (ABPP) chemoproteomic platforms to discover that nimbolide reacts with a novel functional cysteine crucial for substrate recognition in the E3 ubiquitin ligase RNF114.  Nimbolide impairs breast cancer cell proliferation in-part by disrupting RNF114-substrate recognition, leading to inhibition of ubiquitination and degrdn. of tumor suppressors such as p21, resulting in their rapid stabilization.  We further demonstrate that nimbolide can be harnessed to recruit RNF114 as an E3 ligase in targeted protein degrdn. applications and show that synthetically simpler scaffolds are also capable of accessing this unique reactive site.  Our study highlights the use of ABPP platforms in uncovering unique druggable modalities accessed by natural products for cancer therapy and targeted protein degrdn. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5pXgwBOxeG7Vg90H21EOLACvtfcHk0lj85vx7FF_b3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFymtbjJ&md5=02b64cab829d7307b6dd6555617aa796</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fs41589-019-0304-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41589-019-0304-8%26sid%3Dliteratum%253Aachs%26aulast%3DSpradlin%26aufirst%3DJ.%2BN.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DWard%26aufirst%3DC.%2BC.%26aulast%3DBrittain%26aufirst%3DS.%2BM.%26aulast%3DJones%26aufirst%3DM.%2BD.%26aulast%3DOu%26aufirst%3DL.%26aulast%3DTo%26aufirst%3DM.%26aulast%3DProudfoot%26aufirst%3DA.%26aulast%3DOrnelas%26aufirst%3DE.%26aulast%3DWoldegiorgis%26aufirst%3DM.%26aulast%3DOlzmann%26aufirst%3DJ.%2BA.%26aulast%3DBussiere%26aufirst%3DD.%2BE.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DMcKenna%26aufirst%3DJ.%2BM.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DMaimone%26aufirst%3DT.%2BJ.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26atitle%3DHarnessing%2520the%2520anti-cancer%2520natural%2520product%2520nimbolide%2520for%2520targeted%2520protein%2520degradation%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D15%26spage%3D747%26epage%3D755%26doi%3D10.1038%2Fs41589-019-0304-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Priyadarsini, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugan, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sripriya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karunagaran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">The neem limonoids azadirachtin and nimbolide induce cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">624</span>â <span class="NLM_lpage">634</span>, <span class="refDoi">Â DOI: 10.3109/10715761003692503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3109%2F10715761003692503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=20429769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVWis7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2010&pages=624-634&author=R.+V.+Priyadarsiniauthor=R.+S.+Muruganauthor=P.+Sripriyaauthor=D.+Karunagaranauthor=S.+Nagini&title=The+neem+limonoids+azadirachtin+and+nimbolide+induce+cell+cycle+arrest+and+mitochondria-mediated+apoptosis+in+human+cervical+cancer+%28HeLa%29+cells&doi=10.3109%2F10715761003692503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The neem limonoids azadirachtin and nimbolide induce cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells</span></div><div class="casAuthors">Priyadarsini, R. Vidya; Murugan, R. Senthil; Sripriya, P.; Karunagaran, D.; Nagini, S.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">624-634</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Limonoids from the neem tree (Azadirachta indica) have attracted considerable research attention in recent years owing to their potent antioxidant and anti-proliferative effects.  The present study was designed to investigate the cellular and mol. mechanisms by which azadirachtin and nimbolide exert cytotoxic effects in the human cervical cancer (HeLa) cell line.  Both azadirachtin and nimbolide significantly suppressed the viability of HeLa cells in a dose-dependent manner by inducing cell cycle arrest at G0/G1 phase accompanied by p53-dependent p21 accumulation and down-regulation of the cell cycle regulatory proteins cyclin B, cyclin D1 and PCNA.  Characteristic changes in nuclear morphol., presence of a subdiploid peak and annexin-V staining pointed to apoptosis as the mode of cell death.  Increased generation of reactive oxygen species with decline in the mitochondrial transmembrane potential and release of cytochrome c confirmed that the neem limonoids transduced the apoptotic signal via the mitochondrial pathway.  Altered expression of the Bcl-2 family of proteins, inhibition of NF-ÎºB activation and over-expression of caspases and survivin provide compelling evidence that azadirachtin and nimbolide induce a shift of balance toward a pro-apoptotic phenotype.  Antioxidants such as azadirachtin and nimbolide that can simultaneously arrest the cell cycle and target multiple mols. involved in mitochondrial apoptosis offer immense potential as anti-cancer therapeutic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPK8XWd7ubObVg90H21EOLACvtfcHk0lgIUzZKnZUYVQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVWis7s%253D&md5=c1e644d072998b475796951be6e91456</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.3109%2F10715761003692503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10715761003692503%26sid%3Dliteratum%253Aachs%26aulast%3DPriyadarsini%26aufirst%3DR.%2BV.%26aulast%3DMurugan%26aufirst%3DR.%2BS.%26aulast%3DSripriya%26aufirst%3DP.%26aulast%3DKarunagaran%26aufirst%3DD.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DThe%2520neem%2520limonoids%2520azadirachtin%2520and%2520nimbolide%2520induce%2520cell%2520cycle%2520arrest%2520and%2520mitochondria-mediated%2520apoptosis%2520in%2520human%2520cervical%2520cancer%2520%2528HeLa%2529%2520cells%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2010%26volume%3D44%26spage%3D624%26epage%3D634%26doi%3D10.3109%2F10715761003692503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harish
Kumar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra Mohan, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagannadha Rao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide a limonoid from Azadirachta indica inhibits proliferation and induces apoptosis of human choriocarcinoma (BeWo) cells</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">246</span>â <span class="NLM_lpage">252</span>, <span class="refDoi">Â DOI: 10.1007/s10637-008-9170-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs10637-008-9170-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=18719855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1yhs7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=246-252&author=G.+Harish%0AKumarauthor=K.+V.+Chandra+Mohanauthor=A.+Jagannadha+Raoauthor=S.+Nagini&title=Nimbolide+a+limonoid+from+Azadirachta+indica+inhibits+proliferation+and+induces+apoptosis+of+human+choriocarcinoma+%28BeWo%29+cells&doi=10.1007%2Fs10637-008-9170-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide a limonoid from Azadirachta indica inhibits proliferation and induces apoptosis of human choriocarcinoma (BeWo) cells</span></div><div class="casAuthors">Harish Kumar, G.; Chandra Mohan, K. V. P.; Jagannadha Rao, A.; Nagini, S.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">246-252</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We investigated the cytotoxic effects of nimbolide, a limonoid present in leaves and flowers of the neem tree (Azadirachta indica) on human choriocarcinoma (BeWo) cells.  Treatment with nimbolide resulted in dose- and time-dependent inhibition of growth of BeWo cells with IC50 values of 2.01 and 1.19 Î¼M for 7 and 24 h resp., accompanied by downregulation of proliferating cell nuclear antigen.  Examn. of nuclear morphol. revealed fragmentation and condensation indicating apoptosis.  Increase in the generation of reactive oxygen species (ROS) that was reversed by addn. of reduced glutathione suggested ROS involvement in the cytotoxicity of nimbolide.  A decrease in Bcl-2/Bax ratio with increased expression of Apaf-1 and caspase-3, and cleavage of poly(ADP-ribose) polymerase provide compelling evidence that nimbolide-induced apoptosis is mediated by the mitochondrial pathway.  The results of the present study suggest that nimbolide has immense potential in cancer prevention and therapy based on its antiproliferative and apoptosis inducing effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxaV-0ZNVbtrVg90H21EOLACvtfcHk0lgIUzZKnZUYVQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1yhs7k%253D&md5=128c967901626a7f4492588664edb5da</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs10637-008-9170-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-008-9170-z%26sid%3Dliteratum%253Aachs%26aulast%3DHarish%2BKumar%26aufirst%3DG.%26aulast%3DChandra%2BMohan%26aufirst%3DK.%2BV.%26aulast%3DJagannadha%2BRao%26aufirst%3DA.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DNimbolide%2520a%2520limonoid%2520from%2520Azadirachta%2520indica%2520inhibits%2520proliferation%2520and%2520induces%2520apoptosis%2520of%2520human%2520choriocarcinoma%2520%2528BeWo%2529%2520cells%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2009%26volume%3D27%26spage%3D246%26epage%3D252%26doi%3D10.1007%2Fs10637-008-9170-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takenaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinmoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsushida, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of colon cancer (HT-29) cell proliferation by a triterpenoid isolated from Azadirachta indica is accompanied by cell cycle arrest and up-regulation of p21</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">917</span>â <span class="NLM_lpage">923</span>, <span class="refDoi">Â DOI: 10.1055/s-2006-946694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1055%2Fs-2006-946694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=16858664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpsl2itbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=917-923&author=M.+K.+Royauthor=M.+Koboriauthor=M.+Takenakaauthor=K.+Nakaharaauthor=H.+Shinmotoauthor=T.+Tsushida&title=Inhibition+of+colon+cancer+%28HT-29%29+cell+proliferation+by+a+triterpenoid+isolated+from+Azadirachta+indica+is+accompanied+by+cell+cycle+arrest+and+up-regulation+of+p21&doi=10.1055%2Fs-2006-946694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of colon cancer (HT-29) cell proliferation by a triterpenoid isolated from Azadirachta indica is accompanied by cell cycle arrest and up-regulation of p21</span></div><div class="casAuthors">Roy, Molay Kumar; Kobori, Masuko; Takenaka, Makiko; Nakahara, Kazuhiko; Shinmoto, Hiroshi; Tsushida, Tojiro</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">917-923</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Nimbolide, a natural triterpenoid present in the edible parts of the neem tree (Azadirachta indica), was found to be growth-inhibitory in human colon carcinoma HT-29 cells.  Nimbolide treatment of cells at 2.5 - 10 Î¼M resulted in moderate to very strong growth inhibition.  Flow cytometric anal. of HT-29 cells showed that nimbolide treatment (2.5 Î¼M, 12 h) caused a 6.5-fold increase in the no. of cells (55.6%) in the G2/M phase compared with the control cells (8.8%).  At 48 h, the cell population in the G2/M phase decreased to 18%, while that in the G0/G1 phase increased to 52.3%.  Western blot anal. revealed that nimbolide-mediated G2/M arrest was accompanied by the up-regulation of p21, cyclin D2, Chk2; and down-regulation of cyclin A, cyclin E, Cdk2, Rad17.  At G0/G1 cell cycle arrest, modulation in the expression of the cell cycle regulatory mols. was also obsd.  We found that nimbolide-induced growth inhibition and cell cycle arrest were not assocd. with cellular differentiation.  Quantification of cells with respect to the expression of phosphatidylserine in the outer cell membrane showed an increase in apoptotic cells by about 13% after 48 h of nimbolide treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJUcwlDjsuQbVg90H21EOLACvtfcHk0lgIUzZKnZUYVQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpsl2itbw%253D&md5=41b9a8fc6f7060b3bb66698163cf47f9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-946694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-946694%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DM.%2BK.%26aulast%3DKobori%26aufirst%3DM.%26aulast%3DTakenaka%26aufirst%3DM.%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DShinmoto%26aufirst%3DH.%26aulast%3DTsushida%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520colon%2520cancer%2520%2528HT-29%2529%2520cell%2520proliferation%2520by%2520a%2520triterpenoid%2520isolated%2520from%2520Azadirachta%2520indica%2520is%2520accompanied%2520by%2520cell%2520cycle%2520arrest%2520and%2520up-regulation%2520of%2520p21%26jtitle%3DPlanta%2520Med.%26date%3D2006%26volume%3D72%26spage%3D917%26epage%3D923%26doi%3D10.1055%2Fs-2006-946694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babykutty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">S, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">J, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopala, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide retards tumor cell migration, invasion, and angiogenesis by downregulating MMP-2/9 expression via inhibiting ERK1/2 and reducing DNA-binding activity of NF-ÎºB in colon cancer cells</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">475</span>â <span class="NLM_lpage">490</span>, <span class="refDoi">Â DOI: 10.1002/mc.20812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fmc.20812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=21678498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFyhtrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=475-490&author=S.+Babykuttyauthor=P.+P.+Sauthor=N.+R.+Jauthor=M.+A.+Kumarauthor=M.+S.+Nairauthor=P.+Srinivasauthor=S.+Gopala&title=Nimbolide+retards+tumor+cell+migration%2C+invasion%2C+and+angiogenesis+by+downregulating+MMP-2%2F9+expression+via+inhibiting+ERK1%2F2+and+reducing+DNA-binding+activity+of+NF-%CE%BAB+in+colon+cancer+cells&doi=10.1002%2Fmc.20812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide retards tumor cell migration, invasion, and angiogenesis by downregulating MMP-2/9 expression via inhibiting ERK1/2 and reducing DNA-binding activity of NF-ÎºB in colon cancer cells</span></div><div class="casAuthors">Babykutty, Suboj; Priya, P. S.; Nandini, R. J.; Kumar, M. A. Suresh; Nair, Mangalam S.; Srinivas, Priya; Gopala, Srinivas</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">475-490</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Nimbolide, a plant-derived limonoid has been shown to exert its antiproliferative effects in various cell lines.  We demonstrate that nimbolide effectively inhibited proliferation of WiDr colon cancer cells through inhibition of cyclin A leading to S phase arrest.  It also caused activation of caspase-mediated apoptosis through the inhibition of ERK1/2 and activation of p38 and JNK1/2.  Further nimbolide effectively retarded tumor cell migration and invasion through inhibition of metalloproteinase-2/9 (MMP-2/9) expression, both at the mRNA and protein level.  It was also a strong inhibitor of VEGF expression, promoter activity, and in vitro angiogenesis.  Finally, nimbolide suppressed the nuclear translocation of p65/p50 and DNA binding of NF-ÎºB, which is an important transcription factor for controlling MMP-2/9 and VEGF gene expression. Â© 2011 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjjfdRwRjx0LVg90H21EOLACvtfcHk0lisNVojUaOKuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFyhtrg%253D&md5=9f055b666e384b7ee450391aa8595b5b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fmc.20812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.20812%26sid%3Dliteratum%253Aachs%26aulast%3DBabykutty%26aufirst%3DS.%26aulast%3DS%26aufirst%3DP.%2BP.%26aulast%3DJ%26aufirst%3DN.%2BR.%26aulast%3DKumar%26aufirst%3DM.%2BA.%26aulast%3DNair%26aufirst%3DM.%2BS.%26aulast%3DSrinivas%26aufirst%3DP.%26aulast%3DGopala%26aufirst%3DS.%26atitle%3DNimbolide%2520retards%2520tumor%2520cell%2520migration%252C%2520invasion%252C%2520and%2520angiogenesis%2520by%2520downregulating%2520MMP-2%252F9%2520expression%2520via%2520inhibiting%2520ERK1%252F2%2520and%2520reducing%2520DNA-binding%2520activity%2520of%2520NF-%25CE%25BAB%2520in%2520colon%2520cancer%2520cells%26jtitle%3DMol.%2520Carcinog.%26date%3D2012%26volume%3D51%26spage%3D475%26epage%3D490%26doi%3D10.1002%2Fmc.20812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethumadhavan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, B. B.</span></span> <span> </span><span class="NLM_article-title">Nimbolide, a limonoid triterpene, inhibits growth of human colorectal cancer xenografts by suppressing the proinflammatory microenvironment</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4465</span>â <span class="NLM_lpage">4476</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-13-0080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1158%2F1078-0432.CCR-13-0080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=23766363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSitrzP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=4465-4476&author=S.+C.+Guptaauthor=S.+Prasadauthor=D.+R.+Sethumadhavanauthor=M.+S.+Nairauthor=Y.+Y.+Moauthor=B.+B.+Aggarwal&title=Nimbolide%2C+a+limonoid+triterpene%2C+inhibits+growth+of+human+colorectal+cancer+xenografts+by+suppressing+the+proinflammatory+microenvironment&doi=10.1158%2F1078-0432.CCR-13-0080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide, a Limonoid Triterpene, Inhibits Growth of Human Colorectal Cancer Xenografts by Suppressing the Proinflammatory Microenvironment</span></div><div class="casAuthors">Gupta, Subash C.; Prasad, Sahdeo; Sethumadhavan, Dhanya R.; Nair, Mangalam S.; Mo, Yin-Yuan; Aggarwal, Bharat B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4465-4476</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Extensive research over the past decade has revealed that the proinflammatory microenvironment plays a crit. role in the development of colorectal cancer.  Whether nimbolide, a limonoid triterpene, can inhibit the growth of colorectal cancer was investigated in the present study.  Exptl. Design: The effect of nimbolide on proliferation of colorectal cancer cell lines was examd. by MTT assay, apoptosis by caspase activation and poly-ADP ribose polymerase cleavage, NF-ÎºB activation by DNA-binding assay, and protein expression by Western blotting.  The effect of nimbolide on the tumor growth in vivo was examd. in colorectal cancer xenografts in a nude mouse model.  Results: Nimbolide inhibited proliferation, induced apoptosis, and suppressed NF-ÎºB activation and NF-ÎºB-regulated tumorigenic proteins in colorectal cancer cells.  The suppression of NF-ÎºB activation by nimbolide was caused by sequential inhibition of IÎºB kinase (IKK) activation, IÎºBÎ± phosphorylation, and p65 nuclear translocation.  Furthermore, the effect of nimbolide on IKK activity was found to be direct.  In vivo, nimbolide (at 5 and 20 mg/kg body wt.), injected i.p. after tumor inoculation, significantly decreased the vol. of colorectal cancer xenografts.  The limonoid-treated xenografts exhibited significant downregulation in the expression of proteins involved in tumor cell survival (Bcl-2, Bcl-xL, c-IAP-1, survivin, and Mcl-1), proliferation (c-Myc and cyclin D1), invasion (MMP-9, ICAM-1), metastasis (CXCR4), and angiogenesis (VEGF).  The limonoid was found to be bioavailable in the blood plasma and tumor tissues of treated mice.  Conclusions: Our studies provide evidence that nimbolide can suppress the growth of human colorectal cancer through modulation of the proinflammatory microenvironment.  Clin Cancer Res; 19(16); 4465-76. Â©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp30IQjfm0ztrVg90H21EOLACvtfcHk0lisNVojUaOKuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSitrzP&md5=3d2f0873757d724a55912403c5647464</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-0080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-0080%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DSethumadhavan%26aufirst%3DD.%2BR.%26aulast%3DNair%26aufirst%3DM.%2BS.%26aulast%3DMo%26aufirst%3DY.%2BY.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DNimbolide%252C%2520a%2520limonoid%2520triterpene%252C%2520inhibits%2520growth%2520of%2520human%2520colorectal%2520cancer%2520xenografts%2520by%2520suppressing%2520the%2520proinflammatory%2520microenvironment%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D4465%26epage%3D4476%26doi%3D10.1158%2F1078-0432.CCR-13-0080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chantana, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yenjai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubroycharoen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waiwut, P.</span></span> <span> </span><span class="NLM_article-title">Combination of nimbolide and TNF-alpha-increases human colon adenocarcinoma cell death through JNK-mediated DR5 up-regulation</span>. <i>Asian Pac. J. Cancer Prev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2637</span>â <span class="NLM_lpage">2641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=27268643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FnvVKhtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=2637-2641&author=C.+Chantanaauthor=C.+Yenjaiauthor=P.+Reubroycharoenauthor=P.+Waiwut&title=Combination+of+nimbolide+and+TNF-alpha-increases+human+colon+adenocarcinoma+cell+death+through+JNK-mediated+DR5+up-regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of Nimbolide and TNF-Î±-Increases Human Colon Adenocarcinoma Cell Death through JNK-mediated DR5 Up- regulation</span></div><div class="casAuthors">Chantana Chantana; Yenjai Chavi; Reubroycharoen Prasert; Waiwut Pornthip</div><div class="citationInfo"><span class="NLM_cas:title">Asian Pacific journal of cancer prevention : APJCP</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2637-41</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tumor necrosis factor (TNF-Î±), an inflammatory cytokine that plays an important role in the control of cell proliferation, differentiation, and apoptosis, has previously been used in anti-cancer therapy.  However, the therapeutic applications of TNF-Î± are largely limited due to its general toxicity and anti-apoptotic influence.  To overcome this problem, the present study focused on the effect of active constituents isolated from a medicinal plant on TNF-Î±-induced apoptosis in human colon adenocarcinoma (HT-29) cells.  Nimbolide from Azadirachta indica was evaluated for cytotoxicity by methyl tetrazolium 3-[4,5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide (MTT) assay and phase contrast microscopy.  Effects on apoptotic signaling proteins were investigated using Western blot analysis.  Nimbolide showed cytotoxicity against HT-29 cells that was significantly different from the control group (<0.01), a concentration of 10 Î¼M significantly inducing cell death (<0.01).  In combination with TNF-Î±, nimbolide significantly enhanced-induced cell death.  In apoptotic pathway, nimbolide activated c-Jun N-terminal kinase (JNK) phosphorylation, BH3 interacting-domain death agonist (Bid) and up-regulated the death receptor 5 (DR5) level.  In the combination group, nimbolide markedly sensitized TNF-Î±-induced JNK, Bid, caspase-3 activation and the up-regulation of DR5.  Our findings overall indicate that nimbolide may enhance TNF-Î±-mediated cellular proliferation inhibition through increasing cell apoptosis of HT-29 cells by up-reglation of DR5 expression via the JNK pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgbnNXk6v3a9-cVm4E2RlLfW6udTcc2eYVjvQnsoI24rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FnvVKhtg%253D%253D&md5=70cae3a4768978f5b06ebd6c149cc210</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChantana%26aufirst%3DC.%26aulast%3DYenjai%26aufirst%3DC.%26aulast%3DReubroycharoen%26aufirst%3DP.%26aulast%3DWaiwut%26aufirst%3DP.%26atitle%3DCombination%2520of%2520nimbolide%2520and%2520TNF-alpha-increases%2520human%2520colon%2520adenocarcinoma%2520cell%2520death%2520through%2520JNK-mediated%2520DR5%2520up-regulation%26jtitle%3DAsian%2520Pac.%2520J.%2520Cancer%2520Prev.%26date%3D2016%26volume%3D17%26spage%3D2637%26epage%3D2641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wangjam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabang, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wargovich, M. J.</span></span> <span> </span><span class="NLM_article-title">A supercritical CO2 extract of neem leaf (A. indica) and its bioactive liminoid, nimbolide, suppresses colon cancer in preclinical models by modulating pro-inflammatory pathways</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1156</span>â <span class="NLM_lpage">1165</span>, <span class="refDoi">Â DOI: 10.1002/mc.22832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fmc.22832" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29697164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt1alur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=1156-1165&author=M.+J.+Patelauthor=S.+Tripathyauthor=K.+D.+Mukhopadhyayauthor=T.+Wangjamauthor=A.+B.+Cabangauthor=J.+Morrisauthor=M.+J.+Wargovich&title=A+supercritical+CO2+extract+of+neem+leaf+%28A.+indica%29+and+its+bioactive+liminoid%2C+nimbolide%2C+suppresses+colon+cancer+in+preclinical+models+by+modulating+pro-inflammatory+pathways&doi=10.1002%2Fmc.22832"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A supercritical CO2 extract of neem leaf (A. indica) and its bioactive liminoid, nimbolide, suppresses colon cancer in preclinical models by modulating pro-inflammatory pathways</span></div><div class="casAuthors">Patel, Mandakini J.; Tripathy, Shreya; Mukhopadhyay, Keya D.; Wangjam, Tamna; Cabang, April B.; Morris, Jay; Wargovich, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1156-1165</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second leading cause of cancer death in men and women in the United States.  Anti-inflammatory blockade has been proven to be a promising avenue of colorectal cancer prevention.  However, NSAIDs while effective in curbing CRC risk are too toxic for long-term use in cancer prevention.  The Neem tree (Azadirachta indica) is rich in liminoid terpenoids, collectively known as azadiractoids and has been shown to have anti-inflammatory effects.  To explore a role of neem in CRC, human colon cancer cell lines HCT116 and HT29 cells were treated with purified Super Crit. Neem Ext. (SCNE) or the neem liminoid, nimbolide.  SCNE treatment resulted in a dose dependent inhibition of CRC cell proliferation and an increase in apoptosis.  Treatment with SCNE and nimbolide decreased the expression of transcriptional factors, STAT3 and NF-ÎºB which plays a major role in gene regulation of multiple cellular processes.  Protein expression of COX1, IL-6, and TNF-Î± were decreased on treatment with SCNE in CRC cells.  Western blots and Zymogram assays results revealed anti-invasive effect by decreased expression of MMP2 and MMP9 proteins in CRC cells.  Overall, these data confirm a potential anti-cancer effect of SCNE, reducing cell proliferation, inflammation, migration, and invasion in human colon cancer cells.  Confirming these indications, we found that treatment of mice bearing HT29 and HCT116 xenografted tumors exhibited striking inhibition of colon tumor growth.  Clearly we must explore the effect of neem in preclin. animal models for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU-Gy1oPlXCbVg90H21EOLACvtfcHk0lgdeXTBMQUMZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt1alur8%253D&md5=40bc7e1e2c7b31b26f2283300a6306c7</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fmc.22832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.22832%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%2BJ.%26aulast%3DTripathy%26aufirst%3DS.%26aulast%3DMukhopadhyay%26aufirst%3DK.%2BD.%26aulast%3DWangjam%26aufirst%3DT.%26aulast%3DCabang%26aufirst%3DA.%2BB.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DWargovich%26aufirst%3DM.%2BJ.%26atitle%3DA%2520supercritical%2520CO2%2520extract%2520of%2520neem%2520leaf%2520%2528A.%2520indica%2529%2520and%2520its%2520bioactive%2520liminoid%252C%2520nimbolide%252C%2520suppresses%2520colon%2520cancer%2520in%2520preclinical%2520models%2520by%2520modulating%2520pro-inflammatory%2520pathways%26jtitle%3DMol.%2520Carcinog.%26date%3D2018%26volume%3D57%26spage%3D1156%26epage%3D1165%26doi%3D10.1002%2Fmc.22832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrijauskaite, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wargovich, M. J.</span></span> <span> </span><span class="NLM_article-title">Disruption of epigenetic silencing in human colon cancer cells lines utilizing a novel supercritical CO2 extract of neem leaf (Azadirachta indica)</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">5473</span>â <span class="NLM_lpage">5481</span>, <span class="refDoi">Â DOI: 10.21873/anticanres.13740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.21873%2Fanticanres.13740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31570441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1OhtL%252FP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=5473-5481&author=Z.+Qiuauthor=K.+Andrijauskaiteauthor=J.+Morrisauthor=M.+J.+Wargovich&title=Disruption+of+epigenetic+silencing+in+human+colon+cancer+cells+lines+utilizing+a+novel+supercritical+CO2+extract+of+neem+leaf+%28Azadirachta+indica%29&doi=10.21873%2Fanticanres.13740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of epigenetic silencing in human colon cancer cells lines utilizing a novel supercritical CO2 Extract of Neem Leaf (Azadirachta indica)</span></div><div class="casAuthors">Qiu, Zhifang; Andruauskaite, Kristina; Morris, Jay; Wargovich, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5473-5481</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background!Aim: Aerial parts and seeds of the neem tree (Azadirachta indica) have long been used in traditional medicine such as Ayurveda for health-related purposes.  Our interest in neem bioactives lies in their potential use as standalone anticancer agents, or as adjuvants to std. therapy.  The aim of the present study was to explore a supercrit. CO2 ext. (SCNE) of neem leaf and a prominent Iiminoid in neem leaf, nimbolide, for epigenetic activity.  Materials and Methods: Human colorectal cancer cell lines (HCTIJ6 and HT29) were cultured for 48 h in the presence of neem ext. or nimbolide and evaluatedfor growth inhibition and evidence of suppression of histone deacetylation and DNA methylation.  Results: Both SCNE and nimbolide suppressed the proliferation of colon cancer cells by inducing epigenetic modifications.  Conclusion: Neem leaf contains bioactive constituents which modify epigenetic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_S8So1gu1q7Vg90H21EOLACvtfcHk0lgdeXTBMQUMZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1OhtL%252FP&md5=29923eb27f0c13c1087972a93ee50a4c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.21873%2Fanticanres.13740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21873%252Fanticanres.13740%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DZ.%26aulast%3DAndrijauskaite%26aufirst%3DK.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DWargovich%26aufirst%3DM.%2BJ.%26atitle%3DDisruption%2520of%2520epigenetic%2520silencing%2520in%2520human%2520colon%2520cancer%2520cells%2520lines%2520utilizing%2520a%2520novel%2520supercritical%2520CO2%2520extract%2520of%2520neem%2520leaf%2520%2528Azadirachta%2520indica%2529%26jtitle%3DAnticancer%2520Res.%26date%3D2019%26volume%3D39%26spage%3D5473%26epage%3D5481%26doi%3D10.21873%2Fanticanres.13740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karkare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chhipa, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasilina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nassar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roychoudhury, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. P</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauletti, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, B.</span></span> <span> </span><span class="NLM_article-title">Direct inhibition of retinoblastoma phosphorylation by nimbolide causes cell-cycle arrest and suppresses glioblastoma growth</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">199</span>â <span class="NLM_lpage">212</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-13-0762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1158%2F1078-0432.CCR-13-0762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=24170547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislKluw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=199-212&author=S.+Karkareauthor=R.+R.+Chhipaauthor=J.+Andersonauthor=X.+Liuauthor=H.+Henryauthor=A.+Gasilinaauthor=N.+Nassarauthor=J.+Roychoudhuryauthor=J.+P+Clarkauthor=A.+Kumarauthor=G.+M.+Paulettiauthor=P.+K.+Ghoshauthor=B.+Dasgupta&title=Direct+inhibition+of+retinoblastoma+phosphorylation+by+nimbolide+causes+cell-cycle+arrest+and+suppresses+glioblastoma+growth&doi=10.1158%2F1078-0432.CCR-13-0762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Inhibition of Retinoblastoma Phosphorylation by Nimbolide Causes Cell-Cycle Arrest and Suppresses Glioblastoma Growth</span></div><div class="casAuthors">Karkare, Swagata; Chhipa, Rishi Raj; Anderson, Jane; Liu, Xiaona; Henry, Heather; Gasilina, Anjelika; Nassar, Nicholas; Roychoudhury, Jayeeta; Clark, Jason P.; Kumar, Ashish; Pauletti, Giovanni M.; Ghosh, Pradip K.; Dasgupta, Biplab</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-212</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Classical pharmacol. allows the use and development of conventional phytomedicine faster and more economically than conventional drugs.  This approach should be tested for their efficacy in terms of complementarity and disease control.  The purpose of this study was to det. the mol. mechanisms by which nimbolide, a triterpenoid found in the well-known medicinal plant Azadirachta indica, controls glioblastoma growth.  Exptl. Design: Using in vitro signaling, anchorage-independent growth, kinase assays, and xenograft models, we investigated the mechanisms of its growth inhibition in glioblastoma.  Results: We show that nimbolide or an ethanol sol. fraction of A. indica leaves (Azt) that contains nimbolide as the principal cytotoxic agent is highly cytotoxic against glioblastoma multiforme in vitro and in vivo.  Azt caused cell-cycle arrest, most prominently at the G1-S stage in glioblastoma multiforme cells expressing EGFRvIII, an oncogene present in about 20% to 25% of glioblastoma multiformes.  Azt/nimbolide directly inhibited CDK4/CDK6 kinase activity leading to hypophosphorylation of the retinoblastoma protein, cell-cycle arrest at G1-S, and cell death.  Independent of retinoblastoma hypophosphorylation, Azt also significantly reduced proliferative and survival advantage of glioblastoma multiforme cells in vitro and in tumor xenografts by downregulating Bcl2 and blocking growth factor-induced phosphorylation of Akt, extracellular signal-regulated kinase 1/2, and STAT3.  These effects were specific because Azt did not affect mTOR or other cell-cycle regulators.  In vivo, Azt completely prevented initiation and inhibited progression of glioblastoma multiforme growth.  Conclusions: Our preclin. findings demonstrate nimbolide as a potent anti-glioma agent that blocks cell cycle and inhibits glioma growth in vitro and in vivo.  Clin Cancer Res; 20(1); 199-212. Â©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSCkKL-3wHz7Vg90H21EOLACvtfcHk0lgdeXTBMQUMZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislKluw%253D%253D&md5=857bedb8c580c61101ca0a4e4f2f3ef4</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-0762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-0762%26sid%3Dliteratum%253Aachs%26aulast%3DKarkare%26aufirst%3DS.%26aulast%3DChhipa%26aufirst%3DR.%2BR.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHenry%26aufirst%3DH.%26aulast%3DGasilina%26aufirst%3DA.%26aulast%3DNassar%26aufirst%3DN.%26aulast%3DRoychoudhury%26aufirst%3DJ.%26aulast%3DClark%26aufirst%3DJ.%2BP%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DPauletti%26aufirst%3DG.%2BM.%26aulast%3DGhosh%26aufirst%3DP.%2BK.%26aulast%3DDasgupta%26aufirst%3DB.%26atitle%3DDirect%2520inhibition%2520of%2520retinoblastoma%2520phosphorylation%2520by%2520nimbolide%2520causes%2520cell-cycle%2520arrest%2520and%2520suppresses%2520glioblastoma%2520growth%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D199%26epage%3D212%26doi%3D10.1158%2F1078-0432.CCR-13-0762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takenaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinmoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsushida, T.</span></span> <span> </span><span class="NLM_article-title">Antiproliferative effect on human cancer cell lines after treatment with nimbolide extracted from an edible part of the neem tree (Azadirachta indica)</span>. <i>Phytother. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">245</span>â <span class="NLM_lpage">250</span>, <span class="refDoi">Â DOI: 10.1002/ptr.2058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fptr.2058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=17163581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlSgt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=245-250&author=M.+K.+Royauthor=M.+Koboriauthor=M.+Takenakaauthor=K.+Nakaharaauthor=H.+Shinmotoauthor=S.+Isobeauthor=T.+Tsushida&title=Antiproliferative+effect+on+human+cancer+cell+lines+after+treatment+with+nimbolide+extracted+from+an+edible+part+of+the+neem+tree+%28Azadirachta+indica%29&doi=10.1002%2Fptr.2058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative effect on human cancer cell lines after treatment with nimbolide extracted from an edible part of the neem tree (Azadirachta indica)</span></div><div class="casAuthors">Roy, Molay Kumar; Kobori, Masuko; Takenaka, Makiko; Nakahara, Kazuhiko; Shinmoto, Hiroshi; Isobe, Seiichiro; Tsushida, Tojiro</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">245-250</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Nimbolide, a triterpenoid extd. from the flowers of the neem tree (Azadirachta indica), was found to have antiproliferative activity against some cancer cell lines.  Treatment of cells with 0.5-5.0 Î¼m concns. of nimbolide resulted in moderate to very strong growth inhibition in U937, HL-60, THP1 and B16 cell lines.  Flow cytometric anal. of U937 cells showed that nimbolide treatment (1-2.5 Î¼m) resulted in cell cycle disruption by decreasing the no. of cells in G0/G1 phase, with initial increases in S and G2/M phases.  Cells exposed to a higher dose of nimbolide for a longer period displayed a severely damaged DNA profile, resulting in a remarkable increase in the no. of cells in the sub-G1 fraction, with a reciprocal decrease of cells in all phases.  Quantification of the expression of phosphatidylserine in the outer cell membrane showed that doses of nimbolide higher than 0.4 Î¼m exerted remarkable lethality, with over 60% of cells exhibiting apoptotic features after exposure to 1.2 Î¼m nimbolide.  The antiproliferative effect of nimbolide and its apoptosis-inducing property raise hope for its use in anticancer therapy by enhancing the effectiveness of cell cycle disruption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU8l75KPgH67Vg90H21EOLACvtfcHk0lhJyMKI4UU_iQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlSgt78%253D&md5=bd927805400598e0ece9d1d929ac68e0</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fptr.2058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.2058%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DM.%2BK.%26aulast%3DKobori%26aufirst%3DM.%26aulast%3DTakenaka%26aufirst%3DM.%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DShinmoto%26aufirst%3DH.%26aulast%3DIsobe%26aufirst%3DS.%26aulast%3DTsushida%26aufirst%3DT.%26atitle%3DAntiproliferative%2520effect%2520on%2520human%2520cancer%2520cell%2520lines%2520after%2520treatment%2520with%2520nimbolide%2520extracted%2520from%2520an%2520edible%2520part%2520of%2520the%2520neem%2520tree%2520%2528Azadirachta%2520indica%2529%26jtitle%3DPhytother.%2520Res.%26date%3D2007%26volume%3D21%26spage%3D245%26epage%3D250%26doi%3D10.1002%2Fptr.2058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannappan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravindran, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hema, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, B. B.</span></span> <span> </span><span class="NLM_article-title">Modification of cysteine 179 of IkappaBalpha kinase by nimbolide leads to down-regulation of NF-kappaB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">35406</span>â <span class="NLM_lpage">35417</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M110.161984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1074%2Fjbc.M110.161984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=20829362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyntLvO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=35406-35417&author=S.+C.+Guptaauthor=S.+Prasadauthor=S.+Reuterauthor=R.+Kannappanauthor=V.+R.+Yadavauthor=J.+Ravindranauthor=P.+S.+Hemaauthor=M.+M.+Chaturvediauthor=M.+Nairauthor=B.+B.+Aggarwal&title=Modification+of+cysteine+179+of+IkappaBalpha+kinase+by+nimbolide+leads+to+down-regulation+of+NF-kappaB-regulated+cell+survival+and+proliferative+proteins+and+sensitization+of+tumor+cells+to+chemotherapeutic+agents&doi=10.1074%2Fjbc.M110.161984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of Cysteine 179 of IÎºBÎ± Kinase by Nimbolide Leads to Down-regulation of NF-ÎºB-regulated Cell Survival and Proliferative Proteins and Sensitization of Tumor Cells to Chemotherapeutic Agents</span></div><div class="casAuthors">Gupta, Subash C.; Prasad, Sahdeo; Reuter, Simone; Kannappan, Ramaswamy; Yadav, Vivek R.; Ravindran, Jayaraj; Hema, Padmanabhan S.; Chaturvedi, Madan M.; Nair, Mangalam; Aggarwal, Bharat B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">35406-35417</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Reverse pharmacol., also called the "bedside to bench" approach, that deals with new uses for a well known mol. entity has been used extensively in cancer drug development to identify novel compds. and delineate their mechanisms of action.  Here, we show that nimbolide, a triterpenoid isolated from Azadirachta indica, enhanced the apoptosis induced by inflammatory cytokines and chemotherapeutic agents in tumor cells.  This limonoid abrogated the expression of proteins assocd. with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-ÎºB.  Nimbolide inhibited the activation of NF-ÎºB induced by carcinogens and inflammatory stimuli.  Constitutively active NF-ÎºB found in most tumor cells was also inhibited.  We found that suppression of NF-ÎºB activation by nimbolide was caused by inhibition of IÎºB kinase (IKK), which led to suppression of IÎºBÎ± phosphorylation and degrdn., nuclear translocation, DNA binding, and gene transcription.  Reducing agent reversed the action of the limonoid, suggesting the involvement of a cysteine residue.  Replacement of Cys179 of IKK-Î² with alanine abolished the effect of nimbolide, suggesting that Cys179 plays a crit. role in inhibiting the NF-ÎºB activation.  Overall, our results indicate that nimbolide can sensitize tumor cells to chemotherapeutic agents through interaction with IKK, leading to inhibition of NF-ÎºB-regulated proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEICPSk2cC7rVg90H21EOLACvtfcHk0lhJyMKI4UU_iQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyntLvO&md5=98f883ffc274ce0d75d81b823c313804</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.161984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.161984%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DReuter%26aufirst%3DS.%26aulast%3DKannappan%26aufirst%3DR.%26aulast%3DYadav%26aufirst%3DV.%2BR.%26aulast%3DRavindran%26aufirst%3DJ.%26aulast%3DHema%26aufirst%3DP.%2BS.%26aulast%3DChaturvedi%26aufirst%3DM.%2BM.%26aulast%3DNair%26aufirst%3DM.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DModification%2520of%2520cysteine%2520179%2520of%2520IkappaBalpha%2520kinase%2520by%2520nimbolide%2520leads%2520to%2520down-regulation%2520of%2520NF-kappaB-regulated%2520cell%2520survival%2520and%2520proliferative%2520proteins%2520and%2520sensitization%2520of%2520tumor%2520cells%2520to%2520chemotherapeutic%2520agents%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D35406%26epage%3D35417%26doi%3D10.1074%2Fjbc.M110.161984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chitta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caulfield, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhtar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ailawadhi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckman, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanan-Khan, A.</span></span> <span> </span><span class="NLM_article-title">Nimbolide targets BCL2 and induces apoptosis in preclinical models of WaldenstrÃ¶ms macroglobulinemia</span>. <i>Blood Cancer J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e260</span>, <span class="refDoi">Â DOI: 10.1038/bcj.2014.74</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fbcj.2014.74" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=25382610" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=e260&author=K.+Chittaauthor=A.+Paulusauthor=T.+R.+Caulfieldauthor=S.+Akhtarauthor=M.+K.+Blakeauthor=S.+Ailawadhiauthor=J.+Knightauthor=M.+G.+Heckmanauthor=A.+Pinkertonauthor=A.+Chanan-Khan&title=Nimbolide+targets+BCL2+and+induces+apoptosis+in+preclinical+models+of+Waldenstr%C3%B6ms+macroglobulinemia&doi=10.1038%2Fbcj.2014.74"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fbcj.2014.74&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbcj.2014.74%26sid%3Dliteratum%253Aachs%26aulast%3DChitta%26aufirst%3DK.%26aulast%3DPaulus%26aufirst%3DA.%26aulast%3DCaulfield%26aufirst%3DT.%2BR.%26aulast%3DAkhtar%26aufirst%3DS.%26aulast%3DBlake%26aufirst%3DM.%2BK.%26aulast%3DAilawadhi%26aufirst%3DS.%26aulast%3DKnight%26aufirst%3DJ.%26aulast%3DHeckman%26aufirst%3DM.%2BG.%26aulast%3DPinkerton%26aufirst%3DA.%26aulast%3DChanan-Khan%26aufirst%3DA.%26atitle%3DNimbolide%2520targets%2520BCL2%2520and%2520induces%2520apoptosis%2520in%2520preclinical%2520models%2520of%2520Waldenstr%25C3%25B6ms%2520macroglobulinemia%26jtitle%3DBlood%2520Cancer%2520J.%26date%3D2014%26volume%3D4%26spage%3De260%26doi%3D10.1038%2Fbcj.2014.74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahmoud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, M. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klauck, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greten, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efferth, T.</span></span> <span> </span><span class="NLM_article-title">Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">35762</span>â <span class="NLM_lpage">35779</span>, <span class="refDoi">Â DOI: 10.18632/oncotarget.26299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.18632%2Foncotarget.26299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=30515268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3cros1KgtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=35762-35779&author=N.+Mahmoudauthor=M.+E.+M.+Saeedauthor=Y.+Sugimotoauthor=S.+M.+Klauckauthor=H.+J.+Gretenauthor=T.+Efferth&title=Cytotoxicity+of+nimbolide+towards+multidrug-resistant+tumor+cells+and+hypersensitivity+via+cellular+metabolic+modulation&doi=10.18632%2Foncotarget.26299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation</span></div><div class="casAuthors">Mahmoud Nuha; Saeed Mohamed E M; Efferth Thomas; Sugimoto Yoshikazu; Klauck Sabine M; Greten Henry J; Greten Henry J</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">87</span>),
    <span class="NLM_cas:pages">35762-35779</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nimbolide is considered a promising natural product in cancer prevention and treatment.  However, it is not known yet, whether the different mechanisms of multidrug resistance (MDR) influence its anticancer activity.  In this study, well-known MDR mechanisms (ABCB1, ABCG2, ABCB5, TP53, EGFR) were evaluated against nimbolide.  The P-glycoprotein (ABCB1/MDR1)-overexpressing CEM/ADR5000 cell line displayed remarkable hypersensitivity to nimbolide, which was mediated through upregulation of the tumor suppressor, PTEN, and its downstream components resulted in significant downregulation in ABCB1/MDR1 mRNA and P-glycoprotein.  In addition, nimbolide targeted essential cellular metabolic-regulating elements including HIF1Î±, FoxO1, MYC and reactive oxygen species.  The expression of breast cancer resistance protein (BCRP) as well as epidermal growth factor receptor (EGFR) and mutant tumor suppressor TP53 did not correlate to nimbolide's activity.  Furthermore, this paper looked for other molecular determinants that might determine tumor cellular response towards nimbolide.  COMPARE and hierarchical cluster analyses of transcriptome-wide microarray-based mRNA expressions of the NCI 60 cell line panel were performed, and a set of 40 genes from different functional groups was identified.  The data suggested NF-ÎºB as master regulator of nimbolide's activity.  Interestingly, HIF1Î± was determined by COMPARE analysis to mediate sensitivity to nimbolide, which would be of great benefit in targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4op8c3dWl04JKJbLTgsvCfW6udTcc2eZPNWraCWGNubntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cros1KgtQ%253D%253D&md5=e872fa8f385268f0f34e6054746fc585</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.26299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.26299%26sid%3Dliteratum%253Aachs%26aulast%3DMahmoud%26aufirst%3DN.%26aulast%3DSaeed%26aufirst%3DM.%2BE.%2BM.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DKlauck%26aufirst%3DS.%2BM.%26aulast%3DGreten%26aufirst%3DH.%2BJ.%26aulast%3DEfferth%26aufirst%3DT.%26atitle%3DCytotoxicity%2520of%2520nimbolide%2520towards%2520multidrug-resistant%2520tumor%2520cells%2520and%2520hypersensitivity%2520via%2520cellular%2520metabolic%2520modulation%26jtitle%3DOncotarget%26date%3D2018%26volume%3D9%26spage%3D35762%26epage%3D35779%26doi%3D10.18632%2Foncotarget.26299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kavitha, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidya Priyadarsini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anitha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramalingam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakthivel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purushothaman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karunagaran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide, a neem limonoid abrogates canonical NF-ÎºB and Wnt signaling to induce caspase-dependent apoptosis in human hepatocarcinoma (HepG2) cells</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>681</i></span>,  <span class="NLM_fpage">6</span>â <span class="NLM_lpage">14</span>, <span class="refDoi">Â DOI: 10.1016/j.ejphar.2012.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.ejphar.2012.01.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=22327045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC38XivFygtro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=681&publication_year=2012&pages=6-14&author=K.+Kavithaauthor=R.+Vidya+Priyadarsiniauthor=P.+Anithaauthor=K.+Ramalingamauthor=R.+Sakthivelauthor=G.+Purushothamanauthor=A.+K.+Singhauthor=D.+Karunagaranauthor=S.+Nagini&title=Nimbolide%2C+a+neem+limonoid+abrogates+canonical+NF-%CE%BAB+and+Wnt+signaling+to+induce+caspase-dependent+apoptosis+in+human+hepatocarcinoma+%28HepG2%29+cells&doi=10.1016%2Fj.ejphar.2012.01.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide, a neem limonoid abrogates canonical NF-ÎºB and Wnt signaling to induce caspase-dependent apoptosis in human hepatocarcinoma (HepG2) cells</span></div><div class="casAuthors">Kavitha, Krishnamurthy; Vidya Priyadarsini, Ramamurthi; Anitha, Prabukumar; Ramalingam, Krishnan; Sakthivel, Ramasamy; Purushothaman, Gempuraj; Singh, Abhishek Kumar; Karunagaran, Devarajan; Nagini, Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">681</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">6-14</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nuclear factor kappa B (NF-ÎºB), an oncogenic signaling factor plays a crit. role in the development and progression of various cancers.  The objective of this study was to investigate the effect of nimbolide, a neem derived tetranortriterpenoid on NF-ÎºB signaling and its downstream events - Wnt/Î²-catenin activation and apoptosis evasion in human hepatocarcinoma (HepG2) cells by evaluating NF-ÎºB family members (NF-ÎºB-p50, p65, IÎºB-Î±, p-IÎºB-Î±, and IKKÎ²), members of Wnt signaling (GSK-3Î² and Î²-catenin), and intrinsic apoptosis (Bcl-2, Bax, cytochrome c, Smac/DIABLO, caspase-3, and caspase-9).  Our results demonstrate that nimbolide concurrently abrogates canonical NF-ÎºB and Wnt signaling and induces intrinsic apoptosis in HepG2 cells.  These data suggest that phytochems. such as nimbolide that can target multiple steps along the NF-ÎºB signaling circuit are promising candidates for future phytochem.-based mechanistic pathway targeted anticancer regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEREiaPxfMnLVg90H21EOLACvtfcHk0lgDbto4PUCHOw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivFygtro%253D&md5=8c22dff348b4ffe6eed4dc3a78cd5521</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DKavitha%26aufirst%3DK.%26aulast%3DVidya%2BPriyadarsini%26aufirst%3DR.%26aulast%3DAnitha%26aufirst%3DP.%26aulast%3DRamalingam%26aufirst%3DK.%26aulast%3DSakthivel%26aufirst%3DR.%26aulast%3DPurushothaman%26aufirst%3DG.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DKarunagaran%26aufirst%3DD.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DNimbolide%252C%2520a%2520neem%2520limonoid%2520abrogates%2520canonical%2520NF-%25CE%25BAB%2520and%2520Wnt%2520signaling%2520to%2520induce%2520caspase-dependent%2520apoptosis%2520in%2520human%2520hepatocarcinoma%2520%2528HepG2%2529%2520cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D681%26spage%3D6%26epage%3D14%26doi%3D10.1016%2Fj.ejphar.2012.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsueh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, Y. H.</span></span> <span> </span><span class="NLM_article-title">Nimbolide induced apoptosis by activating ERK-mediated inhibition of c-IAP1 expression in human hepatocellular carcinoma cells</span>. <i>Environ. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">913</span>â <span class="NLM_lpage">922</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29962003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1eisLjL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=913-922&author=K.+C.+Hsuehauthor=C.+L.+Linauthor=J.+N.+Tungauthor=S.+F.+Yangauthor=Y.+H.+Hsieh&title=Nimbolide+induced+apoptosis+by+activating+ERK-mediated+inhibition+of+c-IAP1+expression+in+human+hepatocellular+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide induced apoptosis by activating ERK-mediated inhibition of c-IAP1 expression in human hepatocellular carcinoma cells</span></div><div class="casAuthors">Hsueh, Kuan-Chun; Lin, Chia-Liang; Tung, Jai-Nien; Yang, Shun-Fa; Hsieh, Yi-Hsien</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">913-922</span>CODEN:
                <span class="NLM_cas:coden">ETOXFH</span>;
        ISSN:<span class="NLM_cas:issn">1520-4081</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Nimbolide is one of the major compds. from the leaves and flowers of the neem tree and exhibits antitumor properties on various cancer cells.  However, no report has shown that nimbolide induces apoptosis in vitro and in vivo in human hepatocellular carcinoma cells.  Our results indicated that it inhibited cell growth in Huh-7 and PLC/PRF/5 cells.  We also found that nimbolide induced cell death through the induction of G2/M phase arrest and mitochondrial dysfunction, accompanied by the increased expression of cleaved caspase-7, caspase-9, caspase-3, caspase-PARP, and Bax and decreased expression of Mcl-1 and Bcl-2.  A human apoptosis antibody array anal. demonstrated that inhibition of the apoptosis family proteins (XIAP, c-IAP1, and c-IAP2) was one of the major targets of nimbolide.  Addnl., nimbolide sustained activation of ERK expression.  Moreover, pretreatment with U0126 (MEK inhibitor) markedly abolished nimbolide-inhibited cell viability, induced cell apoptosis, ERK phosphorylation, cleaved caspase-9, caspase-3, cleaved-PARP activation, and increased c-IAP1 expression in Huh-7 cells.  An in vivo study showed that nimbolide significantly reduced Huh-7 tumor growth and wt. in a xenograft mouse model.  This study indicated the antitumor potential of nimbolide in human hepatocellular carcinoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolM-4DfaR-WrVg90H21EOLACvtfcHk0lgDbto4PUCHOw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1eisLjL&md5=31599c2e87b293209bd66ec7c9f970b5</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsueh%26aufirst%3DK.%2BC.%26aulast%3DLin%26aufirst%3DC.%2BL.%26aulast%3DTung%26aufirst%3DJ.%2BN.%26aulast%3DYang%26aufirst%3DS.%2BF.%26aulast%3DHsieh%26aufirst%3DY.%2BH.%26atitle%3DNimbolide%2520induced%2520apoptosis%2520by%2520activating%2520ERK-mediated%2520inhibition%2520of%2520c-IAP1%2520expression%2520in%2520human%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DEnviron.%2520Toxicol.%26date%3D2018%26volume%3D33%26spage%3D913%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide suppresses non-small cell lung cancer cell invasion and migration via manipulation of DUSP4 expression and ERK1/2 signaling</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">340</span>â <span class="NLM_lpage">346</span>, <span class="refDoi">Â DOI: 10.1016/j.biopha.2017.05.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.biopha.2017.05.072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=28554129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1entbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2017&pages=340-346&author=H.+Linauthor=S.+Qiuauthor=L.+Xieauthor=C.+Liuauthor=S.+Sun&title=Nimbolide+suppresses+non-small+cell+lung+cancer+cell+invasion+and+migration+via+manipulation+of+DUSP4+expression+and+ERK1%2F2+signaling&doi=10.1016%2Fj.biopha.2017.05.072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide suppresses non-small cell lung cancer cell invasion and migration via manipulation of DUSP4 expression and ERK1/2 signaling</span></div><div class="casAuthors">Lin, Hua; Qiu, Shiyang; Xie, Lihua; Liu, Chun; Sun, Shenghua</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">340-346</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Nimbolide plays an important role in treating human diseases.  In these years, the anticancer property of nimbolide has been paid more and more attention.  However, the role of nimbolide in non-small cell lung cancer (NSCLC) remains unclear.  In this study, we found that nimbolide treatment suppressed the invasion and migration of NSCLC cells, in a dose-dependent manner.  Moreover, nimbolide treatment dose-dependently inhibited ERK1/2 activation, decreased Snail and MMP-3 expression, and increased E-cadherin expression.  Further, we found that nimbolide treatment upregulated DUSP4 expression.  DUSP4 knockdown attenuated nimbolide-mediated inhibition of cell invasion, migration and ERK1/2 activation.  We also found that DUSP4 knockdown suppressed the effect of nimbolide on MMP-3, Snail and E-cadherin expression.  Taken together, our study demonstrates that nimbolide treatment can upregulate the expression of DUSP4, thus inhibiting ERK1/2 activation.  Inhibition of ERK1/2 pathway by nimbolide decreases MMP-3 and Snail expression, and increases E-cadherin expression, which finally inhibits NSCLC cell invasion and migration.  Therefore, nimbolide may act as a novel drug to inhibit NSCLC invasion and metastasis through manipulation of ERK1/2 signaling and DUSP4 expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPYq8X7vmnXrVg90H21EOLACvtfcHk0lgDbto4PUCHOw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1entbo%253D&md5=a2c02d252e3aeaf8b5089f5b2237f1fb</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2017.05.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2017.05.072%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DH.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DS.%26atitle%3DNimbolide%2520suppresses%2520non-small%2520cell%2520lung%2520cancer%2520cell%2520invasion%2520and%2520migration%2520via%2520manipulation%2520of%2520DUSP4%2520expression%2520and%2520ERK1%252F2%2520signaling%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D92%26spage%3D340%26epage%3D346%26doi%3D10.1016%2Fj.biopha.2017.05.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsi, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.-K.</span></span> <span> </span><span class="NLM_article-title">Nimbolide induces apoptosis in human nasopharyngeal cancer cells</span>. <i>Environ. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2085</span>â <span class="NLM_lpage">2092</span>, <span class="refDoi">Â DOI: 10.1002/tox.22423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Ftox.22423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=28383207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1Wis7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=2085-2092&author=S.-Y.+Chienauthor=C.-H.+Hsuauthor=C.-C.+Linauthor=Y.-C.+Chuangauthor=Y.-S.+Loauthor=Y.-T.+Hsiauthor=M.-J.+Hsiehauthor=M.-K.+Chen&title=Nimbolide+induces+apoptosis+in+human+nasopharyngeal+cancer+cells&doi=10.1002%2Ftox.22423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide induces apoptosis in human nasopharyngeal cancer cells</span></div><div class="casAuthors">Chien, Su-Yu; Hsu, Ching-Hui; Lin, Chia-Chieh; Chuang, Yi-Ching; Lo, Yu-Sheng; Hsi, Yi-Ting; Hsieh, Ming-Ju; Chen, Mu-Kuan</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2085-2092</span>CODEN:
                <span class="NLM_cas:coden">ETOXFH</span>;
        ISSN:<span class="NLM_cas:issn">1520-4081</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Nasopharyngeal carcinoma (NPC), a tumor arising from epithelial cells that cover the surface and line the nasopharynx, is a rare malignancy worldwide but is prevalent in certain geog. areas, such as Southern Asia (Taiwan, Hong Kong, Singapore, Malaysia, and Southern China) and North Africa.  Despite advances in diagnostic techniques and improvements in treatment modalities, the prognosis of NPC remains poor.  Therefore, an effective chemotherapy regimen that enhances tumor sensitivity to chemotherapeutics is urgently required.  Nimbolide, derived from Azadirachta indica, has a wide range of beneficial effects, including anti-inflammatory and anticancer properties.  The present study evaluated the antitumor activity of nimbolide in NPC cells and its underlying mechanisms.  Our results revealed that the treatment of HONE-1 cells with nimbolide potently inhibited cell viability.  Moreover, nimbolide led to cell cycle arrest, which subsequently activated caspase-3, -8, and -9 and poly (ADP-ribose) polymerase to induce cell apoptosis.  Moreover, nimbolide induced Bik, Bax, and t-Bid expression in HONE-1 cells.  The results indicated that nimbolide induces apoptosis through the modulation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) pathways.  Nimbolide induces apoptosis in human NPC cells and is a potential chemopreventive agent against NPC proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzzosvPwV0dLVg90H21EOLACvtfcHk0lh_7qGCrzJZ6A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1Wis7g%253D&md5=47ced1f67e83924318b7314d521c2637</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Ftox.22423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Ftox.22423%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DS.-Y.%26aulast%3DHsu%26aufirst%3DC.-H.%26aulast%3DLin%26aufirst%3DC.-C.%26aulast%3DChuang%26aufirst%3DY.-C.%26aulast%3DLo%26aufirst%3DY.-S.%26aulast%3DHsi%26aufirst%3DY.-T.%26aulast%3DHsieh%26aufirst%3DM.-J.%26aulast%3DChen%26aufirst%3DM.-K.%26atitle%3DNimbolide%2520induces%2520apoptosis%2520in%2520human%2520nasopharyngeal%2520cancer%2520cells%26jtitle%3DEnviron.%2520Toxicol.%26date%3D2017%26volume%3D32%26spage%3D2085%26epage%3D2092%26doi%3D10.1002%2Ftox.22423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De La, Chapa J.J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabang, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fountzilas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wargovich, M. J.</span></span> <span> </span><span class="NLM_article-title">The highly pure neem leaf extract, SCNE, inhibits tumorigenesis in oral squamous cell carcinoma via disruption of pro-tumor inflammatory cytokines and cell signaling</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">890</span>, <span class="refDoi">Â DOI: 10.3389/fonc.2019.00890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3389%2Ffonc.2019.00890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31572681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3MnjvFSnuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=890&author=J.+Morrisauthor=C.+B.+Gonzalesauthor=Chapa+J.J.+De+Laauthor=A.+B.+Cabangauthor=C.+Fountzilasauthor=M.+Patelauthor=S.+Orozcoauthor=M.+J.+Wargovich&title=The+highly+pure+neem+leaf+extract%2C+SCNE%2C+inhibits+tumorigenesis+in+oral+squamous+cell+carcinoma+via+disruption+of+pro-tumor+inflammatory+cytokines+and+cell+signaling&doi=10.3389%2Ffonc.2019.00890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The Highly Pure Neem Leaf Extract, SCNE, Inhibits Tumorigenesis in Oral Squamous Cell Carcinoma via Disruption of Pro-tumor Inflammatory Cytokines and Cell Signaling</span></div><div class="casAuthors">Morris Jay; Cabang April B; Patel Mandakini; Orozco Stephanie; Wargovich Michael J; Gonzales Cara B; De La Chapa Jorge J; Fountzilas Christos</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">890</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Oral squamous cell carcinoma (OSCC) is a deadly disease that comprises 60% of all head and neck squamous cell cancers.  The leaves of the Neem tree (Azadirachta indica) have been used in traditional Ayurvedic medicine for centuries to treat numerous oral maladies and are known to have significant anti-inflammatory properties.  We hypothesize that a highly pure super critical CO2 Neem leaf extract (SCNE) prevents initiation and progression of OSCC via downregulation of intra-tumor pro-inflammatory pathways, which promote tumorigenesis.  Hence, we investigated the anticancer effects of SCNE using in vitro and in vivo platforms.  OSCC cell lines (SCC4, Cal27, and HSC3) were treated with SCNE while inflammation, proliferation, and migration were analyzed over time.  SCNE treatment significantly inhibited OSCC cell proliferation and migration and reduced MMP activity in vitro, suggesting its potential to inhibit tumor growth and metastasis.  The preventive effects of SCNE in ectopic xenograft and 4NQO-1 (4-Nitroquinoline-1-oxide) carcinogen-induced mouse models of OSCC were also evaluated.  Indeed, xenografted nude mice showed significant reduction of OSCC tumor volumes.  Likewise, SCNE significantly reduced the incidence of tongue dysplasia in the 4NQO-1 OSCC initiation model.  In both OSCC animal models, SCNE significantly depressed circulating pro-cancer inflammatory cytokines (host and tumor-secreted) including NFkB, COX2, IL-1, IL-6, TNFÎ±, and IFNÎ³.  In addition, we demonstrate that SCNE downregulates STAT3 and AKT expression and activity in vitro.  We also demonstrate that the primary active component, nimbolide (NIM), has significant anticancer activity in established OSCC xenografts.  Lastly, we show that SCNE induces an M1 phenotype in tumor associated macrophages (TAMS) in vivo.  Taken together, these data strongly support SCNE as means of preventing OSCC via downregulation of pro-cancer inflammatory cascades and NIM as a potential new therapy for existing OSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlkAoUFo4KjZagfuraLLzSfW6udTcc2eaH_p8Wnp0pT7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MnjvFSnuw%253D%253D&md5=d42008f722c4e68e5ce7359e52a1c620</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2019.00890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2019.00890%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DGonzales%26aufirst%3DC.%2BB.%26aulast%3DDe%2BLa%26aufirst%3DChapa%2BJ.J.%26aulast%3DCabang%26aufirst%3DA.%2BB.%26aulast%3DFountzilas%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DOrozco%26aufirst%3DS.%26aulast%3DWargovich%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520highly%2520pure%2520neem%2520leaf%2520extract%252C%2520SCNE%252C%2520inhibits%2520tumorigenesis%2520in%2520oral%2520squamous%2520cell%2520carcinoma%2520via%2520disruption%2520of%2520pro-tumor%2520inflammatory%2520cytokines%2520and%2520cell%2520signaling%26jtitle%3DFront.%2520Oncol.%26date%3D2019%26volume%3D9%26spage%3D890%26doi%3D10.3389%2Ffonc.2019.00890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sophia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowshik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwivedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhutia, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manavathi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3Î² signalling pathway in oral cancer</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1087</span>, <span class="refDoi">Â DOI: 10.1038/s41419-018-1126-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fs41419-018-1126-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=30352996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3cvisFSltA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1087&author=J.+Sophiaauthor=J.+Kowshikauthor=A.+Dwivediauthor=S.+K.+Bhutiaauthor=B.+Manavathiauthor=R.+Mishraauthor=S.+Nagini&title=Nimbolide%2C+a+neem+limonoid+inhibits+cytoprotective+autophagy+to+activate+apoptosis+via+modulation+of+the+PI3K%2FAkt%2FGSK-3%CE%B2+signalling+pathway+in+oral+cancer&doi=10.1038%2Fs41419-018-1126-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3Î² signalling pathway in oral cancer</span></div><div class="casAuthors">Sophia Josephraj; Kowshik Jaganathan; Nagini Siddavaram; Dwivedi Anju; Manavathi Bramanandam; Bhutia Sujit K; Mishra Rajakishore</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1087</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Of late, nimbolide, a limonoid from the neem tree (Azadirachta indica) has gained increasing research attention owing to its potent antiproliferative and apoptosis-inducing effects.  The present study was designed to investigate the effect of nimbolide on autophagy and the time point at which the phosphorylation status of GSK-3Î² and PI3K dictate the choice between autophagy and apoptosis in SCC131 and SCC4 oral cancer cells.  Additionally, we analysed changes in the expression of proteins involved in autophagy and apoptosis after therapeutic intervention with nimbolide in a hamster model of oral oncogenesis.  Furthermore, we also demonstrate changes in the expression of key genes involved in apoptosis and autophagy during the stepwise evolution of hamster and human OSCCs.  Nimbolide-induced stereotypical changes in oral cancer cells characteristic of both apoptosis and autophagy.  Time-course experiments revealed that nimbolide induces autophagy as an early event and then switches over to apoptosis.  Nimbolide negatively regulates PI3K/Akt signalling with consequent increase in p-GSK-3Î²(Tyr216), the active form of GSK-3Î² that inhibits autophagy.  Downregulation of HOTAIR, a competing endogenous RNA that sponges miR-126 may be a major contributor to the inactivation of PI3K/Akt/GSK3 signalling by nimbolide.  Analysis of key markers of apoptosis and autophagy as well as p-Akt(Ser473) during sequential progression of hamster and human OSCC revealed a gradual evolution to a pro-autophagic and antiapoptotic phenotype that could confer a survival advantage to tumors.  In summary, the results of the present study provide insights into the molecular mechanisms by which nimbolide augments apoptosis by overcoming the shielding effects of cytoprotective autophagy through modulation of the phosphorylation status of Akt and GSK-3Î² as well as the ncRNAs miR-126 and HOTAIR.  Development of phytochemicals such as nimbolide that target the complex interaction between proteins and ncRNAs that regulate the autophagy/apoptosis flux is of paramount importance in cancer prevention and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScmbQ8u9AhUFUIs6wFK5xJfW6udTcc2eaH_p8Wnp0pT7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvisFSltA%253D%253D&md5=dca3631d9b3de9fa6c58e5c843002d63</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fs41419-018-1126-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-018-1126-4%26sid%3Dliteratum%253Aachs%26aulast%3DSophia%26aufirst%3DJ.%26aulast%3DKowshik%26aufirst%3DJ.%26aulast%3DDwivedi%26aufirst%3DA.%26aulast%3DBhutia%26aufirst%3DS.%2BK.%26aulast%3DManavathi%26aufirst%3DB.%26aulast%3DMishra%26aufirst%3DR.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DNimbolide%252C%2520a%2520neem%2520limonoid%2520inhibits%2520cytoprotective%2520autophagy%2520to%2520activate%2520apoptosis%2520via%2520modulation%2520of%2520the%2520PI3K%252FAkt%252FGSK-3%25CE%25B2%2520signalling%2520pathway%2520in%2520oral%2520cancer%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2018%26volume%3D9%26spage%3D1087%26doi%3D10.1038%2Fs41419-018-1126-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, S. M.</span></span> <span> </span><span class="NLM_article-title">Nimbolide induces ROS-regulated apoptosis and inhibits cell migration in osteosarcoma</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">23405</span>â <span class="NLM_lpage">23424</span>, <span class="refDoi">Â DOI: 10.3390/ijms161023405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3390%2Fijms161023405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=26426012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCrsb7I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=23405-23424&author=J.+F.+Liuauthor=C.+H.+Houauthor=F.+L.+Linauthor=Y.+T.+Tsaoauthor=S.+M.+Hou&title=Nimbolide+induces+ROS-regulated+apoptosis+and+inhibits+cell+migration+in+osteosarcoma&doi=10.3390%2Fijms161023405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide induces ROS-regulated apoptosis and inhibits cell migration in osteosarcoma</span></div><div class="casAuthors">Liu, Ju-Fang; Hou, Chun-Han; Lin, Feng-Ling; Tsao, Ya-Ting; Hou, Sheng-Mou</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">23405-23424</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Osteosarcoma (OS) is a primary malignant tumor of bone and is most prevalent in children and adolescents.  OS is frequently assocd. with pulmonary metastasis, which is the main cause of OS-related mortality.  OS has a poor prognosis and is often unresponsive to conventional chemotherapy.  In this study, we detd. that Nimbolide, a novel anti-cancer therapy, acts by modulating multiple mechanisms in osteosarcoma cells.  Nimbolide induces apoptosis by increasing endoplasmic reticulum (ER) stress, mitochondrial dysfunction, accumulation of reactive oxygen species (ROS), and finally, caspase activation.  We also detd. that Nimbolide inhibits cell migration, which is crucial for metastasis, by reducing the expression of integrin Î±vÎ²5.  In addn., our results demonstrate that integrin Î±vÎ²5 expression is modulated by the PI3K/Akt and NF-ÎºB signaling cascade.  Nimbolide has potential as an anti-tumor drug given its multifunctional effects in OS.  Collectively, these results help us to understand the mechanisms of action of Nimbolide and will aid in the development of effective therapies for OS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeDYElEE8xBrVg90H21EOLACvtfcHk0ljaLJeieRwIxg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCrsb7I&md5=a32a8269c5113118661584de960cf49f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.3390%2Fijms161023405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms161023405%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DHou%26aufirst%3DC.%2BH.%26aulast%3DLin%26aufirst%3DF.%2BL.%26aulast%3DTsao%26aufirst%3DY.%2BT.%26aulast%3DHou%26aufirst%3DS.%2BM.%26atitle%3DNimbolide%2520induces%2520ROS-regulated%2520apoptosis%2520and%2520inhibits%2520cell%2520migration%2520in%2520osteosarcoma%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2015%26volume%3D16%26spage%3D23405%26epage%3D23424%26doi%3D10.3390%2Fijms161023405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subramani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arumugam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonkoungou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwivedi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmanaswamy, R.</span></span> <span> </span><span class="NLM_article-title">Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">19819</span>, <span class="refDoi">Â DOI: 10.1038/srep19819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fsrep19819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=26804739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtl2lurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=19819&author=R.+Subramaniauthor=E.+Gonzalezauthor=A.+Arumugamauthor=S.+Nandyauthor=V.+Gonzalezauthor=J.+Medelauthor=F.+Camachoauthor=A.+Ortegaauthor=S.+Bonkoungouauthor=M.+Narayanauthor=A.+K.+Dwivediauthor=R.+Lakshmanaswamy&title=Nimbolide+inhibits+pancreatic+cancer+growth+and+metastasis+through+ROS-mediated+apoptosis+and+inhibition+of+epithelial-to-mesenchymal+transition&doi=10.1038%2Fsrep19819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition</span></div><div class="casAuthors">Subramani, Ramadevi; Gonzalez, Elizabeth; Arumugam, Arunkumar; Nandy, Sushmita; Gonzalez, Viviana; Medel, Joshua; Camacho, Fernando; Ortega, Andrew; Bonkoungou, Sandrine; Narayan, Mahesh; Dwivedi, Alok kumar; Lakshmanaswamy, Rajkumar</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19819</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mortality and morbidity rates of pancreatic cancer are high because of its extremely invasive and metastatic nature.  Its lack of symptoms, late diagnosis and chemo-resistance and the ineffective treatment modalities warrant the development of new chemo-therapeutic agents for pancreatic cancer.  Agents from medicinal plants have demonstrated therapeutic benefits in various human cancers.  Nimbolide, an active mol. isolated from Azadirachta indica, has been reported to exhibit several medicinal properties.  This study assessed the anticancer properties of nimbolide against pancreatic cancer.  Our data reveal that nimbolide induces excessive generation of reactive oxygen species (ROS), thereby regulating both apoptosis and autophagy in pancreatic cancer cells.  Expts. with the autophagy inhibitors 3-methyladenine and chloroquine diphosphate salt and the apoptosis inhibitor z-VAD-fmk demonstrated that nimbolide-mediated ROS generation inhibited proliferation (through reduced PI3K/AKT/mTOR and ERK signaling) and metastasis (through decreased EMT, invasion, migration and colony forming abilities) via mitochondrial-mediated apoptotic cell death but not via autophagy.  In vivo expts. also demonstrated that nimbolide was effective in inhibiting pancreatic cancer growth and metastasis.  Overall, our data suggest that nimbolide can serve as a potential chemo-therapeutic agent for pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTlJpQ_WHLP7Vg90H21EOLACvtfcHk0ljaLJeieRwIxg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtl2lurY%253D&md5=6664989670a7451c627354e1aacbc6df</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fsrep19819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep19819%26sid%3Dliteratum%253Aachs%26aulast%3DSubramani%26aufirst%3DR.%26aulast%3DGonzalez%26aufirst%3DE.%26aulast%3DArumugam%26aufirst%3DA.%26aulast%3DNandy%26aufirst%3DS.%26aulast%3DGonzalez%26aufirst%3DV.%26aulast%3DMedel%26aufirst%3DJ.%26aulast%3DCamacho%26aufirst%3DF.%26aulast%3DOrtega%26aufirst%3DA.%26aulast%3DBonkoungou%26aufirst%3DS.%26aulast%3DNarayan%26aufirst%3DM.%26aulast%3DDwivedi%26aufirst%3DA.%2BK.%26aulast%3DLakshmanaswamy%26aufirst%3DR.%26atitle%3DNimbolide%2520inhibits%2520pancreatic%2520cancer%2520growth%2520and%2520metastasis%2520through%2520ROS-mediated%2520apoptosis%2520and%2520inhibition%2520of%2520epithelial-to-mesenchymal%2520transition%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D19819%26doi%3D10.1038%2Fsrep19819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inigo, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâMalley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balachandar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attwood, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochwald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, D.</span></span> <span> </span><span class="NLM_article-title">Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>413</i></span>,  <span class="NLM_fpage">82</span>â <span class="NLM_lpage">93</span>, <span class="refDoi">Â DOI: 10.1016/j.canlet.2017.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.canlet.2017.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29107110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2lsL7I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2018&pages=82-93&author=S.+Kumarauthor=J.+R.+Inigoauthor=R.+Kumarauthor=A.+K.+Chaudharyauthor=J.+O%E2%80%99Malleyauthor=S.+Balachandarauthor=J.+Wangauthor=K.+Attwoodauthor=N.+Yadavauthor=S.+Hochwaldauthor=X.+Wangauthor=D.+Chandra&title=Nimbolide+reduces+CD44+positive+cell+population+and+induces+mitochondrial+apoptosis+in+pancreatic+cancer+cells&doi=10.1016%2Fj.canlet.2017.10.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells</span></div><div class="casAuthors">Kumar, Sandeep; Inigo, Joseph R.; Kumar, Rahul; Chaudhary, Ajay K.; O'Malley, Jordan; Balachandar, Srimmitha; Wang, Jianmin; Attwood, Kristopher; Yadav, Neelu; Hochwald, Steven; Wang, Xinjiang; Chandra, Dhyan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">413</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-93</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is highly aggressive disease and current treatment regimens fail to effectively cure PDAC.  Development of resistance to current therapy is one of the key reasons for this outcome.  Nimbolide (NL), a triterpenoid obtained from Azadirachta indica, exhibits anticancer properties in various cancer including PDAC cells.  However, the underlying mechanism of this anticancer agent in PDAC cells remains undefined.  We show that NL exerts a higher level of apoptotic cell death compared to the first-line agent gemcitabine for PDAC, as well as other anticancer agents including sorafenib and curcumin.  The anticancer efficacy of NL was further evidenced by a redn. in the CD44+ as well as cancer stem-like cell (CSC) population, as it causes decreased sphere formation.  Mechanistically, the anticancer efficacy of NL assocs. with reduced mutant p53 as well as increased mitochondrial activity in the form of increased mitochondrial reactive oxygen species and mitochondrial mass.  Together, this study highlights the therapeutic potential of NL in mutant p53 expressing pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWaM4J0Gt34LVg90H21EOLACvtfcHk0ljaLJeieRwIxg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2lsL7I&md5=200e394249c261cc9bce68f32d88cc2c</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DInigo%26aufirst%3DJ.%2BR.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DChaudhary%26aufirst%3DA.%2BK.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DJ.%26aulast%3DBalachandar%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAttwood%26aufirst%3DK.%26aulast%3DYadav%26aufirst%3DN.%26aulast%3DHochwald%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChandra%26aufirst%3DD.%26atitle%3DNimbolide%2520reduces%2520CD44%2520positive%2520cell%2520population%2520and%2520induces%2520mitochondrial%2520apoptosis%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D413%26spage%3D82%26epage%3D93%26doi%3D10.1016%2Fj.canlet.2017.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugam, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siveen, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arfuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samym, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deivasigamanim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span> <span> </span><span class="NLM_article-title">Nimbolide-induced oxidative stress abrogates STAT3 signaling cascade and inhibits tumor growth in transgenic adenocarcinoma of mouse prostate model</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">575</span>â <span class="NLM_lpage">589</span>, <span class="refDoi">Â DOI: 10.1089/ars.2015.6418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1089%2Fars.2015.6418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=26649526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVeis7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=575-589&author=J.+Zhangauthor=K.+S.+Ahnauthor=C.+Kimauthor=M.+K.+Shanmugamauthor=K.+S.+Siveenauthor=F.+Arfusoauthor=R.+P.+Samymauthor=A.+Deivasigamanimauthor=L.+H.+Limauthor=L.+Wangauthor=B.+C.+Gohauthor=A.+P.+Kumarauthor=K.+M.+Huiauthor=G.+Sethi&title=Nimbolide-induced+oxidative+stress+abrogates+STAT3+signaling+cascade+and+inhibits+tumor+growth+in+transgenic+adenocarcinoma+of+mouse+prostate+model&doi=10.1089%2Fars.2015.6418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model</span></div><div class="casAuthors">Zhang, Jingwen; Ahn, Kwang Seok; Kim, Chulwon; Shanmugam, Muthu K.; Siveen, Kodappully Sivaraman; Arfuso, Frank; Samym, Ramar Perumal; Deivasigamanim, Amudha; Lim, Lina Hsiu Kim; Wang, Lingzhi; Goh, Boon Cher; Kumar, Alan Prem; Hui, Kam Man; Sethi, Gautam</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">575-589</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: Prostate cancer (PCa) is one of the most commonly diagnosed cancers worldwide.  Currently available therapies for metastatic PCa are only marginally effective, hence novel treatment modalities are urgently required.  Considerable evidence(s) suggest that deregulated activation of oncogenic transcription factor, signal transducer and activator of transcription 3 (STAT3) plays a pivotal role in the development and progression of PCa.  Thus, agents that can abrogate STAT3 activation could form the basis of novel therapy for PCa patients.  In the present study, we analyzed whether the potential anticancer effects of nimbolide (NL), a limonoid triterpene derived from Azadirachta indica, against PCa cell lines and transgenic adenocarcinoma of mouse prostate (TRAMP) model are mediated through the neg. regulation of STAT3 pathway.  Results: Data from the in vitro studies indicated that NL could significantly inhibit cell viability, induce apoptosis, and suppress cellular invasion and migration.  Interestingly, NL also abrogated STAT3 activation and this effect was found to be mediated via an increased prodn. of reactive oxygen species (ROS) due to GSH/GSSG imbalance.  Oral administration of NL significantly suppressed the tumor growth and metastasis in TRAMP mouse model without exhibiting any significant adverse effects.  Innovation: The present study demonstrates the crit. role of GSH/GSSG imbalance-mediated ROS prodn. contributing to the STAT3 inhibitory and tumor-suppressive effect of NL in PCa.  Conclusion: Overall, our findings indicate that NL exhibits significant anticancer effects in PCa that may be primarily mediated through the ROS-regulated inhibition of STAT3 signaling cascade.  Antioxid. Redox Signal. 24, 575-589.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGYSso-6wEnLVg90H21EOLACvtfcHk0lhtcr9RJ1er7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVeis7o%253D&md5=07b23bd2354fda2208198132f6de2d77</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1089%2Fars.2015.6418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2015.6418%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DShanmugam%26aufirst%3DM.%2BK.%26aulast%3DSiveen%26aufirst%3DK.%2BS.%26aulast%3DArfuso%26aufirst%3DF.%26aulast%3DSamym%26aufirst%3DR.%2BP.%26aulast%3DDeivasigamanim%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DL.%2BH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGoh%26aufirst%3DB.%2BC.%26aulast%3DKumar%26aufirst%3DA.%2BP.%26aulast%3DHui%26aufirst%3DK.%2BM.%26aulast%3DSethi%26aufirst%3DG.%26atitle%3DNimbolide-induced%2520oxidative%2520stress%2520abrogates%2520STAT3%2520signaling%2520cascade%2520and%2520inhibits%2520tumor%2520growth%2520in%2520transgenic%2520adenocarcinoma%2520of%2520mouse%2520prostate%2520model%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2016%26volume%3D24%26spage%3D575%26epage%3D589%26doi%3D10.1089%2Fars.2015.6418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priya, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunkumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharmila, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajalakshmi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunakaran, J.</span></span> <span> </span><span class="NLM_article-title">Nimbolide inhibits androgen independent prostate cancer cells survival and proliferation by modulating multiple pro-survival signaling pathways</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1623</span>â <span class="NLM_lpage">1634</span>, <span class="refDoi">Â DOI: 10.1016/j.biopha.2016.10.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.biopha.2016.10.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=27889231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGjsL7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2016&pages=1623-1634&author=P.+R.+Singhauthor=E.+S.+Priyaauthor=S.+Balakrishnanauthor=R.+Arunkumarauthor=G.+Sharmilaauthor=M.+Rajalakshmiauthor=J.+Arunakaran&title=Nimbolide+inhibits+androgen+independent+prostate+cancer+cells+survival+and+proliferation+by+modulating+multiple+pro-survival+signaling+pathways&doi=10.1016%2Fj.biopha.2016.10.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide inhibits androgen independent prostate cancer cells survival and proliferation by modulating multiple pro-survival signaling pathways</span></div><div class="casAuthors">Singh, P. Raja; Priya, E. Sugantha; Balakrishnan, S.; Arunkumar, R.; Sharmila, G.; Rajalakshmi, M.; Arunakaran, J.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1623-1634</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Prostate cancer is the most prominent cancer in men, experiencing a relapse in disease often express high serum TNF-Î± levels.  It has been correlated with increased cell survival and proliferation of prostate cancer cells.  Previous studies reported that nimbolide, a terpenoid derived from the leaves and flowers of neem tree inhibits cancer growth through selective modulation of cell signaling pathways linked to inflammation, survival, proliferation, angiogenesis and metastasis.  The present study aimed to examine the effect of nimbolide at 1 and 2 Î¼M concns. on TNF-Î±/TNFR1 mediated signaling mols. involved in cell survival and proliferation in PC-3 cell line via NF-ÎºB and MAPK pathways by real time PCR and western blot.  Protein and compd. interaction were performed by Mol. docking anal.  Our results indicate that nimbolide treatment suppressed expression of TNF-Î±, SODD, Grb2, SOS mRNA and modulated TNF-Î±/TNFR1 regulated NF-ÎºB and MAPK signaling mols. in PC-3 cells.  Addnl. mol. dynamics simulation studies confirmed the stability of nimbolide and signaling mols. binding interactions.  Binding pose anal. revealed the significance of hydrogen bond interactions for effective stabilization of virtual ligand protein complexes.  Nimbolide inhibited prostate cancer cell survival and proliferation via NF-ÎºB and MAPK pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCM5EtWSIV2LVg90H21EOLACvtfcHk0lhtcr9RJ1er7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGjsL7M&md5=6cf4c4a60aaafcb414da05784e776998</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2016.10.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2016.10.076%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DP.%2BR.%26aulast%3DPriya%26aufirst%3DE.%2BS.%26aulast%3DBalakrishnan%26aufirst%3DS.%26aulast%3DArunkumar%26aufirst%3DR.%26aulast%3DSharmila%26aufirst%3DG.%26aulast%3DRajalakshmi%26aufirst%3DM.%26aulast%3DArunakaran%26aufirst%3DJ.%26atitle%3DNimbolide%2520inhibits%2520androgen%2520independent%2520prostate%2520cancer%2520cells%2520survival%2520and%2520proliferation%2520by%2520modulating%2520multiple%2520pro-survival%2520signaling%2520pathways%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2016%26volume%3D84%26spage%3D1623%26epage%3D1634%26doi%3D10.1016%2Fj.biopha.2016.10.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, J. P.</span></span> <span> </span><span class="NLM_article-title">Induction of cell cycle arrest, DNA damage, and apoptosis by nimbolide in human renal cell carcinoma cells</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">7539</span>â <span class="NLM_lpage">7547</span>, <span class="refDoi">Â DOI: 10.1007/s13277-015-3477-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs13277-015-3477-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovVemur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=7539-7547&author=Y.+H.+Hsiehauthor=C.+H.+Leeauthor=H.+Y.+Chenauthor=S.+C.+Hsiehauthor=C.+L.+Linauthor=J.+P.+Tsai&title=Induction+of+cell+cycle+arrest%2C+DNA+damage%2C+and+apoptosis+by+nimbolide+in+human+renal+cell+carcinoma+cells&doi=10.1007%2Fs13277-015-3477-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of cell cycle arrest, DNA damage, and apoptosis by nimbolide in human renal cell carcinoma cells</span></div><div class="casAuthors">Hsieh, Yi-Hsien; Lee, Chien-Hsing; Chen, Hsiao-Yun; Hsieh, Shu-Ching; Lin, Chia-Liang; Tsai, Jen-Pi</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">7539-7547</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Nimbolide is a tetranortriterpenoid isolated from the leaves and flowers of Azadirachta indica which has been shown to exhibit anticancer, antioxidant, anti-inflammatory, and anti-invasive properties in a variety of cancer cells.  However, the anti-tumor effect on human renal cell carcinoma (RCC) cells is unknown.  In this study, we found that nimbolide treatment had a cytotoxic effect on 786-O and A-498 RCC cells in a dose-dependent manner.  According to flow cytometric anal., nimbolide treatment resulted in G2/M arrest in 786-O and A-498 cells accompanied with an increase in the phosphorylation status of p53, cdc2, cdc25c, and decreased expressions of cyclin A, cyclin B, cdc2, and cdc25c.  Nimbolide also caused DNA damage in a dose-dependent manner as detd. by comet assay and measurement of Î³-H2AX.  In addn., apoptotic cells were obsd. in an Annexin V-FITC/propidium iodide double-stained assay.  The activities of caspase-3, -9, and poly ADP-ribose polymerase (PARP) were increased, and the expression of pro-caspase-8 was decreased in nimbolide-treated 786-O and A-498 cells.  Western blot anal. revealed that the levels of intrinsic-related apoptotic proteins Bax and extrinsic-related proteins (DR5, CHOP) were significantly increased in nimbolide-treated 786-O and A-498 cells.  In addn., the expressions of Bcl-2 and Mcl-1 were decreased in 786-O and A-498 cells after nimbolide treatment.  We conclude that nimbolide can inhibit the growth of human RCC cells by inducing G2/M phase arrest by modulating cell cycle-related proteins and cell apoptosis by regulating intrinsic and extrinsic caspase signaling pathways.  Nimbolide may be a promising therapeutic strategy for the treatment of RCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocpLCQZIlxmrVg90H21EOLACvtfcHk0lhtcr9RJ1er7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovVemur4%253D&md5=bfab244db64b685bdba2fea57e58eba6</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2Fs13277-015-3477-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-015-3477-0%26sid%3Dliteratum%253Aachs%26aulast%3DHsieh%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DH.%2BY.%26aulast%3DHsieh%26aufirst%3DS.%2BC.%26aulast%3DLin%26aufirst%3DC.%2BL.%26aulast%3DTsai%26aufirst%3DJ.%2BP.%26atitle%3DInduction%2520of%2520cell%2520cycle%2520arrest%252C%2520DNA%2520damage%252C%2520and%2520apoptosis%2520by%2520nimbolide%2520in%2520human%2520renal%2520cell%2520carcinoma%2520cells%26jtitle%3DTumor%2520Biol.%26date%3D2015%26volume%3D36%26spage%3D7539%26epage%3D7547%26doi%3D10.1007%2Fs13277-015-3477-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harish
Kumar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidya Priyadarsini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinothini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VidjayaLetchoumy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">392</span>â <span class="NLM_lpage">401</span>, <span class="refDoi">Â DOI: 10.1007/s10637-009-9263-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs10637-009-9263-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=19458912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlyhu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=392-401&author=G.+Harish%0AKumarauthor=R.+Vidya+Priyadarsiniauthor=G.+Vinothiniauthor=P.+VidjayaLetchoumyauthor=S.+Nagini&title=The+neem+limonoids+azadirachtin+and+nimbolide+inhibit+cell+proliferation+and+induce+apoptosis+in+an+animal+model+of+oral+oncogenesis&doi=10.1007%2Fs10637-009-9263-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis</span></div><div class="casAuthors">Harish Kumar, G.; Vidya Priyadarsini, R.; Vinothini, G.; Vidjaya Letchoumy, P.; Nagini, S.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">392-401</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Limonoids from the neem tree (Azadirachta indica) have attracted considerable research attention for their cytotoxicity against human cancer cell lines.  However, the antiproliferative and apoptosis inducing effects of neem limonoids have not been tested in animal tumor models.  The present study was therefore designed to evaluate the relative chemopreventive potential of the neem limonoids azadirachtin and nimbolide in the hamster buccal pouch (HBP) carcinogenesis model by analyzing the expression of proliferating cell nuclear antigen (PCNA), p21waf1, cyclin D1, glutathione S-transferase pi (GST-P), NF-ÎºB, inhibitor of ÎºB (IÎºB), p53, Fas, Bcl-2, Bax, Bid, Apaf-1, cytochrome C, survivin, caspases-3, -6, -8 and -9, and poly(ADP-ribose) polymerase (PARP) by RT-PCR, immunohistochem., and Western blot analyses.  The results provide compelling evidence that azadirachtin and nimbolide mediate their antiproliferative effects by downregulating proteins involved in cell cycle progression and transduce apoptosis by both the intrinsic and extrinsic pathways.  On a comparative basis, nimbolide was found to be a more potent antiproliferative and apoptosis inducing agent and offers promise as a candidate agent in multitargeted prevention and treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql8dp_iMI_arVg90H21EOLACvtfcHk0lgpJMaLT5xPTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlyhu7o%253D&md5=2245bc4172b2ca9498514592552c86ef</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs10637-009-9263-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-009-9263-3%26sid%3Dliteratum%253Aachs%26aulast%3DHarish%2BKumar%26aufirst%3DG.%26aulast%3DVidya%2BPriyadarsini%26aufirst%3DR.%26aulast%3DVinothini%26aufirst%3DG.%26aulast%3DVidjayaLetchoumy%26aufirst%3DP.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DThe%2520neem%2520limonoids%2520azadirachtin%2520and%2520nimbolide%2520inhibit%2520cell%2520proliferation%2520and%2520induce%2520apoptosis%2520in%2520an%2520animal%2520model%2520of%2520oral%2520oncogenesis%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2010%26volume%3D28%26spage%3D392%26epage%3D401%26doi%3D10.1007%2Fs10637-009-9263-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sophia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiran Kishore, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowshik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide, a neem limonoid inhibits phosphatidyl inositol-3 kinase to activate glycogen synthase kinase-3Î² in a hamster model of oral oncogenesis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">22192</span>, <span class="refDoi">Â DOI: 10.1038/srep22192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fsrep22192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=26902162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1egtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=22192&author=J.+Sophiaauthor=T.+K.+Kiran+Kishoreauthor=J.+Kowshikauthor=R.+Mishraauthor=S.+Nagini&title=Nimbolide%2C+a+neem+limonoid+inhibits+phosphatidyl+inositol-3+kinase+to+activate+glycogen+synthase+kinase-3%CE%B2+in+a+hamster+model+of+oral+oncogenesis&doi=10.1038%2Fsrep22192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3Î² in a hamster model of oral oncogenesis</span></div><div class="casAuthors">Sophia, Josephraj; Kiran Kishore T., Kranthi; Kowshik, Jaganathan; Mishra, Rajakishore; Nagini, Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22192</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3Î² (GSK-3Î²), a serine/threonine kinase is frequently inactivated by the oncogenic signalling kinases PI3K/Akt and MAPK/ERK in diverse malignancies.  The present study was designed to investigate GSK-3Î² signalling circuits in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis model and the therapeutic potential of the neem limonoid nimbolide.  Inactivation of GSK-3Î² by phosphorylation at serine 9 and activation of PI3K/Akt, MAPK/ERK and Î²-catenin was assocd. with increased cell proliferation and apoptosis evasion during stepwise evolution of HBP carcinomas.  Administration of nimbolide inhibited PI3K/Akt signalling with consequent activation of GSK-3Î² thereby inducing trafficking of Î²-catenin away from the nucleus and enhancing the expression of miR-126 and let-7.  Mol. docking studies confirmed interaction of nimbolide with PI3K, Akt, ERK and GSK-3Î².  Furthermore, nimbolide attenuated cell proliferation and induced apoptosis as evidenced by increased p-cyclin D1Thr286 and pro-apoptotic proteins.  The present study has unravelled aberrant phosphorylation as a key determinant for oncogenic signalling and acquisition of cancer hallmarks in the HBP model.  The study has also provided mechanistic insights into the chemotherapeutic potential of nimbolide that may be a useful addn. to the armamentarium of natural compds. targeting PI3K for oral cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3DgWhliy6OrVg90H21EOLACvtfcHk0ljD--JNp2-Lmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1egtbY%253D&md5=fc4ef6c29a137abfecad42af5d948e0b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fsrep22192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep22192%26sid%3Dliteratum%253Aachs%26aulast%3DSophia%26aufirst%3DJ.%26aulast%3DKiran%2BKishore%26aufirst%3DT.%2BK.%26aulast%3DKowshik%26aufirst%3DJ.%26aulast%3DMishra%26aufirst%3DR.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DNimbolide%252C%2520a%2520neem%2520limonoid%2520inhibits%2520phosphatidyl%2520inositol-3%2520kinase%2520to%2520activate%2520glycogen%2520synthase%2520kinase-3%25CE%25B2%2520in%2520a%2520hamster%2520model%2520of%2520oral%2520oncogenesis%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D22192%26doi%3D10.1038%2Fsrep22192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of cancer: The next generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">646</span>â <span class="NLM_lpage">674</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+The+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0ljD--JNp2-Lmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520The%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shahar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larisch, S.</span></span> <span> </span><span class="NLM_article-title">Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">100712</span>, <span class="refDoi">Â DOI: 10.1016/j.drup.2020.100712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.drup.2020.100712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32599435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB38nlvFyhtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2020&pages=100712&author=N.+Shaharauthor=S.+Larisch&title=Inhibiting+the+inhibitors%3A+Targeting+anti-apoptotic+proteins+in+cancer+and+therapy+resistance&doi=10.1016%2Fj.drup.2020.100712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance</span></div><div class="casAuthors">Shahar Nir; Larisch Sarit</div><div class="citationInfo"><span class="NLM_cas:title">Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">100712</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The cytotoxic effect of anti-cancer drugs relies on their ability to induce programmed cell death known as apoptosis.  Evading apoptosis is a common characteristic of cancer cells and it is linked to both carcinogenesis and anticancer drug resistance.  To escape apoptosis, cancer cells often express high levels of anti-apoptotic proteins and become "addicted "to them for their survival.  Consequently, anti-apoptotic proteins have emerged as attractive druggable targets for the development of cancer therapeutics.  In this review we focus on two major anti-apoptotic protein families: IAPs (Inhibitor of Apoptosis) proteins and Bcl-2 (B-cell lymphoma-2) family members.  We also discuss insights into the regulation of these proteins by natural antagonists, which has provided the conceptual basis for developing novel anti-cancer drugs.  Significantly, the pro-apoptotic protein ARTS (apoptosis-related protein in the TGF-Î² signaling pathway; Sept4_i2) acts as a dual antagonist of both X-linked inhibitor of apoptosis protein (XIAP) and Bcl-2.  Because upregulation of anti-apoptotic proteins in response to cancer therapy contributes to drug resistance, targeted inhibition of these proteins is expected to enhance the efficacy of chemotherapy.  Finally, we discuss the role of proteasome-mediated degradation in the regulation of apoptosis, and how this mechanism can be harnessed to develop small molecules that stimulate degradation of anti-apoptotic proteins for cancer therapy.  This strategy has the potential to overcome drug resistance more effectively than mere inhibition.  Therefore, this approach may allow use of lower drug concentrations and thereby reduce cytotoxicity and untoward side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYsIJWD7spUsyail4HZd-ifW6udTcc2eZIkCXZ4q6J5bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38nlvFyhtQ%253D%253D&md5=31920b881f86727c398222d4220d0607</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2020.100712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2020.100712%26sid%3Dliteratum%253Aachs%26aulast%3DShahar%26aufirst%3DN.%26aulast%3DLarisch%26aufirst%3DS.%26atitle%3DInhibiting%2520the%2520inhibitors%253A%2520Targeting%2520anti-apoptotic%2520proteins%2520in%2520cancer%2520and%2520therapy%2520resistance%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2020%26volume%3D52%26spage%3D100712%26doi%3D10.1016%2Fj.drup.2020.100712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span>; <span class="NLM_string-name">Vidya Priyadarsini, R.</span></span> <span> </span><span class="NLM_article-title">Apoptosis induction by nimbolide, a limonoid from Azadirachta indica: Molecular targets and signaling networks</span>. In  <i>Novel apoptotic regulators in carcinogenesis</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. C.</span>, <span class="NLM_string-name">Lai, P. B. S.</span></span>, Eds.; <span class="NLM_publisher-name">Springer Verlag</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">27</span>â <span class="NLM_lpage">44</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=27-44&author=S.+Nagini&author=R.+Vidya+Priyadarsiniauthor=G.+C.+Chen&author=P.+B.+S.+Lai&title=Novel+apoptotic+regulators+in+carcinogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DApoptosis%2520induction%2520by%2520nimbolide%252C%2520a%2520limonoid%2520from%2520Azadirachta%2520indica%253A%2520Molecular%2520targets%2520and%2520signaling%2520networks%26btitle%3DNovel%2520apoptotic%2520regulators%2520in%2520carcinogenesis%26aulast%3DChen%26aufirst%3DG.%2BC.%26pub%3DSpringer%2520Verlag%26date%3D2012%26spage%3D27%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, D.</span></span> <span> </span><span class="NLM_article-title">Neem components as potential agents for cancer prevention and treatment</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1846</i></span>,  <span class="NLM_fpage">247</span>â <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.bbcan.2014.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=25016141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1OqsbjJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1846&publication_year=2014&pages=247-257&author=F.+Haoauthor=S.+Kumarauthor=N.+Yadavauthor=D.+Chandra&title=Neem+components+as+potential+agents+for+cancer+prevention+and+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Neem components as potential agents for cancer prevention and treatment</span></div><div class="casAuthors">Hao, Fang; Kumar, Sandeep; Yadav, Neelu; Chandra, Dhyan</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1846</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">247-257</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Azadirachta indica, also known as neem, is commonly found in many semi-tropical and tropical countries including India, Pakistan, and Bangladesh.  The components extd. from neem plant have been used in traditional medicine for the cure of multiple diseases including cancer for centuries.  The exts. of seeds, leaves, flowers, and fruits of neem have consistently shown chemopreventive and antitumor effects in different types of cancer.  Azadirachtin and nimbolide are among the few bioactive components in neem that have been studied extensively, but research on a great no. of addnl. bioactive components is warranted.  The key anticancer effects of neem components on malignant cells include inhibition of cell proliferation, induction of cell death, suppression of cancer angiogenesis, restoration of cellular redn./oxidn. (redox) balance, and enhancement of the host immune responses against tumor cells.  While the underlying mechanisms of these effects are mostly unclear, the suppression of NF-ÎºB signaling pathway is, at least partially, involved in the anticancer functions of neem components.  Importantly, the anti-proliferative and apoptosis-inducing effects of neem components are tumor selective as the effects on normal cells are significantly weaker.  In addn., neem exts. sensitize cancer cells to immunotherapy and radiotherapy, and enhance the efficacy of certain cancer chemotherapeutic agents.  This review summarizes the current updates on the anticancer effects of neem components and their possible impact on managing cancer incidence and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPwcs3R1OE5rVg90H21EOLACvtfcHk0ljn6dnprTcyyA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1OqsbjJ&md5=b8339f4d4a1fd08fe6db180ed981090a</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2014.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2014.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DF.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DN.%26aulast%3DChandra%26aufirst%3DD.%26atitle%3DNeem%2520components%2520as%2520potential%2520agents%2520for%2520cancer%2520prevention%2520and%2520treatment%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2014%26volume%3D1846%26spage%3D247%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuya, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, B. C.</span></span> <span> </span><span class="NLM_article-title">Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">44790</span>â <span class="NLM_lpage">44802</span>, <span class="refDoi">Â DOI: 10.18632/oncotarget.8316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.18632%2Foncotarget.8316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=27027349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC28fkvVGrsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=44790-44802&author=L.+Wangauthor=D.+D.+Phanauthor=J.+Zhangauthor=P.+S.+Ongauthor=W.+L.+Thuyaauthor=R.+Sooauthor=A.+L.+Wongauthor=W.+P.+Yongauthor=S.+C.+Leeauthor=P.+C.+Hoauthor=G.+Sethiauthor=B.+C.+Goh&title=Anticancer+properties+of+nimbolide+and+pharmacokinetic+considerations+to+accelerate+its+development&doi=10.18632%2Foncotarget.8316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development</span></div><div class="casAuthors">Wang Lingzhi; Phan Do Dang Khoa; Thuya Win Lwin; Soo Ross; Wong Andrea Li-Ann; Yong Wei Peng; Lee Soo Chin; Goh Boon Cher; Wang Lingzhi; Zhang Jingwen; Sethi Gautam; Goh Boon Cher; Phan Do Dang Khoa; Ong Pei-Shi; Thuya Win Lwin; Ho Paul Chi-Lui; Soo Ross; Wong Andrea Li-Ann; Yong Wei Peng; Lee Soo Chin; Goh Boon Cher</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">44790-44802</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nimbolide is one of the main components in the leaf extract of Azadirachta indica (A. indica).  Accumulating evidence from various in vitro and in vivo studies indicates that nimbolide possesses potent anticancer activity against several types of cancer and also shows potential chemopreventive activity in animal models.  The main mechanisms of action of nimbolide include anti-proliferation, induction of apoptosis, inhibition of metastasis and angiogenesis, and modulation of carcinogen-metabolizing enzymes.  Although multiple pharmacodynamic (PD) studies have been carried out, nimbolide is still at the infant stage in the drug development pipeline due to the lack of systematic pharmacokinetic (PK) studies and long-term toxicological studies.  Preclinical PK and toxicological studies are vital in determining the dosage range to support the safety of nimbolide for first-in-human clinical trials.  In this review, we will provide a comprehensive summary for the current status of nimbolide as an anticancer and chemopreventive lead compound, and highlight the importance of systematic preclinical PK and toxicological studies in accelerating the process of application of nimbolide as a therapeutic agent against various malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRi_DV2txfJVny-c-E1v-fmfW6udTcc2eacLOJkCGv0o7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fkvVGrsg%253D%253D&md5=67bb5ca109816b6a367c1ed03239fe76</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8316%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPhan%26aufirst%3DD.%2BD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DOng%26aufirst%3DP.%2BS.%26aulast%3DThuya%26aufirst%3DW.%2BL.%26aulast%3DSoo%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DA.%2BL.%26aulast%3DYong%26aufirst%3DW.%2BP.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DHo%26aufirst%3DP.%2BC.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DGoh%26aufirst%3DB.%2BC.%26atitle%3DAnticancer%2520properties%2520of%2520nimbolide%2520and%2520pharmacokinetic%2520considerations%2520to%2520accelerate%2520its%2520development%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D44790%26epage%3D44802%26doi%3D10.18632%2Foncotarget.8316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaiswara, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawat, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span> <span> </span><span class="NLM_article-title">Nimbolide induces cell death in T lymphoma cells: Implication of altered apoptosis and glucose metabolism</span>. <i>Environ. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, in press</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=33274819" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=P.+K.+Jaiswaraauthor=V.+K.+Guptaauthor=P.+Sonkerauthor=S.+G.+Rawatauthor=R.+K.+Tiwariauthor=C.+Pathakauthor=S.+Kumarauthor=A.+Kumar&title=Nimbolide+induces+cell+death+in+T+lymphoma+cells%3A+Implication+of+altered+apoptosis+and+glucose+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaiswara%26aufirst%3DP.%2BK.%26aulast%3DGupta%26aufirst%3DV.%2BK.%26aulast%3DSonker%26aufirst%3DP.%26aulast%3DRawat%26aufirst%3DS.%2BG.%26aulast%3DTiwari%26aufirst%3DR.%2BK.%26aulast%3DPathak%26aufirst%3DC.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DA.%26atitle%3DNimbolide%2520induces%2520cell%2520death%2520in%2520T%2520lymphoma%2520cells%253A%2520Implication%2520of%2520altered%2520apoptosis%2520and%2520glucose%2520metabolism%26jtitle%3DEnviron.%2520Toxicol.%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulcahy
Levy, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorburn, A.</span></span> <span> </span><span class="NLM_article-title">Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">843</span>â <span class="NLM_lpage">857</span>, <span class="refDoi">Â DOI: 10.1038/s41418-019-0474-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fs41418-019-0474-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31836831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3MbgtV2itQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2020&pages=843-857&author=J.+M.+Mulcahy%0ALevyauthor=A.+Thorburn&title=Autophagy+in+cancer%3A+moving+from+understanding+mechanism+to+improving+therapy+responses+in+patients&doi=10.1038%2Fs41418-019-0474-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients</span></div><div class="casAuthors">Mulcahy Levy Jean M; Mulcahy Levy Jean M; Mulcahy Levy Jean M; Thorburn Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Cell death and differentiation</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">843-857</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autophagy allows for cellular material to be delivered to lysosomes for degradation resulting in basal or stress-induced turnover of cell components that provide energy and macromolecular precursors.  These activities are thought to be particularly important in cancer where both tumor-promoting and tumor-inhibiting functions of autophagy have been described.  Autophagy has also been intricately linked to apoptosis and programmed cell death, and understanding these interactions is becoming increasingly important in improving cancer therapy and patient outcomes.  In this review, we consider how recent discoveries about how autophagy manipulation elicits its effects on cancer cell behavior can be leveraged to improve therapeutic responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMGtKuqQuoSe2qxNLjzXe8fW6udTcc2eacLOJkCGv0o7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MbgtV2itQ%253D%253D&md5=2c94adad3884746f0fecd7a2ad270d8f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fs41418-019-0474-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-019-0474-7%26sid%3Dliteratum%253Aachs%26aulast%3DMulcahy%2BLevy%26aufirst%3DJ.%2BM.%26aulast%3DThorburn%26aufirst%3DA.%26atitle%3DAutophagy%2520in%2520cancer%253A%2520moving%2520from%2520understanding%2520mechanism%2520to%2520improving%2520therapy%2520responses%2520in%2520patients%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2020%26volume%3D27%26spage%3D843%26epage%3D857%26doi%3D10.1038%2Fs41418-019-0474-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikoletopoulou, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palikaras, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavernarakis, N.</span></span> <span> </span><span class="NLM_article-title">Crosstalk between apoptosis, necrosis and autophagy</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1833</i></span>,  <span class="NLM_fpage">3448</span>â <span class="NLM_lpage">3459</span>, <span class="refDoi">Â DOI: 10.1016/j.bbamcr.2013.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.bbamcr.2013.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=23770045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVCgsLfK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1833&publication_year=2013&pages=3448-3459&author=V.+Nikoletopoulouauthor=M.+Markakiauthor=K.+Palikarasauthor=N.+Tavernarakis&title=Crosstalk+between+apoptosis%2C+necrosis+and+autophagy&doi=10.1016%2Fj.bbamcr.2013.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Crosstalk between apoptosis, necrosis and autophagy</span></div><div class="casAuthors">Nikoletopoulou, Vassiliki; Markaki, Maria; Palikaras, Konstantinos; Tavernarakis, Nektarios</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1833</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3448-3459</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Apoptosis and necrosis are the two major modes of cell death, the mol. mechanisms of which have been extensively studied.  Although initially thought to constitute mutually exclusive cellular states, recent findings reveal cellular contexts that require a balanced interplay between these two modes of cellular demise.  Several death initiator and effector mols., signaling pathways and subcellular sites have been identified as key mediators in both processes, either by constituting common modules or alternatively by functioning as a switch allowing cells to decide which route to take, depending on the specific situation.  Importantly, autophagy, which is a predominantly cytoprotective process, has been linked to both types of cell death, serving either a pro-survival or pro-death function.  Here we review the recent literature that highlights the intricate interplay between apoptosis, necrosis and autophagy, focusing on the relevance and impact of this crosstalk in normal development and in pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNvA37bCDG17Vg90H21EOLACvtfcHk0lhThyxHc7gWQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVCgsLfK&md5=c4efdd529cb9724fb03dca0f6800d244</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2013.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2013.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DNikoletopoulou%26aufirst%3DV.%26aulast%3DMarkaki%26aufirst%3DM.%26aulast%3DPalikaras%26aufirst%3DK.%26aulast%3DTavernarakis%26aufirst%3DN.%26atitle%3DCrosstalk%2520between%2520apoptosis%252C%2520necrosis%2520and%2520autophagy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2013%26volume%3D1833%26spage%3D3448%26epage%3D3459%26doi%3D10.1016%2Fj.bbamcr.2013.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vijayarathna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jothy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanwar, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasidharan, S.</span></span> <span> </span><span class="NLM_article-title">Anti-cancer natural products inducing cross-talk between apoptosis and autophagy mutual proteins to regulate cancer cell death: Design of future green anticancer therapies</span>. <i>Asian Pac. J. Cancer Prev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">6175</span>â <span class="NLM_lpage">6176</span>, <span class="refDoi">Â DOI: 10.7314/APJCP.2015.16.14.6175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.7314%2FAPJCP.2015.16.14.6175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=26320517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC287ns1Kkug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=6175-6176&author=S.+Vijayarathnaauthor=S.+L.+Jothyauthor=Y.+Chenauthor=J.+R.+Kanwarauthor=S.+Sasidharan&title=Anti-cancer+natural+products+inducing+cross-talk+between+apoptosis+and+autophagy+mutual+proteins+to+regulate+cancer+cell+death%3A+Design+of+future+green+anticancer+therapies&doi=10.7314%2FAPJCP.2015.16.14.6175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Cancer Natural Products Inducing Cross-talk between Apoptosis and Autophagy Mutual Proteins to Regulate Cancer Cell Death: Design of Future Green Anticancer Therapies</span></div><div class="casAuthors">Vijayarathna Soundararajan; Jothy Subramanion L; Chen Yeng; Kanwar Jagat R; Sasidharan Sreenivasan</div><div class="citationInfo"><span class="NLM_cas:title">Asian Pacific journal of cancer prevention : APJCP</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6175-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRhCZiIeyQYMkwlCcfExbvbfW6udTcc2eZfkW-D-F3vxrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287ns1Kkug%253D%253D&md5=99dce9c3c5dd0ecf7b088c2609507ee4</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.7314%2FAPJCP.2015.16.14.6175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7314%252FAPJCP.2015.16.14.6175%26sid%3Dliteratum%253Aachs%26aulast%3DVijayarathna%26aufirst%3DS.%26aulast%3DJothy%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKanwar%26aufirst%3DJ.%2BR.%26aulast%3DSasidharan%26aufirst%3DS.%26atitle%3DAnti-cancer%2520natural%2520products%2520inducing%2520cross-talk%2520between%2520apoptosis%2520and%2520autophagy%2520mutual%2520proteins%2520to%2520regulate%2520cancer%2520cell%2520death%253A%2520Design%2520of%2520future%2520green%2520anticancer%2520therapies%26jtitle%3DAsian%2520Pac.%2520J.%2520Cancer%2520Prev.%26date%3D2015%26volume%3D16%26spage%3D6175%26epage%3D6176%26doi%3D10.7314%2FAPJCP.2015.16.14.6175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. C.</span></span> <span> </span><span class="NLM_article-title">Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">6139</span>â <span class="NLM_lpage">6156</span>, <span class="refDoi">Â DOI: 10.1038/s41388-020-01432-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fs41388-020-01432-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32839493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1KjsrzE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2020&pages=6139-6156&author=Q.+Weiauthor=Y.+Qianauthor=J.+Yuauthor=C.+C.+Wong&title=Metabolic+rewiring+in+the+promotion+of+cancer+metastasis%3A+mechanisms+and+therapeutic+implications&doi=10.1038%2Fs41388-020-01432-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications</span></div><div class="casAuthors">Wei, Qinyao; Qian, Yun; Yu, Jun; Wong, Chi Chun</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">6139-6156</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Abstr.: Tumor metastasis is the major cause of mortality from cancer.  Metabolic rewiring and the metastatic cascade are highly intertwined, co-operating to promote multiple steps of cancer metastasis.  Metabolites generated by cancer cells influence the metastatic cascade, encompassing epithelial-mesenchymal transition (EMT), survival of cancer cells in circulation, and metastatic colonization at distant sites.  A variety of mol. mechanisms underlie the prometastatic effect of tumor-derived metabolites, such as epigenetic deregulation, induction of matrix metalloproteinases (MMPs), promotion of cancer stemness, and alleviation of oxidative stress.  Conversely, metastatic signaling regulates expression and activity of rate-limiting metabolic enzymes to generate prometastatic metabolites thereby reinforcing the metastasis cascade.  Understanding the complex interplay between metab. and metastasis could unravel novel mol. targets, whose intervention could lead to improvements in the treatment of cancer.  In this review, we summarized the recent discoveries involving metab. and tumor metastasis, and emphasized the promising mol. targets, with an update on the development of small mol. or biol. inhibitors against these aberrant situations in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_PxF6z7qzr7Vg90H21EOLACvtfcHk0lhThyxHc7gWQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1KjsrzE&md5=b98a641dac58116929105caf0811b628</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fs41388-020-01432-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41388-020-01432-7%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DQ.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DC.%2BC.%26atitle%3DMetabolic%2520rewiring%2520in%2520the%2520promotion%2520of%2520cancer%2520metastasis%253A%2520mechanisms%2520and%2520therapeutic%2520implications%26jtitle%3DOncogene%26date%3D2020%26volume%3D39%26spage%3D6139%26epage%3D6156%26doi%3D10.1038%2Fs41388-020-01432-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">RECKing MMP: relevance of reversion-inducing cysteine-rich protein with Kazal motifs as a prognostic marker and therapeutic target for cancer (a review)</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">718</span>â <span class="NLM_lpage">725</span>, <span class="refDoi">Â DOI: 10.2174/187152012802650237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.2174%2F187152012802650237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=22292753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsF2nsrnO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=718-725&author=S.+Nagini&title=RECKing+MMP%3A+relevance+of+reversion-inducing+cysteine-rich+protein+with+Kazal+motifs+as+a+prognostic+marker+and+therapeutic+target+for+cancer+%28a+review%29&doi=10.2174%2F187152012802650237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">RECKing MMP: relevance of reversion-inducing cysteine-rich protein with Kazal motifs as a prognostic marker and therapeutic target for cancer (a review)</span></div><div class="casAuthors">Nagini, Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">718-725</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is a membrane-anchored glycoprotein that neg. regulates the activities of matrix metalloproteinases (MMPs) and inhibits tumor invasion, metastasis, and angiogenesis.  RECK is essential for normal development and is a key mediator of tissue remodeling and stabilization of tissue architechture.  Downregulation of RECK documented in a wide range of malignant neoplasms correlates with poor prognosis, and tumor metastasis.  The RECK gene is a common neg. target for oncogenic signals that act on the Sp1-binding site of the RECK promoter.  Both natural and synthetic agents have been identified as upregulators of RECK.  Several strategies have been proposed to enhance RECK expression including forced expression of RECK, use of mimetics, recombinant peptides, microRNA antagonists, and gene therapy.  Upregulation of RECK could be a valuable therapeutic option to improve prognosis and block tumor progression.  This review addresses the potential value of RECK as a prognostic marker and as a mol. target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmxG-fnlsN67Vg90H21EOLACvtfcHk0lhThyxHc7gWQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsF2nsrnO&md5=24516f2e5d210d055f3d57ea9350782e</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.2174%2F187152012802650237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152012802650237%26sid%3Dliteratum%253Aachs%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DRECKing%2520MMP%253A%2520relevance%2520of%2520reversion-inducing%2520cysteine-rich%2520protein%2520with%2520Kazal%2520motifs%2520as%2520a%2520prognostic%2520marker%2520and%2520therapeutic%2520target%2520for%2520cancer%2520%2528a%2520review%2529%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D718%26epage%3D725%26doi%3D10.2174%2F187152012802650237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teleanu, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chircov, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grumezescu, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teleanu, D. M.</span></span> <span> </span><span class="NLM_article-title">Tumor angiogenesis and anti-angiogenic strategies for cancer treatment</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">84</span>, <span class="refDoi">Â DOI: 10.3390/jcm9010084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3390%2Fjcm9010084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsVCks7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=84&author=R.+I.+Teleanuauthor=C.+Chircovauthor=A.+M.+Grumezescuauthor=D.+M.+Teleanu&title=Tumor+angiogenesis+and+anti-angiogenic+strategies+for+cancer+treatment&doi=10.3390%2Fjcm9010084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor angiogenesis and anti-angiogenic strategies for cancer treatment</span></div><div class="casAuthors">Teleanu, Raluca Ioana; Chircov, Cristina; Grumezescu, Alexandru Mihai; Teleanu, Daniel Mihai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Angiogenesis is the process through which novel blood vessels are formed from pre-existing ones and it is involved in both physiol. and pathol. processes of the body.  Furthermore, tumor angiogenesis is a crucial factor assocd. with tumor growth, progression, and metastasis.  In this manner, there has been a great interest in the development of anti-angiogenesis strategies that could inhibit tumor vascularization.  Conventional approaches comprise the administration of anti-angiogenic drugs that target and block the activity of proangiogenic factors.  However, as their efficacy is still a matter of debate, novel strategies have been focusing on combining anti-angiogenic agents with chemotherapy or immunotherapy.  Moreover, nanotechnol. has also been investigated for the potential of nanomaterials to target and release anti-angiogenic drugs at specific sites.  The aim of this paper is to review the mechanisms involved in angiogenesis and tumor vascularization and provide an overview of the recent trends in anti-angiogenic strategies for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvl88ZQmHgabVg90H21EOLACvtfcHk0liHCydDs2ID2Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsVCks7w%253D&md5=d68a26796decf8f1cfb66cfabf8eee51</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.3390%2Fjcm9010084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm9010084%26sid%3Dliteratum%253Aachs%26aulast%3DTeleanu%26aufirst%3DR.%2BI.%26aulast%3DChircov%26aufirst%3DC.%26aulast%3DGrumezescu%26aufirst%3DA.%2BM.%26aulast%3DTeleanu%26aufirst%3DD.%2BM.%26atitle%3DTumor%2520angiogenesis%2520and%2520anti-angiogenic%2520strategies%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2020%26volume%3D9%26spage%3D84%26doi%3D10.3390%2Fjcm9010084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kowshik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sophia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rautray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anbarasu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahalingam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide upregulates RECK by targeting miR-21 and HIF-1Î± in cell lines and in a hamster oral carcinogenesis model</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2045</span>, <span class="refDoi">Â DOI: 10.1038/s41598-017-01960-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1038%2Fs41598-017-01960-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=28515436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC1crotl2ltA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=2045&author=J.+Kowshikauthor=R.+Mishraauthor=J.+Sophiaauthor=S.+Rautrayauthor=K.+Anbarasuauthor=G.+D.+Reddyauthor=M.+Dixitauthor=S.+Mahalingamauthor=S.+Nagini&title=Nimbolide+upregulates+RECK+by+targeting+miR-21+and+HIF-1%CE%B1+in+cell+lines+and+in+a+hamster+oral+carcinogenesis+model&doi=10.1038%2Fs41598-017-01960-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide upregulates RECK by targeting miR-21 and HIF-1Î± in cell lines and in a hamster oral carcinogenesis model</span></div><div class="casAuthors">Kowshik Jaganathan; Sophia Josephraj; Rautray Satabdi; Nagini Siddavaram; Mishra Rajakishore; Anbarasu Kumaraswamy; Dixit Madhulika; Mahalingam Sundarasamy; Reddy G Deepak</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2045</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Reversion-inducing cysteine-rich protein with Kazal motifs (RECK), a potent inhibitor of matrix metalloproteinases (MMPs) is a common negative target of oncogenic signals and a potential therapeutic target for novel drug development.  Here, we show that sequential RECKlessness stimulates angiogenesis and Notch signalling in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis model, a paradigm for oral oncogenesis and chemointervention.  We also report the chemotherapeutic effect of nimbolide, a limonoid from the neem tree (Azadirachta indica) based on the upregulation of RECK as well as modulation of the expression of key molecules involved in invasion and angiogenesis.  We demonstrate that nimbolide upregulates RECK by targeting miR-21, and HIF-1Î± resulting in reduced MMP activity and blockade of VEGF and Notch signalling.  Nimbolide reduced microvascular density, confirming its anti-angiogenic potential.  Molecular docking analysis revealed interaction of nimbolide with HIF-1Î±.  Additionally, we demonstrate that nimbolide upregulates RECK expression via downregulation of HIF-1Î± and miR-21 by overexpression and knockdown experiments in SCC4 and EAhy926 cell lines.  Taken together, these findings provide compelling evidence that targeting RECK, a keystone protein that regulates mediators of invasion and angiogenesis with phytochemicals such as nimbolide may be a robust therapeutic approach to prevent oral cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxLKh8DGKPB3tlzo9xastyfW6udTcc2ea8de3uO4Ff4Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crotl2ltA%253D%253D&md5=322ad3581707fc54d6c74a2ea6e8ed16</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-01960-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-01960-5%26sid%3Dliteratum%253Aachs%26aulast%3DKowshik%26aufirst%3DJ.%26aulast%3DMishra%26aufirst%3DR.%26aulast%3DSophia%26aufirst%3DJ.%26aulast%3DRautray%26aufirst%3DS.%26aulast%3DAnbarasu%26aufirst%3DK.%26aulast%3DReddy%26aufirst%3DG.%2BD.%26aulast%3DDixit%26aufirst%3DM.%26aulast%3DMahalingam%26aufirst%3DS.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DNimbolide%2520upregulates%2520RECK%2520by%2520targeting%2520miR-21%2520and%2520HIF-1%25CE%25B1%2520in%2520cell%2520lines%2520and%2520in%2520a%2520hamster%2520oral%2520carcinogenesis%2520model%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D2045%26doi%3D10.1038%2Fs41598-017-01960-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baby, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajguru, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakkannavar, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujari, V. B.</span></span> <span> </span><span class="NLM_article-title">Inflammation and cancer</span>. <i>Ann. Afr. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">121</span>â <span class="NLM_lpage">126</span>, <span class="refDoi">Â DOI: 10.4103/aam.aam_56_18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.4103%2Faam.aam_56_18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31417011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3MvosVWmtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=121-126&author=N.+Singhauthor=D.+Babyauthor=J.+P.+Rajguruauthor=P.+B.+Patilauthor=S.+S.+Thakkannavarauthor=V.+B.+Pujari&title=Inflammation+and+cancer&doi=10.4103%2Faam.aam_56_18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and cancer</span></div><div class="casAuthors">Singh Nitin; Baby Deepak; Rajguru Jagadish Prasad; Patil Pankaj B; Thakkannavar Savita S; Pujari Veena Bhojaraj</div><div class="citationInfo"><span class="NLM_cas:title">Annals of African medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">121-126</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammation is often associated with the development and progression of cancer.  The cells responsible for cancer-associated inflammation are genetically stable and thus are not subjected to rapid emergence of drug resistance; therefore, the targeting of inflammation represents an attractive strategy both for cancer prevention and for cancer therapy.  Tumor-extrinsic inflammation is caused by many factors, including bacterial and viral infections, autoimmune diseases, obesity, tobacco smoking, asbestos exposure, and excessive alcohol consumption, all of which increase cancer risk and stimulate malignant progression.  In contrast, cancer-intrinsic or cancer-elicited inflammation can be triggered by cancer-initiating mutations and can contribute to malignant progression through the recruitment and activation of inflammatory cells.  Both extrinsic and intrinsic inflammations can result in immunosuppression, thereby providing a preferred background for tumor development.  The current review provides a link between inflammation and cancer development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpl6QIfQj1zGgRQsDqrjW_fW6udTcc2ea8de3uO4Ff4Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvosVWmtQ%253D%253D&md5=ca8897670da47b68187a3c98daed8d60</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.4103%2Faam.aam_56_18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252Faam.aam_56_18%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DBaby%26aufirst%3DD.%26aulast%3DRajguru%26aufirst%3DJ.%2BP.%26aulast%3DPatil%26aufirst%3DP.%2BB.%26aulast%3DThakkannavar%26aufirst%3DS.%2BS.%26aulast%3DPujari%26aufirst%3DV.%2BB.%26atitle%3DInflammation%2520and%2520cancer%26jtitle%3DAnn.%2520Afr.%2520Med.%26date%3D2019%26volume%3D18%26spage%3D121%26epage%3D126%26doi%3D10.4103%2Faam.aam_56_18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. X.</span></span> <span> </span><span class="NLM_article-title">Natural products and their derivatives: Promising modulators of tumor immunotherapy</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">493</span>â <span class="NLM_lpage">508</span>, <span class="refDoi">Â DOI: 10.1002/JLB.3MR0320-444R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2FJLB.3MR0320-444R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32678943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtl2qt7vF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2020&pages=493-508&author=L.+J.+Dengauthor=M.+Qiauthor=N.+Liauthor=Y.+H.+Leiauthor=D.+M.+Zhangauthor=J.+X.+Chen&title=Natural+products+and+their+derivatives%3A+Promising+modulators+of+tumor+immunotherapy&doi=10.1002%2FJLB.3MR0320-444R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Natural products and their derivatives: Promising modulators of tumor immunotherapy</span></div><div class="casAuthors">Deng, Li-Juan; Qi, Ming; Li, Nan; Lei, Yu-He; Zhang, Dong-Mei; Chen, Jia-Xu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">493-508</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">1938-3673</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  A wealth of evidence supports the role of tumor immunotherapy as a vital therapeutic option in cancer.  In recent decades, accumulated studies have revealed the anticancer activities of natural products and their derivs.  Increasing interest has been driven toward finding novel potential modulators of tumor immunotherapy from natural products, a hot research topic worldwide.  These works of research mainly focused on natural products, including polyphenols (e.g., curcumin, resveratrol), cardiotonic steroids (e.g., bufalin and digoxin), terpenoids (e.g., paclitaxel and artemisinins), and polysaccharide exts. (e.g., lentinan).  Compelling data highlight that natural products have a promising future in tumor immunotherapy.  Considering the importance and significance of this topic, we initially discussed the integrated research progress of natural products and their derivs., including target T cells, macrophages, B cells, NKs, regulatory T cells, myeloid-derived suppressor cells, inflammatory cytokines and chemokines, immunogenic cell death, and immune checkpoints.  Furthermore, these natural compds. inactivate several key pathways, including NF-ÎºB, PI3K/Akt, MAPK, and JAK/STAT pathways.  Here, we performed a deep generalization, anal., and summarization of the previous achievements, recent progress, and the bottlenecks in the development of natural products as tumor immunotherapy.  We expect this review to provide some insight for guiding future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4TwBZ7eFkj7Vg90H21EOLACvtfcHk0liJEjKsnR5bfw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtl2qt7vF&md5=acce72428fb0da0e20de2eae6f8d3891</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2FJLB.3MR0320-444R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252FJLB.3MR0320-444R%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DL.%2BJ.%26aulast%3DQi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLei%26aufirst%3DY.%2BH.%26aulast%3DZhang%26aufirst%3DD.%2BM.%26aulast%3DChen%26aufirst%3DJ.%2BX.%26atitle%3DNatural%2520products%2520and%2520their%2520derivatives%253A%2520Promising%2520modulators%2520of%2520tumor%2520immunotherapy%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2020%26volume%3D108%26spage%3D493%26epage%3D508%26doi%3D10.1002%2FJLB.3MR0320-444R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rad, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tee, A. R.</span></span> <span> </span><span class="NLM_article-title">Oncogenic signalling through mechanistic target of rapamycin (mTOR): A driver of metabolic transformation and cancer progression</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">5</span>, <span class="refDoi">Â DOI: 10.3390/cancers10010005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3390%2Fcancers10010005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisV2ru7nF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=5&author=E.+Radauthor=J.+T.+Murrayauthor=A.+R.+Tee&title=Oncogenic+signalling+through+mechanistic+target+of+rapamycin+%28mTOR%29%3A+A+driver+of+metabolic+transformation+and+cancer+progression&doi=10.3390%2Fcancers10010005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic signalling through mechanistic target of rapamycin (mTOR): a driver of metabolic transformation and cancer progression</span></div><div class="casAuthors">Rad, Ellie; Murray, James T.; Tee, Andrew R.</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5/1-5/17</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Throughout the years, research into signalling pathways involved in cancer progression has led to many discoveries of which mechanistic target of rapamycin (mTOR) is a key player. mTOR is a master regulator of cell growth control. mTOR is historically known to promote cell growth by enhancing the efficiency of protein translation.  Research in the last decade has revealed that mTOR's role in promoting cell growth is much more multifaceted.  While mTOR is necessary for normal human physiol., cancer cells take advantage of mTOR signalling to drive their neoplastic growth and progression.  Oncogenic signal transduction through mTOR is a common occurrence in cancer, leading to metabolic transformation, enhanced proliferative drive and increased metastatic potential through neovascularisation.  This review focuses on the downstream mTOR-regulated processes that are implicated in the "hallmarks" of cancer with focus on mTOR's involvement in proliferative signalling, metabolic reprogramming, angiogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE9-Hny_J3ALVg90H21EOLACvtfcHk0liJEjKsnR5bfw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisV2ru7nF&md5=b027b848a78dfdd624e10d75d20e10b8</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.3390%2Fcancers10010005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers10010005%26sid%3Dliteratum%253Aachs%26aulast%3DRad%26aufirst%3DE.%26aulast%3DMurray%26aufirst%3DJ.%2BT.%26aulast%3DTee%26aufirst%3DA.%2BR.%26atitle%3DOncogenic%2520signalling%2520through%2520mechanistic%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%253A%2520A%2520driver%2520of%2520metabolic%2520transformation%2520and%2520cancer%2520progression%26jtitle%3DCancers%26date%3D2018%26volume%3D10%26spage%3D5%26doi%3D10.3390%2Fcancers10010005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Vega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armenia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatila, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitriadoy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantheti, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghafinia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foltz, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shmulevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heins, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochoa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandoth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahceci, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dervishi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogrusoz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Way, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bivona, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazar, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammer, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McArthur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tward, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group">Cancer Genome Atlas Research Network</span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Allen, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherniack, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sander, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, N.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Oncogenic signaling pathways in the cancer genome atlas</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">321</span>â <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.cell.2018.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29625050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntFahsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2018&pages=321-337&author=F.+Sanchez-Vegaauthor=M.+Minaauthor=J.+Armeniaauthor=W.+K.+Chatilaauthor=A.+Lunaauthor=K.+C.+Laauthor=S.+Dimitriadoyauthor=D.+L.+Liuauthor=H.+S.+Kanthetiauthor=S.+Saghafiniaauthor=D.+Chakravartyauthor=F.+Daianauthor=Q.+Gaoauthor=M.+H.+Baileyauthor=W.+W.+Liangauthor=S.+M.+Foltzauthor=I.+Shmulevichauthor=L.+Dingauthor=Z.+Heinsauthor=A.+Ochoaauthor=B.+Grossauthor=J.+Gaoauthor=H.+Zhangauthor=R.+Kundraauthor=C.+Kandothauthor=I.+Bahceciauthor=L.+Dervishiauthor=U.+Dogrusozauthor=W.+Zhouauthor=H.+Shenauthor=P.+W.+Lairdauthor=G.+P.+Wayauthor=C.+S.+Greeneauthor=H.+Liangauthor=Y.+Xiaoauthor=C.+Wangauthor=A.+Iavaroneauthor=A.+H.+Bergerauthor=T.+G.+Bivonaauthor=A.+J.+Lazarauthor=G.+D.+Hammerauthor=T.+Giordanoauthor=L.+N.+Kwongauthor=G.+McArthurauthor=C.+Huangauthor=A.+D.+Twardauthor=M.+J.+Frederickauthor=F.+McCormickauthor=M.+Meyersonauthor=Cancer+Genome+Atlas+Research+Networkauthor=E.+M.+Van+Allenauthor=A.+D.+Cherniackauthor=G.+Cirielloauthor=C.+Sanderauthor=N.+Schultz&title=Oncogenic+signaling+pathways+in+the+cancer+genome+atlas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic signaling pathways in the cancer genome atlas</span></div><div class="casAuthors">Sanchez-Vega, Francisco; Mina, Marco; Armenia, Joshua; Chatila, Walid K.; Luna, Augustin; La, Konnor C.; Dimitriadoy, Sofia; Liu, David L.; Kantheti, Havish S.; Saghafinia, Sadegh; Chakravarty, Debyani; Daian, Foysal; Gao, Qingsong; Bailey, Matthew H.; Liang, Wen-Wei; Foltz, Steven M.; Shmulevich, Ilya; Ding, Li; Heins, Zachary; Ochoa, Angelica; Gross, Benjamin; Gao, Jianjiong; Zhang, Hongxin; Kundra, Ritika; Kandoth, Cyriac; Bahceci, Istemi; Dervishi, Leonard; Dogrusoz, Ugur; Zhou, Wanding; Shen, Hui; Laird, Peter W.; Way, Gregory P.; Greene, Casey S.; Liang, Han; Xiao, Yonghong; Wang, Chen; Iavarone, Antonio; Berger, Alice H.; Bivona, Trever G.; Lazar, Alexander J.; Hammer, Gary D.; Giordano, Thomas; Kwong, Lawrence N.; McArthur, Grant; Huang, Chenfei; Tward, Aaron D.; Frederick, Mitchell J.; McCormick, Frank; Meyerson, Matthew; Van Allen, Eliezer M.; Cherniack, Andrew D.; Ciriello, Giovanni; Sander, Chris; Schultz, Nikolaus</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-337.e10</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Genetic alterations in signaling pathways that control cell-cycle progression, apoptosis, and cell growth are common hallmarks of cancer, but the extent, mechanisms, and co-occurrence of alterations in these pathways differ between individual tumors and tumor types.  Using mutations, copy-no. changes, mRNA expression, gene fusions and DNA methylation in 9125 tumors profiled by The Cancer Genome Atlas (TCGA), we analyzed the mechanisms and patterns of somatic alterations in ten canonical pathways: cell cycle, Hippo, Myc, Notch, Nrf2, PI-3-Kinase/Akt, RTK-RAS, TGFÎ² signaling, p53 and Î²-catenin/Wnt.  We charted the detailed landscape of pathway alterations in 33 cancer types, stratified into 64 subtypes, and identified patterns of co-occurrence and mutual exclusivity.  Eighty-nine percent of tumors had at least one driver alteration in these pathways, and 57% percent of tumors had at least one alteration potentially targetable by currently available drugs.  Thirty percent of tumors had multiple targetable alterations, indicating opportunities for combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv_ggbxuypEbVg90H21EOLACvtfcHk0liJEjKsnR5bfw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntFahsrs%253D&md5=3677d3a77b12767c828f48eb80d71141</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez-Vega%26aufirst%3DF.%26aulast%3DMina%26aufirst%3DM.%26aulast%3DArmenia%26aufirst%3DJ.%26aulast%3DChatila%26aufirst%3DW.%2BK.%26aulast%3DLuna%26aufirst%3DA.%26aulast%3DLa%26aufirst%3DK.%2BC.%26aulast%3DDimitriadoy%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DD.%2BL.%26aulast%3DKantheti%26aufirst%3DH.%2BS.%26aulast%3DSaghafinia%26aufirst%3DS.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DDaian%26aufirst%3DF.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DBailey%26aufirst%3DM.%2BH.%26aulast%3DLiang%26aufirst%3DW.%2BW.%26aulast%3DFoltz%26aufirst%3DS.%2BM.%26aulast%3DShmulevich%26aufirst%3DI.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DHeins%26aufirst%3DZ.%26aulast%3DOchoa%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DKundra%26aufirst%3DR.%26aulast%3DKandoth%26aufirst%3DC.%26aulast%3DBahceci%26aufirst%3DI.%26aulast%3DDervishi%26aufirst%3DL.%26aulast%3DDogrusoz%26aufirst%3DU.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DLaird%26aufirst%3DP.%2BW.%26aulast%3DWay%26aufirst%3DG.%2BP.%26aulast%3DGreene%26aufirst%3DC.%2BS.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DIavarone%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DA.%2BH.%26aulast%3DBivona%26aufirst%3DT.%2BG.%26aulast%3DLazar%26aufirst%3DA.%2BJ.%26aulast%3DHammer%26aufirst%3DG.%2BD.%26aulast%3DGiordano%26aufirst%3DT.%26aulast%3DKwong%26aufirst%3DL.%2BN.%26aulast%3DMcArthur%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DTward%26aufirst%3DA.%2BD.%26aulast%3DFrederick%26aufirst%3DM.%2BJ.%26aulast%3DMcCormick%26aufirst%3DF.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3D%26aulast%3DVan%2BAllen%26aufirst%3DE.%2BM.%26aulast%3DCherniack%26aufirst%3DA.%2BD.%26aulast%3DCiriello%26aufirst%3DG.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DSchultz%26aufirst%3DN.%26atitle%3DOncogenic%2520signaling%2520pathways%2520in%2520the%2520cancer%2520genome%2520atlas%26jtitle%3DCell%26date%3D2018%26volume%3D173%26spage%3D321%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sophia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, R.</span></span> <span> </span><span class="NLM_article-title">Glycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">25</span>â <span class="NLM_lpage">36</span>, <span class="refDoi">Â DOI: 10.1016/j.semcancer.2017.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.semcancer.2017.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29309927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVWrtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2019&pages=25-36&author=S.+Naginiauthor=J.+Sophiaauthor=R.+Mishra&title=Glycogen+synthase+kinases%3A+Moonlighting+proteins+with+theranostic+potential+in+cancer&doi=10.1016%2Fj.semcancer.2017.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer</span></div><div class="casAuthors">Nagini, Siddavaram; Sophia, Josephraj; Mishra, Rajakishore</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-36</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3 (GSK-3), a serine/threonine kinase is an archetypal multifunctional moonlighting protein involved in diverse cellular processes including metab., insulin signaling, proliferation, differentiation, apoptosis, neuronal function and embryonic development.  The two known isoforms, GSK-3Î± and GSK-3Î² that undergo activation/inactivation by post-translational, site-specific phosphorylation incorporate a vast no. of substrates in their repertoire.  Dysregulation of GSK-3 has been linked to diverse disease entities including cancer.  The role of GSK-3 in cancer is paradoxical and enigmatic.  The enzyme functions as a tumor promoter or suppressor based on the context, cell type and phosphorylation status.  GSK-3 is the central hub that orchestrates signals from the Wnt/Î²-catenin, PI3K/PTEN/Akt/mTOR, Ras/Raf/MEK/ERK, hedgehog, Notch and TP53 pathways to elicit regulatory influences on cancer initiation, epithelial-mesenchymal transition, and resistance to therapy.  As a direct target of several microRNAs, GSK-3 influences hallmark attributes of cancer, cancer stemness and treatment resistance.  There is overwhelming evidence to indicate that GSK-3 is aberrantly regulated in different cancer types.  Consequently, GSK-3 has emerged as a potential therapeutic target in cancer.  A plethora of natural and synthetic GSK-3 modulators have been discovered and the no. of patents published for GSK-3 inhibitors has also been steadily increasing in recent years.  This review focuses on the intricate interactions between GSK-3 and oncogenic signalling circuits as well as the feasibility of targeting GSK-3 for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVoZ1tqIrqErVg90H21EOLACvtfcHk0liWPXcR5vRxzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVWrtw%253D%253D&md5=b012c15396c852fd3777a651a1580f1f</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2017.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2017.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DNagini%26aufirst%3DS.%26aulast%3DSophia%26aufirst%3DJ.%26aulast%3DMishra%26aufirst%3DR.%26atitle%3DGlycogen%2520synthase%2520kinases%253A%2520Moonlighting%2520proteins%2520with%2520theranostic%2520potential%2520in%2520cancer%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2019%26volume%3D56%26spage%3D25%26epage%3D36%26doi%3D10.1016%2Fj.semcancer.2017.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alex, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bast, F.</span></span> <span> </span><span class="NLM_article-title">Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer</span>. <i>Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">805</span>, <span class="refDoi">Â DOI: 10.1007/s12032-013-0805-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs12032-013-0805-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=24338270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC2c3otVOmsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=805&author=P.+Singhauthor=J.+M.+Alexauthor=F.+Bast&title=Insulin+receptor+%28IR%29+and+insulin-like+growth+factor+receptor+1+%28IGF-1R%29+signaling+systems%3A+novel+treatment+strategies+for+cancer&doi=10.1007%2Fs12032-013-0805-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer</span></div><div class="casAuthors">Singh Pushpendra; Alex Jimi Marin; Bast Felix</div><div class="citationInfo"><span class="NLM_cas:title">Medical oncology (Northwood, London, England)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">805</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Insulin and insulin-like growth factor (IGF) signaling system, commonly known for fine-tuning numerous biological processes, has lately made its mark as a much sought-after therapeutic targets for diabetes and cancer.  These receptors make an attractive anticancer target owing to their overexpression in variety of cancer especially in prostate and breast cancer.  Inhibitors of IGF signaling were subjected to clinical cancer trials with the main objective to confirm the effectiveness of these receptors as a therapeutic target.  However, the results that these trials produced proved to be disappointing as the role played by the cross talk between IGF and insulin receptor (IR) signaling pathways at the receptor level or at downstream signaling level became more lucid.  Therapeutic strategy for IGF-1R and IR inhibition mainly encompasses three main approaches namely receptor blockade with monoclonal antibodies, tyrosine kinase inhibition (ATP antagonist and non-ATP antagonist), and ligand neutralization via monoclonal antibodies targeted to ligand or recombinant IGF-binding proteins.  Other drug-discovery approaches are employed to target IGF-1R, and IR includes antisense oligonucleotides and recombinant IGF-binding proteins.  However, therapies with monoclonal antibodies and tyrosine kinase inhibition targeting the IGF-1R are not evidenced to be satisfactory as expected.  Factors that are duly held responsible for the unsuccessfulness of these therapies include (a) the existence of the IR isoform A overexpressed on a variety of cancers, enhancing the mitogenic signals to the nucleus leading to the endorsement of cell growth, (b) IGF-1R and IR that form hybrid receptors sensitive to the stimulation of all three IGF axis ligands, and (c) IGF-1R and IR that also have the potential to form hybrid receptors with other tyrosine kinase to potentiate the cellular transformation, tumorigenesis, and tumor vascularization.  This mini review is a concerted effort to explore and fathom the well-recognized roles of the IRA signaling system in human cancer phenotype and the main strategies that have been so far evaluated to target the IR and IGF-1R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTj-XGoenfx9Wx8TEN9K18QfW6udTcc2eZvLheR2H1AKbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3otVOmsA%253D%253D&md5=1c2f19cb1f7810d57a80757afe5deee3</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1007%2Fs12032-013-0805-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12032-013-0805-3%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DAlex%26aufirst%3DJ.%2BM.%26aulast%3DBast%26aufirst%3DF.%26atitle%3DInsulin%2520receptor%2520%2528IR%2529%2520and%2520insulin-like%2520growth%2520factor%2520receptor%25201%2520%2528IGF-1R%2529%2520signaling%2520systems%253A%2520novel%2520treatment%2520strategies%2520for%2520cancer%26jtitle%3DMed.%2520Oncol.%26date%3D2014%26volume%3D31%26spage%3D805%26doi%3D10.1007%2Fs12032-013-0805-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raja
Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugantha Priya, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunkumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharmila, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajalakshmi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunakaran, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cell survival and proliferation by nimbolide in human androgen-independent prostate cancer (PC-3) cells: involvement of the PI3K/Akt pathway</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>427</i></span>,  <span class="NLM_fpage">69</span>â <span class="NLM_lpage">79</span>, <span class="refDoi">Â DOI: 10.1007/s11010-016-2898-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs11010-016-2898-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=28025797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGhs73F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2017&pages=69-79&author=P.+Raja%0ASinghauthor=E.+Sugantha+Priyaauthor=S.+Balakrishnanauthor=R.+Arunkumarauthor=G.+Sharmilaauthor=M.+Rajalakshmiauthor=J.+Arunakaran&title=Inhibition+of+cell+survival+and+proliferation+by+nimbolide+in+human+androgen-independent+prostate+cancer+%28PC-3%29+cells%3A+involvement+of+the+PI3K%2FAkt+pathway&doi=10.1007%2Fs11010-016-2898-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cell survival and proliferation by nimbolide in human androgen-independent prostate cancer (PC-3) cells: involvement of the PI3K/Akt pathway</span></div><div class="casAuthors">Raja Singh, Paulraj; Sugantha Priya, Elayapillai; Balakrishnan, Solaimuthu; Arunkumar, Ramachandran; Sharmila, Govindaraj; Rajalakshmi, Manikkam; Arunakaran, Jagadeesan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">427</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">69-79</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Prostate cancer is most common malignancy among men in the world.  PI3K-Akt signaling appears to be crit. to prostate cancer cell proliferation and survival.  Our earlier study reveals that nimbolide (2 Î¼M) prevents cell survival via IGF signaling pathway through PI3K/Akt and induces apoptosis in PC-3 cell line.  Akt mediates the phosphorylation and activation of mTOR that plays a crit. role in the regulation of protein translation and synthesis, angiogenesis, and cell cycle progression.  The present study was aimed to investigate the effect of nimbolide on tPI3K, tAkt, pAkt, tmTOR, GSK3Î², pGSK3Î², PCNA, c-Myc, Cyclin D1, and Survivin protein levels by western blot anal.  Apoptosis was visualized by Ao/EtBr dual staining (20Ã), and protein expression of PCNA by immunocytochem. was performed.  Mol. docking was performed to understand the possible interaction between nimbolide and Akt, PCNA, and Cyclin D1.  Nimbolide altered the PI3K-Akt-mediated cell survival and proliferative mols.  Thus, nimbolide exerted anticancer effects in vitro by representing the PI3K-Akt-mTOR pathway in PC-3 cells.  Thereby, it acts as a potent anticancer drug for prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX7e7SWuT9jbVg90H21EOLACvtfcHk0liWPXcR5vRxzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGhs73F&md5=ae77737c1488bc308bb147de6275bf80</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1007%2Fs11010-016-2898-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-016-2898-4%26sid%3Dliteratum%253Aachs%26aulast%3DRaja%2BSingh%26aufirst%3DP.%26aulast%3DSugantha%2BPriya%26aufirst%3DE.%26aulast%3DBalakrishnan%26aufirst%3DS.%26aulast%3DArunkumar%26aufirst%3DR.%26aulast%3DSharmila%26aufirst%3DG.%26aulast%3DRajalakshmi%26aufirst%3DM.%26aulast%3DArunakaran%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520cell%2520survival%2520and%2520proliferation%2520by%2520nimbolide%2520in%2520human%2520androgen-independent%2520prostate%2520cancer%2520%2528PC-3%2529%2520cells%253A%2520involvement%2520of%2520the%2520PI3K%252FAkt%2520pathway%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2017%26volume%3D427%26spage%3D69%26epage%3D79%26doi%3D10.1007%2Fs11010-016-2898-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fusella, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SeclÃ¬, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannata, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancaccio, M.</span></span> <span> </span><span class="NLM_article-title">The one thousand and one chaperones of the NF-ÎºB pathway</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">2275</span>â <span class="NLM_lpage">2288</span>, <span class="refDoi">Â DOI: 10.1007/s00018-019-03402-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1007%2Fs00018-019-03402-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31811308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlegsrvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2020&pages=2275-2288&author=F.+Fusellaauthor=L.+Secl%C3%ACauthor=C.+Cannataauthor=M.+Brancaccio&title=The+one+thousand+and+one+chaperones+of+the+NF-%CE%BAB+pathway&doi=10.1007%2Fs00018-019-03402-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">The one thousand and one chaperones of the NF-ÎºB pathway</span></div><div class="casAuthors">Fusella, Federica; Secli, Laura; Cannata, Cristiana; Brancaccio, Mara</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2275-2288</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">The NF-ÎºB pathway represents a crucial signaling mechanism in sensing and integrating a multitude of environmental and intracellular stimuli and directing a coordinated response that from the cellular level may impact on the entire organism.  A plethora of chaperone proteins work at multiple steps of the pathway, from membrane receptor activation to transcription factor binding to DNA.  Indeed, chaperones are required to assist protein conformational changes, to assemble supramol. complexes and to regulate protein ubiquitination, required for pathway activation.  Some chaperones acquired a role as integral components of the signaling complexes, needed for signal progression.  Here we describe the chaperones involved in the NF-ÎºB pathway and their specific roles in the different contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCYrhGUiKN9bVg90H21EOLACvtfcHk0lh6DYG5mUeWlw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlegsrvP&md5=77e910fb28d765cf155e8b91dcf24be1</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs00018-019-03402-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-019-03402-z%26sid%3Dliteratum%253Aachs%26aulast%3DFusella%26aufirst%3DF.%26aulast%3DSecl%25C3%25AC%26aufirst%3DL.%26aulast%3DCannata%26aufirst%3DC.%26aulast%3DBrancaccio%26aufirst%3DM.%26atitle%3DThe%2520one%2520thousand%2520and%2520one%2520chaperones%2520of%2520the%2520NF-%25CE%25BAB%2520pathway%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2020%26volume%3D77%26spage%3D2275%26epage%3D2288%26doi%3D10.1007%2Fs00018-019-03402-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bose, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pumarol, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croley, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishayee, A.</span></span> <span> </span><span class="NLM_article-title">Targeting the JAK/STAT signaling pathway using phytocompounds for cancer prevention and therapy</span>. <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1451</span>, <span class="refDoi">Â DOI: 10.3390/cells9061451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3390%2Fcells9061451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXis1Chs77N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=1451&author=S.+Boseauthor=S.+Banerjeeauthor=A.+Mondalauthor=U.+Chakrabortyauthor=J.+Pumarolauthor=C.+R.+Croleyauthor=A.+Bishayee&title=Targeting+the+JAK%2FSTAT+signaling+pathway+using+phytocompounds+for+cancer+prevention+and+therapy&doi=10.3390%2Fcells9061451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the JAK/STAT signaling pathway using phytocompounds for cancer prevention and therapy</span></div><div class="casAuthors">Bose, Sankhadip; Banerjee, Sabyasachi; Mondal, Arijit; Chakraborty, Utsab; Pumarol, Joshua; Croley, Courtney R.; Bishayee, Anupam</div><div class="citationInfo"><span class="NLM_cas:title">Cells</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1451</span>CODEN:
                <span class="NLM_cas:coden">CELLC6</span>;
        ISSN:<span class="NLM_cas:issn">2073-4409</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Cancer is a prevalent cause of mortality around the world.  Aberrated activation of Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway promotes tumorigenesis.  Natural agents, including phytochems., exhibit potent anticancer activities via various mechanisms.  However, the therapeutic potency of phytoconstituents as inhibitors of JAK/STAT signaling against cancer has only come into focus in recent days.  The current review highlights phytochems. that can suppress the JAK/STAT pathway in order to impede cancer cell growth.  Various databases, such as PubMed, ScienceDirect, Web of Science, SpringerLink, Scopus, and Google Scholar, were searched using relevant keywords.  Once the authors were in agreement regarding the suitability of a study, a full-length form of the relevant article was obtained, and the information was gathered and cited.  All the complete articles that were incorporated after the literature collection rejection criteria were applied were perused in-depth and material was extd. based on the importance, relevance, and advancement of the apprehending of the JAK/STAT pathway and their relation to phytochems.  Based on the crit. and comprehensive anal. of literature presented in this review, phytochems. from diverse plant origins exert therapeutic and cancer preventive effects, at least in part, through regulation of the JAK/STAT pathway.  Nevertheless, more preclin. and clin. research is necessary to completely comprehend the capability of modulating JAK/STAT signaling to achieve efficient cancer control and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaw1BBM7EFLLVg90H21EOLACvtfcHk0lh6DYG5mUeWlw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXis1Chs77N&md5=842acf23595c94c42d58f791fd100f74</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.3390%2Fcells9061451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells9061451%26sid%3Dliteratum%253Aachs%26aulast%3DBose%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DMondal%26aufirst%3DA.%26aulast%3DChakraborty%26aufirst%3DU.%26aulast%3DPumarol%26aufirst%3DJ.%26aulast%3DCroley%26aufirst%3DC.%2BR.%26aulast%3DBishayee%26aufirst%3DA.%26atitle%3DTargeting%2520the%2520JAK%252FSTAT%2520signaling%2520pathway%2520using%2520phytocompounds%2520for%2520cancer%2520prevention%2520and%2520therapy%26jtitle%3DCells%26date%3D2020%26volume%3D9%26spage%3D1451%26doi%3D10.3390%2Fcells9061451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">da
Costa, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galucio, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jesus, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima e Lima, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taube, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">dos Santos, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lameira, J.</span></span> <span> </span><span class="NLM_article-title">Targeting peptidyl-prolyl cis-trans isomerase NIMA-interacting 1: A Structure-based virtual screening approach to find novel inhibitors</span>. <i>Curr. Comput.-Aided Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">605</span>â <span class="NLM_lpage">617</span>, <span class="refDoi">Â DOI: 10.2174/1573409915666191025114009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.2174%2F1573409915666191025114009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31654518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlKhsL7K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2020&pages=605-617&author=K.+S.+da%0ACostaauthor=J.+M.+Galucioauthor=D.+A.+de+Jesusauthor=G.+C.+Gomesauthor=A.+H.+Lima+e+Limaauthor=P.+S.+Taubeauthor=A.+M.+dos+Santosauthor=J.+Lameira&title=Targeting+peptidyl-prolyl+cis-trans+isomerase+NIMA-interacting+1%3A+A+Structure-based+virtual+screening+approach+to+find+novel+inhibitors&doi=10.2174%2F1573409915666191025114009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Peptidyl-prolyl Cis-trans Isomerase NIMA-interacting 1: A Structure-based Virtual Screening Approach to Find Novel Inhibitors</span></div><div class="casAuthors">da Costa, Kaue Santana; Galucio, Joao M.; de Jesus, Deivid Almeida; Gomes, Guelber Cardoso; Lima e Lima, Anderson Henrique; Taube, Paulo S.; dos Santos, Alberto M.; Lameira, Jeronimo</div><div class="citationInfo"><span class="NLM_cas:title">Current Computer-Aided Drug Design</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">605-617</span>CODEN:
                <span class="NLM_cas:coden">CCDDAS</span>;
        ISSN:<span class="NLM_cas:issn">1573-4099</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) is an enzyme that isomerizes phosphorylated serine or threonine motifs adjacent to proline residues.  Pin1 has important roles in several cellular signaling pathways, consequently impacting the development of multiple types of cancers.  Methods: Based on the previously reported inhibitory activity of pentacyclic triterpenoids isolated from the gum resin of Boswellia genus against Pin1, we designed a computational expt. using mol. docking, pharmacophore filtering, and structural clustering allied to mol. dynamics (MD) simulations and binding free energy calcns. to explore the inhibitory activity of new triterpenoids against Pin1 structure.  Results: Here, we report different computational evidence that triterpenoids from neem (Azadirachta indica A. Juss), such as 6-deacetylnimbinene, 6-Oacetylnimbandiol, and nimbolide, replicate the binding mode of the Pin1 substrate peptide, interacting with high affinity with the binding site and thus destabilizing the Pin1 structure.  Conclusions: Our results are supported by exptl. data, and provide interesting structural insights into their mol. mechanism of action, indicating that their structural scaffolds could be used as a start point to develop new inhibitors against Pin1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ9LPnqq5HrLVg90H21EOLACvtfcHk0lh6DYG5mUeWlw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlKhsL7K&md5=6876bde8bc377e85dce07a78b8632c20</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.2174%2F1573409915666191025114009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1573409915666191025114009%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BCosta%26aufirst%3DK.%2BS.%26aulast%3DGalucio%26aufirst%3DJ.%2BM.%26aulast%3Dde%2BJesus%26aufirst%3DD.%2BA.%26aulast%3DGomes%26aufirst%3DG.%2BC.%26aulast%3DLima%2Be%2BLima%26aufirst%3DA.%2BH.%26aulast%3DTaube%26aufirst%3DP.%2BS.%26aulast%3Ddos%2BSantos%26aufirst%3DA.%2BM.%26aulast%3DLameira%26aufirst%3DJ.%26atitle%3DTargeting%2520peptidyl-prolyl%2520cis-trans%2520isomerase%2520NIMA-interacting%25201%253A%2520A%2520Structure-based%2520virtual%2520screening%2520approach%2520to%2520find%2520novel%2520inhibitors%26jtitle%3DCurr.%2520Comput.-Aided%2520Drug%2520Des.%26date%3D2020%26volume%3D16%26spage%3D605%26epage%3D617%26doi%3D10.2174%2F1573409915666191025114009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campitelli, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taipale, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weirauch, M. T.</span></span> <span> </span><span class="NLM_article-title">The human transcription factors</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>172</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">650</span>â <span class="NLM_lpage">665</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2018.01.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.cell.2018.01.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29425488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis1amsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2018&pages=650-665&issue=4&author=S.+A.+Lambertauthor=A.+Jolmaauthor=L.+F.+Campitelliauthor=P.+K.+Dasauthor=Y.+Yinauthor=M.+Albuauthor=X.+Chenauthor=J.+Taipaleauthor=T.+R.+Hughesauthor=M.+T.+Weirauch&title=The+human+transcription+factors&doi=10.1016%2Fj.cell.2018.01.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Transcription Factors</span></div><div class="casAuthors">Lambert, Samuel A.; Jolma, Arttu; Campitelli, Laura F.; Das, Pratyush K.; Yin, Yimeng; Albu, Mihai; Chen, Xiaoting; Taipale, Jussi; Hughes, Timothy R.; Weirauch, Matthew T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">650-665</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Transcription factors (TFs) recognize specific DNA sequences to control chromatin and transcription, forming a complex system that guides expression of the genome.  Despite keen interest in understanding how TFs control gene expression, it remains challenging to det. how the precise genomic binding sites of TFs are specified and how TF binding ultimately relates to regulation of transcription.  This review considers how TFs are identified and functionally characterized, principally through the lens of a catalog of over 1600 likely human TFs and binding motifs for two-thirds of them.  Major classes of human TFs differ markedly in their evolutionary trajectories and expression patterns, underscoring distinct functions.  TFs likewise underlie many different aspects of human physiol., disease, and variation, highlighting the importance of continued effort to understand TF-mediated gene regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGN_jQqNzpvrVg90H21EOLACvtfcHk0lgG2exUa5maeQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1amsbs%253D&md5=a53a2bf38c15419c7589893428efd738</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.01.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.01.029%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DS.%2BA.%26aulast%3DJolma%26aufirst%3DA.%26aulast%3DCampitelli%26aufirst%3DL.%2BF.%26aulast%3DDas%26aufirst%3DP.%2BK.%26aulast%3DYin%26aufirst%3DY.%26aulast%3DAlbu%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DTaipale%26aufirst%3DJ.%26aulast%3DHughes%26aufirst%3DT.%2BR.%26aulast%3DWeirauch%26aufirst%3DM.%2BT.%26atitle%3DThe%2520human%2520transcription%2520factors%26jtitle%3DCell%26date%3D2018%26volume%3D172%26issue%3D4%26spage%3D650%26epage%3D665%26doi%3D10.1016%2Fj.cell.2018.01.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darwiche, N.</span></span> <span> </span><span class="NLM_article-title">Epigenetic mechanisms and the hallmarks of cancer: An intimate affair</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1954</span>â <span class="NLM_lpage">1978</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32774995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisVeisbvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=1954-1978&author=N.+Darwiche&title=Epigenetic+mechanisms+and+the+hallmarks+of+cancer%3A+An+intimate+affair"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic mechanisms and the hallmarks of cancer: an intimate affair</span></div><div class="casAuthors">Darwiche, Nadine</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1954-1978</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Epigenetic mechanisms comprising DNA methylation, histone modifications, and noncoding RNAs affect chromatin structure and regulate gene expression.  These mechanisms control normal embryonic development and adult life and their deregulation contributes to several diseases including cancer.  The process of tumorigenesis is complex and results from the evolution of different "hallmarks of cancer".  Hanahan and Weinberg presented in 2000 and 2011 seminal contributions in the cancer field, first the six hallmarks of cancer and a decade later two addnl. hallmarks and two enabling characteristics were added.  Here, we surmise that epigenetic mechanisms regulate and contribute to every single hallmark in cancer, and thus represent the hallmark of hallmarks in tumorigenesis.  Focusing on epigenetics as a major hallmark in cancer formation has profound preventive, therapeutic, and clin. implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrITfYPjS6-ZbVg90H21EOLACvtfcHk0lgG2exUa5maeQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisVeisbvN&md5=27e405faed70ee5ccdd640bbb90c73c9</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDarwiche%26aufirst%3DN.%26atitle%3DEpigenetic%2520mechanisms%2520and%2520the%2520hallmarks%2520of%2520cancer%253A%2520An%2520intimate%2520affair%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2020%26volume%3D10%26spage%3D1954%26epage%3D1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaitak, V.</span></span> <span> </span><span class="NLM_article-title">Natural products as multidrug resistance modulators in cancer</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">268</span>â <span class="NLM_lpage">291</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2019.05.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.ejmech.2019.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31103904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvFaqt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=268-291&author=A.+Kumarauthor=V.+Jaitak&title=Natural+products+as+multidrug+resistance+modulators+in+cancer&doi=10.1016%2Fj.ejmech.2019.05.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Natural products as multidrug resistance modulators in cancer</span></div><div class="casAuthors">Kumar, Amit; Jaitak, Vikas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">268-291</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Cancer is a prominent cause of death globally.  Currently, many drugs that are in clin. practice are having a high prevalence of side effect and multidrug resistance.  Risk of tumors acquiring resistance to chemotherapy (multidrug resistance) remains a significant hurdle to the successful treatment of various types of cancer.  Membrane-embedded drug transporters, generally overexpressed in cancer, are the leading cause among multiple mechanisms of multidrug resistance (MDR).  P-glycoprotein (P-gp) also MDR1/ABCB1, multidrug resistance assocd. protein 1 (MRP1/ABCC1), MRP2 and breast cancer resistance protein (BCRP/ABCG2) are considered to be a prime factor for induction of MDR.  To date, several chem. substances have been tested in a no. of clin. trials for their MDR modulatory activity which are not having devoid of any side effects that necessitates to find newer and safer way to tackle the current problem of multidrug resistance in cancer.  The present study systematically discusses the various classes of natural products i.e flavonoids, alkaloids, terpenoids, coumarins (from plants, marine, and microorganisms) as potential MDR modulators and/or as a source of promising lead compds.  Recently a bisbenzyl isoquinoline alkaloid namely tetrandrine, isolated from Chinese herb Stephania tetrandra (Han-Fang-Chi) is in clin. trials for its MDR reversal activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlwWahGUuxErVg90H21EOLACvtfcHk0lgG2exUa5maeQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvFaqt78%253D&md5=9c78294e42891916b342ab92529f0e1a</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DJaitak%26aufirst%3DV.%26atitle%3DNatural%2520products%2520as%2520multidrug%2520resistance%2520modulators%2520in%2520cancer%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D176%26spage%3D268%26epage%3D291%26doi%3D10.1016%2Fj.ejmech.2019.05.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashyap, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, R.</span></span> <span> </span><span class="NLM_article-title">Role and regulation of proapoptotic Bax in oral squamous cell carcinoma and drug resistance</span>. <i>Head Neck</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">185</span>â <span class="NLM_lpage">197</span>, <span class="refDoi">Â DOI: 10.1002/hed.25471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1002%2Fhed.25471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=30549344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB3cnhvFymtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2019&pages=185-197&author=M.+Alamauthor=T.+Kashyapauthor=P.+Mishraauthor=A.+K.+Pandaauthor=S.+Naginiauthor=R.+Mishra&title=Role+and+regulation+of+proapoptotic+Bax+in+oral+squamous+cell+carcinoma+and+drug+resistance&doi=10.1002%2Fhed.25471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Role and regulation of proapoptotic Bax in oral squamous cell carcinoma and drug resistance</span></div><div class="casAuthors">Alam Manzar; Kashyap Tanushree; Panda Aditya K; Mishra Rajakishore; Mishra Prajna; Nagini Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">Head & neck</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">185-197</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Bax, a proapoptotic protein but its regulation during oral cancer progression and resistance remains elusive.  METHODS:  A total of 127 samples including adjacent normal, primary tumor, and resistance to chemoradiation therapy (RCRT) samples from oral squamous cell carcinoma (OSCC) patients were used.  The status of Bax was analyzed at DNA/mRNA/protein levels and the results were correlated with p53 and Akt expression in tissue samples/cisplatin-resistant oral tongue SCC (SCC9/SCC4-CisR) cell line.  RESULTS:  Frequent progressive decrease of Bax expression with infrequent promoter methylation, polymorphisms G(-248)A, and mutations was observed in OSCC progression/resistance.  Furthermore, by targeting Akt pathway, induction of Bax-dependent cell death was observed and this was further enhanced with nimbolide treatment in SCC9/SCC4-CisR cells.  CONCLUSION:  Hence, the Bax gene alteration and its deregulation through p53/Akt pathway are important for OSCC progression and drug resistance.  Akt Inhibitor VIII and nimbolide synergistically induce Bax, and it is therefore beneficial for chemosensitizing cisplatin-resistant human OSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQz9C6iDAEbA75oR8RchjrrfW6udTcc2ebjKp-Velhtvbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cnhvFymtA%253D%253D&md5=e59b03b88f88991c28a6d896a790a682</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1002%2Fhed.25471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhed.25471%26sid%3Dliteratum%253Aachs%26aulast%3DAlam%26aufirst%3DM.%26aulast%3DKashyap%26aufirst%3DT.%26aulast%3DMishra%26aufirst%3DP.%26aulast%3DPanda%26aufirst%3DA.%2BK.%26aulast%3DNagini%26aufirst%3DS.%26aulast%3DMishra%26aufirst%3DR.%26atitle%3DRole%2520and%2520regulation%2520of%2520proapoptotic%2520Bax%2520in%2520oral%2520squamous%2520cell%2520carcinoma%2520and%2520drug%2520resistance%26jtitle%3DHead%2520Neck%26date%3D2019%26volume%3D41%26spage%3D185%26epage%3D197%26doi%3D10.1002%2Fhed.25471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phi, L. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sari, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, H. Y.</span></span> <span> </span><span class="NLM_article-title">Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment</span>. <i>Stem Cells Int.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">5416923</span>, <span class="refDoi">Â DOI: 10.1155/2018/5416923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1155%2F2018%2F5416923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29681949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC1MjltlGgsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=5416923&author=L.+T.+H.+Phiauthor=I.+N.+Sariauthor=Y.+G.+Yangauthor=S.+H.+Leeauthor=N.+Junauthor=K.+S.+Kimauthor=Y.+K.+Leeauthor=H.+Y.+Kwon&title=Cancer+stem+cells+%28CSCs%29+in+drug+resistance+and+their+therapeutic+implications+in+cancer+treatment&doi=10.1155%2F2018%2F5416923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment</span></div><div class="casAuthors">Phi Lan Thi Hanh; Sari Ita Novita; Yang Ying-Gui; Lee Sang-Hyun; Jun Nayoung; Kim Kwang Seock; Lee Yun Kyung; Kwon Hyog Young</div><div class="citationInfo"><span class="NLM_cas:title">Stem cells international</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2018</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5416923</span>
        ISSN:<span class="NLM_cas:issn">1687-966X</span>.
    </div><div class="casAbstract">Cancer stem cells (CSCs), also known as tumor-initiating cells (TICs), are suggested to be responsible for drug resistance and cancer relapse due in part to their ability to self-renew themselves and differentiate into heterogeneous lineages of cancer cells.  Thus, it is important to understand the characteristics and mechanisms by which CSCs display resistance to therapeutic agents.  In this review, we highlight the key features and mechanisms that regulate CSC function in drug resistance as well as recent breakthroughs of therapeutic approaches for targeting CSCs.  This promises new insights of CSCs in drug resistance and provides better therapeutic rationales to accompany novel anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ832gT2olHIa91pGlMMoT5fW6udTcc2ebDezopFp5NAbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MjltlGgsQ%253D%253D&md5=e90fa5e53fbb5ccf47d267ce645daf2a</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1155%2F2018%2F5416923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2018%252F5416923%26sid%3Dliteratum%253Aachs%26aulast%3DPhi%26aufirst%3DL.%2BT.%2BH.%26aulast%3DSari%26aufirst%3DI.%2BN.%26aulast%3DYang%26aufirst%3DY.%2BG.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DJun%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DLee%26aufirst%3DY.%2BK.%26aulast%3DKwon%26aufirst%3DH.%2BY.%26atitle%3DCancer%2520stem%2520cells%2520%2528CSCs%2529%2520in%2520drug%2520resistance%2520and%2520their%2520therapeutic%2520implications%2520in%2520cancer%2520treatment%26jtitle%3DStem%2520Cells%2520Int.%26date%3D2018%26volume%3D2018%26spage%3D5416923%26doi%3D10.1155%2F2018%2F5416923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baira, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khurana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somagoni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talluri, M. V. N. K.</span></span> <span> </span><span class="NLM_article-title">First report on the pharmacokinetic profile of nimbolide, a novel anticancer agent in oral and intravenous administrated rats by LC/MS method</span>. <i>J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1092</i></span>,  <span class="NLM_fpage">191</span>â <span class="NLM_lpage">198</span>, <span class="refDoi">Â DOI: 10.1016/j.jchromb.2018.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.jchromb.2018.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29908468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFCqsb7E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1092&publication_year=2018&pages=191-198&author=S.+M.+Bairaauthor=A.+Khuranaauthor=J.+Somagoniauthor=R.+Srinivasauthor=C.+Goduguauthor=M.+V.+N.+K.+Talluri&title=First+report+on+the+pharmacokinetic+profile+of+nimbolide%2C+a+novel+anticancer+agent+in+oral+and+intravenous+administrated+rats+by+LC%2FMS+method&doi=10.1016%2Fj.jchromb.2018.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">First report on the pharmacokinetic profile of nimbolide, a novel anticancer agent in oral and intravenous administrated rats by LC/MS method</span></div><div class="casAuthors">Baira, Shandilya Mahamuni; Khurana, Amit; Somagoni, Jaganmohan; Srinivas, R.; Godugu, Chandraiah; Talluri, M. V. N. Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1092</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">191-198</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nimbolide is a novel, natural compd. with promising potential as a drug candidate for anticancer activity.  It is isolated from the Indian traditional medicinal plant Azadirachta indica popularly known as neem.  The present study was undertaken to explore the oral bioavailability and pharmacokinetic characteristics of nimbolide in rats using the LC/QTOF/MS method.  A simple protein pptn. method using acetonitrile was employed for extg. nimbolide from rat plasma.  The chromatog. sepn. of nimbolide and the internal std. (regorafenib) was attained on an Aquity BEH C18 column (100Ã2.1mm, 2.7Î¼m), using ACN and 0.1% of formic acid in water as mobile phase components in a gradient elution mode at a flow rate of 0.45mL/min over a short run time of 4min.  A mass detection was carried out using target ions of [M+H]+ at m/z 467.2074 for nimbolide and m/z 483.0847 for the internal std.  The LC/MS method was validated and all the parameters were found well within the specified limits.  The calibration curve was constructed in the range of 1-1000ng/mL.  The method shows good accuracy (91.66-97.12%) and precision (intra 2.21-6.92% CV and inter-day 2.56-4.62% CV).  This developed LC/MS method was effectively applied to the pharmacokinetic study of nimbolide upon oral and i.v. administration in rats.  In concordance with its physicochem. properties and high lipophilicity, we found that it shows poor oral absorption at different doses (10, 30 and 50mg/kg).  As expected, higher plasma levels were obsd. upon i.v. (10mg/kg) administration.  This method can be extended for evaluation of drug interaction and drug metab. in rats as well as in humans.  Moreover, our rapid and sensitive method may cater the need to accelerate the preclin. formulation development and lead optimization for future drug development of this potent anticancer agent.  Further, our oral bioavailability studies demonstrated that nimbolide possesses poor oral absorption, which could be the probable reason for the delay in therapeutic translation of this promising agent for clin. use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoozrI6BEnwjbVg90H21EOLACvtfcHk0liFBQIdbwHIVA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFCqsb7E&md5=a59323ce4452b99ecc9e7b5bbbd102db</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2018.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2018.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DBaira%26aufirst%3DS.%2BM.%26aulast%3DKhurana%26aufirst%3DA.%26aulast%3DSomagoni%26aufirst%3DJ.%26aulast%3DSrinivas%26aufirst%3DR.%26aulast%3DGodugu%26aufirst%3DC.%26aulast%3DTalluri%26aufirst%3DM.%2BV.%2BN.%2BK.%26atitle%3DFirst%2520report%2520on%2520the%2520pharmacokinetic%2520profile%2520of%2520nimbolide%252C%2520a%2520novel%2520anticancer%2520agent%2520in%2520oral%2520and%2520intravenous%2520administrated%2520rats%2520by%2520LC%252FMS%2520method%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2018%26volume%3D1092%26spage%3D191%26epage%3D198%26doi%3D10.1016%2Fj.jchromb.2018.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuya, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, B. C.</span></span> <span> </span><span class="NLM_article-title">A sensitive liquid chromatography-tandem mass spectrometry method for the determination of nimbolide in mouse serum: Application to a preclinical pharmacokinetics study</span>. <i>Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">123</span>, <span class="refDoi">Â DOI: 10.3390/pharmaceutics10030123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3390%2Fpharmaceutics10030123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVOjt7zL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=123&author=L.+Wangauthor=D.+K.+Phanauthor=N.+Synauthor=X.+Xiangauthor=H.+Songauthor=W.+L.+Thuyaauthor=S.+Yangauthor=A.+L.+Wongauthor=A.+P.+Kumarauthor=W.+P.+Yongauthor=G.+Sethiauthor=P.+C.+Hoauthor=B.+C.+Goh&title=A+sensitive+liquid+chromatography-tandem+mass+spectrometry+method+for+the+determination+of+nimbolide+in+mouse+serum%3A+Application+to+a+preclinical+pharmacokinetics+study&doi=10.3390%2Fpharmaceutics10030123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">A sensitive liquid chromatography-tandem mass spectrometry method for the determination of nimbolide in mouse serum: application to a preclinical pharmacokinetics study</span></div><div class="casAuthors">Wang, Lingzhi; Phan, Do-Dang Khoa; Syn, Nicholas; Xiang, Xiaoqiang; Song, Hongyan; Thuya, Win Lwin; Yang, Shili; Wong, Andrea Li-Ann; Id, Alan Prem Kumar; Yong, Wei Peng; Sethi, Gautam; Ho, Paul Chi-Lui; Goh, Boon Cher</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">123</span>CODEN:
                <span class="NLM_cas:coden">PHARK5</span>;
        ISSN:<span class="NLM_cas:issn">1999-4923</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A sensitive and robust liq. chromatog.-tandem mass spectrometric (LC-MS/MS) method was developed and validated for the detn. of nimbolide in mouse serum.  Exemestane was used as the internal std. (IS).  Here, we employed acetonitrile-based protein pptn. (PPT) for serum sample prepn., and performed chromatog. sepn. using an ODS Hypersil C18 column (100 mm Ã 2.1 mm, 5 Î¼m) with gradient elution (0.1% formic acid in water vs 100% acetonitrile).  The run time was 6 min.  Instrumental anal. was performed by electrospray ionization tandem mass spectrometry (ESI-MS/MS) in the multiple-reaction monitoring (MRM) under pos. mode.  A good linear calibration was achieved in the 5-1000 ng/mL range.  The intra- and inter-day precisions for nimbolide were â¤12.6% and â¤13.9% resp.  Intra-day accuracy ranged from 96.9-109.3%, while inter-day accuracy ranged from 94.3-110.2%.  The matrix effect of nimbolide, detected but consistent at low and high concns., do not affect linearity of std. curve.  In conclusion, we have developed and validated a sensitive anal. method for detn. of a novel natural compd. nimbolide in mouse serum, and it has been successfully applied to our preclin. study in investigating the pharmacokinetic properties of nimbolide, which could greatly facilitate the preclin. development of the promising lead compd. for anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocQj2IA-6qkrVg90H21EOLACvtfcHk0liFBQIdbwHIVA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVOjt7zL&md5=bbaa3fd070b78ea57bc6dd46ea8c84ef</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.3390%2Fpharmaceutics10030123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpharmaceutics10030123%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPhan%26aufirst%3DD.%2BK.%26aulast%3DSyn%26aufirst%3DN.%26aulast%3DXiang%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DThuya%26aufirst%3DW.%2BL.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DA.%2BL.%26aulast%3DKumar%26aufirst%3DA.%2BP.%26aulast%3DYong%26aufirst%3DW.%2BP.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DHo%26aufirst%3DP.%2BC.%26aulast%3DGoh%26aufirst%3DB.%2BC.%26atitle%3DA%2520sensitive%2520liquid%2520chromatography-tandem%2520mass%2520spectrometry%2520method%2520for%2520the%2520determination%2520of%2520nimbolide%2520in%2520mouse%2520serum%253A%2520Application%2520to%2520a%2520preclinical%2520pharmacokinetics%2520study%26jtitle%3DPharmaceutics%26date%3D2018%26volume%3D10%26spage%3D123%26doi%3D10.3390%2Fpharmaceutics10030123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Umar, H. I.</span>; <span class="NLM_string-name">Josiah, S. S.</span>; <span class="NLM_string-name">Saliu, T. P.</span>; <span class="NLM_string-name">Jimoh, T. O.</span>; <span class="NLM_string-name">Ajayi, A.</span>; <span class="NLM_string-name">Danjuma, J. B.</span></span> <span> </span><span class="NLM_article-title">In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants</span>.  <i>J. Taibah Univ Med. Sci.</i> (in press).<span class="NLM_year" style="font-weight: bold;">2021</span><span class="refDoi">Â DOI: 10.1016/j.jtumed.2020.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.jtumed.2020.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=33437230" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&author=H.+I.+Umar&author=S.+S.+Josiah&author=T.+P.+Saliu&author=T.+O.+Jimoh&author=A.+Ajayi&author=J.+B.+Danjuma&title=In-silico+analysis+of+the+inhibition+of+the+SARS-CoV-2+main+protease+by+some+active+compounds+from+selected+African+plants&doi=10.1016%2Fj.jtumed.2020.12.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.jtumed.2020.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jtumed.2020.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DUmar%26aufirst%3DH.%2BI.%26atitle%3DIn-silico%2520analysis%2520of%2520the%2520inhibition%2520of%2520the%2520SARS-CoV-2%2520main%2520protease%2520by%2520some%2520active%2520compounds%2520from%2520selected%2520African%2520plants%26jtitle%3DJ.%2520Taibah%2520Univ%2520Med.%2520Sci.%26date%3D2021%26doi%3D10.1016%2Fj.jtumed.2020.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glinsukon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somjaree, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piyachaturawat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thebtaranonth, Y.</span></span> <span> </span><span class="NLM_article-title">Acute toxicity of nimbolide and nimbic acid in mice, rats and hamsters</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">159</span>â <span class="NLM_lpage">166</span>, <span class="refDoi">Â DOI: 10.1016/0378-4274(86)90098-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2F0378-4274%2886%2990098-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=3754662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADyaL28XksFCit7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1986&pages=159-166&author=T.+Glinsukonauthor=R.+Somjareeauthor=P.+Piyachaturawatauthor=Y.+Thebtaranonth&title=Acute+toxicity+of+nimbolide+and+nimbic+acid+in+mice%2C+rats+and+hamsters&doi=10.1016%2F0378-4274%2886%2990098-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Acute toxicity of nimbolide and nimbic acid in mice, rats and hamsters</span></div><div class="casAuthors">Glinsukon, Thirayudh; Somjaree, Rosenee; Piyachaturawat, Pawinee; Thebtaranonth, Yodhathai</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-66</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    </div><div class="casAbstract">Nimbolide (I)  [25990-37-8] and nimbic acid (II)  [11030-74-3] are toxic to mice only when given i.p. and i.v. but they are less toxic to rats and hamsters than to mice.  The LD50 values of a single i.p. administration of nimbolide in adult male and female and weanling mice were 225, 280, and 240 mg/kg, resp., and its i.v. LD50 value was only 24 mg/kg in adult male mice.  No fatality was obsd. when nimbolide was given orally, i.m. and s.c. to adult male mice.  Estd. LD50 values of nimbolide in rats and hamsters were somewhat greater than 600 and 500 mg/kg, resp.  Twelve-23 h after i.p. administration of an LD, most animals had died of possible dysfunctions in kidneys (tubular necrosis), small intestine hemorrhagic necrosis), pancreas (acinar cell necrosis), and liver (mild fatty infiltration and focal necrosis).  In contrast, mice and rats given an LD of nimbolide (i.v.) died of a marked and sudden drop in arterial blood pressure and respiratory paralysis within about 1-18 min.  Nimbic acid was less toxic than nimbolide to mice, with an i.v. LD50 value of 265 mg/kg and i.p. and oral LD50 values >600 mg/kg.  The possible cause of death induced by nimbic acid may be similar to that by nimbolide given i.v. and this is sudden hypotensive shock.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf3YWv7zwoO7Vg90H21EOLACvtfcHk0lgaEAWibnQ2SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XksFCit7k%253D&md5=ebf0d38e1de96efa0218c5c8e88d920f</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2F0378-4274%2886%2990098-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4274%252886%252990098-6%26sid%3Dliteratum%253Aachs%26aulast%3DGlinsukon%26aufirst%3DT.%26aulast%3DSomjaree%26aufirst%3DR.%26aulast%3DPiyachaturawat%26aufirst%3DP.%26aulast%3DThebtaranonth%26aufirst%3DY.%26atitle%3DAcute%2520toxicity%2520of%2520nimbolide%2520and%2520nimbic%2520acid%2520in%2520mice%252C%2520rats%2520and%2520hamsters%26jtitle%3DToxicol.%2520Lett.%26date%3D1986%26volume%3D30%26spage%3D159%26epage%3D166%26doi%3D10.1016%2F0378-4274%2886%2990098-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uwaifo, A. O.</span></span> <span> </span><span class="NLM_article-title">The mutagenicities of seven coumarin derivatives and a furan derivative (nimbolide) isolated from three medicinal plants</span>. <i>J. Toxicol. Environ. Health</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">521</span>â <span class="NLM_lpage">530</span>, <span class="refDoi">Â DOI: 10.1080/15287398409530517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1080%2F15287398409530517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=6387161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADyaL2cXlvVels7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1984&pages=521-530&author=A.+O.+Uwaifo&title=The+mutagenicities+of+seven+coumarin+derivatives+and+a+furan+derivative+%28nimbolide%29+isolated+from+three+medicinal+plants&doi=10.1080%2F15287398409530517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">The mutagenicities of seven coumarin derivatives and a furan derivative (nimbolide) isolated from three medicinal plants</span></div><div class="casAuthors">Uwaifo, Anthony O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Toxicology and Environmental Health</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4-6</span>),
    <span class="NLM_cas:pages">521-30</span>CODEN:
                <span class="NLM_cas:coden">JTEHD6</span>;
        ISSN:<span class="NLM_cas:issn">0098-4108</span>.
    </div><div class="casAbstract">Seven coumarin derivs. imperatorin (I, R=CH2C:CMe2)  [482-44-0], heraclenin (I, R= dimethyloxiranylmethyl)  [2880-49-1], xanthotoxin (I, R = Me)  [298-81-7], marmesin (II, R1 = CMe2OH; R2 = R3 = H)  [13849-08-6], chalepin (II, R1 = CMe2OH, R2=H, R3 = CMe2CH:CH2)  [13164-04-0], oxypeucedanin  [26091-73-6], and esculin (III)  [531-75-9] and a furan deriv. nimbolide (IV)  [25990-37-8] were screened with Ames tester strains (TA 92, 94, 97, 98, 100, and 102).  Marmesin and imperatorin were mutagenic in all tester strains except TA 94 and 102.  The mutagenicity potencies of marmesin and imperatorin were 20 and 0.2, resp.  Mutagenicity was highest in TA98 and 100 in both compds.  Marmesin was optimally mutagenic at 1.04 Î¼g, and imperatorin at 30.0 Î¼g.  Microsomal activation was not required for mutagenicity in both compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjS5qbM6SVu7Vg90H21EOLACvtfcHk0lgaEAWibnQ2SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXlvVels7c%253D&md5=3ff86bfebc760cfd18dfb5dcfa55ebbc</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1080%2F15287398409530517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15287398409530517%26sid%3Dliteratum%253Aachs%26aulast%3DUwaifo%26aufirst%3DA.%2BO.%26atitle%3DThe%2520mutagenicities%2520of%2520seven%2520coumarin%2520derivatives%2520and%2520a%2520furan%2520derivative%2520%2528nimbolide%2529%2520isolated%2520from%2520three%2520medicinal%2520plants%26jtitle%3DJ.%2520Toxicol.%2520Environ.%2520Health%26date%3D1984%26volume%3D13%26spage%3D521%26epage%3D530%26doi%3D10.1080%2F15287398409530517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumbar, S. B.</span>; <span class="NLM_string-name">Jadaramkunti, U. C.</span>; <span class="NLM_string-name">Aladakatti, R. H.</span></span> <span> </span><span class="NLM_article-title">In-vitro effect of nimbolide, an isoprenoid of neem leaf, on antioxidant system of rat cauda epididymal spermatozoa: A dose dependent study</span>.  <i>J. Appl. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume">2</span>.<span class="refDoi">Â DOI: 10.7324/JAPS.2012.2514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.7324%2FJAPS.2012.2514" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&author=S.+B.+Kumbar&author=U.+C.+Jadaramkunti&author=R.+H.+Aladakatti&title=In-vitro+effect+of+nimbolide%2C+an+isoprenoid+of+neem+leaf%2C+on+antioxidant+system+of+rat+cauda+epididymal+spermatozoa%3A+A+dose+dependent+study&doi=10.7324%2FJAPS.2012.2514"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.7324%2FJAPS.2012.2514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7324%252FJAPS.2012.2514%26sid%3Dliteratum%253Aachs%26aulast%3DKumbar%26aufirst%3DS.%2BB.%26atitle%3DIn-vitro%2520effect%2520of%2520nimbolide%252C%2520an%2520isoprenoid%2520of%2520neem%2520leaf%252C%2520on%2520antioxidant%2520system%2520of%2520rat%2520cauda%2520epididymal%2520spermatozoa%253A%2520A%2520dose%2520dependent%2520study%26jtitle%3DJ.%2520Appl.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D2%26doi%3D10.7324%2FJAPS.2012.2514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aladakatti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukesh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadaramkunti, U. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiremath, M. B.</span></span> <span> </span><span class="NLM_article-title">Effect of graded doses of nimbolide (a major component of Azadirachta indica leaves) on biochemical and sperm functional parameters in male albino rats</span>. <i>J. Laborat. Anim. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">24</span>â <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=24-30&author=R.+Aladakattiauthor=B.+Sukeshauthor=U.+C.+Jadaramkuntiauthor=M.+B.+Hiremath&title=Effect+of+graded+doses+of+nimbolide+%28a+major+component+of+Azadirachta+indica+leaves%29+on+biochemical+and+sperm+functional+parameters+in+male+albino+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAladakatti%26aufirst%3DR.%26aulast%3DSukesh%26aufirst%3DB.%26aulast%3DJadaramkunti%26aufirst%3DU.%2BC.%26aulast%3DHiremath%26aufirst%3DM.%2BB.%26atitle%3DEffect%2520of%2520graded%2520doses%2520of%2520nimbolide%2520%2528a%2520major%2520component%2520of%2520Azadirachta%2520indica%2520leaves%2529%2520on%2520biochemical%2520and%2520sperm%2520functional%2520parameters%2520in%2520male%2520albino%2520rats%26jtitle%3DJ.%2520Laborat.%2520Anim.%2520Sci.%26date%3D2011%26volume%3D1%26spage%3D24%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suttiarporn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choommongkol, V.</span></span> <span> </span><span class="NLM_article-title">Microwave-assisted improved extraction and purification of anticancer nimbolide from Azadirachta indica (Neem) leaves</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2913</span>, <span class="refDoi">Â DOI: 10.3390/molecules25122913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.3390%2Fmolecules25122913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVOhsLvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=2913&author=P.+Suttiarpornauthor=V.+Choommongkol&title=Microwave-assisted+improved+extraction+and+purification+of+anticancer+nimbolide+from+Azadirachta+indica+%28Neem%29+leaves&doi=10.3390%2Fmolecules25122913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Microwave-assisted improved extraction and purification of anticancer nimbolide from Azadirachta indica (Neem) leaves</span></div><div class="casAuthors">Suttiarporn, Panawan; Choommongkol, Vachira</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2913</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Nimbolide, a limonoid present in leaves of the neem tree (Azadirachta indica), is an anticancer compd. against a panel of human cancer cell lines.  The rapid process of extn. and purifn. of the nimbolide from the leaves of neem tree through microwave-assisted extn. (MAE) coupled with a chromatog. technique was accomplished.  The crude with a max. content of nimbolide could be recovered from neem leaves through MAE.  By using three-factors, three-level Box-Behnken design of response surface methodol. (RSM), the optimal conditions for nimbolide extn. (R2 = 0.9019) were solid/liq. ratio 1:16 g/mL, microwave power 280 W, and extn. time 22 min.  The enriched ext. was further purified by a preparative thin-layer chromatog. (PTLC), where nimbolide was obtained as 0.0336 g (0.67% yield, purity over 98%) with Et acetate/hexane = 4:6 in 3.0 h.  Structural elucidation was performed through spectroscopic techniques, including FT-IR, 1H, and 13C-NMR.  This method was simple and had a good potential for the purifn. of bioactive compds. from a natural product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVl84kTczeYrVg90H21EOLACvtfcHk0lgaEAWibnQ2SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVOhsLvM&md5=1fa94ebd3ba490a1846ccb570f1bee94</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.3390%2Fmolecules25122913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules25122913%26sid%3Dliteratum%253Aachs%26aulast%3DSuttiarporn%26aufirst%3DP.%26aulast%3DChoommongkol%26aufirst%3DV.%26atitle%3DMicrowave-assisted%2520improved%2520extraction%2520and%2520purification%2520of%2520anticancer%2520nimbolide%2520from%2520Azadirachta%2520indica%2520%2528Neem%2529%2520leaves%26jtitle%3DMolecules%26date%3D2020%26volume%3D25%26spage%3D2913%26doi%3D10.3390%2Fmolecules25122913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satpathy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, M. D.</span></span> <span> </span><span class="NLM_article-title">Nanodelivery and anticancer effect of a limonoid, nimbolide, in breast and pancreatic cancer cells</span>. <i>Int. J. Nanomed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">8095</span>â <span class="NLM_lpage">8104</span>, <span class="refDoi">Â DOI: 10.2147/IJN.S208540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.2147%2FIJN.S208540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=31632020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslamt7%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=8095-8104&author=A.+Patraauthor=S.+Satpathyauthor=M.+D.+Hussain&title=Nanodelivery+and+anticancer+effect+of+a+limonoid%2C+nimbolide%2C+in+breast+and+pancreatic+cancer+cells&doi=10.2147%2FIJN.S208540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Nanodelivery and anticancer effect of a limonoid, nimbolide, in breast and pancreatic cancer cells</span></div><div class="casAuthors">Patra, Arjun; Satpathy, Swaha; Hussain, Muhammad Delwar</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8095-8104</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2013</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Introduction: Nimbolide (Nim), a limonoid obtained from the neem tree, Azadirachta indica, has several pharmacol. properties, including anticancer effects in different type of cancers.  No drug-delivery system has been reported for enhancing the therapeutic application of this novel hydrophobic mol.  Methods: In the present research, poly(lactic-co-glycolic acid) (PLGA) nanoparticles of Nim (Nim-nano) were formulated by nanopptn., characterized for physicochem. properties, and screened for anticancer potential in breast (MCF-7 and MDA-MB-231) and pancreatic (AsPC-1) cancer cell lines.  Results: The Nim-nano had a particle size of 183.73 Â± 2.22 nm and 221.20 Â± 11.03 nm before and after lyophilization, resp.  Cryoprotectants (mannitol and sucrose) significantly inhibited growth in particle size due to lyophilization.  The Î¶-potential of the Nim-nano was -22.40 Â± 4.40 mV.  Drug loading and encapsulation efficiency of Nim-nano were 5.25% Â± 1.12% and 55.67% Â± 12.42%, resp.  The Nim-nano exhibited sustained release of Nim for more than 6 days in PBS (pH 7.4) and showed two- to three-fold enhanced cytotoxicity in breast and pancreatic cancer cell lines compared with free Nim.  Conclusion: The Nim-nano formulation has great potential for treatment of cancers, such as pancreatic and breast cancer.  Further, the PLGA-polymer surface can be modified by conjugation with polyethylene glycol, receptor-binding ligands (eg, folic acid), and other that which may lead to targeted delivery of Nim in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1llOTZT6GyLVg90H21EOLACvtfcHk0lj-7Zvg3BTYWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslamt7%252FI&md5=c47eceb5e9a2bffd0d4cbf35e769c8c3</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.2147%2FIJN.S208540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S208540%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DA.%26aulast%3DSatpathy%26aufirst%3DS.%26aulast%3DHussain%26aufirst%3DM.%2BD.%26atitle%3DNanodelivery%2520and%2520anticancer%2520effect%2520of%2520a%2520limonoid%252C%2520nimbolide%252C%2520in%2520breast%2520and%2520pancreatic%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2019%26volume%3D14%26spage%3D8095%26epage%3D8104%26doi%3D10.2147%2FIJN.S208540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pooladanda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatikonda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunnapu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwary, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemula, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talluri, M. V. N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">iRGD conjugated nimbolide liposomes protect against endotoxin induced acute respiratory distress syndrome</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">102351</span>, <span class="refDoi">Â DOI: 10.1016/j.nano.2020.102351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.nano.2020.102351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=33418136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3MXht1Smt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2021&pages=102351&author=V.+Pooladandaauthor=S.+Thatikondaauthor=O.+Sunnapuauthor=S.+Tiwaryauthor=P.+K.+Vemulaauthor=M.+V.+N.+K.+Talluriauthor=C.+Godugu&title=iRGD+conjugated+nimbolide+liposomes+protect+against+endotoxin+induced+acute+respiratory+distress+syndrome&doi=10.1016%2Fj.nano.2020.102351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">iRGD conjugated nimbolide liposomes protect against endotoxin induced acute respiratory distress syndrome</span></div><div class="casAuthors">Pooladanda, Venkatesh; Thatikonda, Sowjanya; Sunnapu, Omprakash; Tiwary, Shristy; Vemula, Praveen Kumar; Talluri, M. V. N. Kumar; Godugu, Chandraiah</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">102351</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Acute respiratory distress syndrome (ARDS) is a deadly respiratory illness assocd. with refractory hypoxemia and pulmonary edema.  The recent pandemic outbreak of COVID-19 is assocd. with severe pneumonia and inflammatory cytokine storm in the lungs.  The anti-inflammatory phytomedicine nimbolide (NIM) may not be feasible for clin. translation due to poor pharmacokinetic properties and lack of suitable delivery systems.  To overcome these barriers, we have developed nimbolide liposomes conjugated with iRGD peptide (iRGD-NIMLip) for targeting lung inflammation.  It was obsd. that iRGD-NIMLip treatment significantly inhibited oxidative stress and cytokine storm compared to nimbolide free-drug (f-NIM), nimbolide liposomes (NIMLip), and exhibited superior activity compared to dexamethasone (DEX).  IRGD-NIMLip abrogated the LPS induced p65 NF-ÎºB, Akt, MAPK, Integrin Î²3 and Î²5, STAT3, and DNMT1 expression.  Collectively, our results demonstrate that iRGD-NIMLip could be a promising novel drug delivery system to target severe pathol. consequences obsd. in ARDS and COVID-19 assocd. cytokine storm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkGZnoZMzzVrVg90H21EOLACvtfcHk0lj-7Zvg3BTYWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXht1Smt7c%253D&md5=e0511d096e4d9542bfa824d8da23f562</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2020.102351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2020.102351%26sid%3Dliteratum%253Aachs%26aulast%3DPooladanda%26aufirst%3DV.%26aulast%3DThatikonda%26aufirst%3DS.%26aulast%3DSunnapu%26aufirst%3DO.%26aulast%3DTiwary%26aufirst%3DS.%26aulast%3DVemula%26aufirst%3DP.%2BK.%26aulast%3DTalluri%26aufirst%3DM.%2BV.%2BN.%2BK.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DiRGD%2520conjugated%2520nimbolide%2520liposomes%2520protect%2520against%2520endotoxin%2520induced%2520acute%2520respiratory%2520distress%2520syndrome%26jtitle%3DNanomedicine%26date%3D2021%26volume%3D33%26spage%3D102351%26doi%3D10.1016%2Fj.nano.2020.102351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spradlin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novaes, L. F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brittain, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGregor, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maimone, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span> <span> </span><span class="NLM_article-title">A nimbolide-based kinase degrader preferentially degrades oncogenic BCR-ABL</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1788</span>â <span class="NLM_lpage">1794</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.0c00348</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.0c00348" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1WmsrrF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=1788-1794&author=B.+Tongauthor=J.+N.+Spradlinauthor=L.+F.+T.+Novaesauthor=E.+Zhangauthor=X.+Huauthor=M.+Moellerauthor=S.+M.+Brittainauthor=L.+M.+McGregorauthor=J.+M.+McKennaauthor=J.+A.+Tallaricoauthor=M.+Schirleauthor=T.+J.+Maimoneauthor=D.+K.+Nomura&title=A+nimbolide-based+kinase+degrader+preferentially+degrades+oncogenic+BCR-ABL&doi=10.1021%2Facschembio.0c00348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">A Nimbolide-Based Kinase Degrader Preferentially Degrades Oncogenic BCR-ABL</span></div><div class="casAuthors">Tong, Bingqi; Spradlin, Jessica N.; Novaes, Luiz F. T.; Zhang, Erika; Hu, Xirui; Moeller, Malte; Brittain, Scott M.; McGregor, Lynn M.; McKenna, Jeffrey M.; Tallarico, John A.; Schirle, Markus; Maimone, Thomas J.; Nomura, Daniel K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1788-1794</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeted protein degrdn. (TPD) and proteolysis-targeting chimeras (PROTACs) have arisen as powerful therapeutic modalities for degrading specific proteins in a proteasome-dependent manner.  However, a major limitation of TPD is the lack of E3 ligase recruiters.  Recently, we discovered the natural product nimbolide as a covalent recruiter for the E3 ligase RNF114.  Here, we show the broader utility of nimbolide as an E3 ligase recruiter for TPD applications.  We demonstrate that a PROTAC linking nimbolide to the kinase and BCR-ABL fusion oncogene inhibitor dasatinib, BT1, selectively degrades BCR-ABL over c-ABL in leukemia cancer cells, compared to previously reported cereblon or VHL-recruiting BCR-ABL degraders that show opposite selectivity or, in some cases, inactivity.  Thus, we further establish nimbolide as an addnl. general E3 ligase recruiter for PROTACs, and we demonstrate the importance of expanding upon the arsenal of E3 ligase recruiters, as such mols. confer differing selectivity for the degrdn. of neo-substrate proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAnHS_P6TP_rVg90H21EOLACvtfcHk0lj-7Zvg3BTYWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1WmsrrF&md5=a0f21565aacf07be7d68f7469708937c</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Facschembio.0c00348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.0c00348%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DB.%26aulast%3DSpradlin%26aufirst%3DJ.%2BN.%26aulast%3DNovaes%26aufirst%3DL.%2BF.%2BT.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DMoeller%26aufirst%3DM.%26aulast%3DBrittain%26aufirst%3DS.%2BM.%26aulast%3DMcGregor%26aufirst%3DL.%2BM.%26aulast%3DMcKenna%26aufirst%3DJ.%2BM.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DMaimone%26aufirst%3DT.%2BJ.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26atitle%3DA%2520nimbolide-based%2520kinase%2520degrader%2520preferentially%2520degrades%2520oncogenic%2520BCR-ABL%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2020%26volume%3D15%26spage%3D1788%26epage%3D1794%26doi%3D10.1021%2Facschembio.0c00348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spradlin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boike, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brittain, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maimone, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span> <span> </span><span class="NLM_article-title">Chemoproteomics-enabled discovery of covalent RNF114-based degraders that mimic natural product function</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2021.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.chembiol.2021.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=33513350" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&author=M.+Luoauthor=J.+N.+Spradlinauthor=L.+Boikeauthor=B.+Tongauthor=S.+M.+Brittainauthor=J.+M.+McKennaauthor=J.+A.+Tallaricoauthor=M.+Schirleauthor=T.+J.+Maimoneauthor=D.+K.+Nomura&title=Chemoproteomics-enabled+discovery+of+covalent+RNF114-based+degraders+that+mimic+natural+product+function&doi=10.1016%2Fj.chembiol.2021.01.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2021.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2021.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DM.%26aulast%3DSpradlin%26aufirst%3DJ.%2BN.%26aulast%3DBoike%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DB.%26aulast%3DBrittain%26aufirst%3DS.%2BM.%26aulast%3DMcKenna%26aufirst%3DJ.%2BM.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DMaimone%26aufirst%3DT.%2BJ.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26atitle%3DChemoproteomics-enabled%2520discovery%2520of%2520covalent%2520RNF114-based%2520degraders%2520that%2520mimic%2520natural%2520product%2520function%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2021%26doi%3D10.1016%2Fj.chembiol.2021.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bundela, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisen, P. S.</span></span> <span> </span><span class="NLM_article-title">Potential compounds for oral cancer treatment: Resveratrol, nimbolide, lovastatin, bortezomib, vorinostat, berberine, pterostilbene, deguelin, andrographolide, and colchicine</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0141719</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0141719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1371%2Fjournal.pone.0141719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=26536350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvV2iu7rE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0141719&author=S.+Bundelaauthor=A.+Sharmaauthor=P.+S.+Bisen&title=Potential+compounds+for+oral+cancer+treatment%3A+Resveratrol%2C+nimbolide%2C+lovastatin%2C+bortezomib%2C+vorinostat%2C+berberine%2C+pterostilbene%2C+deguelin%2C+andrographolide%2C+and+colchicine&doi=10.1371%2Fjournal.pone.0141719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Potential compounds for oral cancer treatment: resveratrol, nimbolide, lovastatin, bortezomib, vorinostat, berberine, pterostilbene, deguelin, andrographolide, and colchicines</span></div><div class="casAuthors">Bundela, Saurabh; Sharma, Anjana; Bisen, Prakash S.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e0141719/1-e0141719/31</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Oral cancer is one of the main causes of cancer-related deaths in South-Asian countries.  There are very limited treatment options available for oral cancer.  Research endeavors focused on discovery and development of novel therapies for oral cancer, is necessary to control the ever rising oral cancer related mortalities.  We mined the large pool of compds. from the publicly available compd. databases, to identify potential therapeutic compds. for oral cancer.  Over 84 million compds. were screened for the possible anti-cancer activity by custom build SVM classifier.  The mol. targets of the predicted anti-cancer compds. were mined from reliable sources like exptl. bioassays studies assocd. with the compd., and from protein-compd. interaction databases.  Therapeutic compds. from DrugBank, and a list of natural anti-cancer compds. derived from literature mining of published studies, were used for building partial least squares regression model.  The regression model thus built, was used for the estn. of oral cancer sp. wt.s based on the mol. targets.  These wts. were used to compute scores for screening the predicted anti-cancer compds. for their potential to treat oral cancer.  The list of potential compds. was annotated with corresponding physicochem. properties, cancer specific bioactivity evidences, and literature evidences.  In all, 288 compds. with the potential to treat oral cancer were identified in the current study.  The majority of the compds. in this list are natural products, which are well-tolerated and have minimal side-effects compared to the synthetic counterparts.  Some of the potential therapeutic compds. identified in the current study are resveratrol, nimbolide, lovastatin, bortezomib, vorinostat, berberine, pterostilbene, deguelin, andrographolide, and colchicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFC60xDH826LVg90H21EOLACvtfcHk0lhheNjtR9p5Tg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvV2iu7rE&md5=f085b521e37cfd4fa5c5e04fd4b54f6d</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0141719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0141719%26sid%3Dliteratum%253Aachs%26aulast%3DBundela%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DBisen%26aufirst%3DP.%2BS.%26atitle%3DPotential%2520compounds%2520for%2520oral%2520cancer%2520treatment%253A%2520Resveratrol%252C%2520nimbolide%252C%2520lovastatin%252C%2520bortezomib%252C%2520vorinostat%252C%2520berberine%252C%2520pterostilbene%252C%2520deguelin%252C%2520andrographolide%252C%2520and%2520colchicine%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0141719%26doi%3D10.1371%2Fjournal.pone.0141719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popli, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sircar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhry, A.</span></span> <span> </span><span class="NLM_article-title">A review of the anticancer activity of Azadirachta indica (Neem) in oral cancer</span>. <i>J. Oral Biol. Craniofac. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">206</span>â <span class="NLM_lpage">209</span>, <span class="refDoi">Â DOI: 10.1016/j.jobcr.2020.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1016%2Fj.jobcr.2020.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=32489822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BB38rltV2ruw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=206-209&author=S.+Agrawalauthor=D.+B.+Popliauthor=K.+Sircarauthor=A.+Chowdhry&title=A+review+of+the+anticancer+activity+of+Azadirachta+indica+%28Neem%29+in+oral+cancer&doi=10.1016%2Fj.jobcr.2020.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the anticancer activity of Azadirachta indica (Neem) in oral cancer</span></div><div class="casAuthors">Agrawal Shikha; Bablani Popli Deepika; Sircar Keya; Chowdhry Aman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of oral biology and craniofacial research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">206-209</span>
        ISSN:<span class="NLM_cas:issn">2212-4268</span>.
    </div><div class="casAbstract">Background:  Azadirachta indica (neem), belongs to the family of Meliaceae plants, is found in the Indian subcontinent.  The neem tree is colloquially referred to as the village pharmacy due to its array of biological properties.  Every part of the neem tree like its bark, leaves, sap, fruit, seeds, and twigs find a multitude of uses.  It is customary to use them for management of skin diseases and various other infections.The anticancer properties of neem have been studied in the past and these include its ability to modulate the tumour environment, increase the cytotoxic ability of host monocytes and suppress the proliferation of tumour cells.  The present review was conducted with the objective of scrutinizing and assimilating data about the usefulness Azadirachta indica in oral cancer from all the previously done work.  Material and methods:  A planned review was conducted of all the studies that investigated the role of Azadirachta indica in oral cancer.  Literature search was carried out using PubMed, Scopus and Google scholar databases.  In addition to electronic searching, hand searching, cross referencing and various internet engines were also used to collect data.  The articles were perused and articles not pertinent to our search were omitted.  Results and conclusion:  The anticancer properties of neem were evaluated and the active constituents of neem have been demonstrated to unequivocally have preventive and therapeutic potential against oral cancer.  Although, greater exploration of the anticancer properties of neem are required in order to effectively integrate it into the routine management of oral cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqAADqqazzAxJ5E29YNGvQfW6udTcc2eY37OxYBfjUEbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38rltV2ruw%253D%253D&md5=a84da9f9f07de63ce5f4edc81cc265c4</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.jobcr.2020.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jobcr.2020.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DPopli%26aufirst%3DD.%2BB.%26aulast%3DSircar%26aufirst%3DK.%26aulast%3DChowdhry%26aufirst%3DA.%26atitle%3DA%2520review%2520of%2520the%2520anticancer%2520activity%2520of%2520Azadirachta%2520indica%2520%2528Neem%2529%2520in%2520oral%2520cancer%26jtitle%3DJ.%2520Oral%2520Biol.%2520Craniofac.%2520Res.%26date%3D2020%26volume%3D10%26spage%3D206%26epage%3D209%26doi%3D10.1016%2Fj.jobcr.2020.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovic-Nikolic, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolic, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uliassi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">A perspective on multi-target drug discovery and design for complex diseases</span>. <i>Clin. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3</span>, <span class="refDoi">Â DOI: 10.1186/s40169-017-0181-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=10.1186%2Fs40169-017-0181-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=29340951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;key=1%3ACAS%3A280%3ADC%252BC1MvhsVaiug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&pages=3&author=R.+R.+Ramsayauthor=M.+R.+Popovic-Nikolicauthor=K.+Nikolicauthor=E.+Uliassiauthor=M.+L.+Bolognesi&title=A+perspective+on+multi-target+drug+discovery+and+design+for+complex+diseases&doi=10.1186%2Fs40169-017-0181-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">A perspective on multi-target drug discovery and design for complex diseases</span></div><div class="casAuthors">Ramsay Rona R; Popovic-Nikolic Marija R; Nikolic Katarina; Uliassi Elisa; Bolognesi Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and translational medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn">2001-1326</span>.
    </div><div class="casAbstract">Diseases of infection, of neurodegeneration (such as Alzheimer's and Parkinson's diseases), and of malignancy (cancers) have complex and varied causative factors.  Modern drug discovery has the power to identify potential modulators for multiple targets from millions of compounds.  Computational approaches allow the determination of the association of each compound with its target before chemical synthesis and biological testing is done.  These approaches depend on the prior identification of clinically and biologically validated targets.  This Perspective will focus on the molecular and computational approaches that underpin drug design by medicinal chemists to promote understanding and collaboration with clinical scientists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJhSGsWpifCZcXNb62YGmbfW6udTcc2eZCHlaZmjAP5bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvhsVaiug%253D%253D&md5=5b05a73a3bbc955c77b9b2df93deb946</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1186%2Fs40169-017-0181-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40169-017-0181-2%26sid%3Dliteratum%253Aachs%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26aulast%3DPopovic-Nikolic%26aufirst%3DM.%2BR.%26aulast%3DNikolic%26aufirst%3DK.%26aulast%3DUliassi%26aufirst%3DE.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DA%2520perspective%2520on%2520multi-target%2520drug%2520discovery%2520and%2520design%2520for%2520complex%2520diseases%26jtitle%3DClin.%2520Transl.%2520Med.%26date%3D2018%26volume%3D7%26spage%3D3%26doi%3D10.1186%2Fs40169-017-0181-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c02239&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c02239" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c02239" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0b5bdcc50d1a7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
